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Abstract	
Holoprosencephaly	(HPE)	occurs	due	to	incomplete	division	of	the	developing	forebrain	along	
the	embryonic	midline,	resulting	in	a	failure	to	form	two	distinct	cerebral	hemispheres.	Affecting	
1/250	human	conceptuses,	HPE	is	a	leading	cause	of	pre-	and	post-natal	morbidity	and	mortality.	
Currently,	pathogenic	mutations	in	the	coding	region	of	fifteen	genes	have	been	implicated	in	
both	classic	and	middle	interhemispheric	variants	of	HPE.	Mutation	of	ZIC2	accounts	for	9%	of	
solved	cases,	making	it	the	second	most	common	causative	HPE	gene	after	SHH.	Nevertheless,	
multiple	 aspects	 of	 ZIC2-associated	 HPE	 remain	 unexplored,	 including	 the	 mechanisms	 that	
underlie	HPE-associated	co-morbidities,	and	how	Zic2	expression	is	regulated	in	the	gastrulating	
embryo.	The	work	presented	in	this	thesis	uses	in	silico	analysis,	cultured	human	cells	and	mouse	
models	to	investigate	these	aspects	of	ZIC2-associated	HPE.		
Numerous	Zic2-associated	HPE	probands	exhibit	cardiac	anomalies,	yet	these	defects	are	often	
viewed	as	secondary	to	the	HPE	phenotype	and	their	relationship	to	ZIC2	function	has	not	been	
investigated.	Characterisation	of	the	cardiac	defects	(that	occur	alongside	HPE	in	a	mouse	model	
harbouring	 the	 Zic2	 severe	 loss-of-function	Kumba	 allele)	 shows	 they	 arise	 due	 to	 a	 loss	 of	
asymmetric	gene	expression	at	the	early-somite	node	and	in	the	left	 lateral	plate	mesoderm.	
Furthermore,	ZIC2	acts	upstream	of,	and	is	required	for,	the	correct	formation	and	function	of	
cilia	 in	the	mid-gastrula	node.	This	 is	 the	same	region	of	the	murine	embryo	 in	which	ZIC2	 is	
required	during	normal	development	to	prevent	HPE,	suggesting	a	common	tissue	of	origin	for	
the	 observed	 brain	 and	 cardiac	 defects,	 and	 that	 ZIC2	 mutation	 is	 a	 risk	 factor	 for	 the	
development	of	left-right	defects.	
Analysis	 by	 human	 geneticists	 identified	 single	 nucleotide	 variants	 within	 the	 ZIC2	 3’UTR	 of	
otherwise	unsolved	HPE	probands,	potentially	pinpointing	a	genomic	region	essential	 for	 the	
control	of	ZIC2	expression	during	gastrulation.	Characterisation	of	the	ZIC2	3’UTR	in	a	signalling	
environment	reminiscent	of	the	gastrula	node	indicates	 it	contains	a	regulatory	element	that	
functions	as	 a	 transcriptional	 repressor,	 as	well	 as	multiple	 transcript	 stability	 elements	 that	
regulate	ZIC2	half-life.	This	element	warrants	further	in	vivo	assessment	of	the	mechanism	by	
which	it	controls	ZIC2	expression	and	evaluation	of	the	pathogenicity	of	the	known	SNVs.	
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Chapter	1: Introduction	
	
This	chapter	contains	text	from	the	review:	Barratt,	K.S.	&	Arkell,	R.M	(2017)	Chapter	14:	ZIC2	in	
Holoprosencephaly,	“Zic	family	-	Evolution,	Development	and	Disease”,	Springer	(in	publication).	
	
1.1 Holoprosencephaly	
The	evolution	of	bilaterans	~600	million	years	ago	paved	the	way	 for	 the	establishment	of	a	
vertebrate	brain	in	which	two	hemispheres,	divided	along	the	embryonic	midline,	develop	from	
a	 single	 group	 of	 cells.	 The	 embryological	 process	 that	 leads	 to	 hemisphere	 separation	 is	
estimated	to	completely	or	partially	fail	in	approximately	1/250	human	conceptuses,	resulting	
in	 the	 most	 common	 structural	 defect	 of	 the	 human	 forebrain;	 Holoprosencephaly	 (HPE)	
(Matsunaga	and	Shiota,	1977).	The	crucial	nature	of	hemisphere	separation	is	evidenced	by	the	
positive	 correlation	 between	 the	 degree	 of	 brain	 malformation	 and	 HPE-induced	 mortality	
(Solomon	et	 al.	 2010b)	 and	 the	 reduction	 in	HPE	 frequency	 to	1/10	000	by	birth	 (Orioli	 and	
Castilla,	 2010).	 The	 high	 rate	 of	 HPE	 occurrence	 suggests	 that	 the	 hemisphere	 separation	
process	 is	 incredibly	 fragile,	 comprised	 of	 multiple	 interconnected	 steps	 and	 vulnerable	 to	
interference.	 Furthermore,	 the	 phenotypic	 heterogeneity	 characteristic	 of	 this	 condition	
suggests	that	interference	can	come	from	a	variety	of	sources	(i.e.	environmental	and/or	genetic	
factors)	and	that	multiple	factors	act	co-operatively	in	at	least	some	HPE	cases.	The	degree	of	
brain	 separation	and	whether	 the	 failure	occurs	 ventrally	or	dorsally	distinguishes	 two	main	
classes	of	HPE:	classic	and	middle	interhemispheric	variant	(MIHV).	
1.1.1 Classic	HPE	
In	classic	HPE,	the	lack	of	separation	is	most	severe	ventrally,	extending	to	the	rostral,	dorsal	
and	posterior	domains	of	the	forebrain	in	a	graded	fashion.	This	leads	to	a	spectrum	of	classic	
HPE	 (Table	 1.1,	 Figure	 1.1),	 of	 which	 alobar	 HPE	 (a	 monoventricle	 with	 no	 hemispheric	
separation)	 is	 the	most	 severe	 form,	 followed	 by	 semilobar	 (partial	 hemispheric	 separation,	
resulting	in	fused	left	and	right	frontal	and	parietal	lobes	but	retaining	the	posterior	portion	of	
the	 interhemispheric	 fissure)	 and	 lobar	 HPE	 (hemispheric	 and	 lateral	 vesicle	 separation	 is	
retained,	 except	 for	 in	 the	 rostral	 and	 ventral	 frontal	 lobes)	 (reviewed	 in	 Marcorelles	 and	
Laquerriere	2010).	 It	 is	estimated	 that	10-40%,	43-45%	and	17-33%	of	HPE	cases	are	alobar,	
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Table	1.1:	Human	Holoprosencephaly	types	by	severity*.	
HPE	Subdivisions	 Anatomic	Classification	 Face	and	Brain	Phenotypes	generally	observed	
Alobar	 Small	single	forebrain		
No	interhemispheric	division	
Asbsence	of	olfactory	bulbs	and	tracts	
Absence	or	the	corpus	callosum	
Non	separation	of	deep	grey	nuclei	
Cyclopia	(single	or	double	eye)	
Proboscis,	with	or	without	a	single	nostril	
Distinct	sockets	
Extreme	ocular	hypotelorism/ocuar	hypotelorism	(ie.	close	set	eyes)	
Semilobar	 Rudimentary	cerebral	lobes	
Incomplete	interhemispheric	division	
Absence	or	hypoplasia	of	olfactory	bults	and	tracts	
Absence	of	the	corpus	callosum	
Varying	non	separation	of	deep	grey	nuclei	
Ocular	hypotelorism	
Midline	cleft	lip	
Flat	nose	
Lobar	 Fully	developed	cerebral	lobes	
Dinstinct	interhemispheric	division	
Midline	contnuous	frontal	neocortex	
Absent,	hypoplasic	or	normal	corpus	callosum	
Separation	of	deep	grey	nuclei	
Ocular	hypotelorism	
Midline	cleft	lip	(complete	or	partial)	
Single	central	maxillary	incisor	
Flat	nose	
Iris	colombolar	
Microform	 No	anomalies	seen	with	conventional	neuroimaging	 Mild	microcephaly	
Ocular	hypotelorism	
Single	maxillary	central	incisors	
MIHV	 Failure	of	separation	of	the	posterior	frontal	and	parietal	lobes	
Callosal	genu	and	splenium	normally	formed	
Absence	of	corpus	callosum	
Hypothalamus	and	lentiform	nuclei	normally	separated	
Heteotopic	grey	matter	
Usually	normal	
Hypertelorism	sometimes	observed	
*Modified	from	Dubourg	et	al.	2007;	Solomon,	Lacbawan,	et	al.	2010	and	Krauss	2007.	
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Figure	 1.1:	A	 comparison	of	 the	 four	 subclasses	 of	Holoprosencephaly.	 (a-d)	 Brain	MRIs	 of	
human	 probands	 with	 (a)	 alobar,	 (b)	 semilobar,	 (c)	 lobar	 and	 (d)	 MIHV	 holoprosencephaly	
demonstrating	 the	 degree	 of	 separation	 between	 left	 and	 right	 hemispheres.	 (e-h)	 Facial	
phenotypes	 of	 human	 probands	 with	 (e)	 alobar,	 (f)	 semilobar,	 (g)	 lobar	 and	 (h)	 MIHV	
holoprosencephaly	displaying	a	range	of	classical	symptoms	such	as	hypotelorism,	cleft	palates	
and	a	flattened	nasal	bridge.	Figure	is	modified	from	(Solomon	et	al.,	2010c).	
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semilobar	and	lobar,	respectively	(Solomon	et	al.,	2010a);	however,	the	number	of	cases	at	the	
severe	end	of	the	spectrum	is	likely	is	under-estimated	due	to	early	embryonic	lethality.	
In	addition	to	hemisphere	separation,	HPE	pathogenesis	also	comprises	craniofacial	and	midline	
defects	as	common	co-morbidities.	The	frequent	coincidence	of,	and	correlation	between,	the	
severity	of	 brain	 and	 craniofacial	 symptoms	 in	HPE	 is	 the	basis	 for	 the	notion	 that	 ‘the	 face	
predicts	 the	 brain’,	 as	 observed	 by	 DeMeyer	 and	 colleagues	 in	 1964	 (DeMyer	 et	 al.,	 1964).	
Craniofacial	 phenotypes	 accompanying	 severe	 HPE	 often	 include	 microcephaly,	 cyclopia	 or	
synophthalmia,	 and	 a	 proboscis.	 Less-severely	 affected	 cases	 present	 with	 microcephaly,	
hypotelorism,	midface	 hypoplasia,	 flat	 nasal	 bridges,	 cleft	 lip	 and/or	 palate,	 and/or	 a	 single	
maxillary	incisor	(Solomon	et	al.	2010b;	Table	1.1,	Figure	1.1).	Additionally,	midline	defects	such	
as	undivided	thalami,	absent	corpora	callosa	and	absent	or	hypoplastic	olfactory	and	optic	bulbs	
and	tracts	occur	(Solomon	et	al.,	2010b,	1993).	A	microform	HPE	also	exists,	where	subtle	facial	
phenotypes	such	as	hypotelorism,	a	sharp	and	narrow	nasal	bridge	and	single	maxillary	incisor	
are	 present	 in	 the	 absence	 of	 structural	 brain	 abnormalities.	 These	 cases	 are	 often	 not	
recognized	until	a	severely	affected	relative	with	HPE	is	identified	(Solomon	et	al.,	2010b),	and	
thus	the	frequency	of	microform	HPE	is	underestimated.	
1.1.2 MIHV	HPE	
In	 contrast	 to	 classic	HPE,	MIHV	HPE	 (also	 known	 as	 syntelencephaly)	 presents	with	 normal	
separation	of	the	basal	forebrain,	anterior	frontal	 lobes	and	occipital	regions,	but	a	failure	to	
divide	the	posterior	frontal	and	parietal	regions	of	the	cerebral	hemispheres	along	the	dorsal	
midline	(Barkovich	and	Quint	1993;	Simon	et	al.	2002;	Lewis	et	al.	2002;	Table	1.1,	Figure	1.1).	
Additional	 structures,	 such	 as	 the	 caudate	 nuclei,	 thalami	 and	 mesencephalon	 can	 also	 be	
affected	in	MIHV	cases.	Whilst	some	similarities	occur	between	classic	and	MIHV	HPE	(namely	
non-cleavage	 of	 a	 portion	 of	 the	 cerebral	 hemispheres),	MIHV	HPE	 is	 rarer	 and	milder	 than	
classic	HPE	(Simon	et	al.,	2002),	and	likely	has	a	distinct	embryological	origin	(Fernandes	et	al.	
2007).	
1.2 The	genetics	of	human	HPE	
When	 considered	 as	 a	 single	 disorder,	 HPE	 genetics	 exhibits	 extreme	 heterogeneity	 with	
multiple	classes	of	causative	mutations	and	numerous	modes	of	heredity.	Up	to	50%	of	HPE	
cases	 are	 attributable	 to	 chromosomal	 abnormalities,	 while	 a	 further	 25%	 of	 cases	 are	
syndromic	 and	 25%	 occur	 in	 isolation.	 While	 some	 autosomal	 recessive	 cases	 of	 non-
chromosomal,	non-syndromic	HPE	have	been	reported,	the	condition	is	generally	considered	to	
be	autosomal	dominant	(Barr	and	Cohen,	2002;	Mercier	et	al.,	2011;	Ming	et	al.,	2002;	Mouden	
et	 al.,	 2016;	 Roessler	 et	 al.,	 2012b).	 HPE,	 however,	 does	 not	 exhibit	 simple	 Mendelian	
inheritance	as	evidenced	by	the	facts	that	only	~70%	of	individuals	who	carry	HPE	pathogenic	
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mutations	exhibit	HPE	symptoms	(i.e.	the	condition	is	incompletely	penetrant)	(Mercier	et	al.,	
2011)	and	that	the	same	mutation	can	confer	vastly	different	phenotypes	in	different	carriers	as	
a	 result	of	variable	expressivity.	There	 is	evidence	 from	human	and	animal	studies	 that	both	
genetic	 and	 environmental	 factors	 influence	 the	 HPE	 end-phenotype	 (Hong	 et	 al.,	 2012;	
Kietzman	et	al.,	2014;	Mouden	et	al.,	2016),	therefore	the	ultimate	consideration	when	studying	
HPE	is	the	total	activity	achieved	along	the	particular	embryonic	signalling	pathways	that	direct	
hemisphere	 separation	 (Roessler	 and	Muenke,	 2010).	 Evidently,	 some	 cases	 of	 HPE	 have	 a	
digenic	basis	 (Dubourg	et	al.,	2016;	Mouden	et	al.,	2016).	For	 the	majority	of	HPE	probands,	
however,	the	putative	second	hit	factors	remain	unidentified	and	it	seems	a	model	of	autosomal	
dominant	 with	 modifier	 effects	 most	 aptly	 describes	 HPE	 heritability	 (Odent	 et	 al.,	 1998;	
Roessler	et	al.,	2012b).	
One	clear	source	of	HPE	genetic	variability	is	locus	heterogeneity	(a	single	disorder	is	caused	by	
mutations	 at	 different	 chromosomal	 loci).	 Fourteen	 genes	 have	 been	 implicated	 in	 non-
syndromic	classic	and	microform	HPE	in	humans	(SHH,	ZIC2,	TGIF,	SIX3,	CDON,	DISP1,	DLL,	FGF8,	
FGFR1,	FOXH1,	GAS1,	PTCH1,	NODAL,	TDGF1)	(Arauz	et	al.,	2010;	Bae	et	al.,	2011;	Belloni	et	al.,	
1996;	Brown	et	al.,	2001,	1998;	De	la	Cruz	et	al.,	2002;	Dubourg	et	al.,	2016,	2007;	Dupé	et	al.,	
2011;	Gripp	et	al.,	2000;	Lacbawan	et	al.,	2009;	Mercier	et	al.,	2011;	Ming	et	al.,	2002;	Pineda-
Alvarez	et	al.,	2012;	Ribeiro	et	al.,	2010;	Roessler	et	al.,	2009a,	2009b,	2009c,	1996).	These	genes	
are	classified	as	either	 ‘large	effect’	 (major)	or	 ‘small	effect’	 (minor)	HPE	genes,	according	to	
how	 often	 they	 are	mutated	 in	 the	 disorder.	 In	 classic	 HPE,	 the	 two	 genes	most	 commonly	
mutated	are	SHH	 (12%)	and	ZIC2	 (9%),	which	 together	account	 for	~85%	of	solved	probands	
(Dubourg	et	al.,	2016,	2011;	Roessler	et	al.,	2009a).	Additional	genes	have	been	associated	with	
HPE	 in	 the	mouse,	 indicating	 that	 they	may	be	minor	HPE	genes	and/or	genetic	modifiers	 in	
humans	(reviewed	in	Schachter	and	Krauss	2008).	
Notably,	many	genes	associated	with	classic	HPE	do	not	cause	MIHV	HPE.	In	mice,	Zic2	and	Fgf8,	
as	well	as	the	BMP	ligands,	BMP	antagonists	Chordin	(Chrd)	and	Noggin	(Nog),	BMP	receptors	
Bmpr1a,	Bmpr1b,	 and	 the	 transcription	 factors	 Lhx5	 and	Rfx4,	have	all	been	associated	with	
MIHV	(Anderson	et	al.,	2002;	Cheng	et	al.,	2006;	Dubourg	et	al.,	2016;	Fernandes	et	al.,	2007;	
Lewis	et	al.,	2002;	Nagai	et	al.,	2000;	Simon	et	al.,	2002;	Solomon	et	al.,	2010a;	Storm	et	al.,	
2006;	Warr	et	al.,	2008).	In	contrast,	relatively	few	genes	(ZIC2,	FGF8,	deletion	of	EYA4)	have	
been	associated	with	MIHV	HPE	in	humans	(Abe	et	al.,	2009;	Dubourg	et	al.,	2016;	Solomon	et	
al.,	2010a),	of	which	ZIC2	and	FGF8	are	also	associated	with	classic	HPE.	Animal	models	of	Zic2	
dysfunction	 suggest	 that	 classic	 and	 MIHV	 HPE	 each	 have	 a	 distinct	 embryological	 basis,	
consistent	with	their	observed	differential	involvement	of	the	ventral	versus	dorsal	brain	regions	
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in	human	HPE.	Thus,	some	phenotype	variance	 in	HPE	occurs	as	a	result	of	the	disruption	of	
related	but	distinct	embryonic	processes.	
Despite	recent	progress	in	elucidating	the	genetic	aetiology	of	human	HPE,	only	25%	of	cases	of	
non-chromosomal,	non-syndromic	HPE	have	been	attributed	to	pathogenic	mutations	in	known	
HPE	 genes	 (Dubourg	 et	 al.,	 2007;	 Roessler	 et	 al.,	 2009a).	 Though	 clues	 from	 the	 patient’s	
phenotype	can,	 in	some	cases,	point	to	a	specific	causative	gene,	generally,	newly	diagnosed	
HPE	patients	are	screened	for	pathogenic	deletions	or	point	mutations	via	targeted	gene	panels	
that	sequence	the	coding	region	only	of	the	most	common	HPE-associated	genes	(SHH,	ZIC2,	
SIX3	 and	 TGIF)	 (Dubourg	 et	 al.,	 2016;	 Solomon	 et	 al.,	 1993).	 This	 restricted	 panel	 is	 due	 to	
logistical	considerations,	such	as	the	limited	availability	of	DNA	(particularly	in	in	cases	where	
the	patient	is	deceased)	and	the	frequency	with	which	mutations	in	these	gene	are	identified	in	
HPE	cohorts.	The	remaining	unsolved	 (non-chromosomal)	cases	are	 thought	 to	be	caused	by	
environmental	factors,	unidentified	HPE	genes,	and/or	non-coding-region	variants	that	alter	the	
expression	of	known	HPE-associated	genes.	An	emerging	area	of	HPE	research	aims	to	assess	
the	likely	contribution	of	putative	risk	factors	(such	as	maternal	diabetes,	ethyl	alcohol,	cigarette	
smoking	and	retinoic	acid)	to	the	aetiology	of	HPE,	either	as	single	factors	or	in	combination	with	
pathogenic	 genetic	 lesions.	 Additionally,	 next-generation	 sequencing	 (NGS)	 targeted	 to	 20	
associated	or	candidate	HPE	genes	and	whole	exome	sequencing	are	currently	being	used	to	
identify	new	causative	HPE	loci	in	probands	and	family	members	(Dubourg	et	al.,	2016;	Mouden	
et	al.,	2016).	Whole	exome	sequencing,	however,	fails	to	account	for	variants	in	the	non-coding	
regulatory	regions	of	HPE-associated	genes,	which	are	a	likely	source	for	mutations	in	unsolved	
HPE	cases.	One	such	region,	located	460	kb	upstream	of	SHH,	is	known	to	control	SHH	expression	
in	 the	developing	 forebrain	via	binding	of	 the	 transcription	 factor	SIX3.	A	 rare	variant	 in	 this	
region,	 identified	 in	 one	 proband	 with	 semilobar	 HPE,	 results	 in	 reduced	 SIX3/SIX6	 binding	
affinity	when	analysed	via	EMSA	in	Cos-1	cells	(Jeong	et	al.,	2008).	This	variant	is	hypothesised	
to	result	in	reduced	SHH	expression	in	the	ventral	forebrain.	Though	this	SHH	regulatory	region	
is	included	in	current	NGS	panels,	the	identification	of	similar	regulatory	regions	for	other	HPE-
associated	genes	has	 remained	elusive.	 In	 this	 thesis,	 I	will	 attempt	 to	elucidate	whether	a	
similar	 region	 within	 the	 ZIC2	 3’UTR	 regulates	 Zic2	 expression	 and	 contributes	 to	 HPE	
pathogenesis	when	mutated.		
Studies	to	date	have	already	revealed	that	aspects	of	HPE	pathogenesis	vary	according	to	the	
affected	genetic	locus,	and	thus,	it	is	already	possible	to	delineate	several	distinct	features	of	
ZIC2-associated	HPE.	
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1.3 The	ZIC2	gene	and	protein	
ZIC2,	a	member	of	the	zinc	finger	of	the	cerebellum	family	of	transcription	factors	(ZIC1-5),	is	
arranged	in	a	divergently	transcribed	bigene	pair	with	Zic5	on	chromosome	13	in	humans	(14	in	
mice)	and	consists	of	three	exons	(Figure	1.2).	Orthologues	of	the	Drosphila	odd-paired	(opa),	
the	ZIC	proteins	are	defined	by	 the	presence	of	a	 zinc	 finger	domain	 (ZFD)	consisting	of	 five	
tandem	Cys2His2	zinc	fingers	 (Aruga	et	al.,	2006)(Figure	1.2).	The	ZFD	mediates	DNA	binding	
and	 protein-protein	 interactions	 in	 all	 family	 members,	 and	 is	 essential	 for	 the	 nuclear	
localisation	of	at	least	one	ZIC	protein	(ZIC3)	(Ware	et	al.	2004;	Brown	et	al.	2005;	Bedard	et	al.	
2007;	Hatayama	et	al.	2008;	Pourebrahim	et	al.	2011,	reviewed	in	Houtmeyers	et	al.	2013).	A	
similar	domain	can	be	found	in	GLI,	GLIS	and	NKL	proteins.	In	addition	to	the	ZFD,	ZIC2	contains	
a	zinc	finger	N-terminally	conserved	domain	(ZF-NC),	the	ZIC/Odd	paired	conserved	motif	(ZOC)	
(Aruga	et	al.,	2006),	as	well	as	multiple	polymeric	amino	acid	tracts	such	as	histidine,	alanine	
and	serine/glycine	repeats.	The	presence	of	the	ZOC	domain	and	the	makeup	of	the	first	zinc	
finger	 in	ZIC2	results	 in	 its	classification	as	a	Subclass	A	ZIC	protein,	along	with	ZIC1	and	ZIC3	
(Houtmeyers	et	al.,	2013).	The	ZOC	domain	is	required	for	protein-protein	interactions,	whilst	
expansion	of	the	C	terminal	alanine	tract	results	in	reduced	DNA	binding	activity	despite	the	ZFD	
domain	remaining	functional,	and	has	been	linked	to	multiple	HPE	cases	(Brown	et	al.,	2001;	
Himeda	et	al.,	2013;	Mizugishi	et	al.,	2004).	Recently,	two	additional	domains	were	identified	in	
ZIC1,	2	and	3:	Subclass	A	N-terminally	conserved	domain	 (SANC)	and	Subclass	A	C-terminally	
conserved	domain	(SACC).	Both	domains	are	required	for	ZIC3	transactivation	and	presumably	
have	a	similar	function	in	ZIC2	(Ahmed	et	al,	manuscript	under	review).		
During	 gastrulation	 Zic2,	 Zic3	 and	 Zic5	 are	 expressed	 in	 overlapping	 domains.	 It	 is	 this	
overlapping	expression	that	is	thought	to	contribute	to	functional	redundancies	between	family	
members.	Unique	expression	domains	do	exist,	however,	and	it	is	these	unique	domains	that	
have	been	attributed	to	the	variety	of	diseases	associated	with	Zic	family	members.	At	5.5	dpc,	
Zic2,	 Zic3	 and	 Zic5	 are	 expressed	 in	 the	 ectoderm	 of	 the	 extra-embryonic	 and	 embryonic	
portions	of	 the	egg	cylinder	 (Elms	et	al.,	2004;	Furushima	et	al.,	2000).	Transcripts	have	also	
been	 identified	 in	 the	 mesoderm	 that	 ingresses	 through	 the	 primitive	 streak,	 however	
expression	 is	 absent	 from	 the	mesoderm	 that	migrates	 to	 the	 extraembryonic	 regions.	 The	
distinctive	expression	of	Zic2	begins	at	7.0	dpc	when	it	can	be	detected	in	the	embryonic	node	
(Figure	1.3).	Though	Zic3	is	also	expressed	in	the	node,	this	does	not	occur	until	late	gastrulation-
early	somite	stages	(7.75	-	8.0	dpc)	after	Zic2	node	expression	has	ended	(Elms	et	al.,	2004).	As	
the	mesoderm	 ingresses	 into	 the	primitive	 streak,	Zic2	 transcripts	 recede	 from	the	posterior	
primitive	streak	until	expression	in	the	primitive	streak	is	ceased	at	the	early	headfold	stage	of	
gastrulation	(7.75	dpc).	It	is	during	the	establishment	of	the	neural	plate	that	Zic2	recedes	from	
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Figure	1.2:	The	location	and	structure	of	ZIC2.	(a)	ZIC2	is	arranged	in	a	divergently	transcribed	
pair	with	ZIC5	on	chromosome	13	in	humans	(14	in	mice),	with	three	exons	and	two	introns.	(b)	
Like	the	other	ZIC	family	members,	the	ZIC2	protein	contains	a	highly	conserved	ZF-NC	domain	
followed	by	five	tandem	C2H2	zinc	 finger	domains	which	provide	DNA	binding	activity.	A	ZOC	
domain	can	also	be	found	 in	ZIC2	towards	the	N-terminal,	along	with	several	 low	complexity	
regions	such	as	alanine	and	histidine	tracts	and	serine/glycine	tracts.	Figure	 is	modified	from	
(Houtmeyers	et	al.	2013).		
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Figure	1.3:	Zic2	expression	during	mouse	gastrulation.	(a)	A	5.5	dpc,	pre-streak	stage	embryo.	
(b)	A	transverse	section	through	the	extra	embryonic	region	of	a	pre-streak	stage	embryo	at	the	
level	shown	in	(a).	(c)	A	transverse	section	through	the	embryonic	region	of	a	pre-streak	stage	
embryo	at	the	level	shown	in	(a).	(d)	A	transverse	section	through	the	embryonic	region	of	a	7.0	
dpc,	late-streak	stage	embryo	at	the	level	shown	in	(g).	The	primitive	streak	and	node	are	to	the	
right.	(e)	A	6.5	dpc,	early-streak	stage	embryo	at	the	onset	of	gastrulation.	(f)	A	6.75	dpc	mid-
streak	stage	embryo	with	mesoderm	moving	into	the	posterior	amniotic	fold.	(g)	A	7.0	dpc	late-
streak	stage	embryo.	The	node	is	now	visible	and	Zic2	transcripts	are	seen	in	the	node.	(h)	A	
7.25	 dpc	 early	 allantoic	 bud	 stage	 embryo.	 (i)	 A	 7.5	 dpc	 late	 allantoic	 bud	 stage	 embryo.	
Expression	in	the	node	and	emerging	head	process	is	still	seen.	(j)	A	longitudinal	section	through	
a	7.5	dpc	embryo	such	as	that	shown	in	(i).	Zic2	transcripts	are	not	found	in	the	mesoderm	of	
the	extra	embryonic	region	or	of	the	proximal	embryonic	region.	(k)	A	7.75	dpc	early	head-fold	
stage	embryo.	Zic2	transcripts	are	now	mainly	confined	to	the	anterior	half	of	the	embryo	and	
the	 expression	 in	 the	 node	 has	 ceased.	 ae:	 anterior	 definitive	 endoderm,	 am:	 anterior	
mesoderm,	hp:	head	process,	n:	node,	paf:	posterior	amniotic	fold.	Scale	bar,	50	mm	(a	–	d),	100	
mm	 (e	 –	 g),	 200	mm	 (h,	 i	 and	 k)	 and	 170mm	 (j).	 Figure	 taken	 from	 (Elms	et	 al.,	 2004)	with	
permission.	
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the	posterior	embryo	proper	and	becomes	restricted	 to	 the	anterior	neuroectoderm.	By	 this	
time,	 Zic3	 and	 Zic5	 are	 also	 restricted	 to	 this	 region.	 The	 expression	 of	 the	 Zics	 in	 the	
neuroectoderm	becomes	 limited	 to	 the	dorsal	 region,	which	will	 eventuate	 into	neural	 crest	
cells	and	dorsal	neuron	production	(Elms	et	al.,	2004;	Houtmeyers	et	al.,	2013).	After	the	neural	
tube	closes,	high	 levels	of	Zic2	expression	can	be	detected	 in	the	dorsal	telencephalon	(roof-
plate	and	hippocampal	primordium)	(Cheng	et	al.,	2006;	Okada	et	al.,	2008)	and	in	the	anterior	
and	 posterior	 ventral	 telencephalon	 (Okada	 et	 al.,	 2008).	 It	 is	 postulated	 that	 loss	 of	 Zic2	
expression	in	the	mid-gastrula	node	and	developing	forebrain	results	HPE.		
1.4 The	genetics	of	ZIC2-associated	HPE	
One	unusual	aspect	of	ZIC2	involvement	in	HPE	is	that	probands	with	ZIC2	mutations	have	been	
found	 across	 the	 entire	 HPE	 phenotypic	 spectrum.	 Generally,	 classic	 HPE	 genes	 are	 not	
associated	with	MIHV.	Although	the	vast	majority	of	ZIC2	mutations	result	in	classic	HPE,	a	few	
are	associated	with	MIHV	(Table	1.2).	A	striking	demonstration	of	the	variable	expressivity	of	
ZIC2	mutations	comes	from	the	report	of	monozygotic	twins	with	the	same	de	novo	mutation	at	
a	splice	donor	site	in	ZIC2	(c.1239+1G>C).	These	twins	exhibit	different	classes	of	HPE:	one	twin	
developed	semilobar	HPE	whilst	the	other	had	MIHV	(Nakayama	et	al.,	2016).	As	discussed	later,	
animal	models	suggest	the	classic	and	MIHV	forms	of	HPE	have	a	distinct	embryological	basis	
and	it	appears	that	ZIC2	is	required	for	both	processes	in	man	and	mice.	In	comparison	to	HPE	
as	a	whole,	ZIC2-associated	HPE	manifests	as	highly	penetrant	(93%)	with	relatively	 few	mild	
phenotype	individuals	(Solomon	et	al.,	2010a).	In	fact,	it	is	estimated	that	90%	of	patients	with	
a	ZIC2	mutation	exhibit	structural	brain	anomalies	(Solomon	et	al.,	2010b).	Additionally,	ZIC2	
mutation	 is	 more	 frequently	 associated	 with	 sevre	 structural	 brain	 anomalies,	 (alobar	 or	
semilobar),	which	account	for	75%	of	the	ZIC2–associated	HPE	cases	in	which	phenotype	class	
is	 recorded	 (Table	 1.2).	 In	 contrast,	 a	 similar	 analysis	 of	 92	 individuals	 (probands	 and	 family	
members)	with	clinically	apparent	HPE	and	SHH	mutations	found	that	39%	exhibited	Alobar	or	
Semilobar	 brain	 abnormalities,	 that	 48%	 presented	 with	 no	 brain	 abnormalities	 but	 had	
craniofacial	characteristics	of	microform	HPE	and	none	had	MIHV	(Solomon	et	al.,	2010b).	ZIC2	
mutation	therefore	accounts	 for	the	majority	of	severely	affected	HPE	cases	 (Solomon	et	al.,	
2010b).		
Another	 striking	 observation	 based	 on	 the	 molecular	 subtyping	 of	 HPE	 cases	 is	 that	 ZIC2	
mutation	breaks	the	mantra	‘the	face	predicts	the	brain’,	with	the	craniofacial	defects	typically	
associated	with	classic	HPE	absent	in	those	patients	assessed	(Brown	et	al.,	1998;	Solomon	et	
al.,	 2010a,	 2010b).	 In	 particular,	 Solomon	 et	 al	 (2010a)	 found	 no	 ZIC2-associated	 HPE	 case	
presenting	 with	 facial	 findings	 at	 the	 severe	 end	 of	 the	 spectrum	 (cyclopia,	
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Table	1.2:	Frequency	of	known	HPE	mutations	in	human	ZIC2	arranged	by	mutation	type	and	phenotype.	Polymorphisms	were	not	included.	Identical	mutations	
that	occurred	in	multiple	patients	were	counted	as	independent	instances.	Mutation	data	was	collated	from	(Dubourg	et	al.,	2016;	Mercier	et	al.,	2011;	Nakayama	
et	al.,	2016;	Paulussen	et	al.,	2010;	Ribeiro	et	al.,	2012;	Roessler	et	al.,	2012a,	2012b,	2009a;	Solomon	et	al.,	2010a).	Mic:	microform;	MIHV:	middle	interhemispheric	
variant;	SNV:	single	nucleotide	variant.	
	 Unknown	 Alobar	 Semilobar	 Lobar	 Mic	 MIHV	
Missense	 18	(10.34%)	 7	(4.02%)	 7	(4.02%)	 4	(2.30%)	 2	(1.15%)	 0	(0.00%)	
Nonsense	 7	(4.02%)	 5	(2.87%)	 8	(4.60%)	 2	(1.15%)	 1	(0.57%)	 0	(0.00%)	
Frameshift	 19	(10.92%)	 10	(5.75%)	 23	(13.22%)	 2	(1.15%)	 5	(2.87%)	 0	(0.00%)	
Insertion	 1	(0.57%)	 0	(0.00%)	 1	(0.57%)	 0	(0.00%)	 0	(0.00%)	 0	(0.00%)	
Deletion	 2	(1.15%)	 1	(0.57%)	 1	(0.57%)	 1	(0.57%)	 0	(0.00%)	 1	(0.57%)	
Duplication	 8	(4.60%)	 5	(2.87%)	 9	(5.17%)	 1	(0.57%)	 1	(0.57%)	 3	(1.72%)	
Splice	variant		
(intron)	 6	(3.45%)	 2	(1.15%)	 3	(1.72%)	 0	(0.00%)	 0	(0.00%)	
1	(0.57%)	
SNV	(3’UTR)	 3	(1.72%)	 1	(0.57%)	 1	(0.57%)	 0	(0.00%)	 2	(1.15%)	 0	(0.00%)	
Total	(n=174)	 64	(36.78%)	 31	(17.82%)	 53	(30.46%)	 10	(5.75%)	 11	(6.32%)	 5	(2.87%)	
Total	(n=110)	 	 31	(28.18%)	 53	(48.18%)	 10	(9.09%)	 11	(10.00%)	 5	(4.55%)	
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synophthalmia,	or	a	proboscis)	or	a	combination	of	facial	 features	similar	to	those	caused	by	
mutations	in	other	HPE	genes.	Instead,	a	distinct	phenotype	can	be	seen	in	ZIC2-associated	HPE,	
consisting	of	(but	not	always	containing)	bitemporal	narrowing,	upslanted	palprebral	fissures,	a	
flat	 nasal	 bridge,	 short	 nose	 with	 anteverted	 nares,	 a	 broad	 and	 deep	 philtrum	 and	 the	
appearance	of	large	ears.	Whilst	facial	clefts	occurred	in	both	non-ZIC2	and	ZIC2-associated	HPE,	
the	 frequency	 is	 reduced	by	1/3	 in	 the	 latter	 (Solomon	et	al.,	2010a).	Despite	the	mild	 facial	
phenotype,	these	patients	often	have	severe	HPE	and	neurologic	impairment	(Solomon	et	al.,	
2010a,	2010b).		
Additionally,	other	non-forebrain	phenotypes	are	often	associated	with	ZIC2-HPE.	For	example,	
HPE	patients	with	 intragenic	ZIC2	mutations	have	been	 found	 to	exhibit	neural	 tube	defects	
(4%),	 hydrocephalus	 (12%),	 skeletal	 anomalies	 (14%),	 cardiac	 anomalies	 (9%)	 and	 renal	
anomalies	(7%)	(Solomon	et	al.,	2010a).	Mouse	models	that	recapitulate	ZIC2-associated	HPE	
also	display	a	subset	of	these	co-morbidities.	Both	severe	and	mild	Zic2	loss-of-function	leads	to	
incompletely	 penetrant	 neural	 tube	 defects	 such	 as	 exencephaly	 and	 spina	 bifida,	 due	 to	 a	
requirement	for	ZIC2	during	neurulation	(Elms	et	al.,	2003;	Nagai	et	al.,	2000;	Ybot-Gonzalez	et	
al.,	2007).	In	the	severe	loss-of-function	allele	of	murine	Zic2,	Kumba	(Ku),	spina	bifida	occurs	
due	to	the	downregulation	of	BMP	antagonists	such	as	Noggin	in	the	dorsal	neural	plate.	These	
antagonists	are	 required	 to	 induce	 the	 formation	of	dorsolateral	hinge	points	 (DLHPs)	 in	 the	
neural	tube	of	the	lower	spinal	neuraxis.	In	Zic2Ku/Ku	embryos,	DLHPs	are	absent	from	this	region	
(Ybot-Gonzalez	et	al.,	2007).	The	same	mechanism	is	presumed	to	be	at	play	in	hypomorphic	
Zic2	mouse	mutants	(Zic2tm1Jaru	MGI:2156825;	aka	kd),	where	abnormal	folding	of	the	posterior	
neural	tube	at	9.5	dpc	leads	to	spina	bifida	(Nagai	et	al.,	2000).	Consequently,	these	Zic2	mutants	
provide	an	opportunity	to	model	additional	co-morbidities	of	Zic2-associated	HPE.	In	this	thesis,	
I	will	investigate	whether	Zic2Ku/Ku	embryos	also	exhibit	cardiac	anomalies.	
Comparison	of	relatively	 large	HPE	cohorts	has	also	revealed	aspects	of	ZIC2-HPE	heritability.	
For	 example,	 family	 analysis	 has	 shown	 that	 ZIC2	 mutations	 are	 largely	 de	 novo,	 with	 an	
inheritance	 rate	 of	 only	 27-30%	 (Mercier	et	 al.,	 2011;	Mouden	et	 al.,	 2016;	 Solomon	et	 al.,	
2010b).	In	contrast,	70%	of	SHH	and	SIX3	mutations	are	inherited	(Solomon	et	al.,	2010a).	Of	the	
inherited	ZIC2	cases,	two-thirds	were	maternally	inherited	and	one-third	paternally	inherited.	
Additionally,	 families	 with	 ZIC2	mutations	 in	 greater	 than	 two	 generations	 have	 not	 been	
reported.	A	small	subset	of	ZIC2-associated	HPE	cases,	however,	appear	to	occur	due	to	allelic	
drop	 out	 or	 germline	mosaicism,	 resulting	 in	 parents	 negative	 for	mutations	 siring	multiple	
affected	children	(Solomon	et	al.,	2010a,	2010b).	The	low	rate	of	inheritance	in	ZIC2	cohorts	may	
be	due	to	severely	affected	individuals	being	unable	to	reproduce	(Solomon	et	al.,	1993),	and	
suggests	that	mutations	in	ZIC2	produce	a	higher	level	of	lethality	in	comparison	to	other	HPE	
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genes.	Despite	this,	a	recent	analysis	by	Weiss	et.	al.,	found	that	individuals	with	ZIC2-associated	
HPE	were	more	likely	to	survive	to	adolescence	than	those	with	HPE	due	to	mutations	in	other	
implicated	genes	(Weiss	et	al.,	2017).	It	remains	unclear	from	the	targeted	sequencing	analysis	
to	date	whether	heterozygous	ZIC2	mutation	is	sufficient	to	cause	HPE.	There	are	two	reported	
cases	 of	 ZIC2	 CDS	 mutations	 in	 conjunction	 with	 other	 major	 HPE	 genes	 (ZIC2/SHH	 and	
ZIC2/SIX3),	 and	 mutations	 in	 the	 3’UTR	 of	 ZIC2	 have	 also	 been	 found	 in	 conjunction	 with	
mutations	in	other	HPE	genes	(Lacbawan	et	al.,	2009;	Nanni	et	al.,	1999;	Roessler	et	al.,	2012a).	
Studies	of	other	HPE-associated	genes	show	that,	in	mice,	exposure	to	alcohol	during	gestation	
in	conjunction	with	a	pre-existing	mutation	increases	the	frequency	and	severity	of	HPE	cases	
(Aoto	et	al.,	2008;	Hong	et	al.,	2012;	Kietzman	et	al.,	2014).	It	is	therefore	possible	that	at	least	
some	 cases	 of	 HPE	 arise	when	 a	ZIC2	mutation	 sensitises	 the	 developing	 embryo	 to	 one	 or	
multiple	teratogens.	The	involvement	of	gene	x	gene	and	gene	x	environment	interactions	may	
explain	why	for	ZIC2	(and	other	HPE	associated	genes),	heterozygous	mutations	give	rise	to	the	
HPE	phenotype	in	man	but	not	mouse	(Brown	et	al.,	2005;	Chiang	et	al.,	1996;	Nagai	et	al.,	2000;	
Petryk	et	al.,	2015;	Roessler	et	al.,	2009a;	Schachter	and	Krauss,	2008;	Warr	et	al.,	2008).	
This	 analysis	 of	 HPE	 cohorts	 has	 enabled	 assessment	 of	 the	 ZIC2	 mutational	 spectrum,	
confirming	that	ZIC2-associated	HPE	exhibits	allelic	heterogeneity	(whereby	different	mutations	
in	the	same	gene	give	rise	to	the	same	disease).	In	the	last	12	years	the	number	of	published	
unique	ZIC2-associated	HPE	mutations	has	grown	from	20	(Brown	et	al.,	2005)	to	118	at	the	time	
of	this	thesis	(Table	1.3),	and	will	continue	to	expand	as	sequencing	techniques	become	more	
readily	 available	 and	 the	 unique	 ZIC2–associated	 HPE	 phenotype	 is	 refined.	 Among	 the	 105	
documented	HPE	cases	with	mutations	in	the	ZIC2	coding	sequence,	the	majority	are	predicted	
to	 substantially	 alter	 the	 ZIC2	 transcript	 (44.76%	 are	 frameshift,	 14.29%	 nonsense,	 4.76%	
duplication,	 4.76%	 deletion	 and	 2.86%	 insertion)	 rather	 than	 a	 single	 amino	 acid	 (28.57%	
missense)	(Table	1.3,	Figure	1.4).	Similarly,	of	the	13	mutations	in	ZIC2	non-coding	DNA,	53.85%	
are	 splice	 variants	 and	 predicted	 to	 substantially	 alter	 the	 transcript.	 Consistent	 with	 the	
mutational	 landscape	 of	 ZIC2,	 analysis	 by	 Solomon	 et	 al	 (2010a)	 found	 that	 98%	 of	 all	 ZIC2	
mutations	were	predicted	or	proven	to	be	loss-of-	function.	
Analysis	of	mutation	type	and	location	underscores	the	functional	importance	of	the	ZFD.	For	
example,	 45.71%	 of	 all	 ZIC2	 mutations	 occur	 in	 the	 ZFD	 (Table	 3)	 and	 73%	 (22/30)	 of	 ZFD	
mutations	are	missense,	demonstrating	that	single	amino	acid	changes	in	the	ZFD	are	sufficient	
to	cause	disease.	Furthermore,	no	nonsense	mutations,	nor	most	frameshift	mutations,	produce	
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Table	1.3:	Type	and	frequency	of	known	HPE	mutations	in	human	ZIC2.	Polymorphisms	were	
not	 included.	 Identical	 mutations	 that	 occurred	 in	 multiple	 patients	 were	 counted	 as	 one	
instance.	Mutation	data	was	collated	from	(Dubourg	et	al.,	2016;	Mercier	et	al.,	2011;	Nakayama	
et	al.,	2016;	Paulussen	et	al.,	2010;	Ribeiro	et	al.,	2012;	Roessler	et	al.,	2012a,	2012b,	2009a;	
Solomon	et	al.,	2010a).	SNV:	single	nucleotide	variant,	CDS:	coding	DNA	sequence.	
	 Number	 Percent	 of	 CDS	
mutations		
Percent	 of	 non-
coding	
mutations		
Percent	 of	 all	
mutations		
CDS	 	 	 	 	
Missense	 30	 28.57%	 	 25.42%	
Nonsense	 15	 14.29%	 	 12.71%	
Frameshift	 47	 44.76%	 	 39.83%	
Duplication	 5	 4.76%	 	 4.24%	
Insertion	 3	 2.86%	 	 2.54%	
Deletion	 5	 4.76%	 	 4.24%	
Total	 105	 	 	 	
Non-coding	DNA	 	 	 	 	
Splice	variant	(intron)	 7	 	 53.85%	 5.93%	
SNV	(3’UTR)	 6	 	 46.15%	 5.08%	
Total	 13	 	 	 118	
	
	
	
	
	
Figure	 1.4:	 The	 genomic	 and	 protein	 structure	 of	 ZIC2,	 showing	 the	 known	 human	 HPE-
associated	 variants.	 Polymorphisms	were	 not	 included.	 Identical	mutations	 that	 occurred	 in	
multiple	patients	were	counted	as	one	instance.	Mutation	data	was	collated	from	(Dubourg	et	
al.,	2016;	Mercier	et	al.,	2011;	Nakayama	et	al.,	2016;	Paulussen	et	al.,	2010;	Ribeiro	et	al.,	2012;	
Roessler	et	al.,	2012a,	2012b,	2009a;	Solomon	et	al.,	2010a).	SNV:	single	nucleotide	variant,	ZOC:	
ZIC/Odd	paired	conserved	motif,	ZF-NC:	Zinc	finger	N-terminally	conserved	domain.	
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a	complete	ZFD	when	translated	(Roessler	et	al.,	2009a).	In	contrast,	few	missense	variants	occur	
outside	 of	 the	 ZFD	where	 86%	 of	 known	 variants	 are	 predicted	 to	 drastically	 alter	 the	ZIC2	
transcript.	 Another	 notable	 enrichment	 in	mutation	 type	 is	 found	 in	 the	 C-terminal	 alanine	
repeat	(Table	1.4),	a	region	that	influences	the	strength	of	ZIC2	DNA	binding	and	transcriptional	
activity.	Eight	duplication,	deletions	or	insertions	have	been	identified	in	this	small	(15	amino	
acid)	region	out	of	thirteen	variants	(62%)	of	this	type	across	the	whole	gene.	Functional	analysis	
of	 these	 variants	 shows	 that	 expansion	 from	 15As	 to	 25As	 results	 in	 near-complete	 loss	 of	
transactivation,	yet	reduction	to	2As	results	in	both	an	increase	and	decrease	in	transactivation,	
dependant	on	the	promoter	that	is	used.	This	indicates	that	the	alanine	tract	can	modulate	ZIC2	
transactivation,	contingent	on	the	DNA	sequence	being	targeted	(Brown	et	al.,	2005).	Expansion	
of	the	ZIC2	alanine	repeat	to	25A	has	been	identified	in	multiple	unrelated	families,	and	in	some	
cases	 is	 hypothesized	 to	 occur	 via	 errors	 in	 somatic	 recombination	 in	 the	 patient’s	 fathers	
(Brown	et	al.,	2001).	
The	ongoing	efforts	to	delineate	genotype-phenotype	correlations	in	HPE	have	shed	light	on	the	
genetic	and	embryonic	origin	of	HPE	and,	with	respect	to	aetiology,	have	led	to	the	following	
generalisations:	
• HPE	arises	as	a	consequence	of	failed	dorsal-ventral	(D-V)	forebrain	patterning.	
• Classic	HPE	arises	due	to	failed	ventral	patterning,	whereas	MIHV	HPE	is	associated	with	
failed	dorsal	patterning.	
• Classic	 HPE	 brain	 abnormalities	 can	 occur	 with	 or	 without	 associated	 facial	
abnormalities.	
• For	 some	molecular	 subclasses	 of	 HPE,	 classic	 or	MIHV	HPE	 brain	 abnormalities	 can	
occur	alongside	abnormalities	not	associated	with	the	face	and	forebrain	(e.g.	Zic2).	
	
To	 consider	 how	 ZIC2	 mutation	 causes	 the	 typical	 brain	 abnormalities	 of	 HPE	 requires	
understanding	 how	 D-V	 forebrain	 pattern	 is	 established.	Much	 of	 our	 knowledge	 regarding	
mammalian	 embryonic	 development	 and	 the	 mechanism	 of	 ZIC2	 activity	 during	 brain	
development	is	derived	from	the	analysis	of	mouse	mutant	phenotypes	and	the	next	sections	
will	refer	to	mouse	development.	
1.5 Ventral	forebrain	patterning	during	murine	development	
The	 generation	 of	 a	 correctly	 patterned	 embryo	 is	 dependent	 upon	 inductive	 interactions	
between	progenitor	 tissues	 that	direct	differentiation,	 regionalisation	and	morphogenesis.	 In	
the	 ventral	 forebrain,	 patterning	 is	 a	 consequence	 of	 inductive	 interactions	 between	 the		
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Table	1.4:	Protein	location	and	frequency	of	known	HPE	mutations	in	the	human	ZIC2	protein.	Polymorphisms	and	chromosome	deletions	were	not	 included.	
Identical	mutations	that	occurred	in	multiple	patients	were	counted	as	one	instance.	Mutation	data	was	collated	from	(Dubourg	et	al.,	2016;	Mercier	et	al.,	2011;	
Nakayama	et	al.,	2016;	Paulussen	et	al.,	2010;	Ribeiro	et	al.,	2012;	Roessler	et	al.,	2012b,	2009a;	Solomon	et	al.,	2010a).	ZOC:	ZIC/Odd	paired	conserved	motif,	ZF-
NC:	Zinc	finger	N-terminally	conserved	domain.	
Protein	Domain	 Location	(aa)	 Missense	 Nonsense	 Frameshift	 Duplication	 Insertion	 Deletion	 Total	(n=105)	
Histidine	Repeat	 20-24	 	 	 	 	 	 	 0	(0.00%)	
Alanine	Repeat	 24-34	 	 	 1	 	 	 	 1	(0.95%)	
Alanine	Repeat	 89-98	 	 	 	 	 	 	 0	(0.00%)	
ZOC	 115-126	 	 	 1	 	 	 	 1	(0.95%)	
Alanine	Repeat	 226-231	 	 	 	 	 	 	 0	(0.00%)	
Histidine	Repeat	 231-240	 	 	 	 	 	 	 0	(0.00%)	
ZF-NC	 241-256	 	 1	 	 	 	 	 1	(0.95%)	
C2H2	 Zinc	 Finger	
Domain	
258-416	 22	 8	 16	 1	 1	 	 48	(45.71%)	
Alanine	Repeat	 456-471	 	 	 	 3	 1	 4	 8	(7.62%)	
Serine/Glycine	Repeat	 477-516	 1	 	 8	 	 	 	 9	(8.57%)	
Non-domain	 	 7	 6	 21	 1	 1	 1	 37	(35.24%)	
Total	(n=105)	 	 30	(28.57%)	 15	(14.29%)	 47	(44.76%)	 5	(28.57%)	 3	(2.86%)	 5	(4.76%)	 	
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anterior	 neurectoderm	 and	 the	 underlying	 prechordal	 plate	 (PrCP)	 (reviewed	 in	 Placzek	 and	
Briscoe	2005).	Both	of	these	tissues	arise	during	gastrulation	(reviewed	in	Arkell	and	Tam	2012),	
prior	 to	which	 the	neurectoderm	precursor	cells	are	 located	within	 the	distal	epiblast	where	
they	are	encased	by	the	distal	visceral	endoderm	cells	(Figure	1.5A).	These	visceral	endoderm	
(VE)	 cells	 secrete	 factors	 that	 antagonize	TGF-β	and	WNT	 signalling	activities,	 protecting	 the	
distal	 ectoderm	 cells	 of	 the	 epiblast	 from	 the	 signals	 that	 would	 otherwise	 cause	 them	 to	
differentiate.	By	the	time	gastrulation	begins,	the	future	neurectoderm	cells	are	found	at	the	
anterior	of	the	epiblast	where	they	continue	to	be	protected	from	differentiation	into	endoderm	
or	mesoderm	by	antagonists	 secreted	 from	 the	enveloping	endoderm,	which	at	 this	point	 is	
called	 the	 anterior	 visceral	 endoderm	 (AVE).	During	 gastrulation,	 the	 anterior	 neurectoderm	
population	expands	anteriorly	and	proximally	and	occupies	two-thirds	of	the	ectoderm	layer	by	
mid-gastrulation	(Figure	1.5B,	7.0	days	post-coitum;	dpc).	Although	the	descendants	of	some	of	
these	cells	will	colonise	more	posterior	parts	of	the	brain,	the	cells	in	this	region	are	becoming	
progressively	restricted	to	forebrain	fate.	Approximately	half	of	the	neurectoderm	that	has	been	
produced	 at	 this	 stage	 will	 give	 rise	 to	 the	 forebrain,	 therefore	 perturbations	 in	 neural	
development	at	this	stage	disproportionately	affect	the	forebrain.	
The	tissues	that	will	form	the	PrCP	are	initially	co-localised	with	the	precursors	of	the	definitive	
endoderm,	and	prior	to	gastrulation	are	found	at	the	future	posterior	side	of	the	embryo	about	
halfway	along	the	embryonic	portion	of	the	epiblast	 (Figure	1.5A).	During	gastrulation,	these	
cells	 ingress	 through	 the	 anterior	 segment	 of	 the	 primitive	 streak	 and	 extend	 along	 the	
embryonic	midline	to	reach	the	entire	length	of	the	body	axis.	The	first	cells	to	pass	through	the	
primitive	streak	will	come	to	lie	at	the	embryonic	anterior,	with	the	later	cells	taking	up	an	axial	
position	in	accordance	with	their	time	of	passage	through	the	primitive	streak.	When	the	cells	
first	emerge	from	the	primitive	streak	and	migrate	along	the	midline,	they	do	so	as	a	contiguous	
sheet	of	cells	in	which	the	midline	mesoderm	is	flanked	by	definitive	endoderm.	At	this	stage,	
this	sheet	of	cells	is	named	the	anterior	mesendoderm	(AME).	Later	in	development,	the	cells	at	
the	midline	separate	and	take	up	a	position	among	the	mesoderm	tissues.	The	resulting	axial	
mesoderm	structures	are	named	for	their	position	along	the	body	axis:	the	axial	mesoderm	that	
underlies	the	forebrain	is	called	the	PrCP	and	that	which	associates	with	the	rest	of	the	brain	is	
the	anterior	notochord.	
Clues	to	the	molecular	nature	of	the	ventral	 forebrain	patterning	signals	are	provided	by	the	
resulting	phenotypes	in	murine	embryos	with	particular	genetic	mutations.	Classic	HPE	arises	
following	the	loss	of	morphogenetic	signalling	activity	induced	by	disruption	of	the	HH	ligand	
SHH,	 or	 combined	 mutation	 of	 the	 TGF-β	 antagonists	 Chrd	 and	 Nog	 in	 murine	 embryos	
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Figure	 1.5:	 The	 origin	 of	 the	 prechordal	 plate	 and	 other	 tissues	 involved	 in	 dorsal-ventral	
patterning	of	 the	murine	 telencephalon.	 (a)	A	 cut-away	diagram	of	 the	pre-gastrula	mouse	
embryo	(5.5	dpc)	with	a	superimposed	cellular	fate	map.	The	pre-gastrula	embryo	is	bi-laminar,	
with	the	inner	ectoderm	tissue	(the	epiblast)	enveloped	by	the	visceral	endoderm.	The	position	
of	the	precursor	cells	for	the	ectoderm	(neural;	NE	and	surface;	SE),	mesoderm	(M),	definitive	
endoderm	 (DE)	and	anterior	prechordal	plate	 (PrCP)	 is	 shown.	 (b)	 Cut-away	diagrams	of	 the	
embryonic	portion	of	the	early	(6.5	dpc),	mid	(7.0	dpc)	and	late	(7.5	dpc)	gastrulas.	The	anterior	
(A)	and	posterior	(P)	of	the	embryo	are	marked	and	the	dotted	line	indicates	the	A-P	axis.	Wild	
type	 embryos	 use	 five	 steps	 to	 establish	 the	 ventral	 signalling	 centre	 in	 the	 forebrain	
neurectoderm.	Step	1:	NODAL	signal	in	the	posterior	directs	the	initial	differentiation	of	the	PrCP	
and	anterior	definitive	endoderm	cells	which	transit	the	anterior	primitive	streak	and	migrate	
to	the	anterior	midline	of	the	embryo.	Step	2:	NODAL	signal	induces	the	transition	of	the	anterior	
primitive	streak	cells	into	the	overt	node.	Step	3:	the	anterior	notochord	cells	transit	the	node	
and	 migrate	 to	 the	 anterior	 midline,	 coming	 to	 lie	 caudal	 of	 the	 PrCP.	 Step	 4:	 inductive	
interactions	between	the	PrCP	and	anterior	notochord	(negative	from	PrCP	to	ANC	and	positive	
from	ANC	to	PrCP)	stabilise	PrCP	fate	enabling	SHH	secretion.	Step	5,	SHH	signals	vertically	to	
the	overlying	forebrain	neurectoderm	to	establish	Shh	expression	in	the	rostral	ventral	neural	
midline	and	overlay	ventral	identity	information	on	the	neurectoderm	which	initially	is	dorsal	in	
character.	(c)	The	alterations	in	PrCP	development	in	Zic2Ku/Ku	embryos	are	shown.	At	6.5	dpc	
Zic2Ku/Ku	embryos	are	indistinguishable	from	wild	type	and	Step	1	proceeds	as	normal.	At	7.0	dpc,	
the	lack	of	functional	ZIC2	alters	the	level	of	perceived	NODAL	signal	such	that	the	overt	node	is	
formed	(Step	2),	but	gene	expression	at	the	node	is	abnormal.	Step	3	fails	in	the	Zic2Ku/Ku	mutants	
and	by	7.5	dpc	there	is	no	anterior	notochord.	Consequently,	the	PrCP	degenerates,	does	not	
secrete	SHH	and	Shh	expression	does	not	initiate	in	the	rostral	ventral	neural	midline,	resulting	
in	 classic	HPE.	 dpc:	 days	 post-coitum,	B:	 neural	 plate	 border,	DE:	 definitive	 endoderm,	DVE:	
distal	visceral	endoderm,	Fb:	forebrain	neurectoderm,	M:	mesoderm,	MHb:	mid-	and	hindbrain	
neurectoderm,	NE:	neurectoderm,	SE:	surface	ectoderm.	
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(Anderson	et	al.,	2002;	Chiang	et	al.,	1996).	This	suggests	that	the	HH	pathway	must	be	activated	
and	the	TGF-β	pathway	inhibited	for	ventral	forebrain	patterning	to	proceed.	In	the	HH	pathway	
(Figure	1.6B),	 the	 SHH	 ligand,	 along	with	 co-receptors	CDON,	BOC,	 LRP2	and	GAS1,	binds	 to	
Patched	(PTCH1),	a	transmembrane	receptor.	This	interaction	with	PTCH1	relieves	inhibition	of	
Smoothened	(SMO),	which	then	facilitates	the	production	and	nuclear	transport	of	full	length,	
activating	forms	of	GLI	transcription	factors	to	promote	transcription	of	SHH	targets	(reviewed	
in	 Xavier	 et	 al.	 2016).	 As	 described	 previously,	 mutation	 of	 not	 only	 SHH	 itself	 but	 also	
components	of	the	HH	transduction	pathway	have	been	found	to	be	mutated	in	HPE	probands,	
indicating	HH	signalling	is	also	required	for	human	forebrain	ventral	patterning.	Shh	transcripts	
are	 initially	 found	 in	 the	 PrCP	 itself	 and	 subsequently	 in	 the	 overlying	 rostral-ventral	 neural	
midline	 (RVNM).	 The	 downstream	 components	 and	 target	 genes	 of	 the	 SHH	 transduction	
pathway	 are	 expressed	 in	 the	 RVNM.	 Mutations	 in	 the	 response	 components	 of	 the	 SHH	
pathway	produce	neurectoderm	that	is	incompetent	to	respond	to	the	SHH	signal,	resulting	in	
HPE	(Fuccillo	et	al.,	2004;	Spoelgen	et	al.,	2005).	
In	 the	 TGF-β	pathway	 (Figure	 1.6A	 and	C),	 ligands	 bind	 to	 and	 activate	 a	 Type	 I	 and	 Type	 II	
receptor	complex,	causing	phosphorylation	of	some	members	of	 the	SMAD	family	called	 the	
receptor-associated	 SMADs	 (R-SMADS).	 This	 enables	 their	 interaction	 with	 the	 common	
mediator	 SMAD	 (Co-SMAD)	 resulting	 in	 nuclear	 localization,	 the	 formation	 of	 higher	 order	
transcriptional	complexes	and	regulation	of	TGF-β	target	genes.	In	contrast,	BMP	ligands	signal	
through	different	receptors	and	SMAD	molecules	than	the	NODAL	and	GDF	molecules,	discussed	
below.	Both	gain-	and	loss-of-function	experiments	in	the	mouse	indicate	that	BMP	signalling	
represses	Shh	expression	in	the	RVNM	(Anderson	et	al.,	2002).	The	BMP	antagonists	Chrd	and	
Nog	are	expressed	 in	 the	node	and	axial	mesoderm	derivatives	 (notochord	and	PrCP)	and	 in	
Chrd-/-;Nog+/-	mutant	embryos,	BMP	antagonism	is	reduced,	resulting	 in	embryos	that	exhibit	
cyclopia	and	HPE	in	conjunction	with	loss	of	Shh	expression	in	the	PrCP	(Anderson	et	al.,	2002).	
Counterintuitively,	Bmp7	is	expressed	in	the	node,	notochord	and	caudal	PrCP	alongside	Chrd	
and	Nog	(Anderson	et	al.,	2002;	Arkell	and	Beddington,	1997).	Here,	BMP7	may	(as	in	the	chick)	
modify	the	response	of	ventral	midline	cells	to	SHH	and	induce	a	rostral	identity,	instead	of	a	
floor-plate	identity	that	would	be	induced	by	SHH	on	its	own	(Dale	et	al.,	1997).	Unlike	Bmp7,	
Bmp2	 and	Bmp4	 are	 expressed	 in	 the	 surface	 ectoderm	 and,	 in	 the	 case	 of	Bmp2,	 paraxial	
mesoderm	adjacent	to	the	PrCP,	but	not	in	the	PrCP	itself	(Anderson	et	al.,	2002).	Mutations	in	
the	BMP	part	of	 the	TFG-β	pathway	have	not	yet	been	associated	with	human	HPE,	perhaps	
because	mutations	that	result	in	elevated	signalling	are	relatively	rare	compared	to	those	that	
cause	loss	of	signalling.	
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Figure	 1.6:	 Signalling	 pathways	 involved	 in	 dorsal-ventral	 patterning	 of	 the	 murine	
telencephalon.	(a)	Nodal	signalling.	Mature	Nodal	ligands	complex	with	the	EGF-CFC	co-factor	
TDGF1	(Cripto),	Type	I	receptors	(ALK4/5/7)	and	Type	II	receptors	(ActRII	or	ActRIIB).	Receptor	
activation	leads	to	the	phosphorylation	of	the	type	I	receptor	by	the	type	II	kinase,	as	well	as	
phosphorylation	of	SMAD2	or	SMAD3,	which	dimerize	with	SMAD4.	The	SMAD2/3-4	complex	
translocates	 to	 the	 nucleus	 and	 interact	 with	 the	 transcription	 factor	 FOXH1	 and	 promote	
transcription	of	TGFb	 target	genes,	or	with	ZIC2	 to	promote	 transcription	of	FOXA2.	 (b)	SHH	
signalling.	 In	 the	 absence	 of	 ligand,	 the	 transmembrane	 domain	 protein	 Patched1	 (PTCH)	
inhibits	the	activity	of	Smoothened	(SMO)	in	the	target	cell.	In	a	signalling	cell,	SHH	expression	
is	initiated	by	the	transcription	factors	FOXA2	or	SIX3	binding	to	enhancers.	In	the	extracellular	
space,	the	binding	of	secreted	SHH	to	PTCH	releases	SMO,	allowing	for	regulation	of	HH	target	
genes	by	the	transcription	factors	GLI1,	GLI2	and	GLI3.	 (c)	BMP	signalling.	The	secreted	BMP	
ligand	binds	to	Type	I	(ALK2/3/6)	and	Type	II	receptors	(ACTRII	and	ACTIIB).	This	results	in	the	
phosphorylation	 of	 DNA	 binding	 proteins	 SMAD1/5/8,	 which	 complex	 with	 SMAD4.	 The	
SMAD1/5/8-4	 complex	 translocates	 to	 the	 nucleus	 and	 via	 interactions	 with	 co-factors,	
regulates	transcription	of	TGFb	target	genes	they	regulate	transcription	of	BMP	target	genes.	In	
the	 extracellular	 space,	 the	 secreted	 antagonists	 Chordin	 (CHRD)	 and	Noggin	 (NOG)	 directly	
interact	with	 BMP	 ligands	 to	 prevent	 the	 activation	 of	 downstream	 effectors	whilst	 twisted	
gastrulation	(TWSG1)	can	act	as	both	an	antagonist	or	agonist	of	BMP	signalling	in	a	cells-specific	
manner.	(d)	WNT	signalling.	 In	the	absence	of	 ligand/presence	of	 inhibitors	such	as	DKK1,	b-
catenin	 is	phosphorylated	(P)	by	the	kinase	activity	of	 the	destruction	complex	 (consisting	of	
Axin,	APC,	and	GSK3),	polyubiquitylated	(U)	by	the	SCF	(SKP1,	Cullin,	F-box)/BTrCP	complex	and	
degraded	by	the	proteasome.	ZIC2	acts	as	a	transcriptional	co-repressor,	complexing	with	TCF	
proteins	 to	 prevent	 transcription	 of	WNT	 target	 genes.	 (e)	 FGF	 signalling.	 The	 secreted	 FGF	
ligand	binds	to	tyrosine	kinase	receptors	(FGFR),	activating	multiple	signalling	pathways	such	as	
the	RAS/MAPK,	PLC-γ,	PI3K	and	STAT.	These	pathways	culminate	in	the	promotion	or	repression	
of	FGF	target	genes	by	the	transcription	factor	FOS,	and	the	transcription	factor	families	NFAT	
and	FOXO.	White	bold:	genes	implicated	in	classic	and	MIHV	HPE	in	humans,	black	bold:	genes	
implicated	in	classic	and	MIHV	HPE	in	mice,	blue	bold:	genes	identified	as	modifiers	in	classic	
HPE	in	humans.	PrCP:	prechordal	plate,	RVNM:	rostral-ventral	neural	midline.	
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The	model	 of	 ventral	 forebrain	 patterning	 that	 best	 fits	 the	 experimental	 data	 is	 that	 SHH,	
expressed	in	and	secreted	from	the	PrCP,	signals	vertically	to	the	overlying	neurectoderm.	One	
consequence	of	SHH	signal	reception	and	transduction	by	the	neurectoderm	is	that	SHH	itself	
becomes	expressed	in	the	RVNM,	but	only	if	BMP	signalling	is	low	in	this	tissue	(Anderson	et	al.,	
2002).	 SHH	 expression	 in	 the	 RVNM	 then	 leads	 to	 neuronal	 patterning	 and	maintenance	 of	
ventral	 forebrain	tissue.	The	anterior	mesendoderm	of	 the	 late	gastrula	 is	also	the	source	of	
WNT	antagonism	due	to	the	expression	of	Dkk1	under	the	control	of	the	transcription	factor	
Otx2.	When	Otx2	is	conditionally	inactivated	in	the	AME,	Dkk1	expression	is	not	activated	in	the	
same	 tissue,	 and	head	 truncations	 characteristic	 of	 elevated	WNT	 signalling	 result	 (Ip	et	 al.,	
2014).	Shh	expression	is	not	perturbed	by	the	lack	of	Dkk1	expression	and	HPE	does	not	arise,	
clearly	indicating	that	WNT	ligands	do	not	direct	morphogenetic	activity	required	for	forebrain	
separation.	None-the-less,	classic	HPE	 is	associated	with	 loss	of	 forebrain	 tissue	 (i.e.	anterior	
truncation).	 It	 is	 possible	 that	 this	 is	 a	 consequence	 of	 loss	 of	 midline	 tissue	 which,	 at	 the	
anterior,	expresses	FGF	ligands	from	the	anterior	neural	ridge	(ANR)	as	part	of	Anterior-Posterior	
neural	patterning.	Depletion	of	midline	FGF	will	cause	posteriorisation	and	forebrain	hypoplasia.	
Thus,	 anterior	 truncation	 often	 occurs	 as	 a	 secondary	 consequence	 of	 an	 aberrant	 ventral	
pattern.	 An	 anterior	 truncation	 phenotype	 can	 be	 seen	 in	 isolation	 from	 ventral	 defects,	
however,	and	should	not	of	itself	be	used	to	infer	a	role	in	HPE.	
1.6 PrCP	morphogenesis	during	murine	development		
As	described	above,	cells	in	the	PrCP	synthesise	and	secrete	SHH,	the	critical	ligand	for	ventral	
neural	patterning.	It	follows	that	classic	HPE	can	also	arise	if	the	cells	of	the	PrCP	are	not	formed	
or	do	not	function	properly.	The	PrCP	arises	due	to	a	series	of	inductive	interactions	between	
cells	 at	 the	 anterior	 primitive	 streak	 (APS)	 and	 then	 amongst	 the	 axial	 tissues	 generated	 by	
movement	of	cells	through	the	APS	(Figure	1.5B).	As	described	above,	the	PrCP	is	formed	from	
cells	that	pass	through	the	APS	early	in	gastrulation	(Kinder	et	al.,	2001).	Some	cells	that	transit	
the	APS	and	migrate	anteriorly	adopt	a	paraxial	fate	(i.e.	either	side	of	the	midline)	and	form	the	
anterior	definitive	endoderm	(ADE).	By	mid	gastrulation,	the	APS	cells	have	been	organised	into	
a	structure	called	the	node.	The	cells	of	the	epiblast	which	transit	through	the	node	of	the	mid-
gastrula	differentiate	into	AME	and	migrate	to	the	anterior	midline,	taking	up	a	position	adjacent	
to,	but	posterior	of,	the	cells	of	the	PrCP.	These	cells	form	the	anterior	notochord	(ANC)	(Kinder	
et	 al.,	 2001).	 Inductive	 interactions	 between	 these	 anterior	 tissues	 (ADE,	 PrCP	 and	 ANC)	
influence	not	only	forebrain	patterning	(Hallonet	et	al.,	2002),	but	also	the	fate	and	survival	of	
the	PrCP.	If	the	PrCP	is	removed,	the	ANC	reconstitutes	new	PrCP	tissue.	Conversely,	removal	of	
the	ANC	results	in	failed	PrCP	development,	 indicating	that	the	ANC	promotes	survival	of	the	
PrCP	(Camus	et	al.,	2000).		
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The	molecular	nature	of	the	signals	required	for	PrCP	development	can	also	be	inferred	by	the	
phenotype	 of	 mouse	 mutants.	 An	 extensive	 series	 of	 murine	 alleles	 in	 Nodal	 itself,	 or	
components	of	the	NODAL	signal	transduction	pathway	(Figure	1.6A),	demonstrate	that	NODAL	
signalling	during	gastrulation	is	required	for	steps	1	and	2	of	PrCP	development	(Figure	1.5B).	
Even	a	small	decrease	in	NODAL	signalling	activity	prevents	differentiation	of	the	ADE	and	PrCP	
precursors	via	transit	through	the	APS	(Norris	et	al.,	2002;	Vincent	et	al.,	2003)	and	manifests	as	
moderate	anterior	truncation.	Further	loss	also	interferes	with	node	induction	by	the	APS	and	
results	in	severe	anterior	truncation,	absent	AME,	and	somite	fusion	across	the	midline	(Chu	et	
al.,	2004;	Dunn	et	al.,	2004;	Episkopou	et	al.,	2001;	 Liu	et	al.,	2004).	These	mutations	affect	
processes	beyond	ventral	neural	patterning	and	obscure	the	role	for	NODAL	in	preventing	HPE.	
However,	 embryos	 that	 are	heterozygous	null	 for	Nodal	 and	null	 for	 a	 closely	 related	TGF-β	
signalling	molecule	(Gdf1)	develop	HPE	which	arises	due	to	abberant	anterior	notochord	and	
PrCP	development	(Andersson	et	al.,	2006)	clearly	indicating	the	role	for	the	non-BMP	part	of	
the	TGF-β	pathway	in	PrCP	development.	The	identity	of	the	signals	between	the	anterior	tissues	
(ADE,	PrCP	and	ANC)	that	stabilize	PrCP	fate	are	unknown,	but	SHH	is	a	candidate	for	the	survival	
signal	sent	from	the	ANC	to	the	PrCP	as	indicated	by	chimeric	experiments	between	Shh-/-	and	
wild	type	cells	(Aoto	et	al.,	2009).	
1.7 Zic2	mutation	and	ventral	forebrain	patterning		
Severe	loss-of-function	alleles	of	murine	Zic2,	such	as	the	Kumba	(Ku)	allele,	result	in	classic	HPE	
(Figure	1.7),	suggesting	an	 involvement	 in	ventral	neural	patterning.	Gene	expression	studies	
rule	out	 the	possibility	 that	 the	ZIC2	 transcription	 factor	directly	 regulates	Shh	 expression	 in	
either	the	PrCP	or	RVNM	since	neither	tissue	is	a	site	of	Zic2	expression	at	the	appropriate	stage	
(Elms	et	al.,	2004;	Nagai	et	al.,	1997).	Similarly,	the	lack	of	RVNM	expression	at	the	time	at	which	
ventral	pattern	 is	 imposed	 implies	 that	Zic2	 is	not	part	of	 the	transcriptional	 response	to	HH	
signalling	in	the	murine	forebrain.	None-the-less,	the	high	similarity	between	ZIC	and	GLI	zinc	
finger	domains	and	the	finding	that	ZIC	and	GLI	proteins	can	physically	interact	via	their	ZFDs	
(Kinzler	and	Vogelstein,	1990;	Mizugishi	et	al.,	2001;	Pavletich	and	Pabo,	1993)	suggested	ZIC2	
could	 act	 downstream	 of	 SHH	 signalling	 in	 the	 forebrain	 (Roessler	 and	Muenke,	 2001).	 This	
hypothesis	was	directly	tested	by	cross	of	the	Ku	allele	of	Zic2	(Zic2Ku	MGI:106679)	with	the	Shh	
null	 allele	 (Shhtm1Chg	 MGI:	 1857796)	 (Warr	 et	 al.,	 2008).	 The	 Ku	 mutant	 carries	 a	 missense	
mutation	 in	 the	4th	zinc	 finger	 that	abolishes	 the	DNA	binding	and	 transcriptional	activation	
ability	of	ZIC2	(Elms	et	al.	2003,	Brown	et	al,	2005).	When	intercrossed,	 it	was	observed	that	
neither	gene	was	sensitive	to	a	decreased	dose	of	the	other,	and	double	homozygous	embryos	
exhibited	 a	 novel	 phenotype	 demonstrating	 that	 ZIC2	 does	 not	 act	 downstream	 of	 SHH	 in	
murine	 forebrain	 development	 (Warr	 et	 al.,	 2008).	 Moreover,	 the	 same	 study	
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Figure	1.7:	The	Kumba	allele	of	Zic2-associated	HPE.	Compared	to	(a)	wildtype	(Zic2+/+)	embryos	
at	12.5	dpc,	(b)	Kumba	 (Zic2Ku/Ku)	embryos	exhibit	exencephaly,	spina	bifida,	a	 looped	tail,	an	
internally	 located	 eye	 and	 a	 proboscis.	When	 sectioned	 transversely,	 (d)	 internal	 and	 close	
spaced	eyes	(hypotelorism),	(e)	internal	and	incompletely	separated	eyes	(synophthalmia)	and	
(f)	cyclopia	can	all	be	seen	in	Kumba	embryos,	 in	contrast	to	(c)	a	wildtype	embryo	with	two	
externally	located	eyes	and	divided	left	and	right	forebrain	hemispheres.	e:	eye,	p:	proboscis.	
Figure	is	modified	from	(Warr	et	al.,	2008).	
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showed	 that	 a	 phenotype	 was	 present	 in	 Zic2Ku/Ku	 embryos	 before	 the	 stage	 at	 which	 Shh	
expression	is	first	detected,	and	that	germline	loss	of	all	HH	signalling	(via	Smo	deletion)	does	
not	reproduce	the	early	aspects	of	the	Zic2Ku/Ku	phenotype	(Warr	et	al.,	2008).		
Instead,	it	appears	that	ZIC2	intersects	the	NODAL	signalling	pathway	at	mid	gastrulation.	Nodal	
loss-of-function	is	lethal	at	gastrulation	and	compound	heterozygous	embryos	for	both	ZIC2	and	
NODAL	do	not	survive	to	the	forebrain	stage	of	development.	Sequentially	decreasing	the	dose	
of	NODAL	activity	on	 the	Zic2Ku/Ku	background	shifts	 the	Nodal	phenotype	 towards	 the	more	
severe	 end	 of	 the	 spectrum	 (increased	 frequency	 and	 severity	 of	 anterior	 truncation)	
(Houtmeyers	et	al.,	2016).	Evidently,	 in	the	absence	of	ZIC2	function,	the	embryos	perceive	a	
lower	dose	of	NODAL	signalling,	suggesting	that	Zic2	normally	promotes	NODAL	signalling	at	the	
APS	(Figure	1.5B).	This	is	supported	by	the	analysis	of	Zic2Ku/Ku	embryos	which	show	that	in	the	
absence	of	Zic2	function,	the	derivatives	of	the	APS	(i.e.	the	ADE	and	PrCP	cells)	are	specified	
and	migrate	to	the	embryonic	anterior	to	take	up	their	normal	position	(Warr	et	al.,	2008)	and	
the	node	is	induced	(Elms	et	al.,	2003).	However,	gene	expression	at	the	newly	induced	node	is	
highly	aberrant;	the	expression	of	every	node	specific	gene	so	far	examined	at	mid-gastrulation	
in	 Zic2Ku/Ku	 embryos	 is	 depleted	 (Barratt	 et	 al.,	 2014;	 Warr	 et	 al.,	 2008).	 Cell	 death	 and	
proliferation	of	 the	ANC	 cells	 that	 emerge	 from	 the	mid-gastrula	 node	 is	 unaltered,	 but	 the	
transcripts	of	genes	that	mark	the	emerging	ANC	are	depleted,	suggesting	that	this	tissue	is	not	
specified.	Despite	the	earlier	evidence	of	PrCP	formation,	by	late	gastrulation	the	expression	of	
markers	characteristic	of	the	PrCP	is	absent	in	Ku	embryos.	Consequently,	Shh	expression	in	the	
PrCP	is	not	activated	and	the	expression	of	Shh	and	SHH	target	genes	in	the	RVNM	is	not	initiated	
(Warr	et	al.,	2008).		
The	analysis	of	the	Zic2Ku/Ku	phenotype	suggests	that	PrCP	development	fails	at	stage	3,	and	that	
the	 earliest	 identified	 molecular	 and	 functional	 abnormalities	 are	 at	 the	 mid-gastrula	 node	
(Figure	1.5B,	C).	This	is	therefore	considered	the	stage	and	site	of	primary	Zic2	function	(Warr	et	
al,	2008).	This	functional	analysis	is	consistent	with	the	node	of	the	mid-gastrula	embryo	(the	
structure	that	produces	the	ANC)	being	the	only	unique	site	of	Zic2	gene	expression	at	this	stage	
of	development	compared	to	other	ZIC	family	members.	Other	closely	related	Zic	genes	(Zic3	
and	Zic5)	are	co-expressed	with	Zic2	 in	all	other	areas	of	the	gastrula	at	this	stage,	and	likely	
compensate	for	ZIC2	loss-of-function	in	these	cells	(Elms	et	al.,	2004;	Furushima	et	al.,	2000).	
The	precise	molecular	role	of	ZIC2	at	the	mid-gastrula	node	remains	unclear.	The	level	of	Nodal	
transcript	is	unaltered	in	Zic2Ku/Ku	embryos,	indicating	that	ZIC2	does	not	promote	NODAL	activity	
by	 directly	 controlling	Nodal	 expression,	 but	 instead	 acts	 downstream	 of	 the	 NODAL	 signal	
(Houtmeyers	2016).	Another	hypothesis	is	that	ZIC2	directly	regulates	expression	of	the	Foxa2	
transcription	factor.	Foxa2,	a	NODAL	target	gene	(Hoodless	et	al.,	2001)	expressed	in	the	APS,	
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node	and	AME	(Ang	et	al.,	1993;	Ang	and	Rossant,	1994;	Dufort	et	al.,	1998;	Monaghan	et	al.,	
1993;	Ruiz	 i	Altaba	et	al.,	1993;	Sasaki	and	Hogan,	1993)	 is	known	to	control	Shh	expression	
(Jeong	and	Epstein,	2003).	In	turn,	SHH	can	induce	Foxa2	expression	(Echelard	et	al.,	1993).	A	
scenario	in	which,	during	normal	development,	ZIC2	controls	Foxa2	expression	in	the	node	and	
its	derivative	ANC	cells	to	initiate	the	Foxa2/Shh	auto-induction	loop	and	eventually	provide	the	
SHH-based	survival	signal	to	stabilise	PrCP	cell	development	is	consistent	with	the	phenotype	
analysis	of	the	Zic2Ku/Ku	embryos.	
When	 overexpressed	 in	 mammalian	 cell	 lines,	 ZIC2	 is	 able	 to	 physically	 interact	 with	 both	
SMAD2	 and	 SMAD3	 (the	 receptor	 activated	 proteins	 that	 control	 transcription	 in	 a	 NODAL	
dependent	manner)	(Figure	1.5A).	When	bound	to	SMAD	proteins,	ZIC2	opposes	SMAD	activity	
(it	 dampens	 SMAD	 dependent	 transcription	 or	 overcomes	 SMAD	 dependent	 repression).	 In	
cultured	human	cells,	ZIC2	can	act	in	concert	with	SMAD3	to	promote	FOXA2	expression,	but	
the	 ZIC2	 protein	 encoded	 by	 the	Ku	 allele	 of	 ZIC2	 is	 unable	 to	 do	 so,	 despite	 still	 physically	
interacting	with	SMAD	(Houtmeyers	et	al.,	2016).	Overall,	the	cell	based	data,	in	combination	
with	the	genetic	evidence	that	ZIC2	is	required	to	promote	NODAL	signalling,	supports	a	model	
in	which	expression	of	node	specific	enhancers	is	initially	repressed	and	subsequently	converted	
to	 expression	 activation	 in	 the	 presence	 of	 SMAD/ZIC2	 complexes.	 The	 proposed	molecular	
interactions	between	ZIC2	and	SMAD	molecules,	 and	between	 this	 complex	and	SMAD	DNA	
binding	elements,	are	yet	to	be	demonstrated	in	vitro.	
1.8 Dorsal	forebrain	patterning	during	murine	development		
Initial	 dorsal	 forebrain	 patterning	 is	 a	 consequence	 of	 inductive	 interactions	 between	 the	
anterior	 neurectoderm	 and	 the	 adjacent	 surface	 ectoderm	 (Furuta	 et	 al.,	 1997;	 Liem	 et	 al.,	
1995).	Both	of	these	tissues	arise	during	gastrulation	(for	review	see	Arkell	and	Tam	2012)	with	
the	 origin	 of	 the	 anterior	 neurectoderm	 already	 described	 above.	 Prior	 to	 gastrulation,	
precursor	cells	for	the	surface	ectoderm	are	found	at	the	future	anterior	side	of	the	embryo,	
about	half	way	down	the	embryonic	portion	of	the	epiblast	(Figure	1.5A).	Like	the	prospective	
neurectoderm,	 these	 cells	 do	 not	 pass	 through	 the	 primitive	 streak	 during	 gastrulation	 but	
differentiate	 in	 situ	 into	 surface	 ectoderm.	 During	 gastrulation,	 the	 cells	 are	 arranged	 an	
anterior-posterior	 order,	 but	 in	 a	 more	 lateral	 position	 than	 the	 neurectoderm	 cells.	 The	
progenitors	of	another	non-neural	ectoderm	derivative,	the	neural	crest	cells	(which	gives	rise	
to	 the	 ecto-mesenchyme	 and	 cranial	 ganglia	 in	 the	 head),	 are	 juxtaposed	 between	 the	
neurectoderm	and	surface	ectoderm	cells	at	a	region	known	as	the	neural	plate	border	(Figure	
1.5B,	 7.5	 dpc).	 The	 entire	 ectoderm	 arises	 as	 a	 contiguous	 sheet	which,	 in	 a	 process	 called	
neurulation,	folds	to	form	the	neural	tube	and	overlying	surface	ectoderm.	Consequently,	cells	
from	the	medial	neural	plate	take	up	a	ventral	position	and	cells	from	the	lateral	neural	plate	
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adopt	 a	 dorsal	 position.	 Once	 the	 process	 of	 neurulation	 is	 complete,	 the	 forebrain	
neurectoderm	 at	 the	 dorsal	 midline	 continues	 its	 morphogenesis	 and,	 by	 the	 combined	
strategies	of	low	mitosis	and	high	apoptosis,	undergoes	thinning	and	invagination	to	divide	the	
cerebrum	into	two	hemispheres	(Figure	1.8A)	(Furuta	et	al.,	1997;	Groves	and	LaBonne,	2014).	
In	a	secondary	phase	of	dorsal	patterning,	inductive	interactions	between	the	invaginated	cells	
instruct	the	differentiation	of	specialised	midline	dorsal	structures.	These	include	the	choroid	
plexus	which	will	 secrete	 cerebrospinal	 fluid,	 and	 the	 cortical	 hem	which	 instructs	 adjacent	
neurectoderm	to	differentiate	into	the	hippocampus	(Groves	and	LaBonne,	2014;	Hébert	et	al.,	
2002).	
Much	of	our	knowledge	regarding	dorsal	patterning	of	the	neurectoderm	comes	mainly	from	
studies	 of	 the	 spinal	 cord	 (reviewed	 in	 Le	 Dréau	 and	Martí	 2012),	 but	 aspects	 of	 forebrain	
neurectoderm	patterning	 involve	 distinct	mechanisms.	 For	 example,	 in	 the	 forebrain,	 dorsal	
patterning	occurs	in	close	proximity	to	the	ANR,	a	source	of	morphogenetic	signals	which	sits	at	
the	rostral	junction	of	the	neural	and	surface	ectoderm	(Crossley	and	Martin,	1995;	Shimamura	
and	 Rubenstein,	 1997).	 The	 establishment	 of	 forebrain	 dorsal-ventral	 pattern	 therefore	
intersects	 and	 interacts	 with	 the	 anterior-posterior	 patterning	 system.	 Additionally,	 the	
forebrain	 neurectoderm	 arises	 earliest	 of	 all	 the	 neurectoderm	 subdivisions	 and	 dorsally	
restricted	gene	expression	patterns	 (such	as	 that	of	Pax3	 [Goulding	et	al.	1991])	are	evident	
from	the	time	of	somite	formation.	Despite	this,	the	first	overt	signs	of	dorsal	differentiation	in	
the	 forebrain	 (i.e.	 roof-plate	 thinning)	 occur	 in	 embryos	 with	 approximately	 20	 somites.	 In	
contrast,	dorsal	development	is	evident	in	the	hindbrain	24	hours	earlier	when	the	neural	crest	
first	emerges	from	the	dorsal	neurectoderm	of	the	5-somite	embryo	(Serbedzija	et	al.,	1990).	
The	 influences	 that	 promote	 dorsal	 differentiation	 in	 the	 hindbrain	 region	must	 operate	 in	
concert	with,	or	very	soon	after,	the	signals	late	in	gastrulation	that	induce	the	anterior	epiblast	
to	adopt	a	neural	fate.	Presumably	dorsal-ventral	patterning	of	the	forebrain	also	begins	during	
gastrulation	 and,	 as	 in	 other	 A-P	 regions,	 the	 early	 forebrain	 neurectoderm	 has	 a	 dorsal	
character	which	subsequently	undergoes	modification	to	direct	the	secondary	differentiation	
events	of	midline	development.	Given	the	timing	of	dorsal	differentiation,	it	is	possible	that	the	
neural	crest	derived	mesenchyme	overlying	the	dorsal	forebrain	provides	instructive	signals	to	
drive	invagination	of	the	telencephalic	midline	(Choe	et	al.,	2014),	similar	to	the	role	of	retinoic	
acid	 in	 the	 chick	 (Gupta	and	Sen,	 2016).	 There	 remains	much	 to	 learn	about	 the	 timing	and	
source	of	the	various	morphogenetic	signals	that	control	dorsal	forebrain	fate	and	a	proposed	
model	of	this	multi-step	process	is	shown	in	Figure	1.8A.	
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Figure	1.8:	Proposed	model	of	dorsal	telencephalic	midline	development	and	Zic2-associated	
MIHV	HPE.	(a)	Diagrams	of	transverse	sections	of	the	telencephalon	at	8.5	–	11.5	dpc.	Step	1:	
due	 to	 the	 influence	 of	 WNT	 and	 BMP	 signals	 from	 the	 border	 region,	 the	 forebrain	
neurectoderm	is	initially	dorsal	in	character,	as	shown	by	Zic2	expression	throughout	most	of	
the	neurectoderm.	SHH	signals	ventrally	from	the	PrCP	to	the	overlying	neurectoderm.	Step	2:	
Shh	 expression	 is	 established	 in	 the	 rostral-ventral	 neural	 midline,	 which	 overlays	 ventral	
identity	 information	 onto	 the	 neurectoderm.	WNT	 and	 BMP	 signalling,	 and	 Zic2	 expression	
become	restricted	to	the	dorsal	half	of	the	neurectoderm.	Step	3:	once	neurulation	is	complete	
and	 the	 surface	 ectoderm	overlies	 the	 neurectoderm,	 neural	 crest	 cells	migrate	 in	 from	 the	
hindbrain	and	surround	the	dorsal	neurectoderm.	The	dorsal-most	neurectoderm	cells	exit	the	
cell	cycle.	Step	4:	The	neural	crest	cells	expand	under	the	influence	of	WNT	signalling	and	the	
dorsal	neurectoderm	cells	undergo	apoptosis,	leading	to	thinning	and	invagination	of	the	roof-
plate.	Zic2	expression	 initiates	 in	 the	ventral	midline.	Step	5:	BMP	and	WNT	signalling	 in	 the	
invaginated	tissues	induce	the	cortical	hem,	choroid	plexus	epithelium	and	the	hippocampus.	
(b)	 In	Zic2kd/kd	embryos	at	9.0	 -	9.5	dpc,	WNT	expression	 in	 the	surface	ectoderm	 is	delayed.	
Consequently,	dorsal	neurectoderm	cells	do	not	exit	the	cell	cycle	and	neural	crest	infiltration	is	
reduced.	At	10.5	dpc	the	dorsal	cells	do	not	undergo	apoptosis	and	 invagination	of	the	roof-
plate	does	not	occur.	Though	there	are	few	neural	crest	cells,	WNT	expression	is	initiated.	By	
11.5	 dpc,	 dorsal	 midline	 structures	 are	 absent	 or	 hypoplastic,	 resulting	 in	 MIHV.	 PrCP:	
prechordal	 plate,	 NE:	 neurectoderm,	 SE:	 surface	 ectoderm,	 FPl:	 floor-plate,	 PhE:	 pharangeal	
endoderm,	 RPl:	 roof-plate,	 NCC:	 neural	 crest	 cells,	 CH:	 cortical	 hem,	 ChPE:	 choroid	 plexus	
epithelium.		
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The	identity	of	the	molecular	signals	that	instruct	dorsal	patterning	has	been	elusive,	perhaps	
because	 of	 redundancy	 or	 the	 iterative	 use	 of	 the	 same	 signalling	 pathway	 during	 dorsal	
patterning	and	midline	structure	differentiation	 (Figure	1.8).	Members	of	 the	BMP	and	WNT	
signalling	molecule	families	are	expressed	in	a	spatial-temporal	manner	consistent	with	a	role	
in	dorsal	neural	patterning.	Five	BMP	ligands	(BMP2,	BMP4-7)	are	expressed	at	the	future	dorsal	
midline	in	the	forebrain	neurectoderm	and	surface	ectoderm.	Embryos	null	for	either	Bmp4	or	
Bmp2	die	before	neurulation	is	complete	(Winnier	et	al.,	1995;	Zhang	and	Bradley,	1996),	whilst	
Bmp4	conditional	mutants	develop	a	phenotypically	normal	telencephalon	(Hébert	et	al.,	2003).	
Similarly,	no	neural	phenotype	is	seen	in	Bmp5,	6	and	7	mutants	(Dudley	et	al.,	1995;	Kingsley	
et	al.,	1992;	Luo	et	al.,	1995;	Solloway	et	al.,	1998).	A	role	in	the	relatively	late	events	of	dorsal	
forebrain	patterning	is,	however,	revealed	when	the	BMP-specific	receptors	are	mutated	in	a	
time	and	tissue	dependent	manner.	Animals	that	are	constitutive	null	for	Bmpr1b	and	in	which	
Bmpr1a	is	deleted	in	the	telencephalon	at	~	9.0	dpc	do	not	show	the	characteristic	thinning	of	
the	roof-plate	at	10.5	dpc	that	is	required	for	dorsal	hemisphere	separation.	Subsequently,	they	
exhibit	MIHV	HPE	and	loss	of	all	dorsal	midline	cell	types	(i.e.	the	choroid	plexus	and	cortical	
hem	 fail	 to	 form)	 despite	 maintenance	 of	 Zic2	 expression.	 The	 specification	 of	 ventral	 and	
cortical	cell	types,	however,	remain	unaffected	(Fernandes	et	al.,	2007).	Once	the	midline	cells	
invaginate,	BMP	expression	is	initiated	in	the	choroid	plexus	epithelium	anlagen	(Currle	et	al.,	
2005)	and	overexpression	of	a	constitutively	active	BMPR1a	transforms	cortical	precursors	into	
choroid	plexus	cells	(Panchision	et	al.,	2001),	suggesting	BMP	signalling	induces	choroid	plexus	
cell	fate.	When	the	roof-plate	is	ablated	prior	to	differentiation	of	the	choriod	plexus	and	cortical	
hem,	these	structures	fail	to	form.	The	expression	of	some	dorsal	midline	genes	(but	not	Zic2)	
can	be	rescued	in	tissue	explants	from	roof-plate-ablated	embryos,	however,	by	culture	in	BMP4	
(Cheng	et	al.,	2006).	These	experiments,	therefore,	establish	a	primary	role	for	BMP	signalling	
in	the	prevention	of	MIHV	HPE.	
Similarly,	Wnt1	and	Wnt3a	are	expressed	in	the	future	dorsal	neurectoderm	along	the	length	of	
the	 axis	 prior	 to	 neural	 tube	 closure,	 and	 in	 the	 roof-plate	 following	 closure	 (Megason	 and	
McMahon,	 2002;	 Parr	 et	 al.,	 1993).	 In	 the	 canonical	WNT	 signalling	 pathway	 (Figure	 1.6D),	
binding	of	WNT	ligand	to	a	cognate	receptor	complex	stimulates	a	cascade	of	cytoplasmic	events	
culminating	in	β-catenin	nuclear	entry.	Nuclear	β-catenin	associates	with	transcription	factors	
of	the	TCF/LEF	family	and	converts	target	gene	repression	to	activation	(reviewed	in	Arkell	et	al.	
2013).	WNTs	were	primarily	considered	mitogenic	signals	for	the	neurectoderm	until	elevated	
WNT	 signalling	was	 shown	 to	alter	progenitor	 gene	expression	along	 the	dorsal-ventral	 axis,	
promoting	 the	 production	 of	 dorsal	 progenitors	 and	 suppressing	 ventral	 progenitors.	 WNT	
signalling	acts	via	TCF/LEF	dependent	evolutionarily	conserved	enhancers	to	establish	the	dorsal	
domain	of	Gli3	expression	(Yu	et	al.,	2008).	In	turn,	GLI3,	acting	as	a	transcriptional	repressor,	
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inhibits	the	ventrally	produced	SHH	signal	(Alvarez-Medina	et	al.,	2007).	This	interplay	of	SHH	
and	WNT	signalling	may	also	be	relevant	for	telencephalon	patterning	as	evidenced	by	the	effect	
of	differential	regulation	of	GLI3	upon	the	ventral	and	dorsal	telencephalic	neuronal	subtypes	
generated	from	human	embryonic	stem	cells	(Li	et	al.,	2009).	A	further	role	for	WNT	signalling	
at	later	stages	of	roof-plate	development	is	revealed	by	conditional	deletion	of	b-catenin	in	the	
neural	crest	cells	abutting	the	telencephalic	neurectoderm	which	causes	a	failure	of	neural	crest	
cell	expansion	and	of	telencephalic	midline	invagination	(Choe	et	al.,	2014).	
In	the	forebrain,	the	dorsal-ventral	morphogenetic	signals	of	SHH,	BMP	and	WNT	intersect	those	
provide	by	the	ANR;	a	source	of	FGF	 ligands	(FGF8,	FGF15/19,	FGF17	and	FGF18).	When	FGF	
ligands	bind	to	tyrosine	kinase	receptors	(FGFR),	multiple	signalling	pathways	are	activated	such	
as	the	RAS/MAPK,	PLC-γ,	PI3K	and	STAT	pathways	(Dailey	et	al.,	2005)	(Figure	1.6E).	When	FGF	
signalling	in	the	telencephalon	is	attenuated	or	abolished	via	mutation	of	Fgf8,	the	FGF	receptor	
Fgfr1	alone,	or	other	receptor	combinations,	mice	exhibit	telencephalic	hypoplasia.	In	embryos	
lacking	Fgfr1	and	Fgfr2	in	the	telencephalon,	the	decreased	size	of	the	forebrain	is	attributed	to	
reduced	cell	proliferation	 in	 the	ventral	midline	along	with	 increased	apoptosis	 in	 the	dorsal	
midline	(Gutin	et	al.,	2006;	Storm	et	al.,	2006).	Defects	in	these	animals	resemble	those	defects	
associated	with	the	ventral	forms	of	HPE.	As	reviewed	by	Hoch	et	al.	(2009),	there	is	a	complex	
series	of	interdependencies	between	the	forebrain	signalling	centres.	For	example,	the	ventral	
SHH	signal	maintains	rostral	midline	FGF	ligand	expression	(Hayhurst	et	al.,	2008;	Ohkubo	et	al.,	
2002)	and	simultaneously,	the	dorsal	neurectoderm	expression	of	the	repressor	form	of	GLI3	
(GLI3R)	 represses	 FGF	 ligand	dorsally	 (Theil	et	 al.,	 1999).	 Similarly,	 the	 rostral	 source	of	 FGF	
works	via	the	Foxg1	transcription	factor	(Gutin	et	al.,	2006;	Hébert	and	Fishell,	2008)	to	inhibit	
BMP	signalling,	thus	maintaining	rostral	proliferation	and	preventing	premature	differentiation	
of	neuronal	progenitor	cells	 (Dou	et	al.,	2000,	1999;	Hanashima	et	al.,	2004;	Shimamura	and	
Rubenstein,	 1997).	 Human	 genetics	 indicates	 that	 anterior	 FGF	 signalling	 impacts	 dorsal	
forebrain	patterning	(Dubourg	et	al.,	2016)	but,	despite	evidence	that	FGF	signalling	can	control	
Zic2	 expression	 in	 the	 9.5	 dpc	 telencephalon	 (Hayhurst	 et	 al.,	 2008;	 Okada	 et	 al.,	 2008),	 it	
remains	unclear	whether	FGF	control	of	Zic2	expression	plays	a	role	in	Zic2-associated	MIHV.	
1.9 Zic2	mutation	and	dorsal	forebrain	patterning		
Partial	loss-of-function	alleles	of	murine	Zic2	result	in	MIHV	HPE,	suggesting	an	involvement	for	
ZIC2	 protein	 in	 dorsal	 neural	 patterning	 and	 differentiation	 (Nagai	 et	 al.	 2000).	 Late	 in	
gastrulation,	as	the	neural	plate	is	forming,	Zic2	expression	recedes	from	the	posterior	embryo	
proper	 and	 becomes	 restricted	 to	 the	 anterior	 neuroectoderm.	 By	 this	 time,	 Zic3	 and	 Zic5	
expression	is	also	restricted	to	this	region.	The	expression	of	each	of	these	genes	then	subsides	
in	 the	 medial	 neural	 plate,	 becoming	 progressively	 confined	 to	 the	 lateral	 (future	 dorsal)	
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neuroectoderm	and	the	flanking	surface	ectoderm	(Elms	et	al.,	2004;	Houtmeyers	et	al.,	2013).	
After	 the	neural	 tube	closes,	high	 levels	of	Zic2	 expression	can	be	detected	along	 the	entire	
anterior-posterior	extent	of	the	neural	tube	including	the	dorsal	telencephalon	(roof-plate	and	
hippocampal	primordium)	(Cheng	et	al.,	2006;	Okada	et	al.,	2008)	with	extensive	overlap	in	this	
expression	domain	of	all	Zic	family	members.	Zic2	is	therefore	expressed	in	a	manner	consistent	
with	a	role	in	dorsal	patterning	and	indeed,	loss-of-function	mutations	in	Zic2	lead	to	defects	in	
neural	crest	development,	a	dorsal	cell	type	of	the	hindbrain	and	spinal	cord	(Elms	et	al.,	2003;	
Nagai	et	al.,	2000).	
Embryos	homozygous	for	a	hypomorphic	allele	of	Zic2	in	which	reduced	amounts	of	the	normal	
transcript	 are	 produced	 (Nagai	et	 al.,	 2000)	 lack	 a	 telencephalic	 roof-plate	 at	mid-gestation.	
After	 neural	 tube	 closure	 in	 wild	 type	 embryos,	 the	 dorsal	 midline	 of	 the	 telencephalon	
immediately	becomes	devoid	of	mitotic	cells	and,	within	24	hours,	apoptosis	 in	 this	 tissue	 is	
noticeably	higher	than	in	the	surrounding	tissues	(Figure	1.8A).	Zic2kd/kd	embryos	exhibit	neither	
of	 these	 features	 and,	 consequently,	 roof-plate	 thinning	 and	 invagination	 does	 not	 occur.	
Subsequently,	the	structures	that	should	be	derived	from	the	dorsal	midline	are	either	severely	
hypoplastic	or	absent	(Figure	1.8B).	At	this	stage	of	development,	Wnt3a	should	be	expressed	
in	the	dorsal	midline	of	the	forebrain	and	along	the	spinal	cord	until	the	position	of	the	forelimb	
bud.	In	Zic2kd/kd	embryos	this	expression	is	delayed	such	that	it	has	only	just	been	initiated	in	the	
dorsal	forebrain	(Nagai	et	al.	2000).	This	work	firmly	connects	ZIC2	function	to	the	MIHV	form	
of	 HPE,	 but	 many	 questions	 remain	 unanswered	 regarding	 the	 role	 of	 ZIC2	 in	 roof-plate	
formation.	For	example,	 it	 is	not	known	precisely	when	the	process	of	dorsal	patterning	and	
roof-plate	induction	fails	 in	Zic2kd/kd	embryos.	This	may	reflect	a	role	for	ZIC2	in	earlier	dorsal	
patterning	 events	 rather	 than	 roof-plate	 induction,	 per	 se.	 It	 is	 also	 not	 clear	 whether	 the	
expression	of	Zic2	 in	the	neurectoderm,	flanking	surface	ectoderm	or	both	tissues	is	required	
for	roof-plate	formation.	Alternatively,	it	is	possible	that	the	documented	role	of	ZIC2	in	neural	
crest	cell	development	is	important	since	in	Zic2kd/kd	embryos	there	is	an	evident	lack	of	neural	
crest	 cells	 in	 the	 intrahemispheric	 mesenchyme.	 Furthermore,	 ZIC2	 is	 known	 to	 be	 able	 to	
physically	interact	with	transcriptional	mediators	of	the	WNT,	TGF-β	and	SHH	pathways	(Fujimi	
et	al.,	2012;	Houtmeyers	et	al.,	2016;	Koyabu	et	al.,	2001;	Pourebrahim	et	al.,	2011)	and	whether	
it	does	so	during	dorsal	patterning	is	unknown.	The	experiments	on	Zic2kd/kd	embryos	highlight	
that	roof-plate	formation	and	dorsal	midline	development	are	particularly	sensitive	to	loss	of	
ZIC2	levels,	with	a	reduction	of	Zic2	expression	to	~20%	sufficient	to	generate	MIHV	HPE	in	mice	
(Nagai	et	al.,	2000).	
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1.10 The	dual	role	of	Zic2	in	HPE		
Current	knowledge	indicates	that	ZIC2	plays	two	distinct	roles	in	forebrain	development.	At	mid-
gastrulation,	 ZIC2	 functions	 at	 the	 node	 to	 shape	 the	 NODAL	 gradient.	 Severe	 Zic2	 loss-of-
function	mutations	lead	to	a	transient	failure	in	the	production	of	the	ANC	and,	consequently,	
PrCP	 fate	 is	not	stabilised.	As	such,	 the	SHH	signal	 is	not	sent	 from	the	PrCP	and	the	ventral	
forebrain	signalling	centre	is	not	established,	resulting	in	gross	perturbations	in	forebrain	D–V	
pattern	 and	 classic	 HPE.	 This	 requirement	 appears	 well	 buffered,	 as	mild	 loss-of-function	 is	
compatible	with	correct	function	of	the	ventral	forebrain	signalling	centre	in	man	and	mouse.	A	
second	 requirement	 for	 ZIC2	 function	 occurs	 in	 the	 dorsal	 neurectoderm	 of	 the	 developing	
telencephalon	where	it	acts	to	promote	formation	of	the	dorsal	signalling	centre	responsible	for	
roof-plate	 and	 choroid	 plexus	 development.	 It	 is	 clear	 that	 a	 failure	 of	 ZIC2	 function	 in	 the	
developing	dorsal	 forebrain	 results	 in	MIHV,	but	 just	how	ZIC2	 intersects	 the	 interconnected	
forebrain	signalling	network	is	unknown.	This	requirement	appears	more	sensitive	to	ZIC2	levels	
than	ventral	forebrain	patterning,	as	hypomorphic	mutations	have	been	associated	with	MIHV	
in	both	man	and	mouse	(Brown	et	al.,	2005,	2001;	Nagai	et	al.,	2000;	Solomon	et	al.,	2010a).	
The	precise	molecular	role	of	ZIC2	 in	both	classic	and	MIHV	HPE,	and	how	ZIC2	expression	 is	
regulated	in	the	gastrulating	embryo,	however,	remain	a	subject	of	ongoing	investigation.	
1.11 Non-coding	conserved	elements	at	the	ZIC2	locus		
In	 contrast	 to	 the	 coding	 genome,	 the	 size	 of	 the	 non-coding	 genome	 scales	 with	 organ	
complexity	 (Levine	and	Tjian,	2003),	and	researchers	have	begun	to	elucidate	the	role	of	the	
non-coding	 genome	 in	 regulating	 gene	 expression.	 Comparative	 genomics	 can	 be	 used	 to	
identify	coding	regions	that	may	be	important	for	the	control	of	gene	expression.	Since	DNA	that	
is	 non-essential	 for	 an	 organisms	 survival	 accrues	 nucleotide	 variation	 such	 as	 insertions,	
deletions	and	SNVs,	the	relatively	slow	evolving	(or	conserved)	sequences	within	the	genome	
can	be	catalogued	via	cross-species	genome	comparisons	(Katzman	et	al.,	2007;	Vavouri	et	al.,	
2007;	Vavouri	and	Lehner,	2009).	These	sequences	have	been	 termed	non-coding	conserved	
elements	(NCEs),	with	studies	showing	NCEs	are	frequently	more	conserved	than	protein	coding	
genes	 (Bejerano	et	 al.,	 2004;	Woolfe	et	 al.,	 2005)	 and	are	300	 times	 less	 likely	 to	be	 lost	 in	
evolution	than	neutrally	evolving	DNA	(McLean	and	Bejerano,	2008).	The	compact	genome	of	
the	pufferfish	(Takifugu	rubripes),	who	last	shared	a	common	ancestor	with	humans	450	million	
years	ago,	contains	1,373	NCEs	that	show	84%	similarity	to	human	and	mouse	NCEs	(Woolfe	et	
al.,	 2005).	 Up	 to	 92%	 of	 these	 conserved	 sequences	 exhibit	 enhancer	 activity	 in	 zebrafish	
reporter	assays,	and	50%	exhibit	activity	in	mouse	reporter	assays	(Visel	et	al.,	2008;	Woolfe	et	
al.,	2005).	A	large	portion	of	NCEs	identified	so	far	are	associated	with	transcription	factors	and	
signalling	molecules	essential	 for	embryo	development	 (Bejerano	et	al.,	 2004;	Woolfe	et	al.,	
2005).	Similar	to	developmental	genes,	both	vertebrate	and	invertebrate	NCEs	tend	to	cluster	
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together	 in	 genomic	 regions	 on	 chromosomes	 (Bejerano	 et	 al.,	 2004;	 Vavouri	 et	 al.,	 2007;	
Woolfe	 et	 al.,	 2005),	 with	 their	 target	 genes	 commonly	 within	 a	 few	 megabases	 distance	
(Vavouri	et	al.,	2006).	ZIC1,	ZIC2	and	ZIC4	have	all	previously	been	associated	with	such	clusters	
of	NCEs	in	vertebrates,	nematodes	and	arthropods	(Vavouri	et	al.,	2007).		
In	2012,	Roessler	et	al.	at	 the	National	Human	Genome	Research	 Institute	 (NHGRI),	National	
Institute	 of	 Health	 (NIH)	 used	 EvoPrint	 and	 ECRbase	 to	 screen	 for	 NCEs	 in	 ZIC2	 and	 the	
surrounding	10	 kb	of	DNA,	 identifying	 an	804	bp	 conserved	 structure	within	 the	ZIC2	 3’UTR	
(Figure	 1.9)	 (Roessler	 et	 al.,	 2012a).	 Furthermore,	 the	 study	 identified	 six	 single	 nucleotide	
variants	(SNVs)	in	the	NCE	of	seven	HPE	probands	(Figure	1.9,	Table	1.5),	none	of	which	were	
found	 in	 control	 populations,	 indicating	 the	 region	 was	 under	 selective	 pressure.	 It	 was	
therefore	 hypothesised	 that	 this	 NCE	 regulates	 ZIC2	 expression	 during	 embryogenesis	 and	
prevents	 HPE	 development.	 The	 exact	 nature	 of	 this	 regulation,	 however,	 remains	 to	 be	
determined,	and	could	occur	at	either	the	transcription	or	the	post-transcription	stages	of	gene	
expression.	 The	 NCE	 could	 act	 as	 an	 enhancer/repressor	 element	 (ER	 element),	 regulating	
transcription	of	a	target	gene	via	the	binding	of	protein	complexes	to	transcription	factor	binding	
sites	(TFBSs)	within	the	NCE.	The	NCE	may	also	transcribe	non-coding	RNAs	(ncRNAs)	such	as	
MicroRNAs	 (miRNA),	 Long	 Non-Coding	 RNAs	 (lncRNA)	 or	 Small	 Interfering	 RNAs	 (siRNA;	
Kaikkonen	et	al.,	2011).	Finally,	as	the	NCE	is	situated	within	the	3’UTR,	it	could	direct	mRNA	
transcript	stability	and	decay,	transcript	polyadenylation,	or	mRNA	localisation	and	translation	
(Barrett	 et	 al.,	 2012).	 It	 is	 likely	 that	 a	 combination	 of	 these	 processes	 are	 to	 regulate	 ZIC2	
transcription	during	embryogenesis.		
1.12 Scope	of	this	Thesis	
This	 study	 used	 a	 combination	 of	 mouse	 genetics	 and	 heterologous	 reporter	 assays	 to	
investigate	two	unexplored	areas	of	ZIC2-associated	HPE:	
i. Do	 the	 node	 defects	 which	 underlie	 Zic2-associated	 classic	 HPE	 also	 impact	 the	
establishment	of	the	 left-right	axis	at	gastrulation,	resulting	 in	co-morbidities	such	as	
cardiac	defects?	
ii. Are	the	six	SNVs	in	the	ZIC2	3’UTR	likely	to	be	pathogenic?			
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Figure	1.9:	The	ZIC2	3’UTR	and	NCE.	Roessler	et	al.	identified	an	804	bp	Non-Coding	Conserved	
Element	(NCE)	(red)	in	the	ZIC2	3’UTR	(yellow).	Genetic	screens	of	human	HPE	patients	identified	
six	SNVs	in	this	NCE	region	(shown)	and	two	polymorphisms	(not	shown).		
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Table	1.5:	The	six	human	ZIC2	3’UTR	mutations	and	two	polymorphisms.	This	table	is	modified	from	(Roessler	et	al.,	2012a).	MAF:	minor	allele	frequency	
(%)	in	a	HPE	cohort	and	a	control	cohort.	Variants	were	identified	in	a	cohort	of	528	HPE	patients	and	compared	to	a	control	population	of	≥372	individuals	
of	mixed	ethnicity.		
	
	
	
	
	
	
	
	
	
	
	
	
a	–	common	variant	in	healthy	individuals	
b-	affected	sibling	of	proband	LCL301.		
c	–	in	cis	with	enhancer	variant	by	co-amplification	and	sequencing	 	
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Name	 Variant	 Subject	 Inheritance	 ZIC2	coding	mutations	 Other	HPE	
mutations	
HPE	type	 MAF	(HPE)	 MAF	
(control)	
Poly	 c.1599*456G>A	 Rs13542	
dbSNP	
N.A.	 N.A.	 N.A.	 Unknown	 NA	 33.00	
M1	 c.1599*578T>A	 LCL1349	 Mat	negative	
Pat	N.A.	
-	 SHH	-	c.419A>C	
p.His140Pro	(Mat)	
Microform	 0.095	 0.00	
Poly	 c.1599*587G>T	 FB9622	
LCL7282	
LCL6386	
N.A.	
N.A.	
N.A.	
-	
-	
-	
TGIF	–	c.487C>T	
p.Pro163Sera	
-	
-	
Unknown	 0.280	 0.66	
M2	 c.1599*836C>T	 Brz2172	 N.A.	 c.1215dupC	p.Ser406Glnfs*11c	 N.A.	 Unknown	 0.095	 0.00	
M3	 c.1599*889T>C	 AM6632	 N.A.	 -	 TGIF	–	c.420A>G	
p.Pro140Pro	
TGIF	–	c.488C>T	
p.Prop163Leua	
Alobar	 0.095	 0.00	
M4	 c.1599*899A>G	 LCL301	
LCL7897b	
Pat	positive	
	
c.1059C>T	p.His353His	 SHH	-	c.72C>A	
p.cys24*(Pat)	
Microform	 0.190	 0.00	
M5	 c.1599*954T>A	 Brz37	 N.A.	 N.A.	 N.A.	 Unknown	 0.095	 0.00	
M6	 c.1599*966A>G	 LCL7828	 Mat	positive	
Pat	N.A.	
c.1059C>T	p.His353His	 -	 Semilobar	 0.095	 0.00	
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Chapter	2: Methods	
	
2.1 Generation	of	Constructs	
The	complete	 list	of	 constructs	used	 in	 this	 thesis	can	be	 found	 in	Appendix	Table	A1.1.	The	
following	constructs	were	generated	by	myself,	unless	otherwise	stated:	
2.1.1 Expression	Constructs	
pENTR3C-Foxa2	–	The	1380	bp	murine	Foxa2	coding	DNA	sequence	(CDS)	was	amplified	from	
pBSK-Foxa2	(Sasaki	and	Hogan,	1993)	using	oligonucleotides	containing	XhoI	and	SalI	restriction	
sites	 (RA1825	 and	 RA1824;	 Appendix	 Table	 A1.2).	 Following	 ammonium	 acetate	 clean	 up	
(Section	2.2.10),	 the	Foxa2	 fragment	and	Gateway	Entry	vector	pENTR3C	were	digested	with	
XhoI	and	SalI,	releasing	the	ccdB	gene	fragment	from	pENTR3C.	The	Foxa2	fragment	was	ligated	
into	pENTR3C	via	traditional	T4	ligation	methods.	In	the	subsequent	pENTR3C-Foxa2	construct,	
attL	sites	flank	the	Foxa2	CDS	for	Gateway	LR	based	cloning.	
pV5-Foxa2	–	pV5-Foxa2	was	generated	via	Gateway	LR	cloning	(Section	2.2.14)	of	the	pcDNA3.1-
nV5-DEST	(Invitrogen)	Destination	vector	and	pENTR3C-Foxa2.	The	Foxa2	fragment	was	inserted	
into	pcDNA3.1-nV5-DEST	3’	to	the	V5	epitope	tag.		
pENTR1A-Foxj1	–	The	1266	bp	murine	Foxj1	CDS	was	amplified	from	pYX-ASC-Foxj1	(Cruz	et	al.,	
2010)	using	oligonucleotides	 containing	KpnI	 and	NotI	 restriction	 sites	 (RA1545	and	RA1546;	
Appendix	Table	A1.2).	Following	ammonium	acetate	clean	up,	the	Foxj1	fragment	and	Gateway	
Entry	 vector	 pENTR1A	were	 digested	with	KpnI	 and	NotI,	 releasing	 the	 ccdB	 fragment	 from	
pENTR1A.	The	Foxj1	fragment	was	ligated	into	pENTR1A	via	traditional	T4	ligation	methods.	In	
the	subsequent	pENTR1A-Foxj1	construct,	attL	sites	flank	the	Foxj1	CDS	for	Gateway	LR	based	
cloning.	
pV5-Foxj1	 –	 pV5-Foxj1	 was	 generated	 via	 Gateway	 LR	 cloning	 of	 the	 pcDNA3.1-nV5-DEST	
(Invitrogen)	 Destination	 vector	 and	 pENTR1A-Foxj1.	 The	 Foxj1	 fragment	 was	 inserted	 into	
pcDNA3.1-nV5-DEST	3’	to	the	V5	epitope	tag.		
pENTR2B-NOGGIN	–	The	699	bp	human	NOGGIN	CDS	 (Accn.	No.	NM_005450)	was	amplified	
from	 HEK293T	 genomic	 DNA	 via	 oligonucleotides	 containing	 KpnI	 and	NotI	 restriction	 sites	
(RA1776	 and	 RA1777;	 Appendix	 Table	 A1.2).	 Following	 ammonium	 acetate	 clean	 up,	 the	
NOGGIN	 fragment	 and	 Gateway	 Entry	 vector	 pENTR2B	 were	 digested	 with	 KpnI	 and	 NotI,	
releasing	the	ccdB	fragment	from	pENTR2B.	The	NOGGIN	fragment	was	ligated	into	pENTR2B	
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via	traditional	T4	 ligation	methods.	 In	the	subsequent	pENTR2B-NOGGIN	construct,	attL	sites	
flank	the	NOGGIN	CDS	for	Gateway	LR	based	cloning.	
pV5-NOGGIN	–	pV5-NOGGIN	was	generated	via	Gateway	LR	cloning	of	the	pcDNA3.1-nV5-DEST	
(Invitrogen)	Destination	vector	and	pENTR2B-NOGGIN.	The	NOGGIN	fragment	was	inserted	into	
pcDNA3.1-nV5-DEST	3’	to	the	V5	epitope	tag.		
pENTR3C-ZIC2	–	The	1599	bp	human	ZIC2	CDS	was	cloned	into	pENTR3C	by	Jerry	Ahmed	(Arkell	
laboratory).	 In	 the	 subsequent	 pENTR3C-ZIC2	 construct,	 attL	 sites	 flank	 the	 ZIC2	 CDS	 for	
Gateway	LR	based	cloning.	
pV5-ZIC2	–	pV5-ZIC2	was	generated	by	Radiya	Ali	(Arkell	laboratory)	via	Gateway	LR	cloning	of	
the	pcDNA3.1-nV5-DEST	(Invitrogen)	Destination	vector	and	pENTR3C-ZIC2.	The	ZIC2	fragment	
was	inserted	into	pcDNA3.1-nV5-DEST	3’	to	the	V5	epitope	tag.		
pGEM-3’UTR-WT	–	the	1086	bp	wildtype	ZIC2	3’UTR	was	amplified	from	HEK293T	genomic	DNA	
via	oligonucleotides	containing	XhoI	restriction	sites	(RA1596	and	RA1597;	Appendix	Table	A1.2)	
and	 TA	 cloned	 into	 pGEM-T-Easy	 using	 the	 pGEM-T-Easy	 Vector	 System	 (Cat.	 No.	 A1360,	
Promega).		
pV5-ZIC2-3’UTR	–	pGEM-3’UTR-WT	and	pV5-ZIC2	were	digested	with	XhoI	to	release	the	ZIC2	
3’UTR	fragment	and	linearize	pV5-ZIC2.	The	ZIC2	3’UTR	fragment	was	gel	extracted	and	purified,	
whilst	 pV5-ZIC2	 was	 treated	 with	 Antarctic	 Phosphatase	 to	 remove	 the	 5’	 phosphate	 and	
minimise	self-ligation,	and	purified	via	ammonium	acetate	clean	up.	The	products	were	ligated	
via	traditional	T4	methods	and	the	final	pV5-ZIC2-3’UTR	construct	isolated	via	bacterial	colony	
polymerase	chain	reaction	(PCR).	This	construct	was	created	with	the	help	of	Kathryn	Dickson	
(Arkell	laboratory).		
2.1.2 Luciferase	Assay	Constructs	
pGL4.20-DEST-luc	 –	 pGL4.20-luc	 was	 converted	 into	 a	 Destination	 vector	 via	 the	 Gateway®	
Vector	Conversion	System	(Invitrogen).	pGL4.20-luc	was	digested	with	EcoRV	to	 linearize	 the	
vector	and	purified	via	ammonium	acetate	clean	up.	It	was	then	taken	through	the	Gateway®	
Vector	 Conversion	 System	 to	 ligate	 the	Destination	Reading	 Cassette	A	 into	 the	 pGL4.20-luc	
multiple	cloning	site	(MCS).		
pGL-b-globin-DEST-luc	 -	pGL4.20-DEST-luc	was	digested	with	HindIII	and	BglII	 to	 linearize	the	
vector	and	purified	via	ammonium	acetate	clean	up.	The	b-globin	minimal	promoter	was	PCR	
amplified	 from	pKS:b-globin:lacZ	with	oligonucleotides	containing	HindIII	and	BglII	 restriction	
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sites	(RA1506	and	RA1507;	Appendix	Table	A1.2).	The	amplicon	was	subsequently	digested	and	
ligated	into	the	linearised	pGL4.20-DEST-luc	via	traditional	ligation	methods.		
pGEM-T-Easy-Hsp68	-	The	heat	shock	protein	68	(Hsp68)	minimal	promoter	was	PCR	amplified	
from	pBS-Hsp68	with	oligonucleotides	containing	HindIII	and	BglII	restriction	sites	(RA1640	and	
RA1626;	Appendix	Table	A1.2).	The	amplicon	was	TA	cloned	into	pGEM-T-Easy	to	create	pGEM-
T-Easy-Hsp68.		
pGL-Hsp68-DEST-luc-	pGL4.20-DEST-luc	and	pGEM-T-Easy-Hsp68	were	digested	with	HindIII	and	
BglII	to	linearize	the	vector	and	release	the	Hsp68	minimal	promoter,	respectively.	The	Hsp68	
minimal	promoter	was	gel	extracted	and	purified,	and	pGL4.20-DEST-luc	purified	via	ammonium	
acetate	 clean	 up.	 The	 Hsp68	 fragment	 was	 ligated	 into	 the	 linearised	 pGL4.20-DEST-luc	 via	
traditional	ligation	methods.	
pGL-pZIC3-DEST-luc-	pGL4.20-DEST-luc	and	pGl-pZIC3-luc	were	digested	with	HindIII	and	KpnI	to	
linearize	 the	 vector	 and	 release	 the	ZIC3	promoter,	 respectively.	 The	ZIC3	 promoter	was	 gel	
extracted	and	purified,	and	pGL4.20-DEST-luc	purified	via	ammonium	acetate	clean	up.	The	ZIC3	
fragment	was	ligated	into	the	linearised	pGL4.20-DEST-luc	via	traditional	ligation	methods.	
pGL4.20-b-globin-NCE	(wildtype)	–	pGL4.20-b-globin-NCE	with	the	wildtype	NCE	was	generated	
via	Gateway	LR	cloning	of	the	pGL-b-globin-DEST-luc	Destination	vector	and	pCR8-GW-TOPO-
NCE.	The	ZIC2	NCE	 fragment	was	 inserted	 into	pGL-b-globin-DEST-luc	5’	to	the	promoter	and	
luciferase	gene.	
pGL4.20-Hsp68-NCE	(wildtype)	–	pGL4.20-Hsp68-NCE	with	the	wildtype	NCE	was	generated	via	
Gateway	 LR	 cloning	of	 the	pGL-Hsp68-DEST-luc	 Destination	 vector	 and	pCR8-GW-TOPO-NCE.	
The	ZIC2	NCE	fragment	was	inserted	into	pGL-Hsp68-DEST-luc	5’	to	the	promoter	and	luciferase	
gene.	
pGL4.20-pZIC3-NCE	 (wildtype	and	mutant)	–	pGL4.20-pZIC3-NCE	with	 the	wildtype	NCE	was	
generated	via	Gateway	LR	cloning	of	the	pGL-pZIC3-DEST-luc	Destination	vector	and	pCR8-GW-
TOPO-NCE.	The	ZIC2	NCE	fragment	was	inserted	into	pGL-pZIC3-DEST-luc	5’	to	the	promoter	and	
luciferase	gene.	
2.1.3 Whole	Mount	In	Situ	Hybridization	(WMISH)	Riboprobes	
pGEM-T-Easy-Dand5	-	To	make	the	Dand5	(previously	Cerl2)	probe,	an	888	bp	fragment	of	exon	
2	 and	 3’UTR	 from	mouse	Dand5	 was	 amplified	 from	mouse	 genomic	 DNA	 (NCBI	 Accn.	 No:	
NR033145)	using	oligonucleotides	RA1570	and	RA1571	 (Appendix	Table	A1.2)	and	TA	cloned	
into	pGEM-T-Easy	using	the	pGEM-T-Easy	Vector	System	(Cat.	No.	A1360,	Promega).		
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pGEM-T-Easy-Rfx3	-	To	make	the	Rfx3	probe,	a	472	bp	fragment	of	exon	16	and	the	3’UTR	of	
mouse	 Rfx3	 was	 amplified	 from	 mouse	 genomic	 DNA	 (NCBI	 Accn.	 No.	 NM011265)	 using	
oligonucleotides	RA1592	and	RA1593	(Appendix	Table	A1.2)	and	TA	cloned	into	pGEM-T-Easy	
using	the	pGEM-T-Easy	Vector	System.	
pGEM-T-Easy-Noto	-	To	make	the	Noto	probe,	a	386	bp	fragment	of	the	5’UTR	and	exon	1	of	
mouse	Noto	was	amplified	from	mouse	genomic	DNA	(NCBI	Accn.	No.	NM001007472.2)	using	
oligonucleotides	RA1590	and	RA1591	(Appendix	Table	A1.2)	and	TA	cloned	into	pGEM-T-Easy	
using	the	pGEM-T-Easy	Vector	System.	
2.1.4 PiggyBac	Transposon	Constructs	
pBB262-lacZ	-	p1229	and	pBB262	were	digested	with	XbaI	and	XhoI.	The	lacZ	fragment	released	
from	 p1229	 was	 gel	 extracted	 (Section	 2.1.9)	 and	 ligated	 into	 linearized	 pBB262.	 Following	
electrotransformation	into	DH5a	Escherichia	coli	(E.	coli),	blue-white	colony	screening	was	used	
to	select	colonies	containing	the	pBB262-lacZ	construct.	
pBB262-ZIC2	NCE	(wildtype	and	mutant)	-	The	608	bp	wildtype	ZIC2	NCE,	and	each	of	the	six	
mutated	versions	of	the	ZIC2	NCE,	were	PCR	amplified	from	the	pCR8-GW-TOPO-NCE	constructs	
as	 described	 in	 Section	 2.2.13,	 using	 oligonucleotides	 containing	 XbaI	 restriction	 sites	 and	
homology	to	the	pBB262	MCS	at	the	5’	ends	(RA1443	and	RA1464;	Appendix	Table	A1.2).	An	
artificial	NotI	site	was	also	included	in	oligonucleotide	RA1464	to	facilitate	future	lacZ	cloning.	
pBB262	was	digested	with	Xbal	in	the	MCS	to	linearize	the	plasmid,	and	the	NCE	amplicons	were	
cloned	into	pBB262	via	In-Fusion	Cloning	(Section	2.2.12),	resulting	in	wildtype	and	NCE	mutant	
pBB262-NCE	constructs	(Appendix	Figure	A7.3).	
Wildtype	and	mutant	pBB262-NCE-lacZ	-	Following	isolation	and	large	scale	prepping,	pBB262-
ZIC2	NCE	constructs	were	digested	with	NotI	and	XhoI	to	linearize	the	vector.	p1229,	a	Bluescript	
II	KS	vector	containing	a	4354	bp	lacZ	reporter/SV40	PolyA	cassette,	was	digested	with	NotI	and	
XhoI	to	release	the	 lacZ/SV40	PolyA.	This	was	subsequently	ligated	into	the	digested	pBB262-
NCE	 constructs	 via	 traditional	 T4	 ligation	 as	 described	 in	 Section	 2.2.11.	 Following	
electrotransformation	into	DH5a	E.	coli,	blue-white	colony	screening	(Section	2.2.4)	was	used	
to	select	colonies	containing	wildtype	and	mutant	pBB262-NCE-lacZ	constructs.	
pBB262-mNet	–	pmNetg	and	pBB262	were	digested	with	KpnI	and	NotI	sites	to	release	the	1617	
bp	 mNet	 fragment	 and	 linearize	 the	 vector,	 respectively.	 Following	 gel	 extraction	 and	
purification,	the	mNet	fragment	was	ligated	into	pBB262	via	traditional	T4	ligation	as	described	
in	Section	2.2.11.		
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pBB262-mNet-lacZ	–	Following	isolation	and	large	scale	prepping,	the	pBB262-mNet	construct	
was	 digested	 with	 NotI	 and	 XhoI	 to	 linearize	 the	 vector.	 p1229,	 a	 Bluescript	 II	 KS	 vector	
containing	a	4354	bp	 lacZ	 reporter/SV40	PolyA	cassette,	was	digested	with	NotI	 and	XhoI	 to	
release	 the	 lacZ/SV40	 PolyA.	 This	 was	 subsequently	 ligated	 into	 the	 digested	 pBB262-mNet	
construct	via	traditional	ligation.	Following	electrotransformation	into	DH5a	E.	coli,	blue-white	
colony	screening	(Section	2.2.4)	was	used	to	select	colonies	containing	the	pBB262-mNet-lacZ	
construct.	
2.2 Molecular	Biology	and	Cloning	
2.2.1 Electrotransformation	of	Plasmid	DNA	
Either	20	ng	of	plasmid	DNA	or	1	μL	of	a	precipitated	ligation	reaction	was	mixed	by	pipetting	
with	25	μL	of	electrocompetent	DH5a	E.	coli	in	a	cold	Eppendorf	tube.	The	cells	and	DNA	were	
transferred	to	an	ice	cold	electrocuvette	and	shocked	with	2.5	kV	using	a	BioRad	E.	coli	Pulser	
(BioRad).	Immediately	after	shocking,	500	μL	of	Luria-Bertani	broth	(LB	broth;	0.01%	tryptone,	
0.005%	yeast	extract,	0.01%	NaCl;	Bacto	Laboratories)	was	added	to	the	shocked	cells	and	the	
whole	volume	transferred	into	a	sterile	5	mL	vented	tube.	The	cells	were	allowed	to	recover	for	
one	hour	in	a	37	°C	shaking	incubator.	50	μL	of	a	1:10	dilution	in	LB	broth	was	plated	onto	a	90	
mm	LB	agar	(LB	agar;	0.010%	tryptone,	0.005%	yeast	extract,	0.010%	NaCl,	0.015%	agar;	Bacto	
Laboratories)	 plate	 containing	 100	 μg/mL	 of	 ampicillin,	 kanamycin	 or	 spectinomycin	 (Sigma	
Aldrich).	The	plate	was	incubated	at	37	°C	for	16	hours	to	allow	transformed	colonies	to	grow.		
2.2.2 Heat-Shocking	of	Plasmid	DNA	
Either	10	ng	of	plasmid	DNA	or	1	μl	of	a	precipitated	ligation	reaction	was	mixed	by	pipetting	
with	50	μL	of	heat-shock	competent	Fusion	Blue	cells	(Clontech)	in	a	cold	Eppendorf.	The	cells	
and	DNA	were	incubated	on	ice	for	30	minutes,	shocked	at	42	°C	for	60	seconds	and	following	
this,	 incubated	 on	 ice	 again	 for	 2	minutes.	 250	 μL	 of	 SOC	 broth	 (Super	 Optimal	 broth	with	
Catabolite	 repression;	 0.02%	 tryptone,	 0.005%	 yeast	 extract,	 0.0048%	 MgSO4,	 0.0036%	
dextrose,	0.00005%	NaCl,	0.00002%	KCl;	Scientifix)	was	added	to	the	heat	shocked	cells	and	the	
whole	volume	transferred	to	a	sterile	5	mL	vented	tube.	The	cells	were	allowed	to	recover	for	
one	hour	in	a	37	°C	shaking	incubator.	50	μL	of	a	1:10	dilution	in	SOC	broth	was	plated	onto	a	90	
mm	 LB	 agar	 plate	 containing	 100	 μg/mL	 of	 ampicillin,	 kanamycin	 or	 spectinomycin	 (Sigma	
Aldrich).	The	plate	was	incubated	at	37	°C	for	16	hours	to	allow	transformed	colonies	to	grow.		
2.2.3 Bacterial	Colony	Screening	
To	analyse	whether	ligation	reactions	had	produced	the	desired	constructs,	colony	PCRs	were	
performed	on	the	resulting	bacterial	colonies.	Colonies	were	picked	from	LB	agar	plates	using	a	
sterile	pipette	tip	and	were	resuspended	in	20	µL	of	sterile	H2O.	A	PCR	mastermix	was	prepared	
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as	 described	 in	 Section	2.2.16,	with	 5	µL	of	 the	 suspended	bacteria	 used	 as	 template.	Once	
prepared,	the	reaction	mixture	was	treated	as	a	normal	PCR.	The	remaining	bacterial	suspension	
was	stored	at	4	°C	until	analysis	was	complete.	Colonies	positive	for	the	required	DNA	were	used	
to	 inoculate	 5	 mL	 of	 LB	 broth	 containing	 100	 μg/mL	 of	 either	 ampicillin,	 kanamycin	 or	
spectinomycin	(Sigma	Aldrich)	in	a	vented	15	mL	tube.	The	tubes	were	incubated	in	a	shaking	37	
°C	incubator	for	16	hours	.		
2.2.4 Blue-White	Colony	Selection	
Blue-white	colony	selection	was	used	to	select	colonies	that	contained	a	plasmid	expressing	the	
lacZ	 transgene.	 The	 surface	of	 fresh	 LB	agar	plates	 containing	100	mg/mL	of	 antibiotic	were	
treated	with	80	μL	of	a	solution	containing	0.1	M	Isopropyl	b-D-1-thiogalactopyranoside	(IPTG;	
Sigma	Aldrich)	and	20	mg/mL	X-Gal	(5-bromo-4-chloro-3-indolyl	β-D-galactopyranoside;	Sigma	
Aldrich)	 and	 incubated	 in	 the	 dark	 for	 30	minutes.	 50	μL	 of	 electroporated	or	 heat	 shocked	
bacteria	 were	 plated	 and	 incubated	 at	 37	 °C	 for	 16	 hours	 to	 allow	 colonies	 to	 grow.	 Cells	
transformed	 with	 a	 plasmid	 containing	 the	 lacZ	 transgene	 formed	 blue	 colonies.	 Following	
incubation,	blue	colonies	were	used	to	inoculate	5	mL	of	LB	broth	containing	100	μg/mL	of	either	
ampicillin	or	kanamycin	(Sigma	Aldrich)	in	a	vented	15	mL	tube.	The	tubes	were	incubated	in	a	
shaking	37	°C	incubator	for	16	hours.		
2.2.5 Plasmid	DNA	isolation	
Small	 quantities	 (<2	 μg)	 of	 plasmid	DNA	was	 isolated	 from	 a	 2-3	mL	DH5a	E.	 coli	 overnight	
culture	with	appropriate	antibiotics	using	 the	High	Pure	Plasmid	 Isolation	kit	 (Roche).	 Larger	
quantities	 (>2	 μg)	 of	 plasmid	 DNA	 was	 isolated	 from	 100-200	 mL	 overnight	 culture	 with	
appropriate	 antibiotics	 using	 the	 Nucleobond	 Xtra	Miniprep	 kit	 (Scientifix)	 according	 to	 the	
manufacturer’s	instructions.	In	both	cases	DNA	was	resuspended	in	ddH2O	and	stored	at	-20	°C.	
2.2.6 Agarose	Gel	Electrophoresis	
DNA	 fragments	 were	 separated	 through	 horizontal	 gel	 electrophoresis.	 Agarose	 gels	 were	
created	using	Ultrapure	Agarose	(Life	Technologies)	and	1X	TBE	buffer	(0.1	M	Tris-HCl,	0.09	M	
boric	 acid	 and	 0.001	M	ethylenediaminetetraacetic	 acid	 [EDTA];	 Amresco).	DNA	 that	 ranged	
between	10000	bp	and	500	bp	was	run	on	a	1%	gel,	whilst	DNA	between	500	bp	and	100	bp	was	
run	 on	 a	 2%	 gel.	 RedSafe	 DNA	 Stain	 (1:20	 000	 dilution;	 ChemBio)	 was	 used	 to	 allow	 for	
visualization	 of	 the	 DNA.	 To	 load	DNA	 onto	 the	 gel,	 1	µL	 of	 loading	 dye	 (10X;	 20%	 glycerol	
[Merck],	19.2%	0.5	M	Na2EDTA	[Sigma	Aldrich]	and	0.001%	bromophenol	blue	[Sigma	Aldrich])	
was	added	to	every	9	µL	of	DNA	sample,	or	1	µL	added	to	4	µL	RNA	sample.	DNA	and	RNA	were	
run	parallel	to	an	aliquot	of	1	Kb	Plus	DNA	Ladder	(100-500	ng;	Life	Technologies)	to	allow	for	
size	identification	of	the	DNA	sample	and	ensure	the	integrity	of	the	agarose	gel	for	both	DNA	
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and	RNA	samples.	Agarose	gels	were	electrophoresed	at	5-6	V/cm-1	until	DNA	and	RNA	bands	
had	 separated	 (generally	 20-60	 minutes).	 The	 Gel	 Doc	 XR	 system	 and	 the	 accompanying	
Quantity	One	software	(Bio-Rad)	were	used	to	visualise	DNA	products	on	the	gel	using	an	ultra-
violet	(UV)	light	source,	and	to	photograph	the	gel.		
2.2.7 Restriction	Enzyme	Digests	
DNA	was	digested	with	restriction	enzymes	(New	England	Biolabs	[NEB])	for	analysis	of	plasmids	
and	as	part	of	the	cloning	procedure.	Digests	were	carried	out	using	restriction	enzymes	and	
buffers	 appropriate	 for	 the	DNA	 in	 question	 (Table	 2.1).	 For	 the	 best	 results,	 the	 restriction	
enzymes	were	used	at	a	concentration	of	5	enzyme	unites	(U)/μg	of	DNA	being	digested	(~500	
ng	 plasmid	 DNA	 for	 analysis,	 2-10	 µg	 for	 cloning	 and	 riboprobe	 digestion)	 in	 2	 µL	 of	 the	
appropriate	NEB	buffer	(10X),	2	µL	Bovine	Serum	Albumin	(BSA;	10X),	and	enough	AnalaR	H2O	
to	give	a	total	volume	of	20	µL.	Digest	reactions	were	incubated	at	either	37	°C	or	65	°C	for	1-2	
hours,	 depending	 on	 the	 requirements	 of	 the	 enzyme.	When	 suitable,	 enzyme	 activity	 was	
stopped	by	incubating	the	reaction	at	65	°C	or	80	°C	for	20	minutes.	Inactivated	reactions	were	
purified	via	gel	extraction	or	ammonium	acetate	precipitation.	
2.2.8 Antarctic	Phosphatase	Treatment	
In	 cases	 where	 only	 one	 restriction	 enzyme	 was	 used	 to	 linearize	 plasmid	 DNA,	 Antarctic	
Phosphatase	 treatment	 was	 used	 to	 dephosphorylate	 the	 DNA	 and	 prevent	 unwanted	
religation.	For	the	best	results,	the	Antarctic	Phosphatase	(5000	U/mL;	NEB)	enzyme	was	used	
at	a	concentration	of	5	U/μg	of	digested	DNA,	along	with	6	μL	of	Antarctic	Phosphatase	buffer	
(10X;	NEB).	AnalaR	H2O	added	to	make	the	volume	up	to	60	μL.	Once	prepared,	the	reaction	was	
incubated	 at	 37	 °C	 for	 30	 minutes	 to	 ensure	 the	 DNA	 was	 completely	 dephosphorylated,	
followed	by	a	65	°C	incubation	for	5	minutes	to	inactivate	the	phosphatase.	Inactivated	reactions	
were	purified	via	gel	extraction	or	ammonium	acetate	precipitation.		
2.2.9 Gel	extraction	and	PCR	clean	up	
Upon	PCR	fragment	or	digested	plasmid	DNA	separation	via	agarose	electrophoresis,	the	gel	was	
placed	under	UV	light	to	visualise	the	position	of	the	DNA	bands	and	the	appropriate	band	cut	
out	and	placed	into	a	clean	1.5	mL	Eppendorf	tube	using	a	clean	scalpel.	The	DNA	was	purified	
out	 of	 the	 agarose	 using	 the	 Nucleospin	 Gel	 and	 PCR	 Extraction	 kit	 (Scientifix)	 according	 to	
manufacturer’s	instructions.	
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Table	 2.1:	 Restriction	 enzymes	 used	 in	 molecular	 cloning	 and	 PiggyBac	 transgenesis.	 All	
restrictions	enzymes	were	from	NEB.	
Restriction	
Enzyme	
Buffer	 Incubation	
temperature	
Stop	 reaction	
temperature	
AccI	 NEB	CutSmart	 37°C	 80°C	
BglII	 NEB	3.1	 37°C	 No	
EcoRI	 NEB	CutSmart	 37°C	 65°C	
EcoRV	 NEB	3.1	 37°C	 80°C	
HindIII	 NEB	CutSmart	 37°C	 80°C	
KpnI	 NEB	1.1	 37°C	 No	
NcoI	 NEB	3.1	 37°C	 80°C	
NotI	 NEB	3.1	 37°C	 65°C	
SacI	 NEB	1.1	 37°C	 65°C	
SacII	 NEB	CutSmart	 37°C	 65°C	
SalI	 NEB	3.1	 37°C	 65°C	
XbaI	 NEB	CutSmart	 37°C	 65°C	
XhoI	 NEB	CutSmart	 37°C	 65°C	
XmnI	 NEB	CutSmart	 37°C	 65°C	
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2.2.10 Ammonium	Acetate	Precipitation	
DNA	 that	 did	 not	 need	 to	 be	 isolated	 on	 an	 agarose	 gel	 was	 precipitated	 using	 a	 final	
concentration	of	2.5	M	ammonium	acetate.	10X	volume	of	cold	100%	ethanol	(EtOH)	was	then	
added.	 Following	 centrifuging	 at	 18500	 x	 g,	 4	 °C	 for	 20	 minutes	 to	 pellet	 the	 DNA,	 the	
supernatant	was	removed	and	the	pellet	washed	with	180	μL	of	70%	cold	EtOH	for	two	minutes	
at	 4	 °C	 and	 18500	 x	 g.	 The	 supernatant	 was	 again	 removed	 and	 the	 pellet	 air-dried	 and	
resuspended	in	a	suitable	volume	of	AnalaR	H2O.	
2.2.11 T4	DNA	Ligation	and	Clean	Up	
Ligations	were	set	up	using	T4	DNA	Ligase	(400	U/μL;	Cat.	No.	M0202L,	NEB	Biolabs)	and	10X	T4	
DNA	Ligase	Buffer	(NEB)	according	to	the	manufacturer’s	instructions.	Reactions	were	set	up	as	
either	a	3:1	or	10:1	molar	ratio	of	vector	to	insert,	calculated	with	the	following	formula:	
Insert	length	(bp)	
x	50	ng	vector	 =	x	ng	of	insert	required	for	1:1	molar	ratio		
Vector	length	(bp)	
The	ligation	reaction	was	either	incubated	at	room	temperature	for	one	hour,	or	16	°C	overnight	
to	increase	the	number	of	transformants.		
To	precipitate	ligation	reactions,	5	μL	yeast	tRNA	(at	1	μg/μL),	12.5	μL	of	ammonium	acetate	(at	
7.5	M)	and	70	μL	absolute	EtOH	(at	-20	°C)	were	added	to	the	reaction	and	vortexed	thoroughly	
to	mix.	The	reaction	was	immediately	centrifuged	at	room	temperature	for	20	minutes,	16000	x	
g.	The	supernatant	was	discarded	and	replaced	with	500	μL	of	70%	EtOH	(at	-20°C).	The	reaction	
was	then	centrifuged	for	2	minutes	at	room	temperature,	16000	x	g,	after	which	the	supernatant	
was	 discarded,	 with	 any	 remaining	 EtOH	 allowed	 to	 air	 dry	 off.	 Once	 dry,	 the	 pellet	 was	
resuspended	 in	 10	 μL	 of	 AnalaR	 H2O	 and	 either	 heat-shocked	 or	 electrotransformed	 into	
competent	bacteria.	
2.2.12 In-Fusion	Cloning	
In-Fusion	 cloning	 allows	 for	 directional	 cloning	 of	 DNA	 fragments	 into	 any	 vector,	 via	 a	
proprietary	enzyme	that	recombines	DNA	fragments	containing	at	least	15	bp	of	homology	with	
the	site	of	 insertion	 in	the	 linearized	target	vector.	The	In-Fusion™	Dry-Down	PCR	Cloning	kit	
(Clontech)	was	used,	according	to	the	manufacturer’s	 instructions,	to	 insert	the	wildtype	and	
mutant	ZIC2	NCE	into	pBB262	(Section	2.1)	for	PiggyBac	transposon	transgenic	experiments	and	
to	create	expression	constructs	for	heterologous	reporter	assays.	Briefly,	200	ng	of	insert	and	
100	ng	of	vector	were	combined	with	2	μL	of	5X	 In-Fusion	HD	Enzyme	Premix,	and	the	total	
reaction	volume	brought	up	to	10	μL	with	ddH2O.	The	reaction	was	incubated	at	60	°C	for	15	
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minutes,	 before	 transferring	 to	 ice.	 The	 reaction	 was	 then	 transformed	 into	 Stellar™	
Electrocompetent	Cells	or	Fusion-Blue™	Competent	Cells	(Clontech)	via	heat-shock.	
2.2.13 Gateway	Vector	Conversion	
The	Gateway™	Vector	Conversion	System	with	One	Shot™	ccdB	Survival	Cells	 (Thermo	Fisher	
Scientific;	 Cat.	 No.	 11828-029)	 was	 used	 to	 convert	 pGL4.20	 to	 pGL4.20-DEST	 (Section	 2.1).	
Briefly,	5	µg	of	pGL4.20	was	linearized	with	the	restriction	enzyme	EcoRV	to	create	blunt	ends,	
and	 treated	 with	 Antarctic	 Phosphatase	 to	 remove	 5’	 phosphatases	 and	 prevent	 vector	
religation.	50	ng	of	the	dephosphorylated	vector	was	incubated	with	10	ng	of	Gateway	Reading	
Frame	 Cassette	 A	 (Thermo	 Fisher	 Scientific)	 in	 5X	 T4	 DNA	 ligase	 buffer,	 1U	 T4	 DNA	 ligase	
(Thermo	Fisher	Scientific)	and	ddH2O	at	a	total	volume	of	10	µL,	at	room	temperature	for	1	hour.	
The	reaction	was	then	transformed	into	One	Shot™	ccdB	Survival	Cells	(Thermo	Fisher	Scientific)	
via	heat-shock.	
2.2.14 Gateway	LR	Recombination	
DNA	 sequences	 were	 transferred	 from	 Entry	 vectors	 (pENTR)	 into	 Destination	 expression	
vectors	 (DEST)	 using	 Gateway	 LR	 reactions.	 Gateway	 BP	 and	 LR	 reactions	 are	 used	 by	
bacteriophage	 Lambda	 phage	 to	 insert	 and	 excise	 DNA	 sequences	 into/from	 bacterial	
chromosomes.	 For	 cloning	 purposes,	 the	 LR	 reaction	 can	 be	 triggered	 in	 vitro	 by	 adding	
bacteriophage	Lambda	recombination	proteins	and	the	E.	coli-encoded	protein	Integration	Host	
Factor.	The	reaction	catalyses	recombination	between	plasmids	containing	attL	sites	(in	this	case	
the	Entry	vectors)	and	plasmids	containing	attR	sites	(in	this	case	the	Destination	vectors),	thus	
the	sequence	between	attL	sites	is	transferred	between	the	attR	sites.	The	desired	plasmid	is	
selected	 by	 a	 combination	 of	 antibiotic	 resistance	 and	 the	 negative	 selection	 of	 the	 original	
Destination	vector	based	on	the	presence	of	the	lethal	ccdB	gene.	
Multiple	DNA	sequences	were	transferred	from	pENTR1A,	2B	and	3C	entry	vectors	into	various	
destination	 vectors	 using	 the	 Gateway	 LR	 Clonase	 II	 Enzyme	 mix	 (Invitrogen;	 Section	 2.1),	
according	to	the	manufacturer’s	instructions.	
2.2.15 TA	Cloning	
The	pGEM-T	Easy	Vector	System	(Promega)	was	used	to	clone	multiple	DNA	sequences	in	pGEM-
T-Easy,	 according	 to	 the	 manufacturer’s	 instructions.	 Briefly,	 50-200	 ng	 PCR	 amplicon	 was	
incubated	with	50	ng	of	pGEM-T-Easy	Vector	(Promega)	at	a	1:3	molar	ratio.	Additionally,	5	µL	
of	2X	Rapid	Ligation	Buffer,	3U	T4	DNA	ligase	(Promega)	and	ddH2O	were	added	at	a	total	volume	
of	10	µL.	Reactions	were	incubated	at	room	temperature	for	1	hour.	Following	ligation	clean	up,	
reactions	were	electrotransformed	into	competent	bacteria.	
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2.2.16 Polymerase	Chain	Reaction	
PCR	 was	 carried	 out	 using	 a	 Mastercycler®	 Vapo.protect™	 or	 Mastercycler®	 Epgradient	 S™	
(Eppendorf).	PCR	oligonucleotides	were	designed	for	sequencing,	colony	PCR	and	general	PCR	
amplification	 (Appendix	 Table	 A1.2).	 To	 promote	 specificity,	 each	 oligonucleotide	 had	 a	G/C	
clamp	 at	 the	 3’	 end	 such	 that	 three	 of	 the	 five	 3’	 most	 bases	 were	 G	 or	 C.	 The	 melting	
temperature	 (Tm)	 of	 the	 oligonucleotides	 was	 designed	 to	 be	 within	 45–65	 °C	 and	
oligonucleotide	pairs	were	designed	to	have	a	Tm	within	5	°C	of	each	other.		
PCR	products	were	 amplified	 from	approximately	 20-40	ng	 of	 plasmid	DNA	or	 20	 ng	 of	 PCR	
fragments	using	two	oligonucleotides	at	a	final	concentration	of	0.6	μM	each,	and	a	commercial	
PCR	 mastermix.	 Five	 PCR	 mastermixes	 were	 used,	 dependent	 on	 the	 reaction	 conditions	
(ImmoMix™	[Bioline];	BioMix	Red	[Bioline];	PCR	ReddyMix™	Master	Mix	with	and	without	KCl	
[Thermo	Scientific],	MyTaq™	HS	Mix	[Bioline];	Table	2.2).	Betaine	was	used	at	a	concentration	
of	1	M	for	DNA	that	was	rich	in	dGTPs	and	dCTPs.	A	variety	PCR	programs	were	used,	depending	
on	 the	 source	 of	 the	 template	 DNA	 and	 the	 annealing	 and	 melting	 temperatures	 of	 the	
oligonucleotides	in	each	reaction.	Success	of	the	PCR	was	analysed	via	gel	electrophoresis.	
2.2.17 DNA	sequencing	
The	 BigDye®	 Direct	 Cycle	 Sequencing	 Kit	 (Life	 Technologies)	 was	 used	 to	 sequence	 DNA	
fragments	or	plasmids.	Purified	products	were	amplified	using	3.5	μL	5X	sequencing	buffer	(400	
mM	Tris	pH	9.0,	10	mM	MgCl2),	1	μL	BigDye	Terminator	v3.0	Cycle	Sequencing	Ready	Reaction	
and	3.2	pm	of	 the	desired	oligonucleotide	 (Appendix	Table	A1.2)	 in	a	 total	 volume	of	20	μL.	
Cycling	conditions	used	were	94	˚C	for	5	minutes	and	96	˚C	for	10	seconds,	50	˚C	for	5	seconds,	
60	˚C	for	4	minutes	for	30	cycles,	4	˚C	hold.	The	products	were	then	precipitated;	to	each	20	μL	
reaction,	2	μL	of	125	mM	EDTA	(pH	8.0),	3	μL	of	3M	sodium	acetate	(NaOAc;	pH	5.2)	and	50	μL	
of	100%	EtOH	were	added,	and	samples	incubated	at	room	temperature	for	15	minutes.	Samples	
were	subsequently	centrifuged	for	10	minutes,	3200	x	g,	4	oC	and	the	supernatant	discarded.	
250	μL	of	70%	EtOH	was	added	to	each	sample,	and	then	samples	were	again	centrifuged	for	10	
minutes	at	3200	x	g,	4	oC.	The	supernatant	was	discarded	and	the	samples	air	dried	to	remove	
any	 additional	 EtOH.	 Genomic	 sequencing	 was	 performed	 using	 the	 ABI	 3730	 sequencer	
(Applied	Biosystems)	by	the	Biomolecular	Resource	Facility	(BRF;	John	Curtin	School	of	Medical	
Research,	 Australian	National	University).	 The	 resulting	 sequence	 reads	were	 analysed	using	
Geneious	Pro	5.5.9	(Biomatters).	
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Table	2.2:	PCR	mastermixes	used	for	amplifying	plasmid	and	genomic	DNA.		
Mastermix	 Components	 Brand	
2X	ImmoMix™	 IMMOLASE™	DNA	Polymerase,	Stabiliser,	2	mM	dNTPs,	
32	 mM	 (NH4)2SO4,	 134	 mM	 Tris-HCl	 [pH	 8.3],	 0.02%	
Tween	20,	3	mM	MgCl2	
Bioline	
2X	BioMix	Red	 BIOTAQ™	DNA	Polymerase,	Stabiliser,	2	mM	dNTPs,	32	
mM	(NH4)2SO4,	125	mM	Tris-HCl	[pH	8.8],	0.02%	Tween	
20,	3	mM	MgCl2,	Inert	dye	
Bioline	
2X	 PCR	 ReddyMix™	
Master	Mix	with	KCl	
ThermoPrime	 Taq	 polymerase,	 75	 mM	 Tris-HCl	 (pH	
8.8),	 50	 mM	 KCl,	 20	 mM	 (NH4)2SO4,	 1.5	 mM	 MgCl2,	
0.01%	(v/v)	Tween	20,	0.2	mM	dNTPs,	Inert	dye	
Thermo	
Scientific	
2X	 PCR	 ReddyMix™	
Master	 Mix	 without	
KCl	
ThermoPrime	 Taq	 polymerase,	 75	 mM	 Tris-HCl	 (pH	
8.8),	 20	 mM	 (NH4)2SO4,	 1.5	 mM	 MgCl2,	 0.01%	 (v/v)	
Tween	20,	0.2	mM	dNTPs,	Inert	dye	
Thermo	
Scientific	
2X	MyTaq™	HS	Mix	 MyTaq	 HS™	 DNA	 polymerase,	 2	 mM	 dNTPs,	 MyTaq	
HS™	Buffer	
Bioline	
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2.2.18 RNA	Extraction	and	Integrity	Analysis	
The	total	RNA	from	embryos	was	extracted	immediately	after	dissection	with	the	RNeasy®	Micro	
Kit	 (Qiagen;	Cat.	No.	74004)	according	 to	 the	manufacturer’s	 instructions,	and	quantified	via	
nanodrop.	Additional	DNase	 I	 treatment	(Cat.	No.	04716728001,	10U,	Roche)	at	37	°C	for	20	
minutes	 was	 performed	 to	 ensure	 no	 genomic	 DNA	 contamination	 was	 present.	 This	 was	
confirmed	 via	 standard	 PCR	with	 oligonucleotides	 that	 spanned	 intron	 1	 of	 Shh	 (RA748	 and	
RA749;	Appendix	Table	A1.2),	whereby	no	amplification	indicated	the	samples	were	free	from	
genomic	DNA.	RNA	integrity	was	confirmed	via	agarose	gel	electrophoresis.		
The	 total	 RNA	 from	 transfected	 cells	 was	 extracted	 24	 hours	 post-transfection	 via	 the	
NucleoSpin®	 RNA	 kit	 (Macherey-Nagel;	 Cat.	 No.	 740955)	 according	 to	 the	 manufacturer’s	
instructions	and	quantified	via	nanodrop.	Additional	DNase	I	treatment	(Cat.	No.	04716728001,	
10U,	Roche)	at	37	°C	for	20	minutes	was	performed	to	ensure	no	genomic	DNA	contamination	
was	present.	This	was	confirmed	via	standard	PCR	with	oligonucleotides	that	spanned	the	5’UTR	
of	ZIC2	 (RA1595	 and	RA1622;	Appendix	 Table	A1.2),	whereby	no	 amplification	 indicated	 the	
samples	 were	 free	 from	 genomic	 DNA.	 RNA	 integrity	 was	 confirmed	 via	 agarose	 gel	
electrophoresis.	In	both	cases,	RNA	samples	were	stored	for	up	to	two	weeks	maximum	at	-80	
°C	before	RT-qPCR	analysis.		
2.3 Cell	Culture	
2.3.1 Cell	Lines	
Human	Embryonic	Kidney	293T	(HEK293T)	cells,	a	highly	transfectable	human	epithelial-like	cell	
line,	 were	 cultured	 in	 Dulbecco’s	 Modified	 Eagle	 Medium	 (DMEM;	 Life	 Technologies)	
supplemented	with	2	mM	L-glutamine	 (Life	 Technologies),	 0.1	mM	non-essential	 amino	acid	
solution	(Life	Technologies),	and	10%	(v/v)	foetal	bovine	serum	(FBS;	Life	Technologies)	(referred	
to	as	supplemented	DMEM	herein).	The	cells	were	grown	on	sterile	plasticware	(Corning)	in	a	
humidified	incubator	at	37	oC	and	5%	CO2.		
LLC-PK1	cells,	a	ciliated	kidney	proximal	tubule	pig	cell	line,	were	cultured	in	a	1:1	ratio	of	Ham’s	
Nutrient	 Mixture	 F12	 (Sigma	 Aldrich)	 and	 DMEM	 (Life	 Technologies)	 that	 had	 been	
supplemented	with	2	mM	L-glutamine	 (Life	 Technologies),	 0.1	mM	non-essential	 amino	acid	
solution	 (Life	Technologies),	 and	10%	 (v/v)	FBS	 (Life	Technologies;	10100147)	 (referred	 to	as	
supplemented	F12:DMEM	herein).	The	cells	were	grown	on	sterile	plasticware	 (Corning)	 in	a	
humidified	incubator	at	37	oC	and	5%	CO2.		
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2.3.2 Passaging	Cells	
Cells	grown	in	tissue	culture	plasticware	(T75	cm2	or	T25	cm2)	and	at	60-70%	confluency	were	
first	rinsed	with	1X	phosphate	buffered	saline	(PBS;	Amresco)	and	then	dissociated	into	a	single	
suspension	by	the	addition	of	0.5	g/L	Trypsin	(Life	Technologies)	in	1X	PBS	and	incubation	at	37	
°C	 for	 5	minutes.	 Supplemented	 DMEM	 or	 F12:DMEM	was	 added	 to	 inhibit	 the	 trypsin.	 An	
appropriate	 amount	 of	 the	 cell	 suspension,	 as	 determined	 by	 end	 use	 requirements,	 was	
transferred	to	new	tissue	culture	plastic	ware.	Additional	supplemented	media	was	added	to	
reach	the	minimum	volume	requirements	per	tissue	culture	flask	or	dish.	Luciferase	assays	were	
only	 performed	 on	 cells	 between	 passage	 11	 and	 passage	 15	 to	 ensure	 the	 consistency	 of	
experimental	repeats.	
2.3.3 Transfection	of	Mammalian	Cell	Lines	
Cells	were	 transiently	 transfected	with	 various	plasmids	using	 LipofectamineTM	2000,	 a	 lipid-
based	transfection	agent	(Life	Technologies).	Cells	to	be	transfected	were	plated	into	6	well	or	
12	 well	 sterile	 tissue	 culture	 dish	 (Corning;	 Table	 2.3).	 If	 the	 cells	 were	 to	 be	 used	 for	
immunofluorescence	 or	 X-Gal	 staining,	 circular	 glass	 coverslips	 (13	 mm,	 No.	 1	 thickness;	
ProSciTech)	were	added	to	the	dish	before	the	cells	were	plated.	Cells	were	transfected	when	
60-80%	confluent.		
For	each	well	of	cells	to	be	transfected,	a	total	concentration	of	1500-5000	ng	of	plasmid	DNA	
was	 diluted	 in	 unsupplemented	 DMEM	 or	 unsupplemented	 F12:DMEM,	 mixed	 with	
Lipofectamine™	2000	and	incubated	as	per	the	manufacturer’s	 instructions.	During	this	time,	
the	 media	 on	 the	 cells	 was	 replaced	 with	 2	 mL	 of	 fresh	 supplemented	 media.	 The	 DNA-
Lipofectamine™	2000	mixture	was	added	drop-wise	to	the	well	containing	cells.	The	cells	were	
returned	to	the	37	°C	humidified	incubator	for	a	maximum	of	24	hours.	
2.3.4 Luciferase	Assays	
24	hours	post	transfection,	the	cells	of	each	well	were	dissociated	from	the	growth	surface	by	
replacing	the	media	with	fresh	unsupplemented	DMEM	to	create	a	cell	suspension.	The	amount	
of	DMEM	added	was	calculated	based	on	 the	confluency	of	 the	cells	per	well,	with	 the	 final	
suspension	 representing	 a	 confluency	 of	 90%.	 A	 1:1	 ratio	 of	 cells	 suspension	 to	 ONE-Glo	
Luciferase	reagent	(Promega,	Cat.	No.	E6110)	was	created	by	adding	equal	volumes	of	both	to	a	
sterile	1.5	mL	Eppendorf	tube,	per	sample.	The	remaining	cell	suspension	was	for	Western	blot	
analysis.	100	µL	of	the	resultant	cell	suspension/ONE-Glo	mix	was	plated	into	three	wells	of	a	
solid	 white	 tissue-culture	 treated	 96-well	 plate	 (Corning,	 Cat.	 No.	 CLS3917)	 to	 create	 three	
independent	 internal	 replicates	 for	each	 sample.	The	 intensity	of	 luminescence	produce	was	
measured	 by	 the	 GloMax®-96	 Microplate	 Luminometer	 (Promega),	 or	 the	 TECAN	 Infinite	
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Table	2.3:	Transfection	amounts	based	on	culture	plate	sizes.	Separate	dilutions	were	made	for	
Lipofectamine™	2000	and	plasmid	DNA	e.g.	in	a	12-well	plate,	4	μL	of	Lipofectamine™	2000	was	
diluted	 in	 100	 μL	 of	 unsupplemented	 DMEM,	 whilst	 1.6	 μg	 of	 plasmid	 DNA	 was	 diluted	 in	
another	100	μL	unsupplemented	DMEM.	
	
Dish	type	 Cell	number		
(100%	confluency)	
Lipofectamine™	2000	 Total	plasmid		
DNA	(µg)	
Total	well		
volume	
12	well	plate	 3.8	x	105	 4	µL/well	 1.6	 1.0	mL	
6	well	plate	 9.5	x	105	 10	µL/well	 4.0	 2.5	mL	
	
	 	
	76	
	
M1000	Pro.	The	mean	relative	luciferase	activity	and	standard	deviation	were	calculated	from	
three	internal	repeats	(using	Microsoft	Excel).	Where	pooled	data	is	shown,	data	represents	at	
least	three	independent	repeats,	with	luminescence	values	from	one	representative	experiment	
shown.	To	avoid	the	potential	problem	of	position	bias	by	the	luminometer,	sample	order	on	
the	plate	was	randomized	for	each	experimental	repeat.	
2.3.5 Serum	Starvation	
To	 increase	the	number	of	cilia	 in	LLC-PK1	cells,	 the	cells	were	serum	starved.	24	hours	post	
transfection,	 supplemented	 F12:DMEM	 was	 aspirated	 from	 cells	 and	 replaced	 with	
unsupplemented	F12:DMEM.	48	hours	post	transfection,	media	was	aspirated	and	cells	were	
taken	through	the	immunofluorescence	protocol	as	outlined	in	Section	2.5.2.			
2.4 Reverse	Transcription	Quantitative	PCR	(RT-qPCR)	
RT-qPCR	 oligonucleotide	 sequences	 were	 selected	 over	 intron-exon	 boundaries	 whenever	
possible	to	limit	genomic	DNA	amplification	(Appendix	Table	1.2,	Table	2.4).	One-step	RT-qPCR	
was	performed	on	50	ng	of	RNA	per	sample	per	well	of	a	96	well	sterile	PCR	plate,	using	the	
SensiFAST	SYBR	Hi-ROX	One-Step	Kit	(Bioline)	at	the	recommended	conditions	(Table	2.5).	Plates	
were	sealed	with	UltraClear	Sealing	Film	(Fisher	Biotec)	and	centrifuged	at	180	x	g	for	1	minutes.	
cDNA	conversion	and	melt	curve	analysis	were	performed	using	a	StepOnePlus™	Real-Time	PCR	
System	(Applied	Biosystems®)	and	StepOne	software	(version	2.2.2;	Applied	Biosystems®).	For	
quantification,	 the	 assay	 for	 each	 gene	 consisted	 of	 three	 internal	 replicates	 per	 gene	 per	
sample.	 At	 least	 three	 independent	 experiments	 were	 performed	 for	 each	 RT-qPCR.	 Mean	
values	were	 calculated	 and	 the	 v5.5.9.	Methylation	 and	 acetylation	 values	were	 analysed	 in	
Microsoft	Excel	to	correlate	enrichment	with	the	ZIC2	3’UTR	sequence.		
2.4.1 Statistics	
Luciferase	assays:	The	standard	deviation	(S.	D.)	of	the	internal	repeats	of	the	representative	
experiment	 was	 calculated	 using	 Microsoft	 Excel.	 Pooled	 data	 was	 analysed	 using	 Genstat	
software	 to	 perform	 either	 an	 unpaired	 Student’s	 T-Test	 or	 two-way	 Analysis	 of	 Variance	
(ANOVA)	with	Fischer’s	unprotected	post	hoc	test	on	a	minimum	of	three	external	repeats,	and	
to	calculate	the	standard	error	of	the	mean	(S.E.M.).		
	(CT)	value	used	for	analysis.	
2.4.2 Oligonucleotide	Efficiencies		
All	of	the	RT-qPCR	oligonucleotide	pairs	were	tested	for	their	amplification	efficiency	prior	to	
sample	 analysis.	 PCR	 efficiencies	 were	 calculated	 using	 the	 slope	 of	 a	 calibration	 curve	 as		
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Table	2.4:	RT-qPCR	oligonucleotide	efficiencies.	Oligonucleotide	sequences	can	be	seen	in	Appendix	
Table	A1.2.	
	
Gene	 	 Oligonucleotide	 Species	 Product	size	(bp)	 Slope	 R2	 Efficiency	
H2afz	 F	 RA1719	 Mouse	 202	 -3.30	 0.99	 101.00%	
R	 RA1720	
mP0	 F	 RA1780	 Mouse	 109	 -3.35	 0.99	 99.00%	
R	 RA1781	
mP1	 F	 RA99	 Mouse	 101	 -3.32	 0.99	 100.26%	
R	 RA1782	
mP2/ZIC2		
3’UTR	
F	 RA1714	 Mouse/		
Human	
101/105	 -3.23	 0.99	 103.88%	
R	 RA1715	
mP3	 F	 RA1716	 Mouse	 109	 -3.30	 0.99	 100.85%	
R	 RA1717	
Ubc	 F	 RA1730	 Mouse	 112	 -3.33	 0.99	 99.47%	
R	 RA1731	
Zic2	 F	 RA252	 Mouse	 178	 -3.27	 0.98	 102.34%	
R	 RA96	
ABCE1	 F	 RA1606	 Human	 234	 -3.25	 0.98	 103.06%	
R	 RA1607	
FOXA2	 F	 RA1766	 Human	 90	 -3.16	 0.98	 107.25%	
R	 RA1767	
FOXJ1	 F	 RA1768	 Human	 93	 -3.24	 0.99	 103.63%	
R	 RA1769	
PPP1R8	 F	 RA1604	 Human	 123	 -3.33	 0.99	 99.70%	
R	 RA1605	
ZIC2	 F	 RA1177	 Human	 154	 -3.43	 0.99	 95.61%	
R	 RA1247	
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Table	2.5:	One-step	RT-qPCR	cycling	and	melt	curve	conditions.	Conditions	are	optimised	for	
the	SensiFAST	SYBR	Hi-ROX	One-Step	Kit	(Bioline).		
Program	step	 Temperature	
Initial	hold	 45	°C	20	min	 	
Initial	denaturation	 95	°C	2	min	 	
Denature	 95	°C	5	sec	
X	40	Anneal	 56	°C	10	sec	
Extend	 72	°C	10	sec	
Melt	curve	
95	°C	15	sec	
	
60	°C	1	min,	+0.3	°C	
per	minute	until	 95	
°C	is	reached	
Polish	 95	°C	15	sec	 	
Stop	 4	°C	 Hold	
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described	in	Bustin	et	al	(2009).	Efficiency	was	assessed	using	the	standard	curve	method.	RNA	
samples	with	a	starting	concentration	of	100	ng/μL	were	serially	diluted	10-fold.	These	serial	
dilutions	(100	ng/μL,	10	ng/μL,	1	ng/μL,	0.1	ng/μL,	0.01	ng/μL	and	0.001	ng/μL)	were	then	run	
through	 the	RT-qPCR	protocol	 in	 triplicate.	 For	 each	 target	 sequence,	 the	mean	CT	 obtained	
during	the	amplification	of	each	dilution	was	plotted	against	the	log	of	the	input	concentration	
of	RNA	to	create	a	standard	curve.	The	linear	regression	and	coefficient	of	determination	(R2)	of	
the	standard	curve	were	calculated	using	the	Microsoft	Excel	LINEST	function.	The	efficiency	of	
the	assay	 is	calculated	 from	the	slope	of	 the	regression	 line	of	 the	standard	curve,	using	 the	
formula:	E	=	10−1/slope.	
An	oligonucleotide	pair	was	considered	efficient	if	they	produced	an	R2	value	≥0.98	and,	ideally,	
a	slope	value	of	-3.32	resulting	in	an	efficiency	of	100%	(where	100%	represents	doubling	of	the	
PCR	product	every	cycle).	Due	to	normal	experimental	variability,	efficiency	values	between	90-
110%	were	also	acceptable	for	the	conditions	of	this	RT-qPCR	assay.	RT-qPCR	oligonucleotides	
and	their	efficiencies	are	shown	in	Table	2.4.	
2.4.3 2-DDCT	Calculations		
The	StepOnePlusä	Real-Time	PCR	system	automatically	records	the	PCR	cycle	number	where	
the	fluorescence	signal	of	a	sample	significantly	rises	above	the	background	fluorescence.	This	
CT	is	inversely	proportional	to	the	amount	of	input	target	nucleic	acid	and	thus	allows	the	starting	
amount	of	the	target	sequence	to	be	quantified.	The	StepOnePlusä	RT-PCR	system	plots	the	
negative	first	derivative	of	the	dissociation	curve	for	each	sample,	producing	a	dissociation	peak	
graph	from	which	the	Tm:	(the	point	at	which	50%	of	the	DNA	is	single	stranded)	of	the	DNA	in	
the	sample	can	be	identified.	A	single	peak	observed	on	the	dissociation	curve	indicates	there	is	
a	single	DNA	product	in	the	reaction,	while	multiple	peaks	indicate	multiple	PCR	products	are	
present	 (e.g.	 from	 genomic	 contamination	 or	 oligonucleotide	 dimers).	 The	 CT	 values	 from	
samples	with	melt	curves	showing	multiple	points	were	excluded	from	further	analysis.		
The	2-∆∆CT	method	(Livak	and	Schmittgen,	2001)	was	used	to	calculate	the	fold	increase	in	the	
expression	of	the	target	sequence.	The	mean	and	standard	deviation	of	the	CT	values	for	the	
technical	replicates	of	each	sample	was	calculated	with	Excel.	Replicates	with	a	CT	value	that	
varied	from	the	mean	CT	value	by	more	than	1	cycle	were	discarded	as	outliers	and	a	new	mean	
CT	calculated	from	the	remaining	two	replicates.	The	normalization	process	was	only	carried	out	
between	samples	analysed	in	the	same	RT-qPCR	run	using	the	following	equations:	
ΔCT	=	CT	(target	gene)	−	CT	(reference	gene)	
ΔΔCT	=	ΔCT	(test	sample)	−	ΔCT	(control	sample)	
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Fold	change	=	2−∆∆CT	
The	mean	CT	of	the	target	of	interest	was	normalised	to	that	of	a	reference	gene	(H2afz	and	Ubc	
for	mouse	RNA,	PPP1R8	and	ABCE1	for	human	RNA).	The	normalised	CT	(∆CT)	of	samples	from	
control	samples	is	subtracted	from	that	of	test	samples,	to	account	for	endogenous	expression	
(∆∆CT).	The	fold	change	in	gene	expression	is	then	calculated	simply	as	2−∆∆CT.	
2.5 Cell	Staining	
2.5.1 X-Gal	Staining	of	Cultured	Cells	
For	X-Gal	staining,	cells	were	grown	onto	glass	coverslips	as	described	in	Section	2.2.3.	24	hours	
post	transfection,	cells	were	fixed	in	4%	paraformaldehyde	(PFA)	in	1X	PBS	for	30-60	min.	The	
cells	were	rinsed	in	1X	PBS	before	being	incubated	overnight	in	X-Gal	stain	(5	mg/mL	5-bromo-
4-chloro-3-indolyl	 β-D-galactopyranoside	 in	dimethylformamide,	 Sigma	Aldrich;	 1	mM	MgCl2,	
BDH;	5	mM	potassium	ferrocyanide,	Sigma	Aldrich;	5	mM	potassium	ferricyanide,	Sigma	Aldrich;	
1X	PBS)	at	37	°C.		
Following	incubation	in	stain,	cells	were	rinsed	with	1X	PBS.	The	coverslips	were	mounted	onto	
glass	slides	(76	x	26	mm;	ProSciTech)	with	anti-fade	mounting	agent	(2.4	mM	n-propyl	gallate,	
NPG	[Sigma	Aldrich]	in	a	1:1	solution	of	glycerol	and	1X	PBS).	The	edges	of	the	coverslips	were	
sealed	with	nail	polish	to	prevent	the	cells	from	drying	out.		
2.5.2 Immunofluorescence	
For	 immunofluorescence	 staining,	 cells	 were	 grown	 onto	 glass	 coverslips	 (no.1	 thickness,	
ProSciTech).	24	hours	post	transfection,	cells	were	fixed	in	4%	PFA	(ProSciTech)	in	1X	PBS	for	30-
60	min.	The	cells	were	rinsed	in	1X	PBS	three	times	before	being	permeabilised	in	0.25%	Triton	
X-100	(Sigma	Aldrich)	in	1X	PBS.	The	cells	were	again	rinsed	three	times	in	1X	PBS	before	being	
blocked	 for	 one	 hour	 at	 room	 temperature	 in	 a	 skim	 milk	 blocking	 solution	 (5%	 skim	 milk	
powder,	Diploma;	1	X	PBS)	at	4	°C.		
To	 detect	 proteins	 of	 interest,	 primary	 antibodies	were	 diluted	 in	 skim	milk	 blocking	 buffer	
(Table	2.6)	for	1	hour	at	room	temperature.	The	diluted	primary	antibody	solution	was	applied	
to	the	fixed	and	blocked	cells	for	one	hour	in	a	humidified	chamber.	Subsequently,	the	cells	were	
rinsed	with	blocking	solution	to	remove	unbound	antibody.	Fluorophore	conjugated	secondary	
antibodies	(used	to	detect	the	primary	antibodies;	Table	2.7)	were	diluted	in	blocking	buffer	and	
applied	 to	 the	 primary	 antibody	 stained	 cells	 for	 one	 hour	 in	 a	 darkened	 humidified	
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Table	2.6:	Primary	antibodies	used	in	immunostaining.		
Target	Protein	 Company;	Cat.	No.	 Species	 Dilution	used	
V5	 Sapphire	Biosciences;	R960-25	 Rabbit,	polyclonal	 1:500	
Acetylated	Tubulin	 Sigma	Aldrich;	T7451	 Mouse,	monoclonal	 1:200	
C-Myc	 Thermo	Fisher	Scientific;	132500	 Rabbit,	monoclonal	 1:500	
	
	
	
	
	
	
Table	2.7:	Secondary	antibodies	used	in	immunostaining.		
Secondary	
Antibody	
Species	 Target	
Species	
Company	 Dilution	 Absorption	
Alexa488		 Donkey		 Rabbit	 Thermo	 Fisher	 Scientific;	
A21206	
1:500	 495	nm	
Alexa594		 Donkey		 Mouse	 Thermo	 Fisher	 Scientific;	
A21203	
1:500	 590	nm	
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chamber.	The	cells	were	rinsed	with	1X	PBS	six	times	to	remove	unbound	secondary	antibody	
and	the	coverslips	mounted	onto	glass	slides	with	anti-fade	mounting	agent	(2.4	mM	NPG	[Sigma	
Aldrich]	in	a	1:1	solution	of	glycerol	and	PBS).	The	edges	of	the	coverslips	were	sealed	with	nail	
polish	to	prevent	the	cells	from	drying	out.	
2.6 Cell	Lysis	and	Western	Blotting		
2.6.1 Nuclear/Cytoplasmic	Protein	Extraction		
Protein	for	western	blotting	was	extracted	from	transfected	cells	and	fractionated	using	the	NE-
PER	Nuclear	and	Cytoplasmic	Reagents	 (Pierce)	according	to	 the	manufacturer’s	 instructions,	
but	altering	the	volumes.	Media	was	removed	from	cells	in	a	12	well	plate	and	a	cell	suspension	
made	in	500	µL	fresh,	unsupplemented	DMEM.	Cells	were	pelleted	by	centrifugation	at	18000	x	
g	and	the	media	removed	and	replaced	with	50	μL	of	ice	cold	CER	I	buffer,	with	Protease	Inhibitor	
(cOmplete,	 EDTA-free	 Protease	 Inhibitor,	 Roche)	 and	 Phosphatase	 Inhibitor	 (PhosStop	
Phosphatase	Inhibitor	Cocktail,	Roche)	added	at	final	concentrations	of	1X.	Cells	were	vortexed	
thoroughly	and	 incubated	 for	10	minutes	on	 ice.	Following	 incubation,	2.25	μL	of	CER	 II	was	
added	and	cells	were	again	vortexed	followed	by	incubation	on	ice	for	one	minute	and	a	second	
vortex.	Cells	were	then	pelleted	by	centrifugation	at	18000	x	g	for	15	minutes	at	4	oC,	and	the	
resulting	cytoplasmic	supernatant	transferred	to	a	new	1.5	mL	Eppendorf	tube.	25	μL	of	NER	
buffer,	again	containing	1X	Protease	Inhibitor	and	Phosphatase	Inhibitor,	was	added	to	the	cell	
pellet.	The	cells	were	resuspended	by	vortexing	thoroughly	and	the	samples	incubated	on	ice	
for	40	minutes,	vortexing	every	10	minutes	to	mix.	The	samples	were	pelleted	by	centrifugation	
at	18000	x	g,	for	25	minutes	at	4	oC	and	the	resulting	nuclear	supernatant	transferred	to	a	new	
1.5	mL	tube.		
To	prepare	the	cytoplasmic	and	nuclear	fractions	for	Sodium	Dodecyl	Sulfate-polyacrylamide	gel	
electrophoresis	(SDS-PAGE),	DTT	(dithiothreitol;	Sigma-Aldrich,	at	20X)	and	NuPAGE	LDS	Sample	
Buffer	(Invitrogen;	4X)	were	added	to	the	cell	lysates	to	give	a	final	concentration	of	50	mM	and	
1X	 respectively.	 The	 samples	were	 heated	 at	 90	 oC	 for	 5	minutes	 to	 denature	 the	 proteins.	
Denatured	lysates	were	then	either	used	immediately	or	stored	at	-80	oC.	
2.6.2 SDS-PAGE		
Protein	from	cytoplasmic	and	nuclear	cell	lysates	was	separated	by	molecular	weight	(MW)	on	
an	acrylamide	gel.	Polyacrylamide	10%	running	gel	mixes	(Table	2.8)	were	made	and	cast	in	the	
Mini	PROTEAN®	casting	apparatus	(Bio-Rad)	while	still	liquid.	Running	gels	were	overlaid	with	
hydrated	 butanol	 (Sigma-Aldrich)	 and	 left	 at	 room	 temperature	 to	 polymerise	 for	 1	 hour.	
Following	 polymerisation,	 the	 butanol	 was	 removed,	 the	 running	 gels	 were	 overlaid	 with	 a	
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Table	2.8:	Reagents	and	volumes	for	a	10%	running	polyacrylamide	gel.	Volumes	are	for	one	
gel	of	1.5	mm	thickness.	
Reagent	 Volume		
40%	Acryl:Bisacryl	(37.5:1)	(Sigma-Aldrich;	Cat.	No.	A7168)		 3.13	mL	
1.5	M	Tris	pH	8.8	(Sigma-Aldrich;	Cat	No.	252859)		 3.13	mL	
10%	SDS	(Sigma-Aldrich;	Cat.	No.	L4390)		 125.00	µL	
ddH20		 6.00	mL	
10%	APS	(Sigma-Aldrich;	Cat.	No.	A3678)		 125.00	µL	
TEMED	(Sigma-Aldrich;	Cat.	No.	T9281)		 12.50	µL	
	
	
	
Table	2.9:	Reagents	and	volumes	for	a	3.75%	stacking	polyacrylamide	gel.	Volumes	are	for	one	
gel	of	1.5	mm	thickness.	
Reagent	 Volume		
40%	Acryl:Bisacryl	(37.5:1)	(Sigma-Aldrich;	Cat.	No.	A7168)		 235.00	µL	
0.5	M	Tris	pH	8.8	(Sigma-Aldrich;	Cat	No.	252859)		 625.00	µL	
10%	SDS	(Sigma-Aldrich;	Cat.	No.	L4390)		 25.00	µL	
ddH20		 1.59	mL	
APS	(Sigma-Aldrich;	Cat.	No.	A3678)		 50.00	µL	
TEMED	(Sigma-Aldrich;	Cat.	No.	T9281)		 5.00	µL	
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3.75%	stacking	gel	(Table	2.9)	and	a	comb	was	inserted	to	create	wells	for	loading.	The	gels	were	
again	left	to	polymerise	for	1	hour.	
Once	polymerisation	was	complete,	the	gels	were	placed	into	a	BIORAD	Mini	PROTEAN®	Tetra	
Cell	apparatus	filled	with	1X	SDS-PAGE	Running	Buffer	(192	mM	Glycine,	24.9	mM	Tris	base	and	
3.47	mM	SDS).	5-30	μL	of	each	sample	were	loaded	into	the	separate	wells	of	the	gel.	Alongside	
these	samples,	8	μL	of	PageRuler	Prestained	Protein	Ladder	(Fermentas)	was	added	to	visualise	
the	protein	separation	during	gel	running	and	to	determine	approximate	size	of	proteins	after	
western	blotting.	Gels	were	run	at	100	V	for	1.5-2.5	hours	to	separate	the	proteins,	using	the	
separation	of	the	Protein	Ladder	as	a	guide	for	running	time.		
2.6.3 Wet	Transfer		
Once	the	gel	was	run	to	an	appropriate	extent,	the	protein	was	transferred	onto	a	membrane	
using	wet	transfer.	The	stacking	portion	of	the	gel	was	discarded	and	the	running	gel	placed	on	
a	 piece	 of	 polyvinylidene	 difluoride	 (PVDF)	 membrane,	 which	 had	 been	 activated	 in	 100%	
methanol	 (MeOH).	The	gel	and	membrane	were	sandwiched	between	four	pieces	of	blotting	
paper	(3	mm	chromatography	paper,	Whatman®)	and	two	sponges	within	a	gel	holder	cassette,	
with	all	components	submerged	in	1X	Towbin’s	Buffer	(190	mM	Glycine,	24	mM	Tris	base	and	
20%	MeOH)	to	allow	the	gel	to	equilibrate	and	to	reduce	air	bubbles.	The	gel	holder	cassette	
(containing	 the	 gel,	 PVDF,	 blotting	 paper	 and	 sponges)	was	 transferred	 to	 a	mini	 Trans-Blot	
Module	(Bio-Rad)	within	a	gel	tank	filled	with	1X	Towbin’s	Buffer,	and	run	at	15	V	overnight	(~16	
hours)	to	transfer	the	protein	to	the	PVDF	membrane.	During	this	time,	the	tank	was	surrounded	
by	ice	to	minimise	heating.	
2.6.4 Western	Blotting		
Once	 transfer	was	 complete	 the,	 PDVF	membrane	 (to	which	 the	protein	 is	 now	bound)	was	
removed	from	the	transfer	apparatus	and	blocked	in	blocking	buffer	(5%	skim	milk	[Diploma],	
0.02%	Tween	20	in	PBS)	for	at	least	1	hour	with	agitation.	Following	blocking,	the	membrane	
was	exposed	to	a	primary	antibody	(Table	2.10)	diluted	in	3	mL	of	blocking	buffer	for	2-2.5	hours.	
The	membrane	was	 then	washed	with	blocking	buffer	six	 times,	with	each	wash	 lasting	5-10	
minutes.	 Following	 washing,	 the	 membrane	 was	 exposed	 to	 the	 appropriate	 Horse	 Radish	
Peroxidase	(HRP)	conjugated	secondary	antibody	(Table	2.11)	diluted	 in	3	mL	of	the	blocking	
buffer	for	1-1.5	hours	and	then	washed	with	0.02%	Tween	in	1X	PBS	six	times,	with	each	wash	
lasting	5-10	minutes.	
The	membrane	was	 incubated	 in	SuperSignal	West	Pico	Chemiluminescent	Substrate	(Pierce)	
for	5	minutes	in	darkness.	The	SuperSignal	West	Pico	Chemiluminescent	Substrate	contains	a		
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Table	2.10:	Primary	antibodies	used	in	western	blotting.		
Target	Protein	 Company;	Cat.	No.	 Species	 Dilution	used	
GAPDH	 Abcam;	ab8245	 Mouse,	monoclonal	 1/1000	
HA-probe	(Y-11)	 Santa	Cruz;	sc-805	 Rabbit,	polyclonal	 1/200	
Tata	binding	protein	(TBP)	 Abcam;	ab818	 Mouse,	monoclonal	 1/2000	
V5	 Invitrogen;	R960-25	 Mouse,	monoclonal	 1/3000	
	
	
	
	
Table	2.11:	Secondary	antibodies	used	in	western	blotting.		
Species	 Target	Species	 Company;	Cat.	No.	 Dilution	used	
Rabbit		 Mouse		 Invitrogen;	616520		 1/5000		
Donkey		 Rabbit		 Invitrogen;	A21206		 1/500		
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substrate	 upon	 which	 the	 HRP	 tag	 of	 the	 secondary	 antibody	 can	 act	 to	 produce	 a	
chemiluminescent	signal.	Following	incubation,	the	membrane	was	immediately	exposed	to	a	
charge-coupled	camera	via	the	ImageQuant™	LAS4000	biomolecular	imager	(GE	Healthcare	Life	
Sciences)	for	10	seconds	-	10	minutes	(dependent	on	the	experiment	and	antibody	used)	and	a	
digital	image	produced.	
2.7 Mouse	Husbandry,	Strains	and	Alleles	
Wildtype	embryos	were	taken	from	the	C3H/HeH	colony,	which	was	maintained	by	continuous	
backcross	to	C3H/HeH.	The	Kumba	(Ku)	allele	of	Zic2	(Brown	et	al.,	2000;	Elms	et	al.,	2003;	Warr	
et	al.,	 2008)	was	maintained	on	 two	distinct	 backgrounds	by	 continuous	backcross	 to	 either	
C3H/HeH	or	129/SvEv	mice.	 In	both	cases,	mice	 from	backcross	10	or	beyond	were	used	 for	
analysis.	 Gene	 expression	 and	 phenotype	 were	 found	 to	 be	 identical	 between	 the	 two	
backgrounds	 for	 both	 Zic2Ku/+	 and	 Zic2Ku/Ku	embryos	 at	 embryonic	 stages	 7.0	 –	 9.5	 dpc	 and	
analysis	 of	 embryos	 was	 performed	 using	 mice	 derived	 from	 both	 colonies.	 Mice	 were	
maintained	in	a	light	cycle	of	12	h	light:	12	h	dark,	the	midpoint	of	the	dark	cycle	being	12	A.M.	
2.8 Embryo	Collection	
Embryos	were	collected	from	pregnant	dams	from	6.5	dpc	onwards.	Noon	(12	P.M.)	on	the	day	
of	the	appearance	of	the	vaginal	plug	was	designated	0.5	dpc.	Embryos	were	dissected	from	the	
uterus	 and	 decidua	 in	 a	 solution	 of	 10%	 FBS	 (Life	 Technologies)	 in	 1X	 PBS.	 All	 membranes	
surrounding	 the	embryos	were	dissected	away;	 the	yolk	 sac	and	amnion	 from	mutant	 litters	
were	taken	for	genotyping.	Embryos	were	staged	according	to	Downs	and	Davies	(Downs	and	
Davies	1993).	
For	WMISH,	embryos	were	fixed	overnight	in	4%	PFA	in	1X	PBS	at	4	°C,	and	then	dehydrated	
through	 a	MeOH:PBS	 series	 (25%,	 50%,	 70%	 and	 100%	MeOH,	 respectively).	 Embryos	were	
stored	in	100%	MeOH	at	-20	°C	until	WMISH	was	performed.	For	RT-qPCR,	embryos	were	pooled	
based	on	their	age.	The	total	RNA	was	extracted	immediately	as	per	Section	2.2.18.	
2.9 Genotyping	
2.9.1 Genomic	DNA	Lysis	
Adult	mice	were	genotyped	using	ear	biopsy	DNA.	A	~20	mm2	notch	of	ear	was	taken	from	each	
mouse.	To	each	ear	notch	sample,	50	µL	of	lysis	solution	(50	mM	Tris-HCl	pH	8.5,	1	mM	EDTA,	
5.0%	Tween	20)	and	2	µL	of	Proteinase	K	(PK;	10	mg/mL	in	dH2O)	was	added	and	incubated	at	
55	°C	for	60	minutes,	followed	by	95	°C	for	10	minutes	to	inactivate	the	PK.	Tissue	debris	was	
pelleted	by	centrifuging	at	2000	x	g	for	5	minutes,	and	each	sample	diluted	1:10	in	AnalaR	H2O.	
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Embryos	were	genotyped	using	a	fragment	of	extra	ectoplacental	cone	(7.5	dpc),	amnion	or	yolk	
sac	(³	8.5	dpc).	To	each	embryo	sample,	10	μL	of	lysis	solution	and	2	μL	of	PK	was	added	and	
samples	incubated	at	55	°C	for	25	minutes	and	95	°C	for	5	minutes	to	inactivate	the	PK.	Tissue	
debris	was	pelleted	by	centrifuging	at	2000	x	g	for	5	minutes,	and	each	sample	diluted	1:4	in	
AnalaR	H2O.	
2.9.2 Genotyping	PCRs	
To	genotype	transient	PiggyBac	transgenic	embryos,	oligonucleotide	RA1058	was	paired	with	
oligonucleotide	 RA1547	 (pBB262-NCE-lacZ	 wildtype	 and	mutant),	 RA1548	 (pBB262-lacZ)	 and	
RA1059	 (pBB262-mNet-lacZ).	 All	 reactions	 were	 carried	 out	 in	 a	 10	 μL	 volume	 with	 a	 final	
concentration	of	0.6	μM	of	each	oligonucleotide	and	2X	PCR	ReddyMix™	Master	Mix	without	
KCl	(Table	2.2).	1	M	Betaine	was	included	for	pBB262-NCE-lacZ	genotyping.	PCRs	to	be	analysed	
via	gel	electrophoresis	were	performed	in	96-Well	Clear,	Flat	Top	PCR	plates	(Axygen;	Cat.	No.	
PCR-96-FLT-C).	 All	 PCRs	 were	 performed	 in	 an	 Eppendorf	 Mastercycler®	 using	 the	 TD70	
Touchdown	 PCR	 programs	 (Table	 2.12)	 and	 the	 products	 run	 on	 a	 1.5%	 agarose	 gel.	 The	
production	of	a	443	bp	 (pBB262-mNet-lacZ),	561	bp	 (pBB262-NCE-lacZ	wildtype	and	mutant)	
and	366	bp	(pBB262-lacZ)	were	deemed	a	positive	genotype.		
Genotyping	 of	 CRISPR	 3’UTR	 mutant	 embryos	 was	 performed	 by	 Nay	 Chi	 of	 the	 JCSMR	
Transgenesis	 Facility.	 Briefly,	 all	 reactions	 were	 carried	 out	 in	 a	 50	 μL	 volume	 with	 a	 final	
concentration	of	0.6	μM	of	each	oligonucleotide	(RA1778	and	RA1779,	Appendix	Table	A1.2),	2X	
MyTaq™	HS	Mix	(Bioline;	Table	2.2)	and	1	M	Betaine.	PCRs	to	be	analysed	via	gel	electrophoresis	
were	performed	in	96-Well	Clear,	Flat	Top	PCR	plates	(Axygen;	Cat.	No.	PCR-96-FLT-C).	All	PCRs	
were	performed	in	an	Eppendorf	Mastercycler®	using	a	hot	start	PCR	program	according	to	the	
manufacturer’s	 instructions.	 The	products	 run	on	a	1%	agarose	 gel;	 an	 amplicon	of	 1019	bp	
indicated	a	wildtype	embryo.		
2.9.3 High	Resolution	Melt	Assay	(HRMA)	
Genomic	DNA	extracted	 from	ear	notches	of	 adult	mice	and	embryo	 tissue	were	genotyped	
using	HRMA,	 as	 described	by	 (Thomsen	et	 al.,	 2012).	 PCRs	were	 carried	out	using	 ImmoMix	
(Bioline;	Cat.	No.	BIO-25020)	and	included	the	LC	Green®	Plus+	Melting	Dye	(Idaho	Technology	
Inc.;	Cat.	No.	BCHM-ASY-0005).	All	reactions	were	carried	out	in	a	final	volume	of	10	μL	with	~30	
ng	 of	 digested	 ear	 notch	DNA,	with	 a	 final	 concentration	 of	 0.6	 μM	of	 each	 oligonucleotide	
(Appendix	Table	A1.2).	Reactions	were	set	up	in	Hard-Shell®	96-well	PCR	Plates	(BioRad;	Cat.	No.	
HSP-9665)	covered	with	Axygen	Microplate	Sealing	Film	(Fisher	Scientific;	Cat.	No.	UC500).	To	
avoid	evaporation	during	the	HRMA	process,	each	reaction	was	covered	with	~10	μL	of	mineral	
oil	prior	to	PCR.	All	PCRs	were	performed	in	an	Eppendorf	Mastercycler®	using	three	Touchdown	
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PCR	programs:	TD60,	TD65	and	TD70	(Table	2.12).	On	completion	of	a	PCR	reaction,	the	96-well	
plate	 containing	 PCR	 products	 was	 placed	 directly	 into	 a	 Light	 Scanner	 HR	 96	 (Idaho	
Technologies	Inc.)	and	samples	melted	from	60	°C	to	95	°C	at	a	rate	of	0.1	secs-1.	The	LC	Green®	
dye	specifically	binds	to	double-stranded	DNA	and	emits	fluorescence	that	is	captured	by	the	
Light	Scanner	HR	96	instrument.	As	temperature	increases	double-stranded	DNA	is	converted	
to	single-stranded,	which	dissociates	LC	Green	from	DNA,	resulting	in	a	decrease	in	fluorescence.	
Since	melting	of	DNA	is	dependent	on	sequence	and	length,	each	amplicon	has	a	unique	melt	
profile.	The	data	were	analysed	with	LightScanner	software	(Idaho	Technologies	Inc.).	
Kumba	wildtype	and	heterozygotes	adults	were	genotyped	with	oligonucleotides	RA247	and	
R248	(Appendix	Table	A1.2),	whilst	mNet	wildtype	and	heterozygote	adults	and	embryos	were	
genotyped	with	RA1058	and	RA1059.	A	Shh	control	was	also	amplified	(RA748	and	RA749)	to	
ensure	the	integrity	of	mNet	embryo	gDNA.		
2.9.4 Allelic	Discrimination	Assay	(ADA)	
ADA	 was	 used	 to	 genotype	 Kumba	 embryo	 DNA,	 as	 Zic2Ku/Ku	 homozygotes	 cannot	 be	
distinguished	 via	 HRMA.	 A	 TaqMan®	 Universal	 PCR	Master	Mix	 (Life	 Technologies;	 Cat.	 No.	
4304437),	along	with	TaqMan®	MGB	probes	(Applied	Biosystems)	corresponding	to	the	wildtype	
and	 Kumba	 (Ku)	 alleles	 of	 Zic2	 were	 used	 to	 visualize	 the	 genotype	 of	 each	 embryo.	 The	
sequence	of	the	probes	are	given	in	Table	2.13.	The	wildtype	probes	were	modified	at	the	5’	end	
with	a	6-FAM	(6-carboxyfluorescein)	tag	and	the	mutant	probes	with	VIC®.	The	3’	end	of	each	
probe	was	modified	with	a	non-fluorescent	quencher	and	a	minor	groove	binding	moiety.	The	
probes	were	used	at	half	the	recommended	concentration	(200	nM).	All	reactions	were	carried	
out	in	a	final	volume	of	10	μL	with	~30	ng	of	digested	embryo	DNA	in	the	presence	of	0.9	μM	of	
oligonucleotides	RA247	and	RA248	(Appendix	Table	A1.2).	Reactions	were	set	up	in	96-well	Half-
Skirted	PCR	Microplates	(Axygen®;	Cat.	No.	PCR-96-LP-AB-C)	covered	with	Axygen	Microplate	
Sealing	Film	 (Fisher	Scientific;	Cat.	No.	UC500)	and	performed	using	 the	StepOnePlus™	Real-
Time	 PCR	 System	 (Applied	 Biosystems®).	 The	 StepOne	 Software	 (version	 2.2.2;	 Applied	
Biosystems®)	was	used	to	run	the	assay	using	the	following	conditions:	an	initial	pre-PCR	read	
at	60	°C	for	30	seconds	to	record	background	fluorescence,	followed	by	95	°C	for	10	minutes	to	
denature	the	template	and	a	cycling	stage	of	95	°C	for	15	seconds	and	of	60	°C	for	1	minute	for	
50	 cycles.	 A	 post-PCR	 read	 was	 performed	 at	 60°	 C	 for	 30	 seconds	 to	 collect	 data	 after	
completion	of	the	PCR.	Data	was	analysed	using	the	same	software	that	records	the	pre-	and	
post-PCR	reads	and	calculates	normalized	dye	fluorescence	(∆Rn)	from	the	wildtype	and	mutant	
alleles	 as	 a	 function	 of	 cycle	 number.	 Based	 on	 this	 data	 the	 software	 called	 the	 sample	 as	
homozygous	for	either	wildtype	or	mutant	allele,	or	heterozygous	with	both	alleles.	 	
	89	
	
Table	2.12:	Touchdown	PCR	cycling	conditions.		
Program:	 TD60	 TD65	 TD70	
Initial	
denaturation	
94	°C	4	minutes	 	 94	°C	4	minutes	 	 94	°C	4	minutes	 	
Denature	
94	°C	30	
seconds	
X	29	
94	°C	30	
seconds	
X	19	
92	°C	30	
seconds	
X	20	Anneal	
60	°C,	
decreasing	by	
0.5	°C	per	cycle,	
30	seconds	
65	°C,	
decreasing	by	
0.5	°C	per	cycle,	
30	seconds	
70	°C,	
decreasing	by	
0.5	°C	per	cycle,	
30	seconds	
Extend	
72	°C	30	
seconds	
72	°C	30	
seconds	
72	°C	1	minute	
Denature	
94	°C	30	
seconds	
X	19	
94	°C	30	
seconds	
X	29	
92	°C	30	
seconds	
X	20	Anneal	
45	°C	30	
seconds	
55	°C	30	
seconds	
60	°C	30	
seconds	
Extend	
72	°C	30	
seconds	
72	°C	30	
seconds	
72	°C	1	minute	
Polish	 72	°C	7	minutes	 	 72	°C	7	minutes	 	 72	°C	7	minutes	 	
Stop	 4	°C	 Hold	 4	°C	 Hold	 4	°C	 Hold	
	
	
	
	
Table	2.13:	ADA	probes	for	genotyping	of	Kumba	mice.		
Probe	name	 5’	Tag	 Probe	sequence	 3’	Quencher	
Zic2	WT	 6-FAM	 CGA	GGG	CTG	TGA	CC	 MGBNFQ	
Zic2	Ku	 VIC	 TTC	GAG	GGC	AGT	GAC	 MGBNFQ	
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2.10 Embryo	Hybridization	and	Staining	
2.10.1 WMISH	Riboprobe	Synthesis	from	Plasmid	DNA	
Riboprobes	were	synthesized	from	plasmid	DNA	as	shown	in	Table	2.14.	Dand5,	Rfx3	and	Noto	
were	cloned	 into	pGEM-T-Easy	before	being	synthesised	 (Section	2.1.3).	All	other	 riboprobes	
made	from	plasmid	DNA	were	already	in	plasmid	form	in	the	Arkell	laboratory.	Plasmid	DNA	was	
linearized	using	restriction	enzymes	5’	to	the	probe,	shown	in	Table	2.14.		
Antisense	RNA	probes	were	in	vitro	transcribed	from	1	μg	of	plasmid	DNA.	T7,	T3	or	SP6	RNA	
Polymerase	 (Roche)	 and	 Digoxygenin	 Labelling	 Mix	 (Roche)	 were	 used	 according	 to	 the	
manufacturer’s	instructions	and	with	the	addition	of	RNase	Inhibitor	(Roche).	After	synthesis,	
the	DNA	template	was	digested	using	20	U	of	DNase	I	(RNase	free,	Roche).	All	reactions	were	
stopped	by	the	addition	of	EDTA	at	a	final	concentration	of	16	mM.	The	RNA	was	precipitated	
overnight	at	-20°C	by	the	addition	of	LiCl	to	a	final	concentration	of	0.36	M	and	2.5X	volumes	of	
100%	EtOH.	The	RNA	was	pelleted	by	centrifugation	at	20800	x	g	for	20	minutes	at	4	°C,	and	the	
supernatant	removed.	The	pellet	was	washed	with	200	μL	of	70%	EtOH	and	air	dried.	It	was	then	
resuspended	in	100	μL	of	AnalaR	H2O.	A	5	μL	aliquot	was	electrophoresed	on	a	1%	agarose/1X	
TBE	gel	to	check	the	yield	and	degradation	of	the	RNA	probe.	Probes	were	stored	at	-20	°C	until	
use.		
2.10.2 Whole	Mount	In	Situ	Hybridization		
WMISH	 was	 performed	 as	 previously	 described	 in	Wilkinson	 (1992)	 using	 the	 hybridization	
conditions	of	Rosen	and	Beddington	(1993)	(Rosen	and	Beddington,	1993;	Wilkinson,	1992).	For	
12.5	dpc	embryos,	wash	times	were	extended	to	15	minutes	and	WMISH	was	performed	on	a	
benchtop	 nutating	mixer	 to	 decrease	 trapping.	 PK	 and	 4%	 PFA	 steps	were	 also	 doubled.	 All	
WMISH	embryos	were	destained	in	1X	PBT	(1X	PBS;	Tween	20)	and	post-fixed	in	4%	PFA	in	PBS	
for	one	hour	at	room	temperature	before	being	photographed	as	described	in	Section	2.13.1.	
2.10.3 X-Gal	staining	of	whole	embryos	
Dissected	 embryos	 were	 fixed	 in	 4%	 PFA	 in	 1X	 PBS	 for	 20	 minutes	 at	 room	 temperature.	
Following	this,	embryos	were	rinsed	 in	1X	PBS	and	equilibrated	 in	a	sodium	phosphate	wash	
buffer	(2	mM	magnesium	chloride,	0.01%	deoxycholate,	0.02%	NP40,	98	mM	sodium	phosphate	
buffer	 [23	 mM	 monobasic	 sodium	 phosphate,	 77	 mM	 dibasic	 sodium	 phosphate,	 pH	 7.3,	
Sigma]).	 X-Gal	 stain	 (10	 mg/mL	 5-bromo-4-chloro-3-indolyl	 β-D-galactopyranoside	 in	
dimethylformamide,	 Sigma	 Aldrich;	 40	 mM	 potassium	 ferrocyanide,	 Sigma	 Aldrich;	 40	 mM		
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Table	2.14:	Riboprobes	used	for	WMISH.	Probes	correspond	to	constructs	 listed	in	Appendix	
Table	 A1.1.	 Restriction	 enzymes	 used	 to	 linearise	 plasmid	 DNA,	 and	 RNA	 polymerases	 are	
indicated.		
Probe	 Restriction	Enzyme	 Transcription	
Polymerase	
Reference	
Cdx2	 EcoRV	 T7	 Stefan	Broer,	ANU	
Dand5	 SacII	 SP6	 (Barratt	et	al.,	2014)	
Dkk1	 SalI	 T7	 (Ip	et	al.,	2014)	
Foxa2	 HindIII	 T7	 (Sasaki	and	Hogan,	1993)	
Foxj1	 SalI	 T3	 (Cruz	et	al.,	2010)	
Lefty1/2	 XhoI	 T7	 (Meno	et	al.,	1996)	
Lhx1	 HindIII	 T7	 (Shawlot	and	Behringer,	1995)	
Nodal	 EcoRI	 T3	 (Conlon	et	al.,	1994)	
Noto	 SalI	 T7	 (Barratt	et	al.,	2014)	
Nppa	 EcoRI	 T3	 Dominic	Norris,	MRC	Harwell,	UK	
Pitx2	 SacI	 T3	 (Ryan	et	al.,	1998)	
Pkd1l1	 EcoRI	 T7	 (Field	et	al.,	2011)	
Rfx3	 NcoI	 SP6	 (Barratt	et	al.,	2014)	
Shh	 XbaI	 T7	 (Echelard	et	al.,	1993)	
Sox2	 AccI	 T3	 (Wood	and	Episkopou,	1999)	
Sox3	 NotI	 T7	 (Wood	and	Episkopou,	1999)	
Sox17	 NotI	 T7	 Dominic	Norris,	MRC	Harwell,	UK	
Zic2	 SalI	 T7	 (Elms	et	al.,	2003)	
Zic3	 NcoI	 SP6	 (Elms	et	al.,	2004)	
Zic5	 SalI	 T7	 Arkell	laboratory	
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potassium	 ferricyanide,	 Sigma	 Aldrich;	 200	 mM	 Tris-HCl	 pH	 7.4)	 was	 diluted	 in	 the	 sodium	
phosphate	wash	buffer	and	embryos	were	incubated	in	stain	overnight	in	a	dark	37	°C	shaking	
incubator.	Embryos	were	destained	in	1X	PBT	(1X	PBS;	Tween	20)	and	post-fixed	in	4%	PFA	in	
PBS	 for	 one	 hour	 at	 room	 temperature	 before	 being	 photographed	 as	 described	 in	 Section	
2.13.1.	
2.11 PiggyBac	Transposon	Transgenesis	
2.11.1 Generation	of	PiggyBac	Transposase	mRNA	
To	transcribe	the	PiggyBac	transposase	for	zygote	microinjections,	pBB232	was	linearized	with	
XbaI	 (Table	 2.1).	 The	 transposase	 mRNA	 was	 transcribed	 with	 T3	 RNA	 Polymerase	 and	 the	
mMessage	mMachine	T3	Kit	 (Ambion)	no	more	than	24	hours	before	zygote	microinjections.	
The	resulting	mRNA	was	purified	with	the	MEGAclear	Transcription	Clean-Up	kit	(Ambion),	and	
mRNA	 quality	 and	 yield	 assessed	 via	 agarose	 gel	 electrophoresis	 and	 nanodrop.	 Only	
transposase	mRNA	with	clear	bands,	high	yield	and	no	gDNA	contamination	was	used	 in	 the	
subsequent	microinjections.		
2.11.2 PiggyBac	Pronuclei	Microinjection	and	Implantation	
Embryo	 donor	 FVB/NJ	 mice	 were	 first	 injected	 with	 Pregnant	 Mare	 Serum	 Gonadotrophin,	
followed	by	Human	Chorionic	Gonadotrophin	48	hours	 later	 to	 induce	super	ovulation.	They	
were	then	immediately	placed	with	fertile	stud	males	and	fertilised	zygotes	were	harvested	12	
hours	post-conception.	PiggyBac	transposon	mRNA	and	pBB262	transgene	constructs	(pBB262-
mNet-lacZ,	pBB262-lacZ	and	wildtype	pBB262-NCE-lacZ)	linearized	with	XmnI	(Table	2.1)	were	
co-injected	 into	 the	pronucleus	by	Gene	Elliot	 at	 the	NIH	Transgenic	Core	 Facility.	 Following	
injection,	zygotes	were	incubated	overnight	(37	°C,	5%	CO2)	until	they	reached	the	1-2	cell	stage.	
Unviable	embryos	were	discarded,	whilst	viable	embryos	were	implanted	into	the	right	uterine	
infundibulum	of	anesthetised	pseudopregnant	FVB/NJ	mice	and	left	to	develop	until	the	desired	
dissection	time	point.	Approximately	15	1-2	cell	stage	embryos	were	implanted	in	each	female.	
2.12 CRISPR-Cas9	Mutagenesis	
2.12.1 Guide	Design	
Zic2	3’UTR	deletion	CRISPR	guide	design	was	primarily	performed	by	the	JCSMR	Transgenesis	
Facility	(ANU).	Guide	strands	were	designed	using	the	Zhang	CRISPR	Design	Tool	(Zhang	Lab	and	
MIT,	2015).	Sequences	of	150	bp	5’	and	3’	to	the	Zic2	3’UTR	enhancer	region	were	analysed	for	
appropriate	candidate	sites.	Appropriate	guide	strands	were	identified	based	on	the	presence	
of	a	5’-NGG	PAM	sequence	immediately	downstream	(3’)	of	the	candidate	site.	Candidate	guide	
strands	 were	 deemed	 ideal	 if:	 the	 candidate	 was	 20	 bp	 in	 length,	 >35%	 and	 <80%	 of	 the	
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nucleotides	were	G	or	C,	candidates	had	a	small	number	of	off	target	sites,	and	the	off-target	
sites	that	were	present	had	three	or	more	mismatches	to	the	guide	strand.	Due	to	the	location	
of	the	guide	within	the	Zic2	3’UTR,	however,	these	criteria	were	not	always	met.	A	G	was	added	
to	the	5’	of	those	guide	sequences	that	did	not	already	have	a	G	as	the	first	base	pair.		
2.12.2 Preparation	of	CRISPR	Guide	Plasmid	DNA	and	mRNA	
Guide	oligonucleotides	that	were	purchased	as	DNA	were	cloned	into	pTOPO-Blunt-II	by	Nay	Chi	
of	the	JCSMR	Transgenesis	Facility.	Upon	largescale	isolation,	plasmid	DNA	was	injected	directly	
into	fertilized	zygotes,	as	described	in	Chapter	7.	Guides	that	were	purchased	as	mRNA	were	
directly	injected	into	fertilized	zygotes.		
2.12.3 CRISPR	Guide	mRNA	and	Cas9	Microinjection	and	Implantation	
Embryo	donor	C57BL/6-NCrl	mice	were	first	injected	with	Pregnant	Mare	Serum	Gonadotrophin,	
followed	by	Human	Chorionic	Gonadotrophin	48	hours	 later	 to	 induce	super	ovulation.	They	
were	then	immediately	placed	with	fertile	stud	males	and	fertilised	zygotes	were	harvested	12	
hours	 post-conception.	 CRISPR	 guide	mRNA	or	 plasmid	DNA,	 and	50-100	ng/µL	 CRISPR-Cas9	
protein	 were	 co-injected	 into	 the	 pronucleus	 by	 Nikki	 Ross	 and	 Jenna	 Lowe	 at	 the	 JCSMR	
Transgenesis	Facility.	Following	injection,	zygotes	were	incubated	overnight	(37	°C,	5%	CO2)	until	
they	reached	the	2	cell	stage.	Unviable	embryos	were	discarded,	whilst	viable	embryos	were	
implanted	into	the	right	uterine	infundibulum	of	anesthetised	pseudopregnant	Swiss	mice	and	
left	to	develop	until	the	desired	dissection	time	point	or	pups	were	born.		
2.13 Microscopy	
2.13.1 Differential	Interference	Contrast	(DIC)	Microscopy	
WMISH	 embryos	 were	 post-fixed	 in	 4%	 PFA	 in	 PBS	 for	 one	 hour	 at	 room	 temperature	 and	
transferred	via	a	glycerol	series	(50%,	80%)	to	100%	glycerol.	For	photography,	whole	embryos	
were	flat-mounted	on	a	glass	slide	under	a	glass	coverslip	and	photographed	in	a	Nikon	SMZ	
21500	Stereomicroscope	and	DS-Ri1	camera	(Nikon)	with	DIC	optics.	
For	node	measurements,	fixed	embryos	were	mounted	under	a	glass	coverslip	in	100%	glycerol	
and	their	node	visualized	with	a	40X	objective	(Leica)	in	a	compound	microscope	(Leica	DM5500	
FL	DIC)	using	DIC	optics.	Images	were	captured	using	a	Leica	DFC365	FX	camera	and	LAS	V4.3	
software.	X-Gal	stained	cells	expressing	lacZ	were	imaged	at	40X	with	the	same	microscope.		
2.13.2 Fluorescence	Microscopy	
Cell	immunofluorescence	was	photographed	with	a	100X	oil	immersion	objective	(Zeiss)	using	a	
Zeiss	Axio	Observer	with	a	Apotome	Nikon	TE3000	inverted	fluorescence	microscope.	Images	
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were	 captured	 using	 a	 Zeiss	 AxioCamMRm	 CCD	 camera	 using	 DIC	 optics.	 Fluorescence	 was	
imaged	at	495	nm	and	590	nm	(Table	2.7).		
2.13.3 Scanning	Electron	Microscopy	(SEM)		
Mouse	embryos	at	8.0	dpc	were	dissected	in	10%	(v/v)	FBS	in	PBS	and	fixed	overnight	in	fresh	
2%	PFA/2.5%	gluteraldehyde/0.1	M	cacodylate	buffer	(pH	7.4)	at	4	°C.	After	rinsing	with	0.1	M	
cacodylate	buffer,	 embryos	were	postfixed	 in	1%	osmium	 tetroxide/0.1	M	cacodylate	 for	 20	
minutes	at	room	temperature.	They	were	dehydrated	through	a	graded	EtOH	series	and	dried	
at	 a	 critical	 point	 with	 a	 CPD010	 (Balzers	 Union).	 Embryos	 were	 coated	 in	 platinum	 by	 an	
EMTECH	K550X	sputter	coater.	All	imaging	was	performed	on	a	Hitachi	4300SE/N	FESEM	at	3	kv.	
2.14 Analysis	
2.14.1 Node	and	Cilia	Measurements	
Kumba	node	morphology	and	size	was	examined	using	DIC	optics	on	 three	embryos	of	each	
genotype	 (Zic2+/+,	 Zic2Ku/+	 and	 Zic2Ku/Ku).	 Node	 circumference	 and	 the	 length	 of	 the	 anterior-
posterior	axis	were	measured	using	LAS	V4.3	software.	Cilia	frequency	and	length	were	counted	
in	 three	 embryos	 from	 each	 genotype	 (Zic2+/+,	 Zic2Ku/+	 and	 Zic2Ku/Ku)	 using	 SEM.	 For	 cilia	
frequency	 and	 length	 analysis,	 SEM	 images	were	 recorded	at	 15000X	magnification.	 The	 file	
name	of	each	image	was	altered	to	a	number	and	the	file	order	randomized	by	an	independent	
worker	so	that	the	genotype	of	the	embryo	was	unknown	when	calculating	cilia	frequency	and	
length,	and	node	circumference.	Cilia	length	was	determined	by	measuring	pixel	length	in	Adobe	
Photoshop	CS5	and	converting	it	to	µm	(using	a	factor	determined	by	the	number	of	pixels	per	
µm).	In	total,	ten	node	cilia	were	measured	in	each	of	three	embryos	per	genotype.		
2.14.2 Assessing	Transcript	Decay	Rate		
To	 measure	 the	 rate	 of	 ZIC2	 mRNA	 decay,	 cells	 were	 either	 transfected	 with	 constructs	
containing	V5-ZIC2-3’UTR	or	V5-ZIC2.	24	hours	post	transfection,	the	media	was	aspirated	from	
cells	and	replaced	with	either	supplemented	DMEM	(1	mL)	containing	200	μM	5,6-dichloro-beta	
D-ribofuranosyl-benzimidazole	 (DRB)	 suspended	 in	 dimethyl	 sulfoxide	 (DMSO),	 or	
supplemented	DMEM	containing	an	equivalent	volume	of	0.2%	DMSO	as	a	control.	Immediately,	
the	media	from	a	dish	containing	cells	that	had	not	been	treated	with	DRB	was	removed	and	cell	
lysates	were	stored	at	-80	oC	until	samples	from	all	time	points	were	collected.	This	sample	was	
designated	as	the	0	hour	time	point.	Cells	treated	with	DRB	were	subsequently	lysed	at	1	hour,	
2	hours	and	4	hours	post	DRB	treatment.	The	RNA	was	then	extracted	and	purified	as	described	
in	Section	2.2.18.		
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The	RNA	samples	were	run	through	RT-qPCR	analysis	(Section	2.4)	and	the	fold	change	in	ZIC2	
expression	 in	 each	 cell	 sample	 quantified.	 The	 amount	 of	 ZIC2	 mRNA	 remaining	 after	 DRB	
treatment	was	calculated	as	a	percentage	of	the	ZIC2	 levels	in	untreated	cells	from	the	same	
time	point.	The	proportion	of	ZIC2	mRNA	remaining	in	inhibited	cells	was	plotted	against	time	
used	to	calculate	the	half-life	(t1/2)	of	ZIC2	in	Microsoft	Excel	using	the	formula:		
!"/$ 	= log(2)log{LOGEST[(56, 86) 	 ∶ 	 (5:, 8:)]}	
The	LOGEST	function	estimates	the	slope	of	all	points	over	the	time	course	using	a	nonlinear	
least	 squares	 regression	 (Ti	 is	 the	 initial	 time	 point,	Tf	 is	 the	 final	 time	 point,	Zi	 is	 the	 initial	
proportion	of	ZIC2	mRNA,	Zf	is	the	final	proportion	of	ZIC2	mRNA)	(Geisberg	et	al.,	2014).		
2.14.3 Rapid	Amplification	of	cDNA	Ends	(3’	RACE)	
Wildtype	embryos	at	7.5	dpc,	8.5	dpc	and	9.5	dpc	were	collected	and	pooled	based	on	their	age	
and	 the	 total	 RNA	 extracted	 as	 per	 Section	 2.2.18.	 A	 dT-adapter	 oligonucleotide	 (RA1703;	
Integrated	DNA	Technologies)	was	used	with	the	SuperScipt	 III	One-Step	RT-PCR	system	with	
Platinum	 Taq	 kit	 (Invitrogen,	 Cat.	 No.	 12574018)	 to	 convert	 the	 embryonic	mRNA	 to	 cDNA,	
according	to	the	manufacturer’s	instructions.	The	presence	of	the	‘TTT’	string	ensures	only	RNA	
with	a	poly(A)	 tail	 is	 converted	 into	 cDNA.	Newly	 created	 cDNA	was	purified	 via	 ammonium	
acetate	clean	up	(Section	2.2.10).	
A	TD60	PCR	was	performed	using	an	oligonucleotide	5’	to	the	Zic2	3’UTR	(RA98;	Appendix	Table	
A1.2)	and	an	oligonucleotide	that	recognises	the	dT-adapter	sequence	(RA1704),	in	conjunction	
with	2X	ImmoMix	and	1	M	Betaine.	Following	gel	electrophoresis	to	resolve	the	PCR	amplicon	
fragments,	 clear	 bands	were	 gel	 extracted.	 If	 the	 PCR	 product	was	 smeared,	 the	 entire	 PCR	
reaction	was	purified	via	ammonium	acetate.	The	amplicons	were	re-PCRed	with	RA1704	and	
an	oligonucleotide	 (RA99)	nested	slightly	3’	 to	RA98.	Gel	electrophoresis	was	performed	and	
clear	amplicons	gel	extracted.	Following	purification,	amplicons	were	TA	cloned	into	pGEM-T-
Easy	and	the	ligation	reaction	electrotransformed	into	DH5a	E.	coli.	Following	bacterial	colony	
PCR	to	identify	transcripts	predicted	to	be	the	Zic2	3’UTR,	plasmid	DNA	was	purified	and	Sanger	
sequenced.		
2.14.4 Bioinformatics	Tools	
Many	bioinformatics	tools,	outlined	in	Table	2.15	and	Table	2.16,	were	employed	for	the	analysis	
of	 the	ZIC2	NCE	and	 related	sequences.	The	default	 settings	were	used	 for	each	 tool,	unless	
otherwise	indicated.	Sequence	alignment	figures	and	sequence	annotations	were	generated	in	
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Geneious	Pro	v5.5.9.	Methylation	and	acetylation	values	were	analysed	 in	Microsoft	Excel	 to	
correlate	enrichment	with	the	ZIC2	3’UTR	sequence.		
2.14.5 Statistics	
Luciferase	assays:	The	standard	deviation	(S.	D.)	of	the	internal	repeats	of	the	representative	
experiment	 was	 calculated	 using	 Microsoft	 Excel.	 Pooled	 data	 was	 analysed	 using	 Genstat	
software	 to	 perform	 either	 an	 unpaired	 Student’s	 T-Test	 or	 two-way	 Analysis	 of	 Variance	
(ANOVA)	with	Fischer’s	unprotected	post	hoc	test	on	a	minimum	of	three	external	repeats,	and	
to	calculate	the	standard	error	of	the	mean	(S.	E.	M.).		
RT-qPCR	 analysis:	 Genstat	 software	 was	 used	 perform	 a	 one-way	 ANOVA	 with	 Fischer’s	
unprotected	post	hoc	test	on	a	minimum	of	two	external	repeats,	and	to	calculate	the	S.E.M.	
Statistical	analysis	was	performed	on	normalized	CT	means.	
Cilia	 analysis:	 Genstat	 software	 was	 used	 to	 perform	 a	 two-way	 ANOVA	 with	 Fischer’s	
unprotected	post	hoc	test	on	ten	cilia	each	for	three	embryos	per	genotype,	and	to	calculate	the	
S.E.M.		
Bioinformatics:	 For	 histone	 modification	 enrichment,	 values	 taken	 from	 Layered	 Tracks	
(ENCODE)	were	assigned	 to	a	nucleotide	 location	within	 the	ZIC2	3’UTR	 in	Excel.	Enrichment	
within	the	3’UTR	was	compared	via	a	one-way	ANOVA	with	Fischer’s	unprotected	post	hoc	test	
in	Genstat	 software,	 and	 the	S.E.M.	 calculated.	To	determine	 if	predicted	binding	 sites	were	
enriched	within	the	ZIC2	3’UTR,	a	two-tailed	Chi-squared	goodness	of	 fit	 test	was	performed	
using	the	GraphPad	online	tool	(GraphPad	Software,	2017).	To	determine	if	A	and	U	nucleotides	
were	enriched	within	the	ZIC2	3’UTR	mRNA,	a	two-tailed	Chi-squared	was	performed	using	the	
GraphPad	online	tool	(GraphPad	Software,	2017).	
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Table	2.15:	Databases	and	software	used	for	bioinformatics	analyses.		
Database/Software	 Use	 Reference	
AREsite	 Identification	of	AU-rich	elements	
Poly(A)	site	prediction	
(Gruber	et	al.,	2011)	
BLASTn	(NCBI)	 Alignment	of	DNA	sequences	 (Altschul	et	al.,	1997)	
CLUSTAL	Omega	 Pairwise	identity	percentage	calculations	 (Goujon	 et	 al.,	 2010;	 Sievers	 et	 al.,	
2011)	
DIANA-microT-CDS	 miRNA	binding	site	prediction	 (Paraskevopoulou	 et	 al.,	 2013;	
Reczko	et	al.,	2012)	
EMAGE	 Gene	expression	analysis	in	embryos	 (Richardson	et	al.,	2014)	
ENCODE	 Genome	 Editor	 (via	 the	 UCSC	
Genome	and	Table	Browser)	
Identification	of	chromatin	DNase	I	hypersensitivity	sites	
Identification	of	chromatin	methylation	and	acetylation	enrichment	
Identification	of	p300	binding	enrichment	
Transcription	factor	binding	site	prediction	
(Kent	et	al.,	2002)	
Geneious	Pro	5.5.9	 Alignment	of	DNA	sequences	
Generating	alignment	figures	
Annotation	of	sequences	
(Kearse	et	al.,	2012)	
JASPAR	 Transcription	factor	binding	site	prediction	 (Mathelier	et	al.,	2014)	
MGI	GXD	 Gene	expression	analysis	 (Finger	et	al.,	2011)	
miRanda	 miRNA	binding	site	prediction	 (Betel	et	al.,	2008;	John	et	al.,	2004)	
miRNASNP	 miRNA	binding	site	prediction	 (Gong	et	al.,	2015)	
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miRNA	thermodynamics	binding	prediction	
mrSNP	 miRNA	thermodynamics	binding	prediction	 (Deveci	et	al.,	2014)	
PolyA	Signal	Miner	 Poly(A)	site	prediction	 (Liu	et	al.,	2003)	
Phylogeny.fr	 Phylogenetic	tree	generation	 (Dereeper	et	al.,	2008)	
RBPDB	 RNA	binding	protein	binding	site	prediction	 (Berglund	et	al.,	2008)	
RBPmap	 RNA	binding	protein	binding	site	prediction	 (Paz	et	al.,	2014)	
TRANSFAC	 Transcription	factor	binding	site	prediction	 (Matys	et	al.,	2006)	
UCSC	Genome	and	Table	Browser	 Identification	of	histone	modifications	 (Rosenbloom	et	al.,	2015)	
	
Table	2.16:	Tracks	used	with	the	UCSC	Genome	Browser	and	ENCODE	Genome	Editor.		
Track	 Use	 Cell	type	
CSHL	Long	RNA-seq		 Identification	and	alignment	of	long	(>200	nt)	RNA	transcripts	 GM12878,	HeLa,	Hi-hESC	and	more	
CSHL	Short	RNA-seq	 Identification	and	alignment	of	short	(<200	nt)	RNA	transcripts	 GM12878,	HeLa,	Hi-hESC	and	more	
Layered	Tracks	(ENCODE)	 Chromatin	monomethylation	(H3K4Me1)	enrichment	
Chromatin	trimethylation	(H3K4Me3)	enrichment	
Chromatin	acetylation	(H3K27Ac)	enrichment	
H1-hESC	
Open	Chromatin	DNase	I	HS	(Duke)	 Chromatin	DNase	I	hypersensitivity	sites	 hESC	
SC584	Standard	ChIP-seq	ENCODE/SYDH	 p300	binding	enrichment	 GM12878	
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Chapter	3: Cardiac	defects	in	Zic2	mutant	embryos	are	caused	by	
aberrant	node	function	
	
This	chapter	contains	 text	 from	the	papers:	Barratt,	K.S.,	Glanville-Jones,	H.C.	&	Arkell,	R.M.,	
2014.	The	Zic2	gene	directs	 the	 formation	and	 function	of	node	cilia	 to	control	cardiac	situs.	
Genesis,	52(6),	pp.626–635	and	Diamand,	K.E.M.,	Barratt,	K.S.	&	Arkell,	R.M	(2017)	Chapter	10:	
Overview	of	rodent	Zic	genes,	“Zic	family	-	Evolution,	Development	and	Disease”,	Springer	(in	
publication).	
3.1 Introduction	
Mouse	embryos	homozygous	for	the	Ku	allele	of	Zic2	(Zic2Ku/Ku)	have	apparently	normal	anterior	
primitive	streak	function	with	molecular	abnormalities	first	detected	at	the	stage	of	overt	node	
formation	(7.0	dpc).	The	expression	of	any	gene	so	far	examined	that	would	normally	be	present	
in	the	7.0	dpc	node	or	its	derivatives	is	greatly	diminished	in	Zic2Ku/Ku	embryos	(Warr	et	al.,	2008).	
Tissues	derived	from	the	later	stage	node	(such	as	the	trunk	notochord)	are	more	mildly	affected	
in	9.5	dpc	embryos	(see	Fig.3	O-R	of	Warr	et	al.	2008)	suggesting	that	the	defect	in	node	gene	
expression	and	 function	 is	 transient.	Given	 that	 ZIC2	 is	 required	 to	execute	 the	A-P	and	D-V	
components	of	node	function,	it	is	hypothesised	that	the	node	and	midline	formation	defects	in	
Zic2Ku/Ku	 embryos	 would	 also	 interfere	 with	 L-R	 axis	 formation.	 This	 is	 supported	 by	 the	
observations	that	some	homozygous	embryos	have	incorrect	heart	morphology	at	9.5	dpc	(see	
Fig.3	 O,P	 of	 Warr	 et	 al.	 2008)	 and	 that	 approximately	 5%	 of	 human	 ZIC2-associated	 HPE	
probands	exhibit	co-morbidities	such	as	cardiac	abnormalities	(Solomon	et	al.,	2010a).		
The	establishment	of	the	L-R	embryonic	axis	occurs	at	~8.0	dpc	in	the	mouse,	when	a	leftward	
flow	of	fluid	can	be	detected	in	the	mouse	embryonic	node	(Field	et	al.,	2011;	Norris,	2012).	To	
create	this	axis,	four	main	steps	must	occur	to	achieve	the	correct	orientation	and	asymmetry	
of	 organs:	 the	 breaking	 of	 embryonic	 symmetry,	 the	 establishment	 of	 leftward	 nodal	 flow,	
asymmetric	gene	expression	and	the	nodal	cascade,	and	the	placement	of	developing	organs.	It	
is	 the	 failure	 of	 these	 steps	 to	 correctly	 pattern	 the	 embryo	 that	 results	 in	 congenital	 heart	
defects	and	L-R	axis	defects	such	as	Heterotaxy.		
3.1.1 Morphogenesis	of	the	murine	node	
The	murine	node	forms	as	a	pit	shaped	structure	at	the	anterior	of	the	primitive	streak	at	mid-
gastrulation,	flanked	by	endoderm	and	the	paraxial	mesoderm,	and	flanked	again	by	the	lateral	
plate	 mesoderm	 (LPM)	 which	 contributes	 to	 asymmetric	 organ	 structure	 after	 axis	
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establishment	 (Norris,	 2012)	 (Figure	 3.1).	 At	 the	mid-streak	 stage,	 the	 outer	 surface	 of	 the	
embryo	is	covered	by	squamous	endoderm	cells,	with	APS	cells	arranged	as	a	sheet	beneath	the	
endoderm	 layer	 (Yamanaka	et	al.,	2007).	 Lineage	 tracing	 found	 that	 these	APS	cells	begin	 to	
express	Noto,	 a	 homeobox	 transcription	 factor,	 and	 organise	 into	 columnar	 epithelium	with	
ventral	facing	apical	surfaces,	distinguishing	them	from	other	APS	cell	populations	(Yamanaka	et	
al.,	2007).	These	putative	node	cells	then	begin	to	delaminate	from	the	APS.	By	the	late-streak	
stage	(7.0	dpc),	several	clusters	of	200-300	columnar	epithelial	cells,	called	pit	cells,	with	small	
apical	 surfaces	 and	 cilia	 have	 emerged	between	 the	 endoderm	 cells	 and	 can	 be	 seen	 into	 a	
shallow,	 crescent	 shaped	 depression	 on	 the	 ventral	 side	 of	 the	 embryo	 (Sulik	 et	 al.,	 1994;	
Yamanaka	et	al.,	2007).	Approximately	25-30	crown	cells	surround	the	node,	extending	higher	
into	the	extracellular	space	than	the	pit	cells	to	create	a	barrier	around	the	node	(Figure	3.1)	
(Bellomo	et	al.,	1996;	Nonaka	et	al.,	1998;	Norris,	2012;	Sulik	et	al.,	1994;	Yamanaka	et	al.,	2007).	
By	the	time	the	node	is	completely	revealed,	the	pit	and	crown	cells	are	contiguous	with	the	
surrounding	DE,	where	they	transit	the	node	and	migrate	to	the	anterior	midline,	as	described	
in	Chapter	1	(Kinder	et	al.,	2001;	Robb	and	Tam,	2004).	As	cells	move	out	from	the	node	to	form	
the	notochord,	cells	from	the	APS	are	continuously	recruited	to	repopulate	the	node	(Kinder	et	
al.,	2001).		
Each	pit	and	crown	cell	in	the	ventral	layer	of	the	node	carries	a	monocilium	on	its	apical	surface	
that	extends	into	the	extracellular	space	(Lee	and	Anderson,	2008;	Sulik	et	al.,	1994).	Cilia	on	
the	pit	cells	rotate	in	a	clockwise	direction	and	support	a	flow	of	extracellular	fluid	towards	the	
left	side	of	the	node	(called	nodal	flow)	that	is	posited	to	establish	differential	signal(s)	on	the	
left	and	right	of	the	node	(Nonaka	et	al.,	2002,	1998).	The	cilia	on	the	crown	cells	are	generally	
immotile,	and	these	sensory	cilia	are	thought	to	interpret	the	signal(s)	established	via	nodal	flow	
(McGrath	et	al.,	 2003).	Whilst	 the	 location	and	distribution	of	 cilia	 in	 the	node	pit	 has	been	
shown	to	have	no	effect	on	the	ability	to	generate	a	leftward	nodal	flow,	the	angle	at	which	the	
cilia	project	from	the	pit	cells	is	vital.	Wildtype	cilia	tilt	posteriorly	and	rotate	clockwise	at	~600	
rpm	(Nonaka	et	al.,	2005;	Yoshiba	and	Hamada,	2014).	Studies	of	defective	cilia	in	the	mouse,	
ESCs,	and	zebrafish	have	shown	that	when	the	cilia	do	not	tilt	at	the	correct	angle,	or	a	subset	
tilt	 anteriorly	 instead	 of	 posteriorly,	 a	 vortex	 is	 created	 above	 the	 cilia	 that	 results	 in	
randomisation	 of	 nodal	 flow	 (Maisonneuve	 et	 al.,	 2009;	 Okada	 et	 al.,	 2005,	 1999).	 It	 is	
disruptions	 such	 as	 these	 in	 the	 formation	 or	 function	 of	 node	 cilia	 that	 lead	 to	 the	 loss	 of	
unidirectional	 flow	of	 fluid	across	 the	node	and	result	 in	L-R	patterning	defects	 (Yoshiba	and	
Hamada,	2014).	
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Figure	3.1:	Schematic	of	 L-R	axis	 formation	 in	 the	murine	embryo.	 (a)	 The	embryonic	node	
contains	ciliated	pit	cells	surrounded	by	ciliated	crown	cells.	Endoderm	and	paraxial	mesoderm	
cells	 flank	 the	 node,	 with	 mesoderm	 forming	 the	 right	 (not	 shown)	 and	 left	 lateral	 plate	
mesoderm	(LPM)	down	the	sides	of	the	embryo.	(b)	Steps	involved	in	L-R	axis	formation.	1:	The	
node	is	induced	to	form	at	mid-gastrulation	(7.0	dpc)	and	in	the	next	24	hours	develops	into	a	
shallow,	 crescent	 shaped	 depression	 on	 the	 ventral	 side	 of	 the	 embryo.	 2:	 A	 monocilium,	
extending	into	the	extracellular	space,	forms	on	the	apical	surface	of	each	pit	and	crown	cell;	
these	 become	 posteriorly	 polarised	 over	 time.	 Signalling	 molecules	 (such	 as	 NODAL)	 are	
expressed	in	the	crown	cells.	3:	The	cilia	of	the	pit	cells	rotate	in	a	clockwise	direction	directing	
first	a	disorganised,	then	laminar,	leftward	flow	of	extracellular	fluid	within	the	node.	It	is	posited	
that	this	leftward	nodal-flow	is	sensed	by	crown	cell	cilia,	prompting	a	Ca2+	flux	in	the	left	crown	
cells	which	modifies	gene	expression.	By	the	end	of	 this	24	hour	period	 (at	8.0	dpc)	 the	 first	
known	asymmetries	in	gene	expression	are	detected	within	node	crown	cells	(Dand5,	and	soon	
thereafter	Nodal,	 become	 asymmetrically	 expressed	 in	 the	 node	 crown)	 (reviewed	 in	Norris	
2012).	WNT	ligand	is	also	asymmetrically	expressed	and	canonical	signalling	then	amplifies	the	
initial	Dand5	asymmetry	(Nakamura	et	al.,	2012).	4:	The	asymmetric	signal(s)	are	propagated	to	
the	LPM	and	prevented	from	spreading	to	the	right	LPM	by	the	recently	formed	midline	barrier.	
5:	NODAL	signalling	 in	the	 left	LPM	controls	 its	own	expression,	and	that	of	other	molecules,	
that	 ultimately	 direct	 organ	 position	 and	 other	 asymmetries	 (reviewed	 in	 Norris	 2012).	 A:	
anterior,	P:	posterior,	D:	dorsal,	V:	ventral,	R:	right,	L:	left.	Figure	B	was	obtained	from	R.	Arkell.	
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3.1.2 Requirements	for	cilia	formation	and	function	
A	combination	of	three	homeobox	transcription	factors,	expressed	prior	to	the	generation	of	
nodal	flow,	act	upstream	of	intraflagellar	transport	(IFT)	motor	proteins	and	are	required	for	the	
formation	 of	 immotile	 and	 motile	 cilia	 in	 the	 node.	 The	 forkhead	 homeobox,	 FOXJ1,	 in	
combination	with	members	 of	 the	Not	 homeobox	 (NOTO)	 and	 the	 regulatory	 factor	 X	 (RFX)	
families	(Beckers	et	al.,	2007;	Didon	et	al.,	2013;	Thomas	et	al.,	2010),	control	ciliogenesis	in	the	
embryonic	 node.	 NOTO,	 acting	 upstream	 of	 FOXJ1	 and	 RFX3,	 regulates	 expression	 of	
components	involved	in	cilia	axonemal	assembly	and	function	(Beckers	et	al.,	2007).	In	contrast,	
RFX3	regulates	growth	of	cilia	and	FOXJ1	is	responsible	for	the	differentiation	of	motile	ciliated	
cells	 (Bonnafe	 et	 al.,	 2004).	 Failure	 of	 any	 of	 the	 three	 TFs	 results	 in	 abnormal	 L-R	 axis	
development	 in	mice.	A	 threshold	 amount	of	 FOXJ1	 is	 required	 to	 induce	expression	of	 cilia	
component	genes	in	ciliated	human	airway	epithelium	cells	such	as	DNAL1	and	SPAG6.	Whilst	
FOXJ1	can	induce	cilia	differentiation	on	its	own,	the	addition	of	RFX3	as	a	co-factor	improves	
this	induction	2.9	fold	(Didon	et	al.,	2013).	FOXJ1	therefore	acts	both	upstream	of	RFX3,	and	as	
a	co-factor	of	RFX3,	to	co-regulate	genes	involved	in	cilia	development	and	function	(Didon	et	
al.,	 2013).	 Together	 FOXJ1	 and	 RFX3	 induce	 basal	 progenitor	 cells	 to	 differentiate	 into	 a	
multiciliated	cell	lineage.	
The	detection	of	the	leftward	flow	across	the	node	requires	the	concerted	efforts	of	polycystins	
PKD2	and	PKD1L1.	PKD2	is	ubiquitously	 localised	to	 immotile	cilia	 in	the	crown	cells,	not	 just	
restricted	to	the	cilia	on	the	left	of	the	node,	and	is	thought	to	be	responsible	for	detecting	the	
Ca2+	 spike.	 This	 ubiquitous	 localisation	 around	 the	 entire	 node	 is	 perhaps	 due	 to	 the	
asymmetrical	 expression	 of	 Dand5	 (formally	 Cerl2)	 on	 the	 right	 of	 the	 node,	 which	 is	 a	
downstream	 target	 of	 flow-induced	 PKD2	 signals	 (Yoshiba	 et	 al.,	 2012).	 PKD2,	 acting	 as	 an	
effector,	forms	a	complex	with	PKD1L1,	acting	as	a	sensor,	to	create	a	flow-sensing	complex	not	
just	in	the	embryonic	node	but	also	in	the	kidney	(Norris,	2012;	Pennekamp	et	al.,	2002).	The	
actual	 mechanisms	 of	 how	 this	 PKD2/PKD1L1	 complex	 senses	 the	 fluid	 flow	 is	 yet	 to	 be	
identified,	 with	 suggestions	 of	 chemosensation	 and	 mechanosensation	 currently	 being	
investigated	 (Norris,	 2012).	 Once	 the	 PKD2/PKD1L1	 complex	 detects	 leftward	 flow,	 Dand5	
expression	is	repressed	in	the	left,	but	not	the	right	of	the	embryonic	node.	This	in	turn	results	
in	increase	expression	of	Nodal	in	the	left	of	the	node	(Yoshiba	et	al.,	2012)	and	the	onset	of	the	
L-R	axis	formation.		
3.1.3 Nodal	flow	
Sufficient	nodal	 flow	can	be	created	with	as	 little	as	two	rotating	cilia	 in	the	node	of	mutant	
embryos	 (Shinohara	 et	 al.,	 2012),	 however	 the	 exact	 mechanisms	 behind	 how	 the	 flow	 is	
detected	in	the	embryo	is	still	a	contentious	issue	(Norris,	2012).	Two	distinct	populations	of	cilia	
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in	the	node	are	responsible	for	both	the	generation	and	the	sensing	of	nodal	flow:	monocilia	in	
the	pit	cells	create	the	 leftward	flow	and	 immotile	sensory	cilia	 in	the	crown	cells	detect	the	
leftward	flow	(Field	et	al.,	2011).	It	has	been	hypothesised	that,	as	a	result	of	nodal	flow,	certain	
molecules	become	enriched	on	the	left	side	of	the	node.	Detection	of	this	higher	concentration	
leads	to	an	asymmetric	Nodal	cascade.	The	exact	nature	of	the	morphogen(s)	required	for	this	
process	 is	 still	 unknown,	 but	 this	 theory	 has	 been	 shown	 to	 be	 plausible	 via	 computational	
models	providing	the	molecules	in	question	are	between	15	and	50	kDa.	In	response	to	nodal	
flow,	a	Ca2+	concentration	spike	can	be	detected	at	the	left	of	the	node	but	not	the	right	(Norris,	
2012).	When	Ca2+	blockers	such	as	GdCl3	and	2-ABP	are	introduced,	asymmetric	gene	expression	
in	crown	cells	is	disrupted	(Yoshiba	et	al.,	2012),	suggesting	Ca2+	is	one	of	the	main	morphogens	
involved	in	establishing	the	L-R	axis.	This	elevation	of	Ca2+	is	thought	to	come	about	from	signals	
packaged	in	nodal	vesicular	particles,	which	in	turn	are	regulated	by	SHH,	FGF	and	retinoic	acid	
morphogens	(Hirokawa	et	al.,	2006).	
3.1.4 The	Nodal	cascade	
Dand5	is	the	first	known	asymmetric	gene	expressed	in	the	node,	being	detected	in	crown	cells	
at	8.0	dpc.	Nodal	expression	follows	shortly	after.	Whilst	Nodal	exhibits	a	left	sided	bias	in	the	
crown	cells,	its	antagonist	Dand5	is	expressed	with	a	right	sided	bias	(Collignon	et	al.,	1996;	Lowe	
et	al.,	1996;	Marques	et	al.,	2004;	Norris	and	Grimes,	2012;	Pearce	et	al.,	1999).	It	is	during	this	
time	 that	 Ca2+	 becomes	 elevated	 at	 the	 left	 boundary	 of	 the	 node	 (McGrath	 et	 al.,	 2003).	
Subsequently,	 asymmetric	 signals	 are	 propagated	 from	 the	 node	 to	 the	 left	 LPM	 via	 an	
unresolved	mechanism.	By	the	3-somite	stage	of	development	(8.25	dpc),	Nodal	signalling	in	the	
left	LPM	has	induced	its	own	expression,	as	well	as	that	of	the	Nodal	antagonist	Lefty2,	along	
with	 the	 TF	 Pitx2	 in	 an	 event	 known	 as	 the	 Nodal	 cascade	 (Shiratori	 and	 Hamada,	 2006).	
Activation	of	the	Nodal	cascade	coincides	with	cilia	establishing	a	faster	nodal	flow	than	before	
(Norris,	2012;	Yoshiba	et	al.,	2012).	The	expression	of	another	NODAL	antagonist,	Lefty1,	at	the	
embryonic	midline	forms	a	barrier	that	prevents	the	spread	of	the	Nodal	cascade	to	the	right	
LPM	(Meno	et	al.,	1998),	 fortifying	the	newly	established	L-R	axis.	When	Lefty1	expression	 is	
disrupted,	this	barrier	breaks	down	and	asymmetry	occurs	(Meno	et	al.,	1998).	
Nodal	and	Lefty2	are	only	transiently	expressed	in	the	left	LPM	for	~8	hours	,	in	contrast	to	Pitx2	
which,	 once	 activated,	 remains	 asymmetrically	 expressed	 in	 the	 LPM	 for	 two	 days	 during	
organogenesis	(Ryan	et	al.,	1998;	Yoshioka	et	al.,	1998).	For	this	left-sided	expression	to	occur,	
the	asymmetrical	signals	generated	in	the	node	must	be	transferred	to	the	left.	Whilst	the	best	
candidate	for	transfer	is	currently	a	NODAL	protein,	studies	have	yet	to	confirm	if	this	is	indeed	
the	molecule	that	initiates	left	LPM	asymmetric	expression	(Yoshiba	et	al.,	2012).	Research	has	
instead	focused	on	the	route	by	which	the	signal	is	transferred	from	the	node	to	the	LPM.	Recent	
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studies	 have	 suggested	 that	 Ca2+	 signals	 are	 transferred	 from	 the	 node	 to	 the	 LPM	 via	 gap	
junctions	in	the	definitive	endoderm,	and	it	is	these	signals	that	contribute	to	the	activation	of	
the	Nodal	 cascade	 (Viotti	et	 al.,	 2012).	When	 SOX17,	 a	 homeobox	 TF	 required	 for	 definitive	
endoderm	development,	 is	absent,	embryos	exhibit	L-R	patterning	defects,	a	defective	Nodal	
cascade,	and	are	unable	to	migrate	a	dye	between	endodermal	cells,	signalling	the	loss	of	gap	
junction	activity	 (Viotti	et	al.,	2012).	 In	comparison	to	the	LPM	and	definitive	endoderm,	the	
midline	barrier	between	the	left	and	the	right	of	wildtype	embryos	contains	no	gap	junctions,	
thus	preventing	signals	from	crossing	to	the	right	of	the	embryo	(Viotti	et	al.,	2012).		
3.1.5 Heterotaxy	and	congenital	heart	malformations	
Vertebrate	 organ	 asymmetry	 is	 highly	 conserved	 (Norris,	 2012),	 indicating	 a	 fundamental	
function	 for	 the	placement	and	orientation	of	each	organ.	Though	defects	 in	organ	 situs	 are	
relatively	rare	in	humans,	they	are	most	commonly	associated	with	congenital	heart	disease	and	
ciliopathies	(Norris,	2012).	Alterations	in	the	L-R	axis	are	defined	as	situs	inversus,	whereby	the	
organs	 are	 arranged	 as	 the	 complete	 mirror	 image	 compared	 to	 an	 unaffected	 person,	 or	
heterotaxy	 (situs	ambiguous	 and	 isomerisms),	whereby	 there	 is	a	 lack	of	 concordance	 in	 the	
placement	of	organs,	or	mirror	image	duplication	of	paired	organs	(such	as	two	lungs	that	both	
contain	three	lobes).	Though	pure	situs	inversus	is	not	commonly	associated	with	intracardiac	
cases,	 heterotaxy	 accounts	 for	 3%	 of	 congenital	 heart	 defects	 (Brueckner,	 2007;	 Zhu	 et	 al.,	
2006).	 Additionally,	 defects	 in	 the	 L-R	 patterning	 have	been	 linked	 to	 a	 range	of	 other	 situs	
abnormalities	 such	 as	 biliary	 atresia,	 intestinal	 malrotations,	 stomach	 curvature,	 vertebral	
anomalies	and	 respiratory	distress	 from	primary	ciliary	dyskinesia	 (Cohen,	2012;	Davis	et	al.,	
2017;	Zhu	et	al.,	2006),	as	well	as	alteration	in	the	directionality	of	embryo	turning	(Collignon	et	
al.,	 1996).	 All	 of	 these	 alterations	 in	 organ	 placements	 can	 be	 traced	 back	 to	 defects	 in	 the	
establishment	of	the	L-R	axis	during	embryogenesis,	with	the	direction	of	heart	looping	and	the	
directionality	of	other	organs	appearing	to	be	independent	processes	in	the	same	pathway	(Chin	
et	al.,	2000;	Harvey,	2002).		
3.1.6 Chapter	3	aims	
I	 set	out	 to	quantify	 the	extent	of	 the	heart	defects	seen	 in	Zic2Ku/Ku	embryos,	and	sought	 to	
determine	if	a	defective	node	was	the	cause.		
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3.2 Results	
3.2.1 Cardiac	situs	is	randomised	in	Zic2Ku/Ku	embryos	
To	determine	whether	the	previously	characterised	defect	in	midline	development	in	Zic2Ku/Ku	
embryos	impacts	formation	of	the	L-R	embryonic	axis,	the	direction	of	heart	looping	was	scored	
in	9.5	dpc	embryos	(N=14	Zic2+/+,	N=41	Zic2Ku/+	and	N=16	Zic2Ku/Ku)	WMISH	to	Nppa.	As	Nppa	is	
expressed	 in	 the	 right	 atrium	 and	 left	 ventricle	 of	 the	 developing	 heart	 (Moorman	 and	
Christoffels,	 2003),	 it	 was	 used	 to	 confirm	 the	 identity	 of	 heart	 regions.	 All	 wildtype,	
heterozygous	 and	 56%	 of	 Zic2Ku/Ku	 embryos	 presented	 with	 dextral	 looping	 (Figure	 3.2A,D),	
whereas	31%	of	Zic2Ku/Ku	embryos	exhibited	a	leftward	curve	of	the	heart	tube	(sinistral	looping,	
Figure	3.2B,E)	and	the	remaining	13%	of	Zic2Ku/Ku	embryos	had	a	heart	tube	that	looped	forwards	
(ventral	looping,	Figure	3.2C,F).	
3.2.2 Zic2Ku/Ku	embryos	exhibit	additional	asymmetries	
The	mid-gestation	demise	of	Zic2Ku/Ku	embryos	(Elms	et	al.,	2003)	prevented	the	direct	scoring	
of	later	asymmetric	organs.	Stereotypic	cardinal	vein	morphology,	however,	occurs	in	response	
to	 L-R	 axis	 establishment	 and	 can	 be	 independent	 of	 heart	 looping.	 For	 example,	 defects	 in	
cardinal	 vein	 morphology	 occur	 in	 conjunction	 with	 other	 organ	 asymmetries	 such	 as	 lung	
isomerisms	and	mis-location	of	the	pancreas	in	embryos	that	lack	Pitx2	(Shiratori	et	al.,	2006).	
Pitx2	is	expressed	in	the	left	cardinal	vein	(Meno	et	al.,	1998)	and	was	used	as	a	surrogate	marker	
for	the	correct	establishment	of	asymmetries	other	than	heart	looping.	At	9	–	9.5	dpc,	Pitx2	is	
expressed	in	the	cardinal	vein	on	the	left,	but	not	right,	of	wildtype	embryos	(Figure	3.3A,C).	Left	
cardinal	vein	expression	of	Pitx2	was	detected	 in	the	majority	of	Zic2Ku/Ku	embryos,	but	some	
embryos	lacked	this	expression	domain,	independent	of	the	direction	of	heart	looping	(Figure	
3.3B).	 Other	 embryos	 exhibited	 looping	 defects	 but	 maintained	 normal	 cardinal	 vein	 Pitx2	
expression	(Figure	3.3D).	This	suggests	that	aspects	of	L-R	organ	development	other	than	heart	
looping	may	be	affected	in	Zic2Ku/Ku	embryos.	Interestingly,	ectopic	expression	of	Pitx2	could	be	
seen	in	the	midbrain	of	9.5	dpc	Zic2Ku/Ku	embryos	(Figure	3.3D).	Pitx2	is	expressed	in	the	ventral	
diencephalon	(Martin	et	al.,	2002),	but	not	until	10.5	dpc,	and	wildtype	stage-matched	embryos	
did	not	have	corresponding	Pitx2	expression.	
3.2.3 The	Nodal	cascade	is	absent	in	Zic2Ku/Ku	embryos		
Overt	L-R	axis	formation	is	preceded	by	the	asymmetric	expression	of	certain	genes	in	the	LPM	
and	 by	 the	 establishment	 of	 a	midline	 barrier.	 At	 the	 3-6	 somite	 stage	 of	 development	 the	
secreted	 molecule	 Nodal,	 its	 secreted	 antagonist	 Lefty2	 and	 the	 downstream	 transcription	
factor	Pitx2	are	all	expressed	in	the	left	LPM	and	the	Nodal	antagonist	Lefty1	is	expressed	at	the	
midline.	 Examination	 of	 the	 expression	 of	 these	 genes	 in	 early	 somite	 stage	 embryos	 via	
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Figure	3.2:	Zic2Ku/Ku	embryos	exhibit	cardiac	situs	defects.	(a-c)	Dark-field	images	of	hearts	from	
embryos	with	21	somites	in	ventral	view;	the	dotted	line	shows	the	extent	of	the	heart	tube.	(a)	
Wildtype	heart	formation	(dextral	looping).	(b)	A	Zic2Ku/Ku	embryo	with	reverse	heart	formation	
(sinistral	looping).	(c)	A	Zic2Ku/Ku	embryo	with	abnormal	forward	looping	(ventral	looping).	(d-f)	
Images	of	hearts	following	WMISH	to	Nppa	to	confirm	chamber	identity.	(d)	A	25-somite	Zic2+/+	
embryo	with	dextral	 looping.	 (e)	A	25	 somite	Zic2Ku/Ku	 embryo	with	 sinistral	 looping.	 (f)	A	16	
somite	Zic2Ku/Ku	 embryo	with	 ventral	 looping.	 LV:	 left	 ventricle,	 RA:	 right	 atrium.	Dotted	 line	
indicates	heart	looping.	
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Figure	 3.3:	 Cardinal	 vein	 situs	 is	 randomized	 in	 Zic2Ku/Ku	 embryos.	 Lateral	 view	 of	 embryos	
following	WMISH	 to	Pitx2.	 (a)	A	10	 somite	Zic2+/+	 embryo	with	Pitx2	 transcription	 in	 the	 left	
cardinal	vein	(arrowhead).	(b)	A	10	somite	Zic2Ku/Ku	embryo	lacking	Pitx2	cardinal	vein	expression	
(arrowhead).	 (c)	 A	 16	 somite	Zic2+/+	 embryo	with	Pitx2	 transcription	 in	 the	 left	 cardinal	 vein	
(arrowhead).	(d)	A	16	somite	Zic2Ku/Ku	embryo	with	sinistral	heart	looping,	Pitx2	transcription	in	
the	 left	 cardinal	 vein	 (arrowhead)	 and	 ectopic	 forebrain	 expression	 (asterisk).	 Dotted	 line	
indicates	heart	looping.	
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WMISH	demonstrated	that	each	consequence	of	Nodal	signalling	 is	severely	compromised	 in	
Zic2Ku/Ku	embryos.	The	expression	of	Nodal	was	detected	at	the	node	but	not	in	the	LPM	of	3-
somite	mutant	embryos	(Figure	3.4A,	B).	Likewise,	Lefty2	expression	was	not	detected	 in	the	
LPM	(Figure	3.4C,	D).	The	expression	of	Lefty1	at	the	embryonic	midline	was	severely	depleted	
in	early	somite-stage	Zic2Ku/Ku	embryos	(Figure	3.4C,	D).	The	absence	of	the	midline	barrier	in	the	
presence	of	the	asymmetric	signal	is	typically	associated	with	the	bi-lateral	establishment	of	the	
Nodal	 cascade	 (i.e.	 bi-lateral	 expression	 of	 Nodal,	 Lefty2	 and	 Pitx2)	 (Meno	 et	 al.,	 1998;	
Yamamoto	et	al.,	2003).		
The	expression	of	Pitx2	was	detected	throughout	the	entire	A-P	extent	of	the	LPM	in	wildtype	
embryos	 with	 3-5	 somites,	 whereas	 it	 was	 only	 weakly	 detected	 in	 the	 anterior	 LPM	 of	
equivalent	stage	Zic2Ku/Ku	embryos	(Figure	3.4E,	F).	The	apparent	ability	to	initiate	anterior	LPM	
Pitx2	expression	in	the	absence	of	Nodal	expression	suggests	loss	of	Zic2	function	reveals	a	Nodal	
independent	mechanism	of	Pitx2	expression	 initiation.	The	near	absence	of	both	the	midline	
barrier	and	LPM	expression	of	Nodal,	Lefty2	and	Pitx2	suggests	 that	 the	asymmetric	signal	 is	
generated	and	perceived	but	not	transferred	to	the	LPM,	or	that	it	is	not	correctly	established.	
3.2.4 Definitive	endoderm	gap-junction	function	is	normal	in	Zic2Ku/Ku	embryos	
The	correct	formation	of	the	definitive	endoderm	is	required	to	transfer	the	asymmetric	signal(s)	
to	the	LPM	via	gap-junctions,	with	embryos	lacking	Sox17	expression	unable	to	complete	this	
process	(Viotti	et	al.,	2012).	The	definitive	endoderm	of	Zic2Ku/Ku	embryos	is	aberrant	at	mid-late	
gastrulation	(Warr	et	al.,	2008)	and	may	be	incompetent	for	signal	transfer.	WMISH	to	Sox17	
revealed	 no	 difference	 in	 expression	 between	 wildtype	 and	 mutant	 embryos	 (Figure	 3.5),	
suggesting	the	definitive	endoderm	is	capable	of	signal	transmission	between	the	node	and	left	
LPM.	
3.2.5 Node	function	and	cilia	development	is	compromised	in	Zic2	mutant	embryos	
To	determine	whether	the	asymmetric	midline	signal	is	effectively	established,	gene	expression	
at	 the	 node	 of	 early	 somite	 embryos	was	 examined	 in	 stage-matched	wildtype	 and	mutant	
embryos.	The	expression	of	Nodal	itself	becomes	asymmetric	at	the	node	of	wildtype	embryos	
slightly	before	the	initiation	of	Nodal	LPM	expression	(i.e.	at	the	0-2	somite	stage).	The	perinodal	
expression	domain	of	Nodal	varied	between	homozygous	Ku	embryos,	but	was	always	different	
to	that	of	stage-matched	wildtype	littermates	(Figure	3.6A-D).	In	all	cases	Nodal	expression	was	
diminished	and	in	some	cases	expression	failed	to	become	asymmetric.	Expression	of	another	
secreted	molecule,	 the	 NODAL	 antagonist	Dand5,	 also	 becomes	 asymmetric	 at	 the	 node	 of	
wildtype	embryos	prior	to	the	initiation	of	Nodal	LPM	expression.	
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Figure	 3.4:	 	The	Nodal	 cascade	 and	midline	 barrier	 are	 compromised	 in	 Zic2Ku/Ku	 embryos.	
Ventral	views	of	embryos	following	WMISH	to	the	genes	shown	on	embryos	of	the	genotypes	
and	stage	shown.	Anterior	is	to	the	top	in	all	images.	(a,	b)	Nodal	is	normally	expressed	in	the	
crown	cells	of	the	node	and	in	the	left	LPM;	the	LPM	expression	is	absent	in	Zic2Ku/Ku	embryos.	
(c,	d)	Lefty1	is	normally	expressed	in	the	midline	rostral	of	the	node	and	Lefty2	in	the	left	LPM;	
Lefty1	 expression	 is	 depleted	 and	 Lefty2	 expression	 lost	 in	 Zic2Ku/Ku	 embryos.	 (e,	 f)	 Pitx2	 is	
normally	 expressed	 bilaterally	 in	 the	 cranial	 mesenchyme	 and	 in	 the	 left	 LPM;	 the	 cranial	
mesenchyme	expression	is	retained	and	residual	expression	is	seen	in	the	anterior	left	LPM	of	
Zic2Ku/Ku	embryos	(arrowhead	in	F).	S:	somites.	
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Figure	3.5:	The	definitive	endoderm	is	normal	in	Zic2Ku/Ku	embryos.	Ventral	views	of	embryos	
following	WMISH	to	Sox17	of	the	genotypes	and	stage	shown.	Anterior	is	to	the	top	in	all	images,	
only	the	caudal	half	of	the	embryo	is	shown.	(a)	Sox17	 is	normally	expressed	in	the	definitive	
endoderm;	(b)	this	expression	is	retained	in	Zic2Ku/Ku	embryos.	S:	somites.	
	
	
	
	
Figure	3.6:	Aberrant	gene	expression	 in	the	early	somite	node	of	Zic2Ku/Ku	embryos.	Ventral	
view	of	 3-5	 somite	embryos	of	 the	 genotypes	 shown	 following	WMISH	 to	 the	 genes	 shown.	
Anterior	is	to	the	top.	(a-d)	Nodal	expression	normally	becomes	asymmetric	in	wildtype	2	somite	
embryos;	the	peri-nodal	expression	is	diminished	and/or	fails	to	become	asymmetric	in	Zic2Ku/Ku	
embryos.	(e-h)	Dand5	is	asymmetrically	expressed	in	the	crown	cells	of	the	node	in	wildtype	2	
somite	 embryos;	 the	 peri-nodal	 expression	 is	 diminished	 and	 fails	 to	 become	 asymmetric	 in	
Zic2Ku/Ku	embryos.	
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The	expression	of	Dand5	was	greatly	depleted	in	the	node	of	all	Zic2Ku/Ku	embryos	examined	and	
no	 asymmetric	 expression	 was	 observed	 (Figure	 3.6E-H).	 These	 data	 indicate	 that	 Zic2	 is	
genetically	upstream	of	asymmetric	gene	expression	at	the	node.	
To	determine	whether	the	effects	on	gene	expression	at	the	node	result	from	aberrant	node	
development	 we	 examined	 the	 node	 of	 3-5	 somite-stage	 embryos	 by	 light	microscopy	 (DIC	
optics)	 and	 the	 node	 of	 0-3	 somite-stage	 embryos	 by	 SEM.	 Visual	 inspection	 of	 the	 overall	
morphology	of	the	node	(shape	and	size)	suggested	that	Zic2Ku/Ku	nodes	were	smaller	 (Figure	
3.7A-D),	however	measurement	of	the	node	circumference	and	length	of	the	anterior-posterior	
axis	were	not	found	to	be	significantly	different	from	wildtype	nodes	(p>0.05,	Figure	3.8A-B).	
The	cilia	of	node	pit	cells	occurred	at	the	same	frequency	(i.e.	approximately	1	cilium/cell)	across	
all	genotypes.	Cilia	 length	was	overtly	different	(Figure	3.7E-F’)	and	when	measured	wildtype	
embryos	were	found	to	contain	cilia	with	a	mean	length	of	4	µm.	In	contrast,	Zic2Ku/+	embryos	
had	cilia	with	a	mean	length	of	3.1	µm	whilst	Zic2Ku/Ku	embryos	had	cilia	with	a	mean	length	of	
2.5	µm	(p<0.01)	(Figure	3.8C).	 In	addition,	the	cilia	of	Zic2Ku/Ku	embryos	were	dysmorphic	and	
often	bulbous	at	the	base	(Figure	3.7F-F’).	In	combination	with	the	gene	expression	data,	this	
suggests	that	the	node	cilia	do	not	retain	sufficient	function	for	symmetry	breaking.		
3.2.6 ZIC2	 is	 required	 for	 the	 correct	expression	of	genes	 involved	 in	 cilia	 formation	and	
function	
Zic2	is	not	expressed	in	the	node	of	early	somite	stage	embryos,	whereas	it	is	expressed	in	the	
node	of	mid-late	gastrula	embryos	(Elms	et	al.,	2004).	Since	ZIC2	is	a	transcriptional	regulator	
and	expected	to	act	cell-autonomously,	we	hypothesised	that	ZIC2	is	required	to	(either	directly	
or	indirectly)	regulate	the	expression	of	genes	required	for	node	and	cilia	formation	and	function	
in	the	gastrula.	The	Arkell	 lab	has	previously	shown	that	the	expression	of	Foxa2	 in	 the	mid-
gastrula	node	is	severely	depleted	(Warr	et	al.,	2008)	and	it	is	known	that	embryos	lacking	FOXA2	
are	unable	to	form	a	functional	node	(Ang	and	Rossant,	1994).	To	determine	whether	this	early	
defect	 in	node	 function	may	also	 influence	 L-R	 axis	 formation,	 I	 examined	 the	expression	of	
genes	 required	 for	node	ciliogenesis	 (Noto,	Rfx3,	Foxj1)	 (Beckers	et	al.,	2007;	Bonnafe	et	al.,	
2004;	M.	Zhang	et	al.,	2004)	and	sensory	function	(Pkd1l1)	(Field	et	al.,	2011).	The	expression	of	
each	of	 these	genes	 is	 severely	depleted	 in	7.0	and	7.5	dpc	embryos	 (Figure	3.9),	 suggesting	
widespread	dysgenesis	of	the	node	of	mid-gastrula	Zic2Ku/Ku	embryos.	
3.2.7 ZIC2-wt	and	ZIC2-Kumba	are	not	localised	to	cilia	
The	ZIC	proteins	are	members	of	the	Gli	superfamily	of	transcriptional	regulators	(Brewster	et	
al.,	1998;	Mizugishi	et	al.,	2001;	Sakai-Kato	et	al.,	2008).	As	other	members	(GLI	and	GLIS)	of	the	
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Figure	3.7:	Aberrant	cilia	morphology	in	the	early	somite	node	of	Zic2Ku/Ku	embryos.	Ventral	
view	of	3-5	somite	embryos	of	the	genotypes	shown.	Anterior	is	to	the	left.	(a,	c)	DIC	and	(b,	d)	
SEM	images	of	node	morphology	 in	embryos	of	the	genotypes	shown.	The	 length	of	Zic2Ku/Ku	
nodes	is	not	distinguishable	from	wildtype.	(e-f’)	SEM	images	of	node	cilia	in	3-4	somite	embryos	
of	the	genotypes	shown.	Scale	bar:	5	μm	(f,	g)	and	1	μm	(f’,	g’).	
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Figure	3.8:	Cilia	 in	 the	early	somite	node	of	Zic2Ku/Ku	embryos	are	significantly	shorter	 than	
wildtype	cilia.	(a-b)	A	column	graph	depicting	the	mean	node	circumference	and	length	(mm)	
in	3-5	somite	embryos	of	the	genotypes	shown.	Error	bars:	SEM,	*:	p<0.05,	Student’s	t-test.	(c)	
A	column	graph	depicting	the	mean	cilia	length	(µm)	in	0-3	somite	embryos	of	the	genotypes	
shown.	Error	bars:	SEM,	*:	p<0.01,	Fisher’s	LSD	ANOVA.		
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Figure	3.9:	Aberrant	gene	expression	 in	 the	mid-gastrula	node	of	Zic2Ku/Ku	 embryos.	Lateral	
views	of	embryos	following	WMISH	to	the	genes	shown	on	embryos	of	the	genotypes	shown.	
Anterior	is	to	the	left.	(a,	c,	e,	g)	7.0	dpc,	pre-allantoic	bud	stage.	(b,	d,	f)	7.5	dpc,	early-mid	bud	
stages,	 (h)	 7.75	 dpc,	 late	 bud	 stages.	 (a-b)	 Rfx3	 node	 expression	 is	 diminished	 in	 Zic2Ku/Ku	
embryos.	 (c-d)	 Noto	 node	 expression	 is	 diminished	 in	 Zic2Ku/Ku	 embryos.	 (e-f)	 Foxj1	 node	
expression	is	diminished	in	the	Zic2Ku/Ku	embryos.	(g-h)	Pkd1l1	node	expression	is	diminished	in	
the	Zic2Ku/Ku	embryos.	
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superfamily	are	known	to	localise	to	cilium	(Haycraft	et	al.,	2005;	Kang	et	al.,	2010,	2009),	it	was	
hypothesised	 that	 ZIC2	would	 also.	 A	 ciliated	 cell	 line	 (LLCPK1)	 was	 used	 to	 investigate	 the	
localisation	of	wildtype	ZIC2	and	Kumba	variant	protein.	Cells	were	transfected	with	V5-ZIC2-wt,	
V5-ZIC2-Kumba	or	PKD2-Myc	as	a	positive	control	and	serum	starved	to	induce	cilia	formation.	
24	hours	post-transfection,	cells	were	immunostained	with	a-V5	or	a-C-Myc	to	identify	ZIC2	and	
PKD2	proteins,	and	counterstained	with	a-Acetylated	Tubulin	to	identify	cilia.	In	comparison	to	
PKD2-Myc,	which	 localised	 in	cilia,	neither	V5-ZIC2-wt	nor	V5-ZIC2-Kumba	could	be	detected	
localised	to	cilia	(Figure	3.10).	All	three	proteins	studied	were	localised	in	the	nucleus.		
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Figure	3.10:	ZIC2-wt	and	ZIC2-Kumba	are	not	localised	to	cilia.	LLCPK1	cells	were	transfected	
with	 (a-c)	 V5-ZIC2-wt,	 (d-f)	 V5-ZIC2-kumba	 or	 (g-i)	 PKD2-Myc	and	 immunostained	with	a-V5	
(green;	a,	c,	d	and	f),	a-C-Myc	(green;	g,	i)	or	a-Acetylated	Tubulin	(red;	b,	c,	e,	f,	h	and	i).	(a-f)	
V5-ZIC2-wt	 and	V5-ZIC2-Kumba	were	not	 localised	 to	 the	 cilia.	 In	 contrast,	 (g-i)	 PKD2-myc	 is	
localised	to	the	cilia	(white	arrows).		 	
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3.3 Discussion	
It	has	previously	been	shown	that	ZIC2	dependent	transcription	is	required	for	correct	function	
of	the	7.0	dpc	node	(Brown	et	al.,	2005;	Warr	et	al.,	2008).	 In	this	chapter,	 I	show	that	early	
defects	in	node	function	of	Zic2	mutants	also	compromise	the	establishment	of	the	L-R	axis.	ZIC2	
evidently	acts	upstream	of	the	expression	of	genes	known	to	regulate	ciliogenesis	and	function,	
since	the	expression	of	these	genes	within	the	node	is	greatly	depleted	and	ZIC2	does	not	appear	
to	localise	in	the	cilia.	Pit	cells	within	the	node	of	embryos	that	lack	ZIC2	function	have	short,	
dysmorphic	 cilia	 relative	 to	 their	 wildtype,	 stage-matched	 littermates	 and	 the	 molecular	
hallmarks	 of	 symmetry	 breaking	 at	 the	 embryonic	midline	 are	 abnormal.	 Subsequently,	 the	
Nodal	signalling	cascade	within	the	left	LPM	fails	and	cardiac	situs	is	randomised.	
3.3.1 Signalling	interactions	in	the	embryonic	node	and	cilia	defects	
Zic2	loss-of-function	leads	to	L-R	defects	most	likely	because	it	controls	the	expression	of	genes	
required	 for	 the	 formation	and	 function	of	node	cilia.	Each	of	 the	other	 transcription	factors	
known	 to	 be	 involved	 in	 this	 process	 (Noto,	 Foxj1	 and	 Rfx3)	 uniquely	 affects	 the	 L-R	 axis	
formation	 component	 of	 node	 function.	 In	 contrast	 ZIC2	 appears	 to	 act	 upstream	 of	 genes	
required	for	axial	mesoderm	as	well	as	cilia	formation	and	so	influences	the	development	of	all	
three	embryonic	axes.	Whether	ZIC2	directly	regulates	these	ciliogenesis	genes,	or	is	upstream	
of	genes	that	interact	with	Noto,	Foxj1	or	Rfx3,	is	yet	to	be	determined.		
Embryos	that	lack	Noto,	Foxj1	or	Rfx3	have	disrupted	L-R	axis	formation	and	presumably	have	
compromised	nodal	flow	due	to	cilia	malformation,	but	they	are	often	able	to	initiate	the	Nodal	
cascade	within	the	LPM	(with	cases	of	left,	right	or	bi-lateral	expression	found	in	combination	
with	a	proportion	of	embryos	that	fail	to	show	LPM	expression	of	the	relevant	marker	genes)	
(Beckers	et	al.,	2007;	Bonnafe	et	al.,	2004;	M.	Zhang	et	al.,	2004).	A	combination	of	mutagenesis	
and	 transcriptional	 profiling	 experiments	 in	 a	 variety	 of	 model	 organisms	 has	 led	 to	 the	
conclusion	that	FOXJ1	is	necessary	for	the	biogenesis	of	motile	cilia,	whereas	RFX	proteins	are	
necessary	for	assembly	of	both	motile	and	immotile	cilia	(Thomas	et	al.,	2010).		
In	contrast	to	Zic2Ku/Ku	embryos,	in	which	indicators	of	the	Nodal	cascade	in	both	the	LPM	and	
midline	were	almost	entirely	absent	and	neither	right-sided	nor	bi-lateral	expression	of	Nodal,	
Lefty2	or	Pitx2	was	ever	observed	in	embryos	with	3-5	somites,	Rfx3	mutants	exhibit	phenotypic	
variability	in	the	number	and	length	of	node	cilia,	and	overt	L-R	defects	(Bonnafe	et	al.,	2004;	
Choksi	et	al.,	2014).	Likewise,	node	expression	of	both	Foxj1	and	Rfx3	is	greatly	depleted	in	8.0	
dpc	mouse	embryos	 that	 lack	 the	homeobox	TF	Noto,	with	Noto-/-	 embryos	exhibiting	 short,	
malformed	and	immotile	cilia	(Beckers	et	al.,	2007).	Moreover,	the	cilia	phenotype	of	Noto	null	
embryos	can	be	rescued	by	Foxj1	insertion	into	the	Noto	locus	(Alten	et	al.,	2012),	suggesting	
that	 NOTO	 acts	 upstream	 of	 Foxj1	 and	 Rfx3.	 Mutation	 of	Noto	 does	 not	 affect	 A-P	 or	 D-V	
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patterning	 and	 its	 function	 seems	 specific	 to	 the	 L-R	 axis	 component	 of	 node	 activity.	 In	
combination	with	the	compromised	expression	of	Noto,	Rfx3	and	Foxj1	in	Zic2Ku/Ku	embryos,	this	
suggests	 that	 ZIC2	 acts	 upstream	 of	 these	 transcription	 factors	 to	 initiate	 node	 ciliogenesis	
(Figure	3.11).	
At	least	two	possible	factors	may	account	for	the	more	severe	phenotype	seen	in	Zic2	mutants.	
First,	it	may	be	that	all	Zic2Ku/Ku	embryos	have	no	nodal	flow	(whereas	some	Noto,	Foxj1	and	Rfx3	
mutants	 generate	 at	 least	 a	 small	 amount	 of	 nodal	 flow).	 This	 could	 occur	 because	 of	 a	
difference	 in	 the	 target	 gene	 sets	 of	 these	 transcription	 factors,	 or	 because	 of	 genetic	
background	effects.	Experiments	that	examine	the	precise	structure	of	the	dysmorphic	cilia	or	
that	 examine	 cilia	 motility	 or	 measure	 nodal	 flow	 in	 the	 Zic2Ku/Ku	 mutants	 have	 not	 been	
conducted.	Although	the	cilia	of	embryos	lacking	Noto	or	Foxj1	have	been	shown	to	be	short,	
exhibit	structural	defects	and	be	mainly	immotile	(Alten	et	al.,	2012;	Beckers	et	al.,	2007),	nodal	
flow	has	not	been	measured	in	these	mutants.	To	fully	explore	the	hypothesis	that	nodal	flow	is	
more	severely	compromised	in	the	Zic2	mutants	than	in	Noto,	Foxj1	or	Rfx3	mutants	all	alleles	
would	need	to	be	bred	onto	the	same	genetic	background	and	cilia	morphology,	motility	and	
nodal	flow	systematically	compared.		
A	second	possible	reason	for	the	difference	between	the	phenotype	of	the	Zic2	mutants	and	
that	of	embryos	 lacking	Noto,	Foxj1	 or	Rfx3	 can	be	elucidated	 from	similarities	between	 the	
phenotype	of	Zic2Ku/Ku	embryos	and	that	of	embryos	with	loss-of-function	mutations	of	either	
Pkd1l1	 or	 Pkd2	 (Ermakov	 et	 al.,	 2009;	 Field	 et	 al.,	 2011;	 Pennekamp	 et	 al.,	 2002).	 Loss-of-
function	mutations	in	either	of	these	genes	result	in	a	failure	of	the	Nodal	cascade,	rather	than	
in	bi-lateral	or	 random	activation	of	 the	 cascade.	 These	 related	proteins	 (PKD1L1	and	PKD2)	
physically	interact,	are	co-localised	on	cilia	and	are	proposed	to	sense	the	left-biased	signal	at	
the	node	(Field	et	al.,	2011;	Yoshiba	et	al.,	2012).	Despite	both	genes	being	expressed	 in	the	
embryonic	node	at	a	time	where	the	L-R	axis	is	being	established,	the	nodes	of	Pkd1l1	and	Pkd2	
mutants	 are	 morphologically	 normal	 and	 cilia	 are	 motile,	 in	 sufficient	 numbers	 and	 of	
comparable	 length	 to	wildtype	 littermates	 (Pennekamp	et	al.,	2002).	The	 finding	 that	Pkd1l1	
expression	is	depleted	at	the	node	of	Zic2Ku/Ku	embryos,	suggests	that	the	cilia	of	the	Ku	node	
may	be	compromised	in	their	ability	to	respond	to	whatever	nodal	flow	is	generated	in	these	
embryos.	It	is	possible	that	the	failure	of	stereotypic	cardiac	situs	in	Zic2Ku/Ku	embryos	is	caused	
by	the	cumulative	effect	of	decreased	nodal	flow	and	decreased	perception	of	flow,	and	thus	
positions	ZIC2	upstream	of	all	genes	analysed	in	this	chapter	(Figure	3.11).		
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Figure	3.11:	ZIC2	acts	upstream	of	ciliogenesis	and	the	nodal	cascade	to	 influence	left-right	
axis	formation.	In	the	mouse	embryonic	node,	NOTO,	RFX3	and	FOXJ1	work	in	synergy	to	form	
the	motile	and	non-motile	cilia	required	for	the	formation	and	the	sensing	of	nodal	flow.	PKD2	
complexes	with	PKD1L1	in	non-motile	cilia	of	crown	cells	in	order	to	sense	Ca2+	spikes	brought	
about	by	nodal	flow.	This	results	 in	downregulation	of	Dand5	expression	and	upregulation	of	
Nodal	 expression	 in	 the	 left	of	 the	node.	Nodal	 expression	 in	 the	 crown	cells	of	 the	node	 is	
promoted	further	by	Notch	signalling	in	the	primitive	streak	(TBX6,	DLL1,	NOTCH1),	presomitic	
mesoderm	(TBX6,	DLL1,	NOTCH1)	and	node	(NOTCH2).	Via	further	Ca2+	signalling,	this	leftward	
signal	travels	through	gap-junctions	of	left	endodermal	cells	to	reach	the	left	LPM	and	activate	
the	Nodal	cascade.	LEFTY1	creates	a	barrier	down	the	midline	of	the	embryo,	preventing	signals	
from	travelling	to	the	right.	Antagonism	of	NODAL	by	BMP4	in	the	right	LPM	further	restricts	the	
Nodal	cascade	to	the	left.	Activation	of	the	Nodal	cascade	in	the	left,	but	not	the	right	of	the	
embryo,	results	in	organ	asymmetries	and	the	establishment	of	the	left-right	axis.	I	propose	that	
ZIC2	acts	upstream	of	ciliogenesis	to	influence	the	formation	of	the	left-right	axis,	possibly	via	
interactions	with	TBX6	prior	to	node	development.		 	
		 121	
3.3.2 ZIC2	may	regulate	cilia	retrograde	transport	
Though	ZIC2	is	required	for	the	correct	formation	of	cilia	during	embryogenesis,	the	ZIC2	protein	
itself	does	not	appear	to	be	part	of	the	ciliogenesis	machinery	required	to	form	functioning	cilia	
as	it	was	not	localised	in	LLCPK1	cilia.	ZIC2	may	only	localise	to	cilia	when	in	the	presence	of	a	
co-factor,	 similar	 to	 PKD2	 and	 PKD1L1	 which	 both	 show	 increased	 cilia	 localisation	 when	
expressed	 together	 (Kamura	 et	 al.,	 2011).	 As	 yet,	 no	 candidates	 for	 a	 ZIC2	 co-factor	 in	 this	
process	 have	 been	 identified.	 It	 is	 more	 likely,	 however,	 that	 ZIC2	 acts	 upstream	 of	 genes	
involved	 in	 cilia	 formation.	 As	 ciliogenesis	 occurs	 in	 four	 stages	 (generation	 of	 centrioles,	
migration	of	duplicated	centrioles,	formation	of	basal-body	structures	and	elongation	of	cilia;	
Hagiwara	et	al.	2004),	the	short	length	and	bulging	of	Zic2Ku/Ku	cilia	suggests	an	error	is	occurring	
in	 the	 final	 process:	 cilia	 elongation.	 Short	 and	 bulging	 cilia	 appear	 to	 be	 common	 when	
retrograde	transport	is	defective,	with	mutations	in	IFT144	and	DYNC2H1	resulting	in	bulges	due	
to	accumulation	of	 IFT	particles	at	 the	ciliary	 tip	 (Liem	et	al.,	2012;	Ocbina	et	al.,	2009).	The	
bulging	 seen	 in	 Zic2Ku/Ku	 cilia	 is	 most	 likely	 ‘swollen	 cilia’,	 where	 excess	 cytoplasmic	 matrix,	
tubulin	molecules	 and	axoneme	materials	 accumulate	 in	 various	parts	of	 the	 ciliary	 shaft.	 In	
normal	cilia,	these	swollen	portions	tend	to	disappear	as	the	cilium	elongates	(Hagiwara	et	al.,	
2004),	 however,	 if	 ZIC2	 acts	 upstream	 to	 regulate	 the	 expression	 of	 genes	 involved	 in	 cilia	
retrograde	transport	this	may	not	be	possible	due	to	the	shorter	cilia	length	in	the	absence	of	
ZIC2.		
The	 creation	 of	 a	 Zic2-Ku	 LLCPK1	 cell	 line	 via	 CRISPR-Cas9	 mutagenesis	 would	 allow	 for	
continued	analysis	of	the	Kumba	phenotype.	It	is	expected	that	a	Kumba	cell	line	would	replicate	
the	 cilia	 phenotype	 seen	 in	 the	 mouse	 model,	 and	 thus	 would	 provide	 an	 opportunity	 to	
investigate	how	components	of	the	IFT	motor	protein	complexes	are	effected	by	ZIC2-Ku.	Via	
these	cells,	we	can	elucidate	whether	ciliogenesis	components	are	completely	absent,	present	
in	smaller	concentrations	than	required,	or	localising	incorrectly	in	ZIC2-Ku	cells.	The	creation	of	
a	Kumba	cell	line	would	also	allow	for	the	analysis	of	whether	the	addition	of	exogenous	ZIC2,	
or	 a	 downstream	 protein	 such	 as	 NOTO	 or	 FOXJ1,	 is	 enough	 to	 rescue	 the	 defective	 cilia	
phenotype.	The	mutation	of	ZIC2,	or	even	the	removal	of	ZIC2,	from	a	ciliated	cell	 line	would	
allow	us	to	determine	if	ZIC2	is	essential	for	the	complete	formation	of	cilia.		
As	ZIC2	does	not	appear	to	localise	to	cilia,	it’s	influence	on	cilia	development	most	likely	occur	
earlier	 in	 embryonic	 node	 and	 cilia	 development	 than	 the	 stages	 examined	here.	 Therefore,	
future	 investigation	should	aim	to	 identify	 the	 influence	of	ZIC2	on	genes	upstream	of	 those	
already	examined	to	pinpoint	at	what	time	point	ZIC2	is	essential	for	L/R	axis	establishment.	The	
induction	 of	Nodal	 expression	 in	 the	 crown	 cells	 occurs	 via	 the	 interactions	 of	NOTCH1	 and	
NOTCH2	 receptors	 with	 upstream	 components	 TBX6	 and	 DLL1	 in	 the	 primitive	 streak	 and	
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presomitic	mesoderm,	with	Tbx6-/-	and	Dll1-/-	mice	exhibiting	multiple	L-R	defects	(Hadjantonakis	
et	 al.,	 2008;	 Krebs	 et	 al.,	 2003).	 The	 L-R	 phenotype	 reported	 for	 Tbx6-/-	 embryos	 closely	
resembles	that	of	Zic2Ku/Ku	embryos,	suggesting	a	possible	interaction	between	ZIC2	and	TBX6	
prior	to	node	development	(Figure	3.11).	As	Nodal	expression	is	aberrant	in	Kumba	embryos,	
analysis	of	Tbx6	and	Dll1	expression	in	Zic2Ku/Ku	embryos	will	determine	whether	this	defect	is	
due	 to	 an	 inability	 to	 induce	 Nodal	 expression	 via	 Notch	 signalling	 during	 node	 and	 cilia	
development,	or	whether	ZIC2	exerts	its	influence	further	upstream.		
3.3.3 Congenital	heart	malformations	and	situs	inversus	
Congenital	cardiac	malformations	occur	in	~1%	of	all	live	births,	often	linked	to	other	congenital	
diseases	such	as	Heterotaxy	or	situs	inversus	(Gelb,	2004).	The	work	presented	here	indicates	
that	a	severe	loss-of-function	Zic2	allele	is	associated	with	cardiac	abnormalities.	The	overt	L-R	
axis	defects	seen	in	Zic2Ku/Ku	embryos	not	only	included	hearts	that	exhibited	sinistral	looping,	
but	 also	 hearts	 that	 looped	 ventrally.	 As	 60-100%	 of	 Heterotaxy	 patients	 present	 with	
atrioventricular	septal	defects,	 it	 is	 likely	that	a	subset	of	the	Zic2Ku/Ku	embryos	will	also.	Less	
common	are	abnormalities	of	systemic	and	pulmonary	venous	drainage,	malpositioning	of	the	
great	vessels,	and	subpulmonary	or	aortic	obstructions	(Brueckner,	2007;	Zhu	et	al.,	2006).	Thus,	
further	investigation	into	the	hearts	of	Zic2Ku/Ku	embryos	via	histological	analysis	will	determine	
the	full	extent	of	heart	defects	caused	by	Zic2	mutation,	and	may	reveal	an	underlying	cause	for	
the	early	demise	of	Zic2Ku/Ku	embryos.		
The	 reduction	 in	 the	 Nodal	 cascade	 and	 the	 defects	 seen	 in	 node	 cilia	 in	 Zic2Ku/Ku	 embryos	
suggests	 that	 the	 inability	 to	establish	a	correct	L-R	axis	 is	not	restricted	to	the	heart.	This	 is	
further	 reinforced	 by	 the	 randomized	 Pitx2	 expression	 seen	 in	 the	 cardinal	 vein.	 Thus,	
investigation	 into	 the	 asymmetries	 of	 other	 organs	 should	 be	 investigated.	 Though	 Zic2Ku/Ku	
embryos	die	at	13.5	dpc,	the	positioning	of	the	spleen	and	liver	in	respect	to	the	midline	can	be	
discerned	 prior	 to	 this.	 Additional	 histological	 analysis,	 or	 imaging	 via	 micro-CT	 or	 Optical	
Projection	Tomography	(Hiraiwa	et	al.,	2013;	Quintana	and	Sharpe,	2011),	of	11-12	dpc	embryos	
will	allow	for	investigation	into	the	asymmetries	of	the	other	organs.	Additionally,	the	defective	
cilia	in	the	node	of	Zic2	mutants	raises	the	possibility	of	defects	in	other	ciliated	organs	such	as	
the	trachea	or	kidneys.	Therefore,	antibodies	that	mark	cilia	components	such	as	a-Acetylated	
Tubulin	or	cilia-associated	polycyctins	can	be	used	to	determine	if	the	defective	cilia	in	Zic2Ku/Ku	
embryos	are	restricted	to	the	node.		
3.3.4 Are	defective	cilia	causative	for	other	Zic2-associated	co-morbidities?		
Spina	bifida,	one	of	the	most	common	forms	of	neural	tube	defect	(NTD)	(Au	et	al.,	2010),	results	
from	failure	of	the	posterior	neuropore	to	completely	close	(Greene	and	Copp,	2009).	The	neural	
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tube	forms	along	the	dorsal	midline	of	the	embryo	via	rolling	up	and	fusion	of	the	neural	plate	
(or	neuroepithelium),	made	from	thickened	ectodermal	cells	overlying	the	mesoderm	(Greene	
and	Copp,	2009;	Kibar	et	al.,	2007).	Patterning	of	the	dorsoventral	axis	of	the	neural	tube	occurs	
via	 SHH	 signalling	 (Murdoch	 and	 Copp,	 2010),	 along	 with	 specification	 of	 neural	 cell	 fates	
(reviewed	in	Bay	&	Caspary	2012).	Neural	tube	closure	is	initiated	at	~5	somites	at	the	future	
site	 of	 the	 cervical-hindbrain	 boundary	 and	 continues	 both	 rostrally	 and	 caudally	 along	 the	
length	of	the	embryo.	Tube	formation	is	complete	with	the	closure	of	the	posterior	neuropore	
at	~30	somites	(Greene	and	Copp,	2009).	Cilia	line	the	ventricular	zone	of	the	neural	tube	and	
extend	into	the	lumen	(Bay	and	Caspary,	2012;	Huangfu	and	Anderson,	2005).	Here,	the	cilia	are	
thought	to	transduce	the	SHH	signalling	cascade	in	the	dorsal	neural	tube	via	the	interactions	of	
SMO,	a	transmembrane	receptor,	and	the	transcription	factors	GLI2	and	GLI3.	The	cilia	may	also	
play	a	role	in	transduction	of	WNT	and	BMP	signalling	in	the	ventral	tube	(reviewed	in	Murdoch	
&	Copp	2010),	however	the	mechanisms	behind	signal	transduction	 in	the	neural	tube	 is	still	
largely	unknown,	and	it	is	undetermined	whether	neural	tube	cilia	are	motile	or	if	they	can	sense	
secreted	ligands	in	the	neural	tube	lumen.	
Though	 there	 is	 currently	 no	 evidence	 explicitly	 linking	 spina	 bifida	 to	 cilia	 defects,	 the	 link	
between	 cilia	 defects	 and	 neural	 tube	 defects	 via	 abrogated	 signalling	 pathways	 is	 strong.	
Conditional	Arl13b	mutants	have	been	shown	to	exhibit	spina	bifida,	most	likely	due	to	abnormal	
SHH	 signalling	 in	 the	 neural	 tube.	 ARL13B,	 a	 GTPase	 that	 localises	 to	 the	 cilia,	 leads	 to	
significantly	shorter	cilia	when	mutated.	This	in	turn	results	in	low	levels	of	GLI	activators	in	the	
neural	tube	compared	to	wildtype	embryos,	and	thus	aberrant	SHH	signalling	(Caspary	et	al.,	
2007).	Whether	the	spina	bifida	in	Arl13b	mutants	develops	secondary	to	other	defects	such	as	
exencephaly	is	still	unknown,	however	a	link	between	defective	ciliogenesis	and	spina	bifida	is	
still	 presented.	 Furthermore,	 mutant	 embryos	 for	 the	 cilia-localised	 polycystin	 PKD1	 exhibit	
abnormally	sized	renal	cilia,	as	well	as	spina	bifida	(Lu,	2001;	Nikonova	et	al.,	2014),	providing	
further	evidence	for	a	possible	link	between	the	two	phenotypes.	Additionally,	hydrocephaly,	
an	established	phenotype	of	primary	ciliary	dyskinesia	(Norris	and	Grimes,	2012),	frequently	co-
occurs	 with	 spina	 bifida	 aperta	 (Greene	 and	 Copp,	 2009),	 suggesting	 a	 common	 underlying	
cause.	Hydrocephaly	develops	when	cerebral	spinal	fluid	(CSF)	accumulates	within	the	cerebral	
ventricles.	Motile	cilia	are	required	to	move	CSF	through	the	cerebral	aqueduct	and	ventricles,	
with	cilia	defects	resulting	in	a	build	up	of	CSF	in	the	brain	(reviewed	in	Sotak	&	Gleeson	2012;	
Ibañez-Tallon	et	al.	2004).		
Spina	bifida	aperta	is	regularly	detected	in	murine	alleles	of	Zic2,	with	abnormal	folding	of	the	
posterior	neuropore	at	9.5	dpc	the	origin	of	 the	defect	 (Elms	et	al.,	2003;	Nagai	et	al.,	2000;	
Ybot-Gonzalez	 et	 al.,	 2007).	 Furthermore,	 Zic1+/-;Zic2Kd/+	 compound	 heterozygotes	 exhibit	
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hydrocephalus	(Aruga	et	al.,	2002;	Inoue	et	al.,	2004).	As	the	underlying	molecular	cause	of	spina	
bifida	 in	Zic2	mutants	 is	unknown,	 there	 is	an	opportunity	 to	 investigate	whether	cilia	 in	 the	
Kumba	neural	tube	resemble	those	of	wildtype	embryos.		
3.3.5 HPE	and	Heterotaxy	
Like	 the	 Zic2-associated	 HPE	 phenotype,	 cardiac	 abnormalities	 are	 found	 only	 in	 embryos	
homozygous	for	the	Ku	allele.	Human	patients	with	two	mutated	copies	of	ZIC2	have	never	been	
identified	and	HPE	can	clearly	be	caused	by	loss-of-function	of	one	copy	of	ZIC2	(Roessler	et	al.,	
2009a).	The	reason	for	this	apparent	discrepancy	between	human	and	mouse	genetics	 is	not	
known,	 but	 it	 is	 commonly	 observed	 that	mice	 are	 less	 sensitive	 to	 haploinsufficiency	 than	
humans	(Bogani	et	al.,	2005).	As	50%	of	patients	with	immotile	or	abnormal	cilia	motility	exhibit	
situs	inversus	(Norris,	2012),	it	seems	likely	that	at	least	a	subset	of	human	HPE	patients	with	
mutation	 of	 ZIC2	 will	 have	 cardiac	 and/or	 other	 defects	 of	 L-R	 axis	 formation	 and	 this	 is	
supported	 by	 the	 current	 clinical	 data.	 Whilst	 the	 exact	 manifestations	 of	 non-forebrain	
anomalies	in	human	patients	are	not	well	documented,	it	is	possible	that	a	subset	may	be	due	
to	defects	in	cilia	which	are	known	to	be	involved	in	the	development	and	function	of	each	of	
the	affected	body	systems	(reviewed	in	Fliegauf	et	al.	2007;	Waters	and	Beales	2011).	Thus,	ZIC2	
may	be	an	as	yet	unidentified	influence	for	ciliopathies.	Moreover,	the	observed	incidence	of	
ZIC2-associated	 cardiac	 defects	 would	 likely	 increase	 if	 this	 feature	 is	 specifically	 examined.	
Children	presenting	with	ZIC2-associated	HPE	require	examination	for	cardiac	and	other	visceral	
situs	 problems.	 It	 is	 also	 possible	 that	 mutations	 in	 ZIC2	 will	 emerge	 as	 a	 risk	 factor	 for	
Heterotaxy	once	genome	sequencing	(rather	than	gene	specific	mutation	detection)	of	proband	
DNA	becomes	the	norm.	
3.3.6 Conclusion	
The	asymmetries	exhibited	in	vertebrate	organ	systems	are	derived	from	an	initial	symmetry-
breaking	event	during	early	embryogenesis,	whereby	cilia	 in	 the	embryonic	node	generate	a	
leftward	flow,	turning	on	the	Nodal	cascade	in	the	left,	but	not	the	right,	of	the	embryo.	Errors	
in	any	number	of	the	components	involved	in	establishing	this	L-R	axis	result	in	L-R	and	cardiac	
defects.	The	work	in	this	Chapter	implicates	Zic2	in	cilia	and	L-R	axis	defects	for	the	first	time,	
providing	 an	 aetiology	 for	 the	 cardiac	 defects	 seen	 in	 HPE	 patients	 and	 a	 new	 aim	 for	
phenotyping	and	genetic	 screens	of	human	HPE	and	Heterotaxy	probands.	As	 ZIC2	does	not	
appear	 to	 directly	 localise	 to	 the	 cilium,	 it	most	 likely	 regulates	 components	 involved	 in	 L-R	
determination	 much	 earlier	 than	 node	 development	 and	 ciliogenesis.	 As	 such,	 future	
investigations	should	focus	on	the	role	of	ZIC2	prior	to	node	establishment	at	7.25	dpc.		
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Chapter	4: In	silico	analysis	of	the	ZIC2	NCE	ER	element		
	
4.1 Introduction	
As	 described	 in	 the	 Introduction	 (Section	 1.11),	 in	 2012	 Roessler	 et	 al.	 used	 comparative	
genomics	to	identify	a	NCE	(and	thus	a	putative	regulatory	element)	within	the	ZIC2	3’UTR.	A	
case-control	 study	 of	 variant	 sequences	 across	 the	NCE	 demonstrated	 the	 element	 is	 under	
strong	selective	pressure	and	supported	the	hypothesis	 that	 it	 regulates	ZIC2	expression	 in	a	
manner	that	prevents	HPE	occurrence	(Roessler	et	al.,	2012a).	Gene	expression	can	be	regulated	
by	controlling	the	rate	of	transcription,	a	process	that	is	dependent	upon	the	interaction	of	the	
gene’s	 promoter	with	 non-coding,	 cis-acting	 DNA	 regulatory	 elements,	 independent	 of	 their	
position	or	orientation	in	the	genome	(Blackwood	and	Kadonaga,	1998;	Katzman	et	al.,	2007;	
Woolfe	et	al.,	2005).	Such	regulatory	elements	are	made	up	of	clusters	of	transcription	factor	
binding	sites	(TFBSs)	and	are	termed	enhancers	(E)	or	repressors	(R)	depending	upon	whether	
their	net	influence	up-	or	down-regulates	transcription,	respectively	(Blackwood	and	Kadonaga,	
1998;	Borok	et	al.,	2010).	ER	elements	were	first	discovered	when	SV40	viral	repeat	sequences	
were	shown	to	increase	expression	of	a	rabbit	b-globin	construct	 in	HeLa	cells	(Banerji	et	al.,	
1981).	Subsequently,	their	ability	to	control	gene	expression	in	the	human	genome	in	a	tissue	
specific	manner	was	also	demonstrated	(Banerji	et	al.,	1983).	
It	 is	estimated	that	over	1	million	ER	elements	exist	 in	the	human	genome	(Heintzman	et	al.,	
2009)	and	that	~93%	of	SNVs	associated	with	complex	disease	lie	within	non-coding	regulatory	
elements	that	alter	the	spatial	and	temporal	expression	of	their	target	genes	in	a	tissue	specific	
fashion	(Maurano	et	al.	2012).	Both	enhancer	and	repressor	activity	can	influence	phenotype.	
Genetic	screening	of	autism	patients	identified	a	SNV	in	an	ER	element	that	upregulates	Dlx5	
and	Dlx6	 expression	 in	 the	 di-	 and	 telencephalon.	 The	 SNV	 was	 shown	 to	 inhibit	 enhancer	
activity	in	transgenic	murine	embryos,	leading	to	a	decrease	in	lacZ	reporter	expression	in	the	
telencephalon,	and	reduced	binding	affinity	for	DLX1/2	proteins	in	vitro	at	both	a	site	containing	
the	SNV	and	a	site	nearby	the	SNV	(Poitras	et	al.,	2010;	Zerucha	et	al.,	2000).	Similarly,	an	ER	
element	in	the	5’UTR	of	the	growth-hormone	receptor	(GHR)	gene	was	shown	to	regulate	GHR	
expression	in	a	tissue	specific	manner,	via	the	formation	of	a	repressor	protein	complex	in	cell	
based	assays.	In	mice	predisposed	to	diabetes,	repression	of	GHR	by	this	protein	complex	in	the	
kidney	 protects	 the	 mouse	 from	 developing	 insulin-like	 growth	 factor	 1	 mediated	 insulin-
dependent	 diabetes	 mellitus,	 whereas	 repression	 of	GHR	 in	 the	 liver	 by	 the	 same	 complex	
mediated	diabetes	development	(Gowri	et	al.,	2003).	
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4.1.1 Enhancer	and	repressor	machinery		
In	 eukaryotes,	 a	 typical	 gene	possesses	multiple	 ER	 elements	which	 contribute	 to	 its	 overall	
spatial	and	temporal	expression	throughout	development	(Blackwood	and	Kadonaga,	1998;	Ong	
and	Corces,	2011).	Each	ER	element	itself	can	contain	both	enhancer	and	repressor	domains,	
with	 the	 net	 regulatory	 output	 of	 the	 element	 determined	 by	 integration	 of	 these	 domains	
(Arnosti	and	Kulkarni,	2005).	This	was	elegantly	demonstrated	in	transgenic	Drosophila	embryos	
containing	 compact	 synthetic	 ER	 elements	 with	 different	 combinations	 of	 TFBS	 for	
transcriptional	repressors	and	activators	(Kulkarni	and	Arnosti,	2003).	The	resulting	variation	in	
reporter	expression	patterns	was	dependant	on	the	type,	orientation	and	number	of	each	class	
of	binding	site	present,	with	the	strongest	expression	seen	when	both	activator	and	repressor	
domains	were	activated	at	the	same	time.	Thus,	the	separate	domains	within	an	ER	element	can	
combine	differently	to	control	spatial-temporal	patterns	of	target	gene	expression.	
The	 TF	 proteins	 bound	 directly	 to	 the	 DNA	 of	 ER	 elements	 act	 as	 a	 foundation	 for	 protein	
complexes	termed	enhanceosomes	or	repressosomes.	These	‘-somes’	include	the	co-activators	
or	 co-inhibitors	 that	 control	 interactions	 with	 the	 general	 transcriptional	 machinery	 (Carey,	
1998;	Merika	and	Thanos,	2001).	By	receiving	signals	from	multiple	regulatory	cascades,	they	
produce	 one	 unified	 output	 targeted	 to	 a	 specific	 promoter	 that	 results	 in	 more	 efficient	
regulation	than	would	occur	from	TFs	acting	independently	(Maston	et	al.,	2006;	Panne,	2008).	
Repressosomes	are	often	utilised	by	strong	promoters	to	establish	or	maintain	stable	levels	of	
gene	expression.	In	contrast,	enhanceosomes	are	most	commonly	utilised	by	weak	enhancers	
to	increase	gene	expression	(Struhl,	1999).		
An	enhanceosome	recruits	RNA	polymerase	II	and	the	required	transcriptional	machinery	to	the	
promoter	of	the	target	gene,	facilitating	transcription	of	the	target	(Borok	et	al.,	2010).	First,	
activating	TFs	bind	 to	 the	ER	element	and	 then	 to	 co-activators	 to	 create	a	protein	 complex	
(Merika	and	Thanos,	2001).	Enhanceosome	formation	is	reliant	on	a	stereotypical	arrangement	
of	 TFBSs	 present	 in	 an	 ER	 element	 to	 allow	 for	 cooperative	 recruitment	 of	 co-activators.	
Changing	the	spacing	between	the	active	binding	sites,	or	mutating	a	site,	often	has	a	deleterious	
effect	on	the	function	of	the	‘–some’	(Courey	and	Jia,	2001).	Second,	recruitment	of	chromatin	
remodelling	proteins	occurs,	allowing	the	enhanceosome	to	bind	the	promoter	of	a	target	gene	
and	initiate	transcription	(Visel	et	al.,	2009).	The	current	model	for	how	this	occurs	is	termed	
DNA	 looping	 (Figure	 4.1).	 Upon	 binding	 of	 TFs	 to	 the	 ER	 element,	 the	 DNA	 containing	 the	
element	loops	around	to	bring	the	ER	element-protein	complex	in	line	with	its	target	promoter	
(Blackwood	and	Kadonaga,	1998).	These	looping	interactions	have	been	found	to	be	reliant	on	
the	developmental	stage	of	the	organism	(Palstra	et	al.,	2003)	and	also	require	the	concerted	
effort	 of	 lineage	 specific	 proteins	 (Palstra	 and	 Grosveld,	 2012).	 At	 this	 time,	 nucleosomes	
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flanking	the	ER	element	mask	the	TATA	box	at	the	transcription	start	site.	Once	enhanceosome	
formation	 is	 complete,	 however,	 the	 nucleosomes	 become	 acetylated	 and	 the	 chromatin	 is	
remodelled,	resulting	in	the	repositioning	of	the	nucleosomes	so	the	TATA	box	and	transcription	
start	 site	 are	 accessible	 to	 TATA-binding	 protein	 (TBP),	 RNA	 polymerase	 II	 and	 other	
transcriptional	 machinery	 (Agalioti	 et	 al.,	 2000;	 Panne,	 2008).	 This	 looping	model	 has	 been	
shown	to	occur	with	a	murine	b-globin	ER	element	(HS2)	via	FISH	TRAP	analysis	on	livers	from	
14.5	dpc	embryos.	The	HS2	enhancer	region	loops	around	to	bring	distal	enhancers	into	contact	
with	their	target	genes	in	the	cell	nucleus,	whilst	the	inactive	genes	and	chromatin	between	the	
two	 components	 loops	 out	 (Carter	 et	 al.,	 2002;	 Tolhuis	 et	 al.,	 2002).	When	 an	 ER	 element-
enhanceosome	complex	 is	pre-looped	to	a	target	promoter	yet	unable	to	actively	drive	gene	
expression,	 it	 is	 considered	 poised	 and	 can	 modulate	 target	 transcription	 in	 response	 to	
environmental	 cues.	Poised	enhancers	are	primarily	 linked	 to	early	embryogenetic	processes	
such	as	gastrulation,	neurulation	and	mesoderm	formation,	and	are	hypothesised	to	acquire	an	
active	state	upon	cell	differentiation	to	a	specific	fate	(Rada-Iglesias	et	al.,	2011).	Though	other	
models,	 such	 as	 DNA	 scanning	 and	 facilitated	 tracking	 (Zhu	 et	 al.,	 2007),	 have	 also	 been	
hypothesised	to	bring	an	ER	element	and	‘-some’	to	a	target	promoter,	there	is	less	experimental	
evidence	in	support	of	these.	 It	 is	most	 likely	a	combination	of	all	three	theories	occurring	 in	
cells,	dependant	on	the	ER	element,	co-factors	and	target	genes	in	question.	
In	contrast	to	enhanceosomes,	a	repressosome	prevents	the	recruitment	of	the	transcriptional	
machinery	 to	 a	 target	 promoter.	 Rather	 than	 altering	 the	 recruitment	 of	 polymerase	 (RNA	
polymerase	II	has	been	found	bound	to	many	promoters	even	though	their	target	gene	is	in	a	
dormant	state),	repressosomes	appear	to	prevent	transcriptional	co-activators	from	interacting	
with	the	target	promoter	(Geanacopoulos	et	al.,	1999;	Hochschild	and	Dove,	1998;	Payankaulam	
et	 al.,	 2010).	 In	 E.	 coli,	 the	 galactose	 repressor,	 GalR,	mediated	 by	 a	 repressosome	 protein	
complex	and	the	protein	HU,	loops	around	and	binds	to	tandem	operators	flanking	the	galactose	
operon	promoter	and	represses	transcription.	GalR	repressor	mutants	are	unable	to	form	a	loop	
even	when	their	operator-binding	activity	is	maintained,	and	the	operon	remains	active	when	
bacteria	are	assayed	 for	b-galactosidase	 (Geanacopoulos	et	al.,	1999).	 It	has	been	suggested	
that	 the	 limits	 of	 gene	 expression	during	 embryogenesis	 are	 determined	by	 the	 activities	 of	
transcriptional	 repressors	 (Mannervik	 et	 al.,	 1999),	 which	 can	 be	 long-range	 or	 short-range	
depending	on	their	location	and	targets.	Long-range	repressosomes	block	all	ER	elements	from	
interacting	with	a	target	promoter	no	matter	how	far	away	in	the	genome	they	are;	this	is	often	
referred	to	as	silencing.	Short-range	repressosomes	block	the	function	of	nearby	DNA-bound	
activators	whilst	not	interfering	with	those	bound	more	distally	(Courey	and	Jia,	2001).		
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Figure	 4.1:	 Enhanceosome	and	 repressosome	 formation	 and	 function.	Transcription	 factors	
and	co-activators	are	recruited	to	an	ER	element	to	form	either	an	enhanceosome	complex	or	a	
repressosome	complex.	At	the	same	time,	chromatin	remodelling	proteins	and	transcriptional	
machinery	 (TBP,	RNA	polymerase	 II)	are	recruited	to	a	 target	promoter.	The	ER	element	and	
bound	 protein	 complex	 loops	 around	 to	 interact	 with	 the	 target	 promoter	 and	 machinery.	
Enhanceosomes	 stimulate	 transcription	 of	 the	 target	 gene,	 whilst	 repressosomes	 prevent	
transcription.		
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4.1.2 The	in-silico	identification	and	analysis	of	ER	elements		
Sequence	conservation	is	a	useful	tool	with	which	to	identify	putative	ER	elements	but	does	not	
provide	 information	 about	 whether	 the	 element	 is	 active,	 potential	 interacting	 TFs	 or	 the	
elements’	 chromatin	 state.	 Assessing	 the	 likelihood	 that	 a	NCE	may	 act	 as	 an	 ER	 element	 is	
therefore	facilitated	by	combinatorial	bioinformatics	analyses	that	examine	other	factors.		
Transcription	factor	binding	sites	
The	analysis	of	TFBSs	within	a	NCE	can	be	informative	for	several	reasons.	First,	clusters	of	TFBSs	
are	an	important	indicator	of	an	ER	element	as	the	binding	of	only	one	or	a	small	number	of	TFs	
to	a	 region	of	DNA	 is	usually	 insufficient	 to	activate	or	 repress	 transcription	 (Shlyueva	et	al.,	
2014).	 Second,	 by	 analysing	 the	 location	 and	 type	 of	 TFBSs	 it	 is	 possible	 to	 estimate	 how	
mutations	in	the	element	may	alter	putative	DNA/TF	interactions.	The	introduction	of	SNVs	into	
an	 ER	 element	may	 lead	 to	 the	 failure	 to	 form	 an	 enhanceosome	 and	 instead	 promote	 the	
formation	of	a	repressosome.	This	was	demonstrated	via	the	disruption	of	binding	sites	in	the	
Ciona	Otx-a	enhancer.	The	core	4	bp	sequences	of	GATA	and	ETS	binding	sites	were	preserved,	
whilst	 the	 flanking	 nucleotides	 of	 the	 binding	 site	 were	 randomised,	 resulting	 in	 ectopic	
enhancer	activity	in	the	notochord	due	to	the	creation	of	new	binding	sites.	Altering	the	spaces	
between	these	binding	sites,	or	reversing	the	orientation	of	the	binding	sites,	was	also	found	to	
alter	the	activity	of	the	enhancer	(Farley	et	al.,	2016).	Third,	the	particular	TFs	predicted	to	bind	
a	region	can	be	informative	since,	for	example,	elements	required	during	embryo	development	
will	 have	 a	 large	 number	 of	 binding	 sites	 for	 developmentally	 essential	 TFs.	 Genome-wide	
studies	 of	 DNA/protein	 interactions	 in	 combination	 with	 RNA-profiling	 experiments	 have	
repeatedly	demonstrated	that	only	a	small	fraction	of	the	consensus	binding	sites	within	an	ER	
element	are	typically	occupied	at	a	particular	developmental	time-point	(Carr	and	Biggin,	1999;	
Yang	et	al.,	2006).	Thus	the	expression	patterns	of	the	predicted	TFs	is	also	informative	since	TFs	
must	be	co-expressed	with	the	target	gene	for	functional	interactions	to	occur	(reviewed	in	Spitz	
&	Furlong	2012).	
Transcriptional	co-activators	
Transcriptional	 co-activators	 such	 as	 CREB-binding	 protein	 (CBP)	 and	 p300	 simultaneously	
interact	with	the	general	transcriptional	machinery	(made	up	of	TFIID/TFIIB,	Mediator,	TBP	and	
the	RNA	polymerase	II	holoenzyme;	Kuras	et	al.,	2003;	Yie	et	al.,	1999),	the	‘-somes’	bound	to	
ER	elements	and	with	the	DNA	of	ER	elements	themselves	to	enhance	transcription	of	a	target	
gene.	p300/CBP	promote	the	rapid	formation	of	the	pre-initiation	and	re-initiation	complexes,	
permitting	multiple	rounds	of	transcription	to	occur	at	one	target	gene	(Yie	et	al.,	1999).	Though	
co-activator	binding	 sites	within	an	ER	element	 suggest	 that	 it	 is	 active,	 their	 absence	 is	not	
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necessarily	an	indication	of	inactivity	due	to	their	interactions	with	the	protein	complexes	bound	
to	an	ER	element	(Heintzman	et	al.,	2007;	Ong	and	Corces,	2011;	Shlyueva	et	al.,	2014).		
Chromatin	state	
For	TFs	to	bind	an	ER	element,	the	element	must	be	accessible	to	proteins.	Densely	positioned	
nucleosomes	restrict	TF	access	 to	ER	elements,	 therefore	nucleosome	free	 regions	are	much	
more	 likely	to	be	bound	by	transcriptional	proteins	 (Shlyueva	et	al.,	2014).	Measurements	of	
chromatin	state	such	as	DNase	 I	hypersensitivity	and	histone	modifications	 (methylation	and	
acetylation)	enable	prediction	of	an	active	ER	region.	
DNase	I	hypersensitivity	
DNase	I	is	an	enzyme	that	can	cleave	double	and	single	stranded	DNA,	including	non-condensed	
chromatin.	When	chromatin	is	cleaved	by	DNase	I,	the	underlying	regions	of	DNA	are	exposed	
and	can	be	accessed	by	a	range	of	TFs	and	transcriptional	machinery	(Gross	and	Garrard,	1988).	
Regions	 of	 chromatin	 that	 are	 sensitive	 to	 cleavage	 by	 DNase	 I	 are	 termed	 DNase	 I	
hypersensitivity	sites	(DHSs)	and	can	be	used	as	markers	of	active	cis-regulatory	elements.	DHSs	
have	also	been	found	to	occur	in	promoters,	silencers,	and	insulators,	however,	and	alone	are	
insufficient	to	indicate	ER	activity.	
Histone	modifications	
Genome-wide	studies	that	correlate	histone	modifications	and	gene	expression	have	shown	that	
ER	elements	exhibit	high	levels	of	monomethylation	of	histone	3	at	lysine	4	(H3K4me1)	and	low	
levels	of	trimethylation	of	histone	3	at	lysine	4	(H3K4me3).	In	contrast,	promoters	are	usually	
trimethylated	at	this	residue,	so	methylation	type	and	level	can	be	used	to	distinguish	an	active	
ER	element	from	an	active	promoter	(Heintzman	et	al.,	2007).	Similarly,	active	ERs	are	marked	
by	the	acetylation	of	histones	H3	at	lysine	27	(H3K27Ac)	and	this	has	been	used	to	distinguish	
between	active	and	poised	enhancers	(Creyghton	et	al.,	2010;	Heintzman	et	al.,	2009).	A	change	
of	chromatin	signature	via	 loss	of	H3K27me3	and	gain	of	H3K27Ac	during	cell	differentiation	
effectively	turns	the	enhancer	on,	allowing	transcription	of	a	target	gene	(Calo	and	Wysocka,	
2013;	Rada-Iglesias	et	al.,	2011).	
4.1.3 Chapter	4	aims		
The	aims	of	this	chapter	were:	
• To	 determine	 if	 the	 ZIC2	 3’UTR	 contains	 the	 hallmarks	 of	 an	 active	 ER	 element	 via	
bioinformatics	analyses.	
• To	 identify	 candidate	 TFs	 that	 could	 bind	 and	 regulate	 the	 element	 at	 the	mid-late	
streak	node	during	murine	gastrulation.		 	
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4.2 Results		
4.2.1 Sequence	conservation	varies	across	the	ZIC2	NCE	
In	 2012,	 analysis	 of	 a	 10	 kb	 region	 of	 DNA	 via	 ECRbase	 (Loots	 and	 Ovcharenko,	 2007)	 and	
EvoPrinter	(Odenwald	et	al.,	2005;	Yavatkar	et	al.,	2008)	identified	a	conserved	540	bp	region	in	
the	3’UTR	of	human	ZIC2.	 It	was	hypothesised	that	it	was	an	active	enhancer	(Roessler	et	al.,	
2012a).	Though	Roessler	et	al	investigated	the	sequence	conservation	of	the	region	(designated	
NCE)	in	comparison	to	the	whole	3’UTR,	they	did	not	attempt	to	identify	further	conserved	sub-
regions	within	the	NCE	or	identify	other	hallmarks	of	an	active	ER	element.	Therefore,	to	further	
assess	this	region	and	to	determine	if	there	are	ultraconserved	domains	within	the	ZIC2	NCE,	a	
comparison	 of	 the	 human	 ZIC2	 3’UTR	 to	 a	 range	 of	 different	 species	 was	 performed	 by	
calculating	 the	 pairwise	 identity	 percentage	 between	 species.	Whilst	 there	 is	 no	 established	
target	percentage	to	determine	if	a	sequence	is	evolutionarily	conserved,	it	is	agreed	that	the	
higher	the	pairwise	identity	percentage,	the	higher	the	conservation	between	species.	Though	
conservation	does	not	equate	to	function,	the	longer	the	conserved	region	is,	the	more	likely	it	
is	to	be	functionally	significant	(Frazer	et	al.,	2003).		
Sequences	from	multiple	species	were	also	aligned	to	determine	whether	specific	regions	of	the	
NCE	were	more	conserved	than	others,	deemed	ultraconserved	regions	(UCRs).	Pairwise	identity	
percentage	 was	 calculated	 by	 aligning	 the	 Zic2	 or	 zic2a	 3’UTR/NCE	 human,	 mouse	 (Mus	
musculus),	 zebrafish	 (Danio	 rerio),	 Xenopus	 laevis,	 pufferfish	 (Takifugu	 rubripes),	 and	 the	
predicted	chicken	(Gallus	gallus)	sequences	in	CLUSTAL	Omega	(Goujon	et	al.,	2010;	Sievers	et	
al.,	 2011)	 (Table	4.1,	 Figure	4.2).	As	expected,	 the	mouse	demonstrated	 the	highest	 level	 of	
sequence	conservation	with	human	ZIC2.	In	all	species	examined,	pairwise	identity	percentage	
in	 the	 NCE	 was	 higher	 than	 that	 seen	 in	 the	 overall	 3’UTR	 indicating	 increased	 sequence	
conservation	in	this	region	of	the	3’UTR.	Phylogeny.fr	(Dereeper	et	al.,	2008)	was	employed	to	
create	a	maximum-likelihood	phylogenetic	tree	for	each	region	(Table	4.2).	The	phylogeny	trees	
created	in	Phylogeny.fr	exhibit	two	values:	the	average	rate	of	nucleotide	substitutions	per	site,	
with	a	longer	branch	representing	a	greater	number	of	nucleotide	substitutions	from	the	point	
in	which	 the	node	diverges	 into	 two	sister	branches,	and	a	bootstrap	value	 representing	 the	
percentage	of	times	in	which	that	node	arrangement	occurs	in	100	computations	of	the	tree.	A	
value	of	1.0	indicates	that	that	node	arrangement	is	well	supported,	as	it	occurs	in	every	analysis	
of	those	sequences.	An	unrelated	DNA	sequence	(mouse	Gapdh	CDS)	was	used	as	an	anchor	
sequence	to	root	the	trees;	 it	 is	expected	that	this	sequence	will	always	exist	as	an	outgroup	
compared	to	the	related	sequences	being	analysed.	The	high	level	of	NCE	conservation	was	also	
reflected	in	the	phylogenetic	tree,	with	the	human	and	mouse	sequences	consistently	grouped		
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Table	 4.1:	 Pairwise	 Identity	 Percentage	 comparison	 of	 the	ZIC2	 CDS,	 3’UTR	 and	 conserved	
regions	(NCE,	UCR)	in	multiple	species.	Percent	identity	was	calculated	via	sequence	alignment	
in	CLUSTAL	Omega	2.1	 (Goujon	et	al.,	 2010;	Sievers	et	al.,	 2011).	A	high	 identity	percentage	
represents	a	high	level	of	sequence	conservation.	Light	green;	>80%	similarity.	Fugu:	Takifugu	
rubripes.	CDS:	coding	DNA	sequence,	NCE:	non-coding	conserved	element,	UCR:	ultraconserved	
region.	Table	corresponds	to	Figure	4.2.	
	
	 Accession	#	 CDS	 3’UTR	 NCE	 UCR	
Human	ZIC2	 NM_007129	 100%	 100%	 100%	 100%	
Mouse	Zic2	 NM_009574	 90.31%	 82.85%	 90.4%	 79.27%	
Xenopus	zic2	 NM_001087724	 72.96%	 56.98%	 69.17%	 64.94%	
Zebrafish	zic2a	 NM_131558	 77.75%	 53.43%	 59.78%	 63.75%	
Fugu	zic2a	 XM_011607711,	
Scaffold_31:549,069-
551,451	(ENSEMBL)	
74.18%	 48.94%	 56.36%	 67.86%	
Chicken	ZIC2	 XM_015274914	
Predicted	sequence	
87.81%	 NA	 42.59%	 46.67	
	
	
	
	
	
	
	
	
Figure	 4.2:	 Conserved	domains	between	multiple	 species	 in	 the	ZIC2	 3’UTR.	Zic2	 and	 zic2a	
3’UTR	 sequences	 from	 the	mouse	 (orange),	 chicken	 (yellow),	Xenopus	 (dark	 blue),	 zebrafish	
(green)	and	Fugu	(Takifugu	rubripes,	pink)	were	taken	from	NCBI	and	Ensembl	and	aligned	to	
the	 human	 ZIC2	 3’UTR	 (grey)	 in	 Geneious	 Pro	 (V5.5.9)	 to	 identify	 conserved	 domains.	 The	
majority	 of	 conservation	was	 found	 in	 the	NCE	 region	 (light	 blue),	with	only	 the	mouse	 and	
zebrafish	 sequences	 aligning	 to	 the	 human	 sequence	 outside	 the	 NCE.	 One	 86	 bp	 region,	
containing	 M2,	 was	 ultraconserved	 (red)	 amongst	 all	 species.	 HPE-associated	 SNVs	 are	
annotated	in	black.	
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together.	Additionally,	the	branches	of	the	human	and	mouse	sequences	stemming	from	the	
nodes	are	relatively	short,	 indicating	fewer	nucleotide	substitutions	took	place	between	each	
sequence	and	a	common	ancestor	sequence	(Figure	4.3).	In	comparison,	the	chicken,	pufferfish,	
Xenopus	and	zebrafish	produced	lower	3’UTR	sequence	conservation	to	the	human	3’UTR.	The	
chicken	3’UTR	and	NCE	sequences	are	the	least	conserved	to	the	human,	and	this	is	reflected	by	
longer	branches	 in	the	phylogenetic	 trees	 indicating	a	higher	rate	of	nucleotide	substitutions	
(Figure	4.3C).	 In	contrast,	the	mouse	and,	 interestingly,	the	Xenopus	3’UTRs	and	NCEs	exhibit	
the	closest	relationship	to	the	human	sequences	with	relatively	high	confidence,	whilst	the	Fugu	
and	zebrafish	sequences	frequently	form	their	own	group.	Taken	together,	this	suggests	that	
the	NCE	undergoes	tighter	selective	constraints	compared	to	the	surrounding	3’UTR	sequences,	
and	that	the	relationships	between	species	for	the	3’UTR	is	relatively	conserved.		
To	determine	where	the	conserved	regions	were	 located	within	the	3’UTR,	 the	sequences	of	
each	species’	3’UTR	were	aligned	against	the	human	ZIC2	3’UTR	via	BLASTn	(NCBI)	(Altschul	et	
al.,	1997).	Each	species	displayed	different	regions	of	sequence	similarity	when	aligned	to	the	
human	ZIC2	3’UTR,	with	the	majority	of	similarity	occurring	within	the	putative	NCE	identified	
by	Roessler	et	al	(2012).	One	specific	region	of	~86	bp	(human	c.1599*779-864)	was	conserved	
in	all	species	tested	(Figure	4.2).	This	region,	designated	an	UCR,	is	flanked	either	side	by	SNVs	
M1	 and	 M3,	 with	 M2	 occurring	 within	 the	 region.	 When	 analysed	 for	 pairwise	 identity	
percentage,	the	UCR	was	more	conserved	than	the	surrounding	3’UTR	and	CDS	in	the	chicken,	
pufferfish	and	zebrafish	(Table	4.1),	suggesting	a	significant	role	for	this	region	in	evolution.	Due	
to	the	small	length	of	the	UCR,	a	phylogenetic	tree	was	unable	to	be	constructed	for	this	region.		
The	ZIC3	3’UTR	was	also	found	to	contain	a	similar	NCE	(E.	Roessler	and	M.	Muenke	personal	
communication,	unpublished;	Appendix	Figure	A2.1).	Previous	phylogenetic	analysis	 indicates	
that	the	five	Zic	genes	evolved	from	one	single-copy	Zic	that	underwent	multiple	duplication	and	
divergent	episodes	early	in	the	vertebrate	lineage,	and	redundancies	in	the	roles	of	ZIC	proteins	
in	 embryo	 development	 have	 been	 documented	 (reviewed	 in	 Houtmeyers	 et	 al.	 2013).	 It	 is	
therefore	possible	that	the	conserved	regions	in	the	ZIC2	and	ZIC3	3’UTRs	stem	from	a	common	
ancestor	 gene,	 resulting	 in	 similar	 sequences	 and	 functions.	 A	 pairwise	 identity	 percentage	
alignment	 was	 conducted	 via	 CLUSTAL	 Omega	 and	 a	maximum-likelihood	 phylogenetic	 tree	
created	via	Phylogeny.fr	to	compare	the	3’UTR	sequences	of	all	ZIC	genes,	with	particular	focus	
on	the	similarities	in	the	ZIC2	and	ZIC3	NCE.	
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Figure	 4.3:	 Phylogenetic	 comparison	 of	 Zic2	 sequences	 between	 species.	 Sequences	 were	
aligned	 in	 Phylogenetic.fr	 and	 a	 maximum-likelihood	 phylogenetic	 tree	 generated.	 (a)	
Relationship	 between	 the	 Zic2	 CDS,	 (b)	 Zic2	 3’UTR	 and	 (c)	 Zic2	 NCE	 in	 the	multiple	 species	
indicated.	 Scale	 bar	 represents	 the	 average	 rate	 of	 nucleotide	 substitutions	 per	 site,	 with	 a	
longer	branch	indicating	a	larger	number	of	substitutions	between	species	compared.	Bootstrap	
values	 (red	 numbers)	 represent	 confidence	 in	 that	 node	 arrangement,	 with	 value	 of	 1.0	
signifying	that	that	node	arrangement	occurs	in	100%	of	trees	computed	for	these	sequences.	
Bootstrap	values	<50%	(0.5)	are	indicated	with	a	red	dot	and	are	low	confidence.	mGapdh	CDS	
is	included	as	an	outgroup	to	anchor	the	sequences.	Fugu:	Takifugu	rubripes.
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Both	pairwise	identity	percentage	and	phylogenetic	analysis	indicate	that	the	3’UTRs	of	each	ZIC	
gene	share	relatively	little	sequence	conservation	with	the	other	ZIC	family	members,	and	are	
frequently	more	conserved	between	species	than	with	each	other	(Table	4.2,	Figure	4.4).	For	
example,	 the	 human	ZIC2	 3’UTR	 shares	 86.43%	 sequence	 conservation	with	 the	mouse	Zic2	
3’UTR,	but	<49%	conservation	with	the	3’UTR	of	the	other	ZICs.	Whilst	a	comparison	of	NCEs	
identified	a	small	 increase	 in	conservation	between	Zic2	 and	Zic3	 in	both	human	and	mouse	
sequences	 in	 comparison	 to	 the	 overall	 3’UTR,	 the	 pairwise	 identify	 percentage	 remained	
relatively	 low	 (~50%	 for	 both)	 and	 both	 regions	 were	 pointedly	 more	 conserved	 between	
species,	which	is	also	reflected	by	their	grouping	and	branch	lengths	of	the	phylogenetic	trees.	
Overall,	 the	 low	 level	of	 sequence	conservation	amongst	 the	3’UTR	of	 the	ZIC	members	and	
between	 the	 conserved	 regions	 of	 ZIC2	 and	 ZIC3	 suggest	 it	 is	 unlikely	 they	 share	 a	 similar	
function	and	they	most	likely	evolved	independently.		
4.2.2 Developmental	transcription	factors	are	predicted	to	bind	the	ZIC2	3’UTR		
As	ER	elements	are	defined	by	the	presence	of	multiple	TFBSs,	the	ENCODE	genome	browser	
(Rosenbloom	et	al.	2015),	JASPAR	(Mathelier	et	al.,	2014),	and	TRANSFAC	databases	(Matys	et	
al.,	2006)	were	utilised	to	predict	binding	sites	in	the	ZIC2	3’UTR.	Though	these	databases	can	
predict	 specific	 genes	 that	 bind	 a	 region,	 our	 analysis	 focused	 on	 gene	 families	 to	 take	 into	
account	binding	site	redundancies.	465	TFBSs	were	predicted	to	occur	in	the	ZIC2	3’UTR,	with	
267	of	these	occurring	within	the	NCE	region	and	68	overlapping	with	at	least	one	of	the	six	HPE-
associated	SNVs	(Table	4.3,	Appendix	Figure	A2.2).	A	Chi-squared	goodness	of	fit	test	found	that	
the	 number	 of	 binding	 sites	 was	 significantly	 enriched	 in	 the	 NCE	 compared	 to	 the	 non-
conserved	3’UTR	region	(p<0.01;	Table	4.4	A),	correlating	with	the	observation	that	TF	binding	
sites	 cluster	 within	 ER	 elements	 and	 are	 not	 distributed	 randomly	 within	 the	 3’UTR.	
Furthermore,	 binding	 site	 enrichment	 was	 seen	 at	 the	 nucleotides	 for	 five	 of	 the	 six	 HPE-
associated	 SNVs	when	 compared	 to	 the	 remaining	 3’UTR	 nucleotides	 (p<0.01;	 Table	 4.4	 B),	
suggesting	these	mutations	may	occur	in	TF	binding	hot	spots	within	the	NCE.	The	majority	of	
predicted	TFs	were	from	developmentally	important	families	such	as	SOX,	FOX,	CDX	and	HOX.		
Upon	 introduction	 of	 the	 six	 HPE-associated	 SNVs	 into	 the	 ZIC2	 NCE,	 32	 binding	 sites	 were	
estimated	to	be	lost	(Table	4.3,	Appendix	Figure	A2.2),	with	some	SNVs	having	a	greater	impact	
than	 others.	 The	 introduction	 of	 M3	 resulted	 in	 the	 loss	 of	 14	 predicted	 binding	 sites,	 in	
comparison	 to	 the	 introduction	 of	M1	or	M2	where	 only	 one	binding	 site	was	 lost	 for	 each	
mutation.	In	addition	to	the	loss	of	TFBSs,	the	introduction	of	the	SNVs	created	18	new	binding	
sites	(Table	4.5,	Appendix	Figure	A2.2).	The	creation	of	new	binding	sites,	as	well	as	the	loss	of	
binding	sites,	has	the	potential	to	disrupt	the	formation	of	‘-somes’	required	for	normal	target		
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	A	
	
mZic1	3’UTR	
hZIC1	3’UTR	
mZic2	3’UTR	
hZIC2	3’UTR	
mZic3	3’UTR	
hZIC3	3’UTR	
mZic4	3’UTR	
hZIC4	3’UTR	
mZic5	3’UTR	
hZIC5	3’UTR	
m
Zic1	3’UTR	
100.00	
86.20	
39.16	
42.34	
53.53	
52.54	
52.48	
52.74	
46.39	
44.17	
hZIC1	3’UTR	
86.20	
100.00	
41.70	
41.09	
49.60	
49.93	
48.34	
49.27	
42.11	
46.38	
m
Zic2	3’UTR	
39.16	
41.70	
100.00	
86.43	
43.77	
43.68	
48.72	
48.74	
NA	
43.42	
hZIC2	3’UTR	
42.34	
41.09	
86.43	
100.00	
43.09	
42.76	
48.08	
48.74	
NA	
43.68	
m
Zic3	3’UTR	
53.53	
49.60	
43.77	
43.09	
100.00	
91.44	
44.40	
46.68	
NA	
42.32	
hZIC3	3’UTR	
52.54	
49.93	
43.68	
42.76	
91.44	
100.00	
43.88	
47.22	
NA	
41.11	
m
Zic4	3’UTR	
52.48	
48.34	
48.72	
48.08	
44.40	
43.88	
100.00	
79.53	
52.67	
46.91	
hZIC4	3’UTR	
52.74	
49.27	
48.74	
48.28	
46.68	
47.22	
79.53	
100.00	
53.33	
51.75	
m
Zic5	3’UTR	
46.39	
42.11	
NA	
NA	
NA	
NA	
52.67	
53.33	
100.00	
92.49	
hZIC5	3’UTR	
44.17	
46.38	
43.42	
43.68	
42.32	
41.11	
46.91	
51.75	
92.49	
100.00	
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Table	 4.2:	 Percent	 Identity	 Matrix	 showing	 sequence	 similarity	 of	 annotated	 DNA.	 (a)	
Comparison	of	the	human	and	mouse	3’UTR	sequences	of	all	ZIC	genes.	(b)	Comparison	of	the	
human	and	mouse	NCE	sequences	of	Zic2	and	Zic3.	Percent	identity	was	calculated	via	sequence	
alignment	 in	 CLUSTAL	Omega	 2.1	 (Goujon	 et	 al.,	 2010;	 Sievers	 et	 al.,	 2011).	 A	 high	 identity	
percentage	represents	a	high	level	of	sequence	conservation.	Green;	>80%	homology,	yellow;	
60-80%	homology.	
	
B	
	
	 mZic2	NCE	 hZIC2	NCE	 mZic3	NCE	 hZIC3	NCE	
mZic2	NCE	 100.00	 93.58	 53.83	 52.61	
hZIC2	NCE	 93.58	 100.00	 54.92	 53.91	
mZic3	NCE	 53.83	 54.92	 100.00	 93.65	
hZIC3	NCE	 52.61	 53.91	 93.65	 100.00	
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Figure	 4.4:	 Phylogenetic	 comparison	 of	 the	 3’UTR	 and	 NCE	 of	 ZIC	 genes.	 Sequences	 were	
aligned	 in	 Phylogenetic.fr	 and	 a	 maximum-likelihood	 phylogenetic	 tree	 generated.	 (a)	
Relationship	between	the	mouse	and	human	3’UTRs	of	all	ZIC	family	members.	(b)	Relationship	
between	the	mouse	and	human	ZIC2	NCE	and	ZIC3	NCE.	Scale	bar	represents	the	average	rate	
of	 nucleotide	 substitutions	 per	 site,	 with	 a	 longer	 branch	 indicating	 a	 larger	 number	 of	
substitutions	between	species	compared.	Bootstrap	values	(red	numbers)	represent	confidence	
in	 that	node	arrangement,	with	value	of	1.0	signifying	 that	 that	node	arrangement	occurs	 in	
100%	of	trees	computed	for	these	sequences.	Bootstrap	values	<50%	(0.5)	are	indicated	with	a	
red	 dot	 and	 are	 low	 confidence.	 mGapdh	 CDS	 is	 included	 as	 an	 outgroup	 to	 anchor	 the	
sequences.	
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Table	4.3:	Transcription	factor	binding	sites	predicted	to	occur	in	the	ZIC2	3’UTR,	and	how	the	
introduction	of	SNVs	alter	the	sites.	Frequency:	the	number	of	times	each	transcription	factor	
binding	site	is	estimated	to	occur	in	the	entire	3’UTR.	Binding	sites	that	are	predicted	to	occur	
in	the	540	bp	NCE	region	are	indicated	by	‘+’,	along	with	any	of	the	HPE-associated	SNVs	that	
the	binding	site	overlaps.	Lost:	binding	sites	predicted	to	be	lost	upon	the	introduction	of	the	
SNVs,	 also	 indicated	by	 ‘+’.	Binding	 sites	were	predicted	by	ENCODE,	 JASPAR	and	TRANSFAC	
(Mathelier	 et	 al.,	 2014;	 Matys	 et	 al.,	 2006;	 Rosenbloom	 et	 al.,	 2013).	 Table	 correlates	 to	
Appendix	Figure	A2.2.	
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AFP	 1	 	 	 	 ER	 5	 +	 	 	
AML	 3	 +	 	 	 ERG	 1	 +	 	 	
AP	 6	 +	 	 	 ETF	 5	 +	 M5	 	
AR	 7	 +	 	 	 ETS	 2	 +	 M1	 +	
ARI	 5	 +	 M3,	M4,	M5	 +	 EZF	 1	 	 	 	
ARID	 1	 +	 	 	 FOR	 1	 +	 	 	
ARNT	 1	 	 	 	 FOS	 4	 +	 M3,	M4	 +	
ARP	 2	 	 	 	 FOX	 16	 +	 M4,	M5	 	
BRCA	 2	 +	 	 	 FREACT	 1	 +	 M5	 	
BRN	 1	 +	 M3	 	 GABPA	 1	 	 	 	
CAC	 4	 +	 	 	 GATA	 26	 +	 M4,	M5	 	
CAR	 1	 +	 	 	 GBX	 3	 +	 	 	
CBF	 1	 +	 M6	 	 GR	 16	 +	 M3	 +	
CDX	 5	 +	 M3,	M4,	M5	 +	 HES	 3	 +	 	 	
CEBP	 5	 +	 M6	 +	 HIF1	 1	 	 	 	
COUP	 2	 +	 	 	 HLTF	 13	 +	 M1	 	
CP	 1	 	 	 	 HMG	 1	 	 	 	
CREB	 2	 +	 M3,	M4	 +	 HNF	 23	 +	 	 	
CRX	 2	 +	 M3	 	 HOX	 3	 +	 M3,	M6	 +	
CTCF	 3	 	 	 	 HRP	 5	 	 	 	
DLX	 1	 +	 M3	 	 IL	 2	 +	 	 	
DUX	 2	 +	 M3,	M4	 +	 IPF	 4	 +	 	 	
E2F	 3	 	 	 	 IRF	 2	 	 	 	
EBP	 4	 +	 	 	 ISGF	 2	 +	 	 	
EGR	 1	 	 	 	 JUN	 5	 +	 M3,	M4	 +	
ELF	 1	 +	 	 	 KLF	 4	 	 	 	
ELK	 3	 +	 	 	 LBP	 5	 +	 	 	
EMF	 3	 +	 M6	 +	 LEF	 2	 	 	 	
EN	 1	 +	 M6	 	 LF	 4	 +	 	 	
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LHX	 1	 +	 M3,	M4	 +	 RFX	 1	 +	 M5	 	
LUN	 2	 	 	 	 RUNX	 2	 +	 M6	 	
LXR	 2	 +	 	 	 RXR	 16	 +	 	 	
MAFB	 1	 +	 	 	 SAP	 2	 +	 	 	
MAX	 1	 +	 	 	 SMAD	 1	 	 	 	
MAZ	 1	 	 	 	 SOX	 11	 +	 M5,	M6	 +	
MBP	 1	 	 	 	 SP	 13	 +	 	 	
MEF	 1	 +	 M5	 	 SPIB	 4	 +	 M1	 	
MIT	 1	 +	 	 	 SRF	 5	 +	 M6	 	
MYB	 5	 +	 	 	 SRY	 8	 +	 M3,	M5,	M6	 +	
MYOD	 4	 +	 M6	 +	 STAT	 5	 +	 	 	
MZF1	 1	 +	 	 	 T3R	 7	 +	 	 	
NF	 18	 +	 M2,	M3	 +	 TBP	 18	 +	 M5	 +	
NKX	 6	 +	 M5,	M6	 +	 TCF	 2	 +	 	 	
NOBOX	 1	 +	 M3	 +	 TFIID	 15	 +	 M5	 +	
PAX	 4	 +	 M4	 	 THAP	 2	 +	 	 	
PDX	 1	 +	 M3,	M4	 +	 TME	 1	 +	 M5	 +	
PEA	 2	 +	 	 	 TME	 1	 +	 M5	 +	
PEBP	 1	 +	 	 	 TMF	 1	 +	 	 	
PITX	 2	 	 	 	 TR2	 1	 	 	 	
POU	 9	 +	 M5	 +	 USF	 1	 +	 	 	
POU1F1	 1	 +	 	 	 VDR	 6	 +	 	 	
PPUR	 1	 	 	 	 XFD	 1	 +	 	 	
PR	 2	 +	 	 	 XRP	 5	 +	 	 	
PRRX	 4	 +	 M3,	M4,	M6	 +	 YY	 10	 +	 M4	 	
PU	 1	 +	 	 	 ZFX	 1	 	 	 	
PXR	 1	 +	 	 	 ZIC	 1	 +	 	 	
RAR	 3	 +	 	 	 ZNF354C	 6	 +	 	 	
RBP	 1	 	 	 	 	 	 	 	 	
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Table	4.4:	Predicted	transcription	factor	binding	sites	are	enriched	in	the	ZIC2	NCE	and	at	the	
HPE-associated	SNVs	in	the	wildtype	ZIC2	3’UTR.	A	two-tailed	Chi-squared	goodness	of	fit	test	
was	performed	to	determine	whether	the	predicted	TF	binding	sites	were	randomly	distributed	
within	 the	 3’UTR.	 Significance	 of	 p<0.05	 (*)	 or	 p<0.01	 (**)	 indicates	 predicted	 binding	 site	
enrichment	in	the	region	being	tested.	(a)	Binding	site	enrichment	in	the	non-coding	conserved	
element	(NCE;	540	bp)	compared	to	the	non-conserved	region	(559	bp)	of	the	ZIC2	3’UTR.	(b)	
Binding	 site	 enrichment	 at	 the	 individual	 HPE-associated	 SNVs	 (1	 bp)	 compared	 to	 the	 non-
mutated	3’UTR	(1089	bp).	Observed	and	expected	values	are	indicated.	Degrees	of	freedom	=	1	
for	all	analyses.		
	
A	 Observed	 Expected	 !2	 P	
Non-conserved	
region	
198	 236.52	
12.760	 0.0004**	
NCE	 267	 228.48	
Total:	 465	 465	 	 	
	 	 	 	 	
B	 Observed	(n)	 Expected	 !2	 P	
M1	 3	 0.42	 15.86	 0.0001**	
M2	 1	 0.42	 0.80	 0.3706	
M3	 17	 0.42	 655.11	 0.0001**	
M4	 13	 0.42	 377.14	 0.0001**	
M5	 15	 0.42	 506.59	 0.0001**	
M6	 12	 0.42	 319.57	 0.0001**	
Non-mutated	
3’UTR	
465	–	mutant	
observed	(n)	
464.58	 	 	
Total:	 465	 465	 	 	
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Table	 4.5:	 Transcription	 factor	 binding	 sites	 predicted	 to	 be	 created	 when	 the	 six	 HPE-
associated	SNVs	are	introduced	into	the	ZIC2	3’UTR.	Table	denotes	the	transcription	factor	and	
the	respective	mutation	required	to	create	the	new	binding	site.	Binding	sites	are	predicted	by	
ENCODE,	JASPAR	and	TRANSFAC	(Mathelier	et	al.,	2014;	Matys	et	al.,	2006;	Rosenbloom	et	al.,	
2013).		
Transcription	
factor	
Overlapping	
Mutation	
AR	 M5	
BRCA	 M6	
CEBP	 M3	
EBP	 M4	
FOX	 M6	
MYB	 M6	
MYC	 M6	
NKX	 M3,	M4	
NP	 M3	
POU	 M1,	M3	
RUNX	 M4	
SOX	 M4	
STAT	 M1	
TCF	 M4	
TFAP	 M6	
YY	 M1	
ZEB	 M6	
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gene	transcription.	Not	only	do	these	new	binding	sites	possibly	interrupt	the	precise	spacing	
between	 sites	 required	 for	 the	 formation	 of	 these	 complexes,	 but	 the	 addition	 or	 loss	 of	 a	
component	of	these	complexes	has	the	potential	to	change	the	nature	of	the	‘-some’,	turning	
an	enhanceosome	into	a	repressosome	and	vice	versa.	It	is	important	to	remember,	however,	
that	these	binding	sites	are	mere	predictions,	and	 identifying	those	transcription	factors	that	
bind	 the	 ZIC2	 3’UTR	 requires	 the	 candidates	 be	 narrowed	 down	 further	 via	 experimental	
validation.	
4.2.3 Co-activators	are	predicted	to	bind	the	ZIC2	3’UTR		
The	binding	of	co-activators	such	as	p300	signals	an	active	region	of	non-coding	DNA.	ZIC2	3’UTR	
p300	 binding	 enrichment	 was	 analysed	 in	 GM12878	 cells	 via	 the	 USCS	 Genome	 and	 Table	
Browser	 (Rosenbloom	 et	 al.	 2015;	 SC584	 Standard	 ChIP-seq	 ENCODE/SYDH).	 Binding	 was	
enriched	in	the	NCE	region	only,	with	the	highest	peak	occurring	in	the	3’	end	of	the	NCE	(Figure	
4.5	A).	This	peak	 in	p300	binding	coincides	with	a	peak	 in	monomethylation	(Figure	4.5	C),	a	
trend	 indicative	of	enhancer	elements	 (Heintzman	et	al.,	2007).	No	other	 cells	 line	data	was	
available	for	additional	analysis	at	this	time.		
4.2.4 The	Zic2	3’UTR	chromatin	state	suggests	it	is	an	active	element	
Open	chromatin	allows	transcriptional	machinery	to	interact	with	target	DNA	and	is	indicative	
of	an	active	ER	element.	To	analyse	the	chromatin	state	of	the	ZIC2	3’UTR,	the	ENCODE	Genome	
editor,	which	uses	data	from	multiple	microarrays	(Kent	et	al.,	2002),	was	used	to	identify	DHSs	
and	the	USCS	Genome	and	Table	Browser	(Rosenbloom	et	al.,	2015)	was	used	to	identify	histone	
modifications.	 It	 should	 be	 noted,	 however,	 that	 none	 of	 the	Genome	 Browser	 annotations	
utilised	 in	 this	 analyses	 of	 the	 ZIC2	 NCE	 were	 conducted	 in	 the	 gastrulating	 embryo.	 Using	
ENCODE,	four	DHS	sites	were	identified	in	the	ZIC2	3’UTR	of	hESCs.	As	shown	in	Figure	4.5	B,	the	
third	and	fourth	DHSs	overlap	with	the	NCE,	suggesting	this	is	a	region	of	open	chromatin	highly	
accessible	to	interacting	proteins.	Additionally,	the	fourth	identified	DHS	site	contains	SNVs	M2,	
M3,	and	M4,	and	overlaps	with	the	previously	identified	UCR.	As	such,	if	this	region	is	a	true	ER	
element,	it	is	likely	that	M2,	M3	and	M4	will	have	a	greater	impact	on	target	gene	transcription	
than	the	other	three	SNVs	based	on	the	hypothesis	that	M1,	M5	and	M6	will	be	covered	by	a	
larger	amount	of	 chromatin	and	 inaccessible	 to	 transcriptional	machinery.	Monomethylation	
(H3K4Me1),	trimethylation	(H3K4Me3),	and	acetylation	(H3K27Ac)	enrichment	were	analysed	
in	H1-hESC	in	the	USCS	Genome	and	Table	Browser	(Rosenbloom	et	al.	2015).	The	entire	ZIC2	
3’UTR	demonstrated	significantly	higher	levels	of	monomethylation	and	acetylation	compared	
to	low	levels	of	trimethylation	(Figure	4.5	C,	Figure	4.6,	p<0.05),	suggesting	that	the	ZIC2	3’UTR	
likely	 contains	 an	 active	 ER	 element.	 Upon	 restricting	 the	 analysis	 to	 the	
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Figure	4.5:	Bioinformatic	analyses	of	chromatin	state	and	co-activators	in	the	ZIC2	3’UTR.	(a)	
Enrichment	of	p300	binding	sites	(grey)	was	calculated	in	GM12878	cells	via	the	USCS	Genome	
and	Table	Browser	(Rosenbloom	et	al.	2015).	P300	enrichment	was	restricted	to	the	NCE	region.	
(b)	Four	DNaseI	hypersensitivity	sites	(grey,	1-4)	were	detected	in	the	ZIC2	3’UTR	of	hESCs	via	
the	ENCODE	Genome	browser,	with	two	falling	within	the	NCE	(red)	and	one	overlapping	with	
M2,	M3	 and	M4	 (yellow).	 (c)	Monomethylation	 (H3K4me1,	 blue),	 trimethylation	 (H3K4me3,	
orange)	 and	 acetylation	 (H3K27Ac,	 green)	 rates	 were	 analysed	 in	 H1-hESC	 using	 the	 USCS	
Genome	 and	 Table	 Browser	 (Rosenbloom	 et	 al.	 2015).	 The	 entire	 3’UTR	 demonstrated	 high	
levels	of	monomethylation	and	acetylation,	with	 low	levels	of	trimethylation.	NCE	nucleotide	
location	is	represented	in	(red).	
	
	
	
	
	
Figure	 4.6:	 Histone	 modification	 enrichment	 in	 the	 ZIC2	 3’UTR.	 Comparison	 of	 histone	
modifications	 in	 the	 entire	 ZIC2	 3’UTR.	Mean	 enrichment	 for	monomethylation	 (H3K4me1),	
trimethylation	(H3K4Me3),	and	acetylation	(H3K27Ac)	in	the	ZIC2	3’UTR	and	NCE	in	H1-hESC	was	
quantified	via	Layered	Tracks	(ENCODE)	in	the	USCS	Genome	and	Table	Browser	(Rosenbloom	
et	 al.	 2015).	 A	 high	 level	 of	 enrichment	 is	 represented	 as	 10	 and	 a	 low	 level	 of	 enrichment	
represented	 as	 0.	 Enrichment	 within	 the	 NCE	 only	 was	 not	 significantly	 different	 from	
enrichment	in	the	3’UTR	(not	shown).	Error	bars	=	S.E.M.	Letters	denote	statistical	significance	
of	p<0.05	 calculated	via	a	one-way	ANOVA	with	Fischer’s	unprotected	post	 ad	hoc	 test.	 The	
letter	a	denotes	statistical	significance	to	b	and	so	on.		 	
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NCE	 region	 only,	 or	 the	 non-conserved	 region	 of	 the	 3’UTR,	 a	 similar	 result	was	 found	 (not	
shown),	suggesting	the	entire	3’UTR	is	accessible	to	TFs	and	transcriptional	machinery.	A	track	
to	determine	if	a	H3K27Me3	chromatin	signature	was	present	for	the	ZIC2	3’UTR,	indicating	a	
poised	state,	was	unavailable.	
4.2.5 Candidate	TFs	predicted	to	bind	the	Zic2	3’UTR	are	co-expressed	with	Zic2	at	
gastrulation	
The	 TFs	 predicted	 to	 bind	 the	ZIC2	 NCE	 in	 Section	 4.2.2	 are	 a	 source	 of	 interest	 for	 further	
studies.	It	is	not	feasible,	however,	to	test	the	binding	of	every	potential	family	member	to	the	
NCE.	Instead,	functional	candidates	can	be	narrowed	down	further	via	their	spatial	and	temporal	
co-expression	 with	 Zic2	 during	 embryo	 development.	 As	 HPE	 develops	 from	 the	 defective	
activity	of	Zic2	in	the	embryonic	node	(Warr	et	al.,	2008)	gastrulation	was	chosen	as	the	time	
point	in	which	to	analyse	the	expression	patterns	of	TFs.		
A	 combination	of	EMAGE	gene	expression	databases	 (Richardson	et	al.,	 2014)	and	MGI	GXD	
databases	 (Finger	 et	 al.,	 2011),	 which	 contain	 gene	 expression	 patterns	 published	 in	 peer-
reviewed	articles,	were	used	to	identify	the	expression	patterns	of	TFs	known	to	be	expressed	
at	gastrulation.	The	Zic2	expression	pattern	published	in	Elms	et	al	was	used	as	a	comparison	
(Elms	et	al.,	2004).	Those	genes	that	displayed	overlapping	or	inverse	expression	with	Zic2	during	
this	stage	were	identified	as	candidates	to	regulate	the	ZIC2	NCE	(Table	4.6).		
The	EMAGE	and	MGI	GXD	databases	are	made	up	of	expression	profiles	 from	peer-reviewed	
articles,	therefore	it	was	not	possible	to	analyse	the	expression	pattern	of	every	member	of	each	
candidate	 family	 as	 not	 all	 expression	 patterns	 have	 been	 published.	 Additionally,	 some	
candidates	exhibited	overlapping	expression	with	Zic2	at	8.5	dpc	and	9.5	dpc	but	not	at	7.25	dpc	
when	defective	Zic2	is	known	to	result	in	HPE.	Whilst	this	suggests	that	these	candidates	may	
interact	with	 the	Zic2	NCE	 to	 regulate	gene	expression	during	organogenesis,	 they	were	not	
considered	substantial	candidates	for	influencing	HPE	development	at	gastrulation.	
	
Table	 4.6:	 Proteins/genes	 that	 exhibit	 overlapping	 expression	 with	 Zic2	 during	 murine	
gastrulation.	 A	 ‘+’	 represents	positive	 expression	 in	 that	 embryonic	 region.	Most	 expression	
patterns	were	identified	via	EMAGE	and	MGI	GXD	databases	(Finger	et	al.,	2011;	Richardson	et	
al.,	2014).	Orange:	enzyme;	green:	receptor;	blue:	TF;	purple:	secreted	molecule;	and	red:	mRNA	
binding	protein.		
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Zic2	 +	 +	 +	 +	 +	 +	 +	 +	 +	 +	 (Elms	et	al.,	2004)	
ATP9A	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
Bicc1	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
Bmp7	 	 	 	 	 +	 	 	 	 +	 +	 EMAGE/MGI	GXD	
CAPSL	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
CAR3	 	 	 	 	 	 	 	 	 +	 +	 EMAGE/MGI	GXD	
CELSR1	 	 	 	 	 	 	 	 	 +	 +	 EMAGE/MGI	GXD	
CERL1	 	 +	 	 	 +	 +	 	 	 	 	 (Barratt	et	al.,	2014)	
CERL2	 	 +	 	 	 	 	 	 	 	 	 EMAGE/MGI	GXD	
CDX1	 	 	 	 	 	 	 	 +	 	 +	 EMAGE/MGI	GXD	
CDX2	 	 	 	 	 	 	 	 	 	 +	 Arkell	lab	(Figure	4.7)	
CFC1	 	 	 	 	 +	 	 	 	 +	 	 EMAGE/MGI	GXD	
CHRD	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
CYB561	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
DKK1	 	 +	 	 	 +	 +	 	 	 	 	 EMAGE/MGI	GXD	
DMGDH	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
EOMES	 	 	 	 	 	 	 	 	 +	 +	 EMAGE/MGI	GXD	
EPHA2	 	 	 	 	 	 	 	 	 +	 +	 EMAGE/MGI	GXD	
FAM183B	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
FGF8	 	 	 	 	 	 	 	 	 	 +	 EMAGE/MGI	GXD	
FGFR1	 +	 	 	 	 +	 +	 +	 +	 	 +	 EMAGE/MGI	GXD	
FOXA1	 +	 +	 +	 	 +	 	 +	 +	 	 +	 EMAGE/MGI	GXD	
FOXA2	 	 	 	 +	 	 +	 	 	 +	 	 Arkell	lab	(Figure	4.7)	
FOXC1	 	 	 	 	 +	 	 	 	 	 +	 EMAGE/MGI	GXD	
FOXC2	 	 	 	 	 	 	 	 +	 	 	 EMAGE/MGI	GXD	
FOXD3	 	 	 	 	 	 +	 	 	 	 	 EMAGE/MGI	GXD	
FOXD4	 	 	 	 	 	 +	 	 	 +	 	 EMAGE/MGI	GXD	
FOXJ1	 	 	 	 	 +	 	 	 	 +	 	 (Barratt	et	al.,	2014)	
FURIN	 	 +	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
GAL	 	 	 	 	 	 	 	 	 +	 +	 EMAGE/MGI	GXD	
GOOSECOID	 	 	 	 	 	 	 	 	 +	 +	 EMAGE/MGI	GXD	
HDC	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
HESX1	 	 	 	 	 	 +	 	 	 	 	 EMAGE/MGI	GXD	
HHEX	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
HOXB1	 	 	 	 	 +	 	 	 	 +	 +	 EMAGE/MGI	GXD	
HOXB8	 	 	 	 	 	 	 	 	 	 +	 EMAGE/MGI	GXD	
IFT88	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
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IGFBP5	 	 	 	 	 +	 	 	 	 +	 	 EMAGE/MGI	GXD	
JOSD2	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
LHX1	 	 +	 	 	 +	 	 	 	 +	 +	 Arkell	lab	(Figure	4.7)	
LYPD6B	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
MESP1	 	 	 	 	 +	 	 	 	 	 +	 EMAGE/MGI	GXD	
MIXL1	 	 	 	 	 	 	 	 	 	 +	 EMAGE/MGI	GXD	
MLF1	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
MMP15	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
MNX1	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
NODAL	 	 	 	 	 	 	 	 	 +	 	 (Barratt	et	al.,	2014)	
NOGGIN	 	 	 	 	 +	 	 	 	 +	 	 EMAGE/MGI	GXD	
NOTCH1	 	 	 	 	 	 	 	 	 	 +	 EMAGE/MGI	GXD	
NOTCH2	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
NOTO	 	 	 	 	 	 	 	 	 +	 	 (Barratt	et	al.,	2014)	
OTX2	 	 +	 	 	 	 	 	 	 	 	 EMAGE/MGI	GXD	
PKD1L1	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
PIM1	 	 	 	 	 	 	 	 	 +	 +	 EMAGE/MGI	GXD	
PIFO	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
PITX2	 	 	 	 	 +	 	 	 	 	 	 (Barratt	et	al.,	2014)	
PLET1	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
POPDC2	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
PPP1R1A	 	 	 +	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
PRICKLE2	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
PRNP	 	 	 +	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
PROX1	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
PRRX1	 +	 	 	 	 +	 	 	 	 	 	 EMAGE/MGI	GXD	
RFX3	 	 	 	 	 	 	 	 	 +	 	 (Barratt	et	al.,	2014)	
SCARA3	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
SHH	 +	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
SMIM22	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
SMOC1	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
SOX2	 +	 	 	 	 	 +	 	 	 	 	 (Wood	and	Episkopou,	1999)	
SOX3	 +	 	 	 	 +	 +	 	 	 	 	 (Wood	and	Episkopou,	1999)	
SOX17	 	 +	 	 	 	 	 	 	 	 	 EMAGE/MGI	GXD	
T	 	 	 	 +	 	 	 	 	 	 +	 EMAGE/MGI	GXD	
TGM2	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
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TRH	 	 +	 +	 	 	 	 	 	 	 	 EMAGE/MGI	GXD	
TMEM176A	 	 	 	 	 	 	 	 	 +	 +	 EMAGE/MGI	GXD	
VTN	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
WNT3A	 	 	 	 	 	 	 	 	 	 +	 EMAGE/MGI	GXD	
WNT11	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
ZEB1	 	 	 +	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
ZEB2	 	 	 +	 	 	 	 	 	 	 +	 EMAGE/MGI	GXD	
ZIC3	 +	 +	 	 	 +	 	 	 	 +	 +	 (Elms	et	al.,	2004)	
ZIC5	 +	 	 +	 	 +	 	 	 	 	 	 (Inoue	et	al.,	2004)	
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A	total	of	79	different	genes	were	identified	that	produce	overlapping	or	inverse	expression	with	
Zic2	during	gastrulation	(Table	4.6).	These	candidates	were	further	broken	down	by	their	roles	
in	 the	 cell	 (TFs,	 secreted	molecules,	 receptors,	 enzymes	 or	 RNA	 binding	 proteins).	 By	 cross	
referencing	these	candidates	with	the	binding	sites	predicted	to	occur	in	the	ZIC2	NCE	(Section	
4.2.2),	or	the	binding	sites	of	their	downstream	targets	in	the	case	of	receptors	and	secreted	
molecules,	a	list	of	19	genes	were	identified	as	the	most	likely	candidates	to	bind	and	regulate	
the	ZIC2	NCE	during	gastrulation:	Cdx1,	Cdx2,	Foxa1,	Foxa2,	Foxc1,	Foxc2,	Foxd3,	Foxd4,	Foxj1,	
Hoxb1,	Hoxb8,	 Lhx1,	 Prrx1,	Rfx3,	 Sox2,	 Sox3,	 Sox17,	 Zic3	and	Zic5.	 As	 some	of	 the	 identified	
candidates	were	easily	obtainable	or	were	already	in	pre-existing	constructs	in	the	Arkell	 lab,	
Cdx2,	Foxa2,	Lhx1,	Sox2,	Sox3,	Zic3	and	Zic5	were	chosen	for	the	initial	analysis.	Zic2	was	also	
considered	a	candidate	to	self-regulate	its	own	expression.	WMISH	on	wildtype	embryos	was	
used	 to	 confirm	 overlapping	 expression	 with	 Zic2	 during	 gastrulation	 (Figure	 4.7)	 and	
candidature	for	the	regulation	of	Zic2	via	NCE	interactions.		
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Figure	 4.7:	 The	 expression	 pattern	 of	 candidate	 transcription	 factors	 during	 mouse	
gastrulation.	The	expression	patterns	of	Cdx2,	Foxa2,	Foxj1,	Lhx1,	Sox2,	Sox3,	Zic3	and	Zic5	were	
analysed	via	WMISH	and	compared	spatially	and	temporally	to	Zic2	expression.	In	all	pictures	
the	anterior	 is	 to	 the	 left	and	embryos	are	shown	 in	 lateral	view.	PrS/ES:	pre-streak	or	early	
streak,	5.5-6.5	dpc;	MS:	mid-streak,	6.75	dpc;	NB/EB:	no	bud	or	early	bud,	7.0-7.25	dpc;	MB:	
mid-bud,	7.25-7.5;	EHF:	early	head	fold,	7.75.	*	indicates	in	situs	performed	by	Ruth	Arkell	and	
published	 in	 (Elms	et	al.,	 2004).	**	 indicates	 in	 situs	 performed	by	Ruth	Arkell,	unpublished.	
PrS/ES	and	EHF	Sox2	and	Sox3	in	situs	are	adapted	from	(Wood	and	Episkopou,	1999).	
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4.3 Discussion	
This	Chapter	extends	the	research	by	Roesseler	et.	al.	(2012a),	providing	bioinformatic	evidence	
for	the	ZIC2	NCE	as	a	putative	ER	element	during	embryonic	development	and	identifying	a	UCR	
within	 the	 NCE.	 Additionally,	 nine	 candidate	 transcription	 factors	 likely	 to	 regulate	 Zic2	
expression	via	interactions	with	the	NCE	during	gastrulation	were	identified.		
4.3.1 The	ZIC2	3’UTR	contains	hallmarks	of	an	active	ER	element	
Analysis	of	predicted	DHSs	sites,	methylation	patterns,	co-factor	binding	and	TF	binding	sites,	
along	with	high	levels	of	sequence	conservation	amongst	species,	indicates	that	the	ZIC2	NCE	is	
likely	an	ER	element.	Additionally,	the	finding	of	high	levels	of	monomethylation	and	acetylation	
along	with	low	levels	of	trimethylation	in	the	ZIC2	3’UTR	of	hESCs	suggest	that	the	element	is	
active.		
The	identification	of	an	UCR	within	the	ZIC2	NCE	provides	evidence	for	a	minimal	region	required	
for	 target	 gene	 regulation.	 If	 the	 ZIC2	 NCE	 is	 confirmed	 to	 be	 an	 enhancer	 or	 repressor	 via	
experimental	methods,	it	will	be	interesting	to	investigate	whether	the	UCR	region	can	maintain	
this	activity	on	its	own	or	whether	the	entire	NCE	is	required	for	element	function.	Additionally,	
the	 positioning	 of	M2	within	 the	 UCR	 suggests	 that	 this	mutation	may	 produce	 the	 largest	
impact	on	element	function	when	compared	to	other	mutations	outside	of	this	region.		
4.3.2 Candidate	NCE-interacting	transcription	factors		
Via	bioinformatic	analysis	and	gene	expression	profiles,	the	list	of	transcription	factors	predicted	
to	bind	the	ZIC2	3’UTR	was	narrowed	down	to	nine	candidates,	including	ZIC2.	All	nine	of	the	
identified	 candidates	 are	 known	 to	 be	 required	 for	 correct	 embryo	 development,	 with	 a	
particular	 focus	 on	 gastrulation.	 Additionally,	 four	 of	 the	 nine	 candidates’	 binding	 sites	 are	
predicted	to	be	lost	when	SNVs	are	introduced	(CDX2,	SOX2,	SOX3	and	LHX1),	whilst	four	binding	
sites	are	predicted	to	be	created	upon	SNV	introduction	(FOXA2,	FOXJ1,	SOX2	and	SOX3).	This	
suggests	 that	SNVs	have	 the	potential	 to	markedly	disrupt	ZIC2	NCE	activity	by	changing	 the	
nature	of	enhanceosome	or	repressosome	formation.	Further	 in	vitro	studies	are	required	to	
determine	if	these	TF	candidates	do	indeed	interact	with	the	ZIC2	NCE	to	regulate	transcription,	
and	how	the	SNVs	affect	these	interactions	(see	Chapter	5).		
One	 candidate	 TF,	 CDX2,	 is	 known	 to	 play	 an	 important	 role	 in	 somitogenesis,	 endoderm	
development	and	neural	tube	closure	during	embryonic	development	(Savory	et	al.,	2011),	and	
is	required	at	gastrulation	for	AP	patterning	and	tissue	extension	via	the	regulation	of	Hox	genes	
and	Wnt	signalling	(Young	et	al.,	2009).	This	regulation	of	Hox	genes	occurs	via	the	binding	of	
CDX2	 to	 two	Hoxc8	 enhancers,	a	gene	 critical	 for	early	development	of	 the	neural	 tube	and	
mesoderm	in	mice	(Taylor	et	al.,	1997),	however	this	interaction	is	cell	specific.	Mutations	of	the	
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two	enhancers	prevented	CDX2	from	binding	specifically	to	both	sites	and	resulted	in	altered	
transgene	expression	in	the	neural	tube	and	somites	of	developing	embryos	(Taylor	et	al.,	1997).	
Similarly,	 the	 ability	 to	bind	 an	 enhancer	 element	has	been	 shown	 for	 LHX1	 (Costello	et	 al.,	
2015),	FOXA2	(Gao	et	al.,	2008)	and	SOX2	(Yuan	et	al.,	1995).	Moreover,	LHX1	and	FOXA2	have	
been	shown	to	complex,	together	with	OTX2	and	LDB1,	to	regulate	target	gene	expression	and	
direct	anterior	mesendoderm,	node	and	midline	development	(Costello	et	al.,	2015).	Together,	
these	studies	provide	precedent	for	the	identified	candidate	TFs	to	actively	bind	ER	elements	
such	as	the	putative	ZIC2	NCE.		
Whilst	 candidate	 transcription	 factors	 were	 analysed	 for	 their	 expression	 patterns	 at	
gastrulation	and	the	occurrence	of	binding	sites	in	the	ZIC2	3’UTR,	the	list	of	factors	identified	
in	this	chapter	is	far	from	exhaustive.	Information	about	the	expression	pattern	at	gastrulation	
of	a	majority	of	the	TFs	identified	in	the	bioinformatics	screen	could	not	be	found.	Likewise,	a	
majority	of	the	79	identified	TFs	with	overlapping	gastrulation	expression	patterns	have	not	had	
any	 known	 binding	 motifs	 published	 and	 therefore	 their	 ZIC2	 3’UTR	 binding	 potential	 is	
unknown.	 Whilst	 this	 study	 focused	 on	 genes	 that	 met	 both	 bioinformatic	 and	 expression	
criteria,	 it	does	not	mean	 that	 identification	of	 candidates	 should	be	 restricted	 to	 the	genes	
listed	in	Section	4.2.4.	Analysis	of	enhancers	based	on	predicted	TFBSs	alone	is	often	dependant	
on	knowledge	of	the	preferred	binding	site	of	the	candidate	proteins.	The	binding	preferences	
of	many	 candidates	 are	 unknown	 at	 this	 stage	 and	 the	 difficulty	 of	 predicting	 candidates	 is	
further	 compounded	by	 the	 fact	 that	many	TF	 require	 a	 co-factor	 to	bind	DNA	 (reviewed	 in	
Andersson	2014).	 Furthermore,	whilst	many	predicted	TFBSs	have	been	 shown	 to	bind	 their	
target	DNA	in	vitro,	these	results	often	do	not	translate	to	in	vivo	studies	as	they	do	not	take	
into	account	variables	such	as	cell	type	specificity	and	chromatin	accessibility	(Andersson,	2014).	
Similarly,	it	is	important	to	note	when	analyzing	binding	site	that	short	motifs	frequently	match	
to	 genomic	 or	 even	 random	 DNA	 sequences	 (for	 example,	 each	 6	 bp	 long	 motif	 would	 be	
expected	 to	 occur	 every	 46	 bp	 =	 4,096	 bp),	 and	 only	 a	 small	 proportion	 of	 all	matches	 in	 a	
genome	are	typically	bound	by	the	corresponding	transcription	factor	in	vivo.	Of	these,	only	a	
small	number	result	in	regulation	of	gene	expression	(Shlyueva	et	al.,	2014;	Yáñez-Cuna	et	al.,	
2012).	Thus,	a	large	number	of	the	candidate	binding	sites	identified	in	this	chapter	are	likely	
false-positives.	Corresponding	binding	site	predictions	to	gene	expression	patterns	will	remove	
a	large	number	of	these	false	positives,	however	there	remains	a	possibilitiy	that	the	final	nine	
candidate	transcription	factors	may	not	interact	with	the	ZIC2	NCE.	
Together,	this	suggests	that	there	remain	multiple	candidates	yet	to	be	identified.	Thus,	whilst	
it	is	important	to	investigate	the	role	of	the	nine	identified	candidates	in	regulating	the	ZIC2	NCE	
in	in	vitro	and	in	vivo	studies,	it	is	also	important	to	continue	to	identify	new	candidate	genes.	
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Due	to	the	nature	of	cis-acting	NCEs,	 it	 is	 likely	 that	 the	TFs	 that	do	bind	the	ZIC2	3’UTR	are	
located	nearby	in	the	genome	and	that	they	serve	a	developmentally	important	role.	As	more	
information	is	acquired	on	gene	expression	patterns	and	binding	sites	are	further	clarified,	the	
identification	of	new	candidate	TFs	will	become	easier.		
At	this	stage,	FOXA2	is	the	only	final	candidate	implicated	in	HPE	development	(Houtmeyers	et	
al.,	2016).	This	affords	an	opportunity	to	identify	a	new	selection	of	HPE	related	genes,	as	it	is	
likely	 that	 the	 introduction	of	 the	 six	 SNVs	will	 alter	 the	 interactions	between	 the	 final	 nine	
candidates	and	the	ZIC2	NCE,	resulting	in	congenital	malformations.		
4.3.3 Conclusion	
The	identification	of	mutations	within	a	putative	NCE	in	ZIC2	3’UTR	in	HPE	probands	by	Roessler	
et	al	(2012a)	lead	to	the	hypothesis	that	this	element	acts	as	an	enhancer	during	gastrulation	to	
regulate	 ZIC2	 transcription.	 In	 this	 Chapter	 I	 have	 shown	 that	 the	 ZIC2	 NCE	 contains	 the	
hallmarks	of	an	active	ER	element,	and	have	identified	nine	TF	candidates	to	bind	and	regulate	
this	element	during	gastrulation.	Furthermore,	I	have	shown	that	each	of	the	six	HPE-associated	
SNVs	have	the	potential	to	disrupt	the	protein	complexes	that	interact	with	the	NCE.	Though	
NCE	function	remains	to	be	determined	experimentally,	it	is	likely	an	important	component	in	
ZIC2	regulation	during	gastrulation	and	the	prevention	of	HPE.			
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Chapter	5: In	vitro	analysis	of	the	ER	element	activity	of	the	ZIC2	NCE	
	
5.1 Introduction	
It	 has	 recently	 been	 found	 that	 enhancers	 can	 not	 only	 switch	 between	 active,	 poised	 and	
repressed	states,	but	can	possess	these	properties	simultaneously	(Palstra	and	Grosveld,	2012).	
This	was	shown	via	chromosome	conformation	capture	and	ChIP	on	the	mouse	a-globin	locus	
in	erythroid	cells	and	progenitors,	where	multiple	domains	within	an	ER	element	establish	a	
poised	state	independently	of	each	other	through	binding	of	specific	multiprotein	complexes.	
Additionally,	multiple	domains	within	one	ER	element	can	establish	a	hierarchy	of	activity,	with	
the	net	activity	of	the	element	the	determinate	for	gene	expression.	For	example,	an	ER	element	
situated	~10	kb	upstream	of	the	murine	Albumin	(Alb1)	gene	possess	three	active	domains.	The	
first	acts	as	a	positive	regulator	of	albumin	expression	in	rat	CWSV1	cells,	whilst	the	second	acts	
as	 a	 repressor	 to	negate	 the	activity	of	 the	 first.	 Finally,	 a	 third	domain	which	overrides	 the	
repressor	 activity	 of	 the	 second	domain	was	 also	 identified	 (Herbst	et	 al.,	 1989).	Moreover,	
transcriptional	machinery	complexes	 form	at	 the	promoter	whether	or	not	an	ER	element	 is	
active,	and	act	as	a	docking	site	for	the	‘-somes’	bound	to	poised	ER	elements	(Vernimmen	et	
al.,	2007).	By	both	the	promoter	and	ER	element	existing	in	a	poised	state,	the	timing	of	gene	
expression	 can	 be	 delayed	 until	 the	 precise	 moment	 it	 is	 required	 in	 a	 cell,	 circumventing	
inappropriate	expression	that	could	disrupt	the	cell	processes.		
ER	elements	can	also	transition	between	states	via	changes	in	the	TFs	that	interact	with	them.	
The	availability	of	each	TF	is	subject	to	the	signalling	pathways	that	are	active	in	the	same	cell	
as	 the	 ER	 element.	Here,	 they	 act	 as	 a	 ‘switch’,	 turning	 on	 transcription	 of	 a	 target	 gene	 in	
response	to	signalling	cues.	As	the	TFs	behind	these	‘switches’	and	their	target	binding	sites	are	
conserved	within	each	major	signalling	pathway,	the	‘switch’	can	be	induced	experimentally	in	
a	desired	cell	line	via	ectopic	activation	of	the	signalling	pathway	(Barolo	and	Posakony,	2002).	
For	 this	 to	 occur,	 developmental	 signalling	 pathways	 must	 adhere	 to	 three	 fundamental	
principles,	as	outlined	by	Barolo	and	Posakony	(2002).	First,	signalling	pathways	exhibit	activator	
insufficiency,	 whereby	 the	 binding	 of	 a	 single	 signal-modified	 TF	 to	 an	 ER	 element	 is	 not	
sufficient	to	activate	full	target	gene	expression.	This	prevents	a	pathway	from	activating	all	of	
its	targets	in	one	signalling	event,	reducing	promiscuous	activation.	Instead,	cooperative	binding	
of	 signal-independent	 local	 activators	 and	 signal-activated	 factors	 must	 occur	 for	 signal-
activated	elements	to	respond,	which	is	the	second	principle	(Barolo	and	Posakony,	2002).	This	
integration	 with	 different	 local	 activators	 that	 generates	 different	 and	 distinct	 expression	
patterns	of	 a	 target	 gene,	 as	 can	be	 seen	with	 the	NOTCH	 responsive	protein	 Suppressor	of	
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Hairless,	 Su(H),	 in	Drosophila.	 By	 pairing	with	 different	 local	 activators,	 Su(H)	 can	 bind	 to	 a	
variety	of	NOTCH	responsive	elements	and	induce	expression	in	unrelated	tissues	such	as	the	
wing	margin,	mesectoderm	cells	and	the	socket	and	shaft	cells	of	the	mechanosensory	bristle	
(Barolo	et	al.,	2000;	Halder	et	al.,	1998;	Morel	et	al.,	2001).	By	employing	the	first	two	principles,	
a	 signalling	 pathway	 specifies	 distinct	 cell	 fates	 via	 activation	 of	 different	 and	 overlapping	
subsets	of	target	genes.	Finally,	signalling	pathways	employ	default	repression	in	the	absence	of	
signalling,	ensuring	target	expression	remains	in	the	off	state	until	sufficient	signal	is	generated.	
This	 is	primarily	achieved	by	active	 repression	of	promoters	or	enhancers	of	 signal-activated	
target	 genes	 in	 any	 conditions	 deemed	 inappropriate	 (Barolo	 and	 Posakony,	 2002).	 Default	
repression	restricts	signalling	to	specific	tissues	or	zones	so	that	activation	of	a	signal	in	one	cell	
is	insufficient	to	cause	activation	of	all	of	its	targets	in	other	cells.	In	the	case	of	WNT	signalling,	
the	 TCF/LEF	 family	 of	 TFs	 (TCF/LEF)	 can	mediate	 default	 repression	 in	 the	 absence	 of	WNT	
signalling	and	then	act	as	activators	 in	signal-responding	cells	(Cadigan,	2008).	Additionally,	a	
fourth	principle	has	been	described	in	which	some	signalling	pathways	repress	a	gene	that	was	
active	before	the	signal	was	generated	(Affolter	et	al.,	2008).	This	directly	conflicts	with	the	third	
principle,	as	default	repression	would	need	to	be	overruled	for	a	signal-dependent	target	gene	
to	 be	 active	 prior	 to	 signalling.	 Nevertheless,	 all	 the	 principles	 described	 contribute	 to	 the	
spatial-temporal	regulation	of	gene	expression	that	is	required	for	correct	patterning	events	to	
occur.	Therefore,	to	establish	if	and	how	a	putative	ER	element	regulates	gene	expression,	the	
element	must	be	assessed	in	the	correct	signalling	context.		
5.1.1 WNT,	BMP	and	NODAL	drive	anterior	primitive	streak	and	node	activity	at	
gastrulation	
At	 the	 onset	 of	 gastrulation	 (6.0	 dpc),	 the	 proximal-distal	 axis	 of	 the	 embryonic	 cylinder	 is	
converted	into	an	anterior-posterior	axis	by	the	co-ordinated	activities	of	WNT,	BMP,	NODAL	
(Figure	5.1)	and	FGF	signalling	pathways	(not	shown)(reviewed	in	Tam	et	al.	2006	and	Pfister	et	
al.	2007).	In	general,	the	positive	(ligand,	agonist)	and	negative	(antagonist)	components	of	each	
pathway	are	expressed	at	opposite	sides	of	the	embryo	to	create	a	morphogen	gradient,	with	
each	cell	within	a	tissue	subject	to	a	specific	morphogen	dose.	Wnt3,	for	example,	is	expressed	
in	the	posterior	PS	throughout	gastrulation	whilst	it’s	antagonist,	Dkk1,	is	expressed	in	the	AVE,	
creating	a	gradient	of	WNT	signalling	activity	across	the	embryo	(Ben-Haim	et	al.,	2006;	Kemp	
et	al.,	2005;	Pfister	et	al.,	2007)	that	can	be	visualised	in	vivo	with	a	transgenic	reporter	such	as	
that	in	the	TCF/Lef:H2B-GFP	mouse	strain	(Ferrer-Vaquer	et	al.,	2010).	
	
	 	
		 159	
	
	 	
		 160	
Figure	5.1:	Signalling	pathway	activity	at	early-mid	gastrulation.	Gastrulation	is	initiated	(6.0	
dpc)	in	the	mouse	embryo	when	BMP4	signalling	from	the	extraembryonic	ectoderm	(ExE)	and	
visceral	endoderm	(VE),	in	conjunction	with	NODAL	and	WNT3	signalling	from	the	ExE,	VE	and	
proximal	epiblast,	induces	primordial	germ	cells	to	move	distally	to	the	posterior	epiblast	and	
prospective	posterior	of	the	embryo	(reviewed	in	Tam	et	al.	2006;	Pfister	et	al.	2007).	BMP4	and	
WNT3	activity	in	the	posterior	VE	activates	T	expression,	thereby	promoting	formation	of	the	
primitive	streak	(Ben-Haim	et	al.,	2006;	Pfister	et	al.,	2007).	The	AVE	suppress	a	posterior	fate	
in	the	underlying	anterior	ectoderm	via	expression	of	TGFb	antagonists	such	as	Cer1	and	Lefty1	
and	WNT	antagonists	such	as	Dkk1,	causing	the	gradient	of	signalling	activity	to	adopt	an	A-P	
orientation	 (Kemp	 et	 al.,	 2005;	 Perea-Gomez	 et	 al.,	 2002;	 Robb	 and	 Tam,	 2004).	 This	
combination	of	a	high	WNT	and	high	NODAL	environment	in	the	posterior	epiblast,	mediated	by	
BMP	signalling,	that	correctly	positions	the	PS	and	induces	mesoderm	formation	(Behringer	et	
al.,	1999;	Ben-Haim	et	al.,	2006;	Rivera-Pérez	and	Magnuson,	2005).	The	mesoderm	expands	
outwards	from	both	sides	of	the	PS	and	distally	towards	the	tip	of	the	egg	cylinder	and	future	
node	 to	 form	mesodermal	 ‘wings’	 (Tam	and	Behringer,	 1997)	 via	 continuous	 recruitment	 of	
epiblast	 cells	 (reviewed	 in	 Rivera-Perez	 and	 Hadjantonakis	 2014).	 The	 APS	 is	 composed	 of	
transitory	populations	of	tissue	precursors	that	will	give	rise	to	the	axial	mesendoderm	that	will	
form	the	PrCP,	notochord	and	node	(Robb	and	Tam,	2004)	and	the	ADE	(Lawson	et	al.,	1991;	
Tam	and	Beddington,	1992;	Wells	and	Melton,	1999),	as	described	in	Chapter	1.	Formation	of	
the	ADE	is	favoured	by	high	levels	of	NODAL	signalling	in	the	APS	(Kubo,	2004;	Lewis	and	Tam,	
2006;	Norris	et	al.,	2002).	In	contrast,	formation	and	maintenance	of	the	node	at	the	mid-late	
streak	stage	(6.75-7.0	dpc)	requires	medium-high	levels	of	NODAL	signalling	in	conjunction	with	
low	 levels	 of	 both	WNT	and	BMP	activity	 (reviewed	 in	Davidson	&	Tam	2000).	Downstream	
NODAL	targets	such	as	Gsc	and	Foxa2	are	also	expressed	 in	 the	node	tissue,	where	they	are	
required	 for	 the	generation	of	 the	 left-right	axis,	PrCP	and	notochord,	 respectively	 (Ang	and	
Rossant,	1994;	Beddington,	1994;	Brennan	et	al.,	2002;	Yamanaka	et	al.,	2007).	As	cells	move	
out	from	the	node	to	form	the	notochord,	cells	from	the	APS	are	recruited	to	repopulate	the	
node	(Kinder	et	al.,	2001).	ExE:	extraembryonic	ectoderm,	AVE:	anterior	visceral	endoderm,	PS:	
primitive	streak,	APS:	anterior	primitive	streak,	AVE:	anterior	visceral	endoderm,	AME:	anterior	
mesoendoderm,	N:	node,	Pr:	proximal,	D:	distal,	A:	anterior,	P:	posterior,	Ant:	antagonists,	Lig:	
ligands.	
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Currently,	 no	 reliable	 reporter	 strains	 exist	 for	 BMP	 or	 NODAL	 signalling,	 therefore	 their	
morphogen	gradient	must	be	inferred	from	gastrula	expression	analysis	and	mutational	screens.	
The	morphogen	dose	a	cell	receives	indicates	its	position	within	the	embryo	and	directs	future	
differentiation,	movement	and	morphogenesis.	Often,	multiple	signalling	pathways	are	active	
within	the	same	cell	to	co-ordinate	transcription	of	target	genes	(Figure	5.2).	Due	to	this,	the	
availability	 of	 downstream	 TFs	 within	 a	 cell	 is	 dependent	 on	 specific	 morphogen	 dose	
requirements	being	met.	When	they	are	not	met,	an	embryo	will	 fail	 to	gastrulate	correctly.	
Wnt3-/-	murine	embryos	do	not	form	a	PS,	mesoderm	or	node	(Behringer	et	al.,	1999).	Similarly,	
embryos	 that	 lack	NODAL	 activity	 arrest	 before	 the	 onset	 of	 gastrulation	 and	 fail	 to	 form	 a	
primitive	streak	and	A-P	axis	 (Conlon	et	al.,	1994;	Robertson	et	al.,	2003;	Zhou	et	al.,	1993),	
whilst	BMP4	null	embryos	fail	to	gastrulate	due	to	a	loss	of	primordial	germ	cells	and	mesoderm	
(Lawson	et	al.,	1999;	Winnier	et	al.,	1995).	Loss	of	the	NODAL	effector	Foxa2	results	in	embryos	
that	 lack	 a	 functional	 APS,	 resulting	 in	 somite	 fusion,	 and	 absent	 AME	 and	 severe	 anterior	
truncation	(Ang	and	Rossant,	1994;	Weinstein	et	al.,	1994).		
The	cells	of	the	APS	can	be	considered	to	form	either	the	early	gastrula	organiser	(EGO;	6.5	dpc)	
or	 the	 mid-gastrula	 organizer	 (MGO;	 6.75	 dpc),	 before	 the	 morphologically	 distinct	 node	
emerges.	Briefly,	the	EGO	consists	of	a	group	of	40	cells	capable	of	inducing	a	secondary	axis	like	
that	developed	by	the	node,	though	murine	fate	mapping	studies	showed	that	the	EGO	on	its	
own	 is	not	sufficient	 for	anterior	axial	mesoderm	generation	 (Robb	and	Tam,	2004;	Tam	and	
Steiner,	1999;	Tam	et	al.,	1997).	The	EGO	expresses	multiple	organiser	related	genes	such	as	
Chrd	to	inhibit	BMP	signalling	in	the	anterior	notochord,	Gsc	to	promote	PrCP	development,	and	
Nodal	and	its	downstream	effector	Foxa2	to	promote	a	high	NODAL	environment	(Ang	et	al.,	
1993;	Filosa	et	al.,	1997;	Klingensmith	et	al.,	1999;	Zhou	et	al.,	1993).	EGO	cells	are	incorporated	
into	the	PS	and	reallocated	anteriorly,	resulting	in	the	formation	of	the	MGO.	The	MGO	contains	
precursors	 for	 the	whole	 anterior	 axial	mesoderm	 and	much,	 but	 not	 all,	 of	 the	 notochord	
(Kinder	et	al.,	2001),	and	expresses	many	similar	transcription	factors	and	signalling	components	
to	 the	EGO.	Unlike	 the	EGO,	however,	Nog	 is	also	expressed	 to	 inhibit	BMP	signalling	 in	 the	
anterior	notochord,	and	T	is	expressed	to	promote	WNT	signalling	in	the	notochord	(Bachiller	et	
al.,	2000;	Belo	et	al.,	1998,	1997;	Kinder	et	al.,	2001;	Pfister	et	al.,	2007).	Additionally,	signalling	
molecules	 such	 as	 BMP7,	 NODAL,	 WNT3a,	 WNT5a	 and	 WNT8	 are	 expressed	 in	 the	 MGO	
(reviewed	in	Robb	&	Tam	2004).		
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Figure	5.2:	BMP,	NODAL	and	WNT	morphogen	gradient	activity	overlaps	 in	 the	developing	
embryos.	When	the	morphogen	gradients	of	NODAL	(red),	WNT	(blue)	and	BMP	(yellow)	are	
overlayed	 in	 a	 late-streak	 stage	 embryo,	 they	 create	 pockets	 of	 high	 and	 low	 signalling	
environments.	For	example,	(1)	the	node	of	a	late-streak	embryo	exhibits	medium-high	NODAL	
signalling	with	low	BMP	and	WNT	signalling,	whilst	(2)	the	APS	exhibits	high	NODAL	signalling	
and	medium-low	levels	of	BMP	and	WNT	signalling.		
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Finally,	 the	 node	 begins	 to	 form	 from	 the	 APS	 at	 the	mid-streak	 stage	 (6.75	 dpc)	 (Lee	 and	
Anderson,	2008;	Yamanaka	et	al.,	2007)	as	described	in	Chapter	3.	The	node	maintains	medium-
high	 levels	of	NODAL	signalling	and	promotes	expression	of	downstream	NODAL	targets	(Gsc	
and	Foxa2),	along	with	low	levels	of	both	WNT	and	BMP	activity	(Figure	5.1-5.2)	owing	to	the	
expression	of	their	respective	antagonists	such	as	Lhx1,	Nog	and	Chrd	(Beddington	1994;	Ang	
and	Rossant	1994;	reviewed	in	Davidson	and	Tam	2000;	Brennan	et	al.	2002;	Yamanaka	et	al.	
2007).	 Despite	 this,	 WNT11	 and	 BMP7	 are	 active	 in	 the	 mid-gastrula	 node	 (Arkell	 and	
Beddington,	1997;	Madabhushi	and	Lacy,	2011;	Robb	and	Tam,	2004;	Sinha	et	al.,	2015).	The	
expression	 of	WNT11	 in	 this	 tissue	 thought	 to	 be	 due	 to	 a	 role	 in	 regulating	 the	migration	
direction	of	cells	from	the	APS	through	the	node,	as	Wnt5-/-;	Wnt11-/-	mutants	exhibit	reduced	
migration	of	PS	stem	cell	descendants	(Andre	et	al.,	2015;	Cambray	and	Wilson,	2007).	As	the	
late-streak	node	 is	 the	presumed	site	of	ZIC2	 requirement	and	 its	expression	 in	 this	 tissue	 is	
critical	for	the	prevention	of	HPE,	the	medium-high	NODAL	environment,	along	with	low	WNT	
and	BMP,	will	affect	the	types	of	TFs	that	are	available	to	bind	or	interact	with	the	ZIC2	NCE.	As	
such,	any	 investigations	 into	ability	of	 the	ZIC2	NCE	 to	drive	gene	expression	must	 take	 into	
consideration	the	environment	that	its	activity	is	being	assayed	in.	
5.1.2 Model	systems	for	studying	developmental	genes	during	gastrulation		
The	 best	 approach	 to	 evaluate	 the	 pathogenicity	 of	 the	 ZIC2	 NCE	 variants	 is	 via	 direct	
manipulation	 of	 the	 mouse	 genome.	 This	 would	 assess	 causality,	 and	 enable	 assay	 of	 the	
direction	of	change	(if	any)	in	Zic2	gene	expression,	but	does	not	establish	the	mechanism	by	
which	the	variants	disrupt	expression.	Mechanistic	studies	would	be	assisted	by	the	production	
of	 a	 cell-based	 model	 of	 NCE	 activity.	 Broadly	 speaking,	 two	 classes	 of	 cell	 lines	 could	 be	
considered	for	the	production	of	such	a	model:	primary	cells	lines	derived	from	a	relevant	tissue	
(in	this	case,	embryonic	stem	(ES)	cells,	epi-stem	cells	(EpiSC),	or	node	derived	primary	cells),	or	
transformed	cell	lines.		
Cells	 that	are	 taken	 from	the	 inner	cell	mass	of	 the	mouse	blastocyst	 (3.5	dpc)	and	cultured	
under	appropriate	conditions	form	undifferentiated	ES	cells	(Evans	and	Kaufman,	1981;	Martin,	
1981).	As	 these	cells	 retain	 the	capacity	 to	 repopulate	 the	embryo	and	also	contribute	 to	all	
tissue	of	the	adult,	including	the	germline,	they	are	considered	naïve,	pluripotent	cells.	(Bradley	
et	al.,	1984;	Nichols	and	Smith,	2009).	In	contrast,	EpiSC	are	pluripotent	cells	that	will	give	rise	
to	all	the	embryonic	germ	layers	(Brons	et	al.,	2007;	Tesar	et	al.,	2007),	but	unlike	ES	cells	they	
exhibit	X-inactivation	and	cannot	contribute	to	blastocyst	chimeras	(Guo	et	al.,	2009;	Tesar	et	
al.,	2007).	ES	and	EpiSCs	share	multiple	benefits,	in	that	they	are	self-renewing	and	can	thus	be	
continuously	propagated,	 can	differentiate	 into	most	embryonic	 cell	 types	under	 the	correct	
conditions,	 and	 exhibit	 relatively	 good	 transfection	 rates	 (~85%)	 (Nichols	 and	 Smith,	 2009;	
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Tamm	et	al.,	2016;	Tesar	et	al.,	2007).	Issues	arise,	however,	when	attempting	to	use	either	cell	
type	 to	model	 specific	embryonic	 structures	 such	as	 the	node.	Differentiation	of	ES	or	EpiSC	
requires	 the	 coordination	 of	 multiple	 factors	 simultaneously	 to	 induce	 a	 target	 cell	 type.	
Previously,	Winzi	et	al	reported	the	generation	of	node/notochord	like	cells	derived	from	murine	
ES	cells,	based	on	the	expression	of	Noto.	The	creation	of	these	cells	first	required	induction	of	
Foxa2	and	Brachyury-expressing	progenitor	cells	via	a	low	Activin	A	concentration,	along	with	
simultaneous	inhibition	of	BMP,	WNT	and	retinoic	acid	signalling	in	the	presence	of	FGF2.	The	
resulting	 cells,	 however,	 exhibited	 markers	 and	 morphology	 of	 both	 node	 and	 notochord	
populations.	 Additionally,	 this	 protocol	 required	 five	 days	 of	 differentiation	 before	 the	
node/notochord-like	cells	could	be	detected,	with	only	10%	of	the	cell	population	reflecting	the	
node/notochord	state	at	day	five	(Winzi	et	al.,	2011).	As	such,	it	would	be	difficult	to	discern	the	
mechanism	of	ZIC2	NCE	activity	in	the	node	via	this	method.		
An	alternative	to	ES	and	EpiSC	is	to	use	node-derived	primary	cells	to	analyse	the	activity	of	the	
ZIC2	NCE.	Primary	cells	espouse	multiple	benefits	including	their	derivation	directly	from	a	tissue	
or	organ,	 therefore	 they	are	 the	closest	 cell	 type	 to	an	 in	 vivo	model	available.	Additionally,	
primary	cell	lines	have	a	relatively	low	mutation	rate,	therefore	false	interactions	with	the	genes	
being	 investigated	 are	 unlikely	 to	 occur.	Unfortunately,	 primary	 cell	 lines	 exhibit	 a	 finite	 life	
span,	grow	relatively	slow,	suffer	changes	with	each	passage	and	require	supplemented	media	
that	is	customised	for	their	tissue	type	(Pan	et	al.,	2009).	There	is	currently	no	available	primary	
cell	line	derived	from	the	mouse	node.	
Transformed	 cell	 lines,	 such	 as	 the	 human	 embryonic	 kidney	 (HEK293T)	 line,	 are	 a	 viable	
alternative	and	have	several	advantages.	They	are	easily	transfectable,	which	enables	the	rapid	
analysis	 of	multiple	 conditions.	 It	 is	 often	 argued	 that	 transformed	 cell	 lines	 do	 not	 contain	
relevant	 tissue-specific	proteins/processes	and	 therefore	provide	 little	value	 for	 the	 study	of	
tissue-specific	mechanism.	On	the	other	hand,	these	cells	can	be	considered	‘test-tubes	with	a	
membrane’	 and	 ideal	 for	 assembling	 various	 mixtures	 of	 tissue-specific	 components	 via	
exogenous	expression	and/or	culture	in	supplemented	media.	
The	experiments	in	this	chapter	were	conducted	using	the	transformed	cell	line	HEK293T	which	
was	originally	derived	from	the	kidneys	of	aborted	human	embryos	with	sheared	adenovirus	
Ad(5)	 DNA,	 but	 is	 thought	 to	 potentially	 be	 derived	 from	neural	 or	 adrenal	 cells	within	 this	
population	(Lin	et	al.,	2014;	Shaw	et	al.,	2002).	The	cells	were	subsequently	modified	to	express	
the	 SV40	 Large	 T-antigen	 (DuBridge	 et	 al.,	 1987),	 which	 interacts	 with	 the	 SV40	 origin	 of	
replication	 present	 on	 the	 expression	 constructs	 used	 in	 this	 project	 to	 drive	 episomal	
replication	 to	 thousands	 of	 copy	 numbers	 per	 cell.	 As	 such,	 the	 effect	 of	 differences	 in	
transfection	conditions	(for	example	amount	of	DNA	or	efficiency)	on	overall	expression	levels	
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are	minimised	whilst	protein	expression	and	luciferase	reporter	activity	are	enhanced	(Mahon,	
2011).	HEK293T	cells	express	endogenous	ZIC2	and	thus	contain	the	fundamental	transcriptional	
machinery	for	this	gene	(Hruz	et	al.,	2011).	The	cells	however,	do	not	express	ZIC2	protein	at	
high	level	(as	judged	by	the	inability	of	ZIC2	Antibodies	to	detect	the	protein	in	non-transformed	
cells).	The	Arkell	laboratory	routinely	uses	this	cell	line	to	conduct	mechanistic	studies	(Ahmed	
et	al.,	2013;	Brown	et	al.,	2005;	Pourebrahim	et	al.,	2011)	and	therefore	protocols	for	the	robust	
and	reliable	transient	transfection	of	ZIC	constructs	already	exist,	as	does	knowledge	regarding	
ways	to	switch	on	and	off	particular	signalling	pathways	in	this	cell	line.	The	HEK293T	cell	line	
was	therefore	selected	for	use	in	the	below	ZIC2	NCE	investigation.	
5.1.3 Chapter	5	aims		
As	the	ZIC2	3’UTR	 is	predicted	to	contain	an	active	ER	element	 (termed	the	NCE)	 that	drives	
expression	of	a	target	gene	-	most	likely	ZIC2	-	the	aims	of	this	chapter	were:		
• To	determine	the	default	activity	of	the	ZIC2	NCE	(enhancer	or	repressor)	
• To	determine	if	the	NCE	is	signal	responsive,	and	if	the	six	HPE-associated	SNVs	alter	this	
response		
• To	determine	whether	any	candidate	TFs	interact	with	the	ZIC2	NCE,	and	establish	what	
effect,	if	any,	the	six	HPE-associated	SNVs	have	on	this	interaction.	
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5.2 Results		
5.2.1 The	ZIC2	NCE	acts	as	a	repressor	in	basal	culture	conditions		
To	determine	if	the	ZIC2	NCE	can	drive	reporter	expression	and	thus	act	as	an	active	ER	element,	
heterologous	reporter	assays	in	HEK293T	cells	were	employed.	As	NCEs	are	known	to	interact	
with	promoters	to	enhance	or	repress	transcription	of	their	targets,	a	range	of	promoters	were	
first	tested	with	the	ZIC2	3’UTR	to	determine	which	produced	the	highest	 levels	of	 luciferase	
reporter	transcription	and	greatest	relative	effect	size.	The	human	b-globin	minimal	promoter,	
amplified	 from	 plasmid	 pKS:β-globin:lacZ	 (Yee	 and	 Rigby	 1993;	 Ahmed	 et.	 al.,	 2017,	 under	
review)	and	a	Hsp68	promoter	(Hamada	laboratory;	Adachi	et	al.	1999)	were	chosen	based	on	
their	proven	ability	 to	 interact	with	NCEs	and	drive	 reporter	expression	 in	 transgenic	mouse	
models	(Shiratori	et	al.,	2006).	An	untested	putative	human	ZIC3	promoter	(Muenke	laboratory,	
NHGRI,	 NIH)	 was	 chosen	 based	 on	 the	 knowledge	 that	 ZIC3	 and	 ZIC2	 share	 high	 levels	 of	
sequence	conformation	and	regions	of	co-expression,	therefore	the	ZIC2	NCE	would	most	likely	
be	able	to	recognise	and	activate	the	ZIC3	promoter.	The	wildtype	ZIC2	NCE	(pCRW-8-TOPO-
NCE-WT)	was	 cloned	 into	 a	 promoterless	 pGL4.20-DEST	 construct	 directly,	 or	 pGL4.20-DEST	
constructs	that	contained	either	the	b-globin	minimal	promoter	(pb),	Hsp68	promoter	(pHsp68)	
or	putative	ZIC3	promoter	(pZ3)	promoter	via	a	Gateway	LR	reaction	(Appendix	Figure	A3.3).	
Upon	transfection	of	HEK293T	cells	with	the	resulting	pGL4.20-NCE	constructs	(Appendix	Figure	
A3.4),	a	luciferase	assay	was	performed	to	detect	reporter	expression	driven	by	the	ZIC2	NCE.	
The	presence	of	 the	wildtype	ZIC2	NCE	significantly	 reduced	 the	 levels	of	 luciferase	 reporter	
transcription	(Figure	5.3	A	and	B)	compared	to	the	empty	vector,	irrespective	of	the	promoter	
used,	 indicating	 the	 NCE’s	 primary	 role	 in	 basal	 culture	 conditions	 is	 as	 a	 transcriptional	
repressor.	Constructs	containing	pZ3	produced	the	highest	levels	of	luminescence	and	largest	
fold	difference	between	the	empty	vector	and	the	WT	ZIC2	NCE	compared	to	all	other	constructs	
tested.	As	pZ3	is	 likely	the	closest	of	the	tested	promoters	to	the	endogenous	ZIC2	promoter	
and	its	inclusion	in	the	constructs	elicited	the	largest	response,	pGl-pZ3-DEST	constructs	were	
used	for	the	remaining	luciferase	experiments	in	this	chapter.	
5.2.2 HPE-associated	SNVs	alter	NCE	transcription	control	
To	determine	whether	the	presence	of	each	of	the	six	HPE-associated	SNVs	affect	NCE	activity,	
each	SNV	was	introduced	into	the	NCE	constructs	with	pZ3	and	the	luciferase	assay	in	HEK293T	
cells	repeated.	The	fold	difference	of	each	NCE	construct	relative	to	the	empty	pGl-pZ3-DEST	is	
shown	 in	 Figure	 5.3	 C.	 Each	HPE-associated	 SNV	 produced	 a	 significant	 increase	 in	 reporter	
activity	 compared	 to	 the	 wildtype	 NCE.	 For	 example,	 the	 M5	 variant	 NCE	 produced	
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Figure	5.3:	The	ability	of	the	WT	ZIC2	NCE	to	repress	reporter	activity	is	altered	by	the	HPE-
associated	 SNVs	 in	 basal	 culture	 conditions.	 (a-b)	HEK293T	 cells	were	 transfected	with	 the	
reporter	constructs	pGL-DEST	(No	Prom),	pGl-b-globin-DEST	(pb),	pGl-Hsp68-DEST	(pHsp68)	and	
pGl-pZIC3-DEST	 (pZ3),	with	 and	without	 the	WT	ZIC2	 NCE.	 Comparisons	 of	 (a)	 luminescence	
levels	and	(b)	fold	values	relative	to	the	empty	vector	are	shown.	*:	p<0.05,	Student’s	T-Test.	(c)	
HEK293T	cells	were	transfected	with	the	empty	reporter	construct	pGl-pZic3-DEST	(p-luc),	pGl-
pZIC3-WT	ZIC2	NCE	(WT),	and	the	mutated	constructs	pGl-pZic3-M1	ZIC2	NCE	to	pGl-pZIC3-M6	
ZIC2	NCE	(M1-M6).	Reporter	activity	was	measured	as	luminescence	and	fold	values	calculated	
relative	 to	 p-luc.	 Letters	 denote	 statistical	 significance	 of	 p<0.05	 calculated	 via	 a	 two-way	
ANOVA	with	Fischer’s	unprotected	post	ad	hoc	test,	where	a	is	statistically	significant	to	b	and	
so	on.	Error	bars	=	S.E.M	of	three	external	repeats.	
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relative	 values	 indistinguishable	 from	 background	 levels	 while	 the	 M2-4	 NCEs	 all	 induced	
relative	values	significantly	higher	than	background.	In	contrast,	the	M6	variant	NCE	retains	its	
repressor	function,	although	to	a	 lesser	degree	than	the	wildtype	NCE.	These	results	 indicate	
that	each	of	the	HPE-associated	SNVs	decreases	the	repressive	effect	of	the	NCE	in	basal	culture	
conditions	and,	in	the	case	of	M1-4,	converts	the	NCE	to	a	weak	enhancer	in	HEK293T	cells.	
5.2.3 The	ZIC2	NCE	is	signal	responsive	
To	determine	if	the	signalling	environment	of	the	cell	determines	NCE	activity,	HEK293T	cells	
cultured	in	basal	conditions	were	transfected	with	three	reporter	constructs:	TOPFLASH	(Helen	
Bellchambers,	Arkell	lab,	unpublished),	[CAGA]12	and	BRE,	(Kumar	et	al.	2001;	Morikawa	et	al.	
2011;	Korchynskyi	&	Ten	Dijke	2002).	Each	reporter	acts	as	a	sensor	for	the	level	of	the	WNT,	
NODAL	 and	 BMP	 pathways,	 respectively.	 In	 unstimulated	 HEK293T	 cells,	 background	
luminescence	levels	of	the	BMP	BRE	reporter	were	considerably	higher	than	the	NODAL	reporter	
(CAGA)12	 or	 the	 WNT	 reporter	 TOPFLASH,	 indicating	 that	 NODAL	 and	 WNT	 signalling	 are	
endogenously	low	in	HEK293T	cells,	whilst	BMP	signalling	is	endogenously	high	(Figure	5.4	A	and	
B,	lanes	with	no	ALK4	and	NOGGIN	added).	Furthermore,	transfection	of	HEK293T	cells	with	the	
BMP	 receptors	 ALK2	 and	 ALK6	 failed	 to	 increase	 BMP	 signalling,	 again	 indicating	 that	 BMP	
signalling	is	endogenously	high	in	HEK293T	cells	(Appendix	Figure	A3.6).	
The	level	of	activity	of	the	pathways	of	interest	can	be	modulated	in	various	ways.	For	example,	
ALK4-HA	transfection	(to	stimulate	NODAL)	(Figure	5.4),	LiCl	(to	stimulate	WNT	[Pourebrahim	et	
al.	2011]),	V5-NOGGIN	(to	inhibit	BMP,	[Yuasa	et	al.	2005;	Zimmerman	et	al.	1996])	(Appendix	
Figure	A3.5),	 or	 a	 combination	of	ALK4-HA	and	V5-NOGGIN	 (to	 stimulate	NODAL	and	 inhibit	
BMP;	Figure	5.4).	Only	the	addition	of	ALK4-HA	and	a	combination	of	ALK4-HA/V5-NOGGIN	will	
be	addressed	in	this	chapter,	as	these	signalling	environments	are	most	likely	to	be	relevant	to	
the	region	of	the	murine	gastrula	where	the	node	develops.	Transfection	of	the	NODAL	receptor	
ALK4	results	in	an	increase	of	NODAL	signalling	as	predicted,	as	well	as	a	significant	decrease	in	
BMP	and	WNT	signalling	(Fig.	5.4,	Table	5.2).	WNT	signalling	was	already	low	(based	on	small	
luminescence	levels)	and	thus	remained	low	with	the	overexpression	of	ALK4.	BMP	signalling,	
however,	was	deemed	to	be	high	 in	 the	absence	of	NODAL	stimulation,	 thus	 the	addition	of	
ALK4	 resulted	 in	 a	 reduction	 of	 BMP	 signalling	 by	 approximately	 half.	 The	 addition	 of	 ALK4	
therefore	 results	 in	 the	 environment	 changing	 from	 a	 low	NODAL,	 high	 BMP	 and	 low	WNT	
environment	to	a	high	NODAL,	medium	BMP	and	low	WNT	environment	(designated	the	‘red’	
environment).	 In	 contrast,	 the	 addition	 of	 the	 BMP	 inhibitor	 NOGGIN	 (which	
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Figure	5.4:	The	signalling	environment	of	HEK293T	cells	can	be	altered.	HEK293T	cells	were	
transfected	with	the	NODAL	reporter	(CAGA)12,	BMP	reporter	BRE	or	WNT	reporter	TOPFLASH,	
as	well	as	ALK4-HA	to	stimulate	NODAL	signalling	and	V5-NOGGIN	to	inhibit	BMP	signalling,	or	
an	empty	control	vector	(V5-DEST).	Reporter	activity	was	measured	as	 luminescence.	(a)	The	
addition	of	ALK4-HA	stimulates	NODAL	signalling	in	HEK293T	cells,	but	decreases	BMP	and	WNT	
signalling	to	create	a	high	NODAL,	medium	BMP	and	low	WNT	environment.	(b)	The	combined	
addition	 of	 ALK4-HA	 and	V5-NOGGIN	 inhibits	 BMP	 and	WNT	 signalling	 in	HEK293T	 cells	 and	
stimulates	NODAL	signalling	to	create	a	high	NODAL,	low	BMP	and	low	WNT	environment.	Error	
bars	=	S.E.M	of	three	external	repeats;	**:	p<0.01,	Student’s	T-Test.	(c-d)	Representative	NODAL	
and	 BMP	 signalling	 experiments	 and	 western	 blots.	 In	 each	 case,	 a	 single	 representative	
experiment	is	shown,	with	error	bars	=	S.D.,	N=3	internal	repeats.	Western	blots	correspond	to	
the	transfections	shown.	a-GAPDH	blots	are	included	as	loading	controls.		 	
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Table	5.1:	Changes	in	HEK293T	signalling	activity	via	addition	of	ALK4-HA	or	a	combination	of	
ALK4-HA	and	V5-NOGGIN.	Direction	of	increase/decrease	is	determined	by	directional	changes	
in	luminescence	and	relative	luciferase	activity	direction	shown	in	Figure	5.5,	whilst	quantitative	
amounts	 (small,	 medium	 and	 large)	 were	 determined	 by	 the	 comparative	 amounts	 of	
luminescence	and	relative	luciferase	activity	for	each	pathway.	
	
Signalling	 NODAL	 BMP	 WNT	
Unstimulated	cells	 Low	 High	 Low	
‘Red’	environment	
High	 Medium	 Low	
Large	increase	 Medium	Decrease	 Small	Decrease	
‘Yellow’	
environment	
High	 Low	 Low	
Large	increase	 Large	decrease	 Small	Decrease	
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reduces	BMP	signalling	 in	HEK293T	cells	 [Appendix	Figure	A3.5])	 in	conjunction	with	ALK4	to	
induce	high	NODAL	signalling	results	in	the	environment	changing	from	a	low	NODAL,	high	BMP	
and	low	WNT	environment	to	a	high	NODAL,	low	BMP	and	low	WNT	environment	(designated	
the	‘yellow’	environment;	Figure	5.4,	Table	5.2).		
When	the	ZIC2	NCE	reporter	constructs	are	transfected	to	either	signalling	environment	(red	or	
yellow),	and	the	results	normalised	to	account	for	the	effect	of	the	signalling	environment	on	
the	 construct’s	 promoter	 activity	 (Appendix	 Figure	 A3.7),	 a	 change	 in	 luciferase	 activity	 is	
observed.	In	the	‘red’	signalling	environment,	the	wildtype	NCE	shows	further	repression	(Figure	
5.8-5.9,	Table	5.3).	 In	contrast,	 repression	 is	alleviated	 in	 the	 ‘yellow’	 signalling	environment	
(p<0.05).	Together,	this	indicates	that	the	NCE	is	a	signal	responsive	repressor.	
5.2.4 Mutation	alters	the	NCEs	response	to	the	signalling	environment	
The	effect	of	the	six	HPE-associated	SNVs	is	altered	by	changes	in	signalling	environment.	For	
example,	in	a	‘red’	signalling	environment	(high	NODAL,	medium	BMP,	low	WNT),	the	M1,	M3	
and	M5	NCEs	 act	 as	 repressors,	 similar	 to	 the	wildtype	 NCE	 (Figure	 5.5	 A,	 Figure	 5.6	 A).	 In	
contrast,	the	M2,	M4	and	M6	NCEs	show	no	further	repression,	suggesting	that	the	mutations	
disrupt	 the	 interactions	 of	 the	 NCE	with	 a	 repressosome/enhanceosome	 responsive	 to	 high	
NODAL	and	medium	BMP	signalling.	 In	contrast,	a	 larger	change	in	variant	NCE	activity	when	
compared	to	the	wildtype	NCE	can	be	seen	in	the	‘yellow’	signalling	environment	(high	NODAL,	
low	BMP,	low	WNT).	Only	the	M5	and	M6	NCEs	alleviate	repression	in	the	same	manner	as	the	
wildtype	 NCE	 under	 these	 signalling	 conditions,	 with	 the	 M1-M4	 NCEs	 showing	 no	 such	
alleviation	(Figure	5.5	B,	Figure	5.6	B).	This	implies	that	a	single	SNV	can	alter	NCE	activity	in	a	
tissue-dependant	manner	in	the	embryo,	depending	on	which	signalling	pathways	are	active	in	
the	tissue.		
It	should	be	noted	that	whilst	the	changes	detected	in	this	assay	are	statistically	different,	they	
also	 represent	 only	 a	 small	 effect	 size.	 This	 may	 be	 due	 to	 the	 use	 of	 a	 non-endogenous	
promoter,	or	the	limited	expression	or	absence	of	endogenous	TFs	in	HEK293T	cells	that	would	
normally	interact	with	the	NCE	in	embryonic	tissues.	Therefore,	candidate	TFs	that	are	predicted	
to	 bind	 the	 ZIC2	 NCE	 should	 be	 added	 to	 the	 assay	 and	 analysed	 to	 determine	 whether	 a	
stronger	effect	can	be	elicited.	
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Figure	5.5:	The	wildtype	and	mutated	ZIC2	NCE	activity	is	signalling	dependant.	HEK293T	cells	
were	transfected	with	the	empty	reporter	construct	pGl-pZic3-DEST	(p-luc),	pGl-pZic3-WT	ZIC2	
NCE	 (WT	NCE-luc),	and	 the	mutated	constructs	pGl-pZic3-M1	ZIC2	NCE	 to	pGl-pZic3-M6	ZIC2	
NCE	(M1-M6	NCE-luc),	as	well	as	(a)	ALK4-HA	to	create	a	high	NODAL,	medium	BMP	and	low	
WNT	environment,	(b)	ALK4-HA	and	V5-NOGGIN	to	create	a	high	NODAL,	low	BMP	and	low	WNT	
environment,	 or	 an	 empty	 control	 vector	 (V5-DEST).	 Reporter	 activity	 was	 measured	 as	
luminescence.	Fold	values	were	calculated	relative	to	p-luc	and	converted	to	the	relative	percent	
(%)	 change	 in	activity	 compared	 to	p-luc,	whereby	a	 value	of	0-60	 represents	an	 increase	 in	
activity	compared	to	background	and	-100-0	represents	repression	of	activity.	The	activity	of	the	
(c)	WT	NCE	and	(d)	six	HPE-associated	SNVs	is	summarised.	‘Y’	indicates	that	the	mutated	NCE	
responds	to	the	addition	of	a	TF	in	a	similar	manner	to	the	wildtype	NCE,	whilst	a	‘N’	indicates	
that	 the	mutation	 responds	 differently.	Error	 bars	 =	 S.E.M	of	 three	 external	 repeats;	 letters	
denote	 statistical	 significance	 of	 p<0.05	 calculated	 via	 a	 two-way	 ANOVA	 with	 Fischer’s	
unprotected	post	ad	hoc	test,	where	a	is	statistically	significant	to	b	and	so	on.	
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Figure	5.6:	Representative	experiment	and	western	blot	 for	 the	wildtype	and	mutant	ZIC2	
NCEs	 in	 different	 signalling	 environments.	HEK293T	 cells	 were	 transfected	 with	 the	 empty	
reporter	 construct	 pGl-pZic3-DEST	 (p-luc),	 pGl-pZic3-WT	 ZIC2	 NCE	 (WT	 NCE-luc),	 and	 the	
mutated	 constructs	 pGl-pZic3-M1	 ZIC2	 NCE	 to	 pGl-pZic3-M6	 ZIC2	 NCE	 (M1-M6	 NCE-luc),	 in	
addition	to	either	ALK4-HA	to	stimulate	NODAL	signalling,	V5-NOGGIN	to	inhibit	BMP	signalling,	
or	an	empty	control	vector	(V5-DEST).	Reporter	activity	was	measured	as	luminescence.	In	each	
case,	a	single	representative	experiment	is	shown,	with	error	bars	=	S.D.,	N=3	internal	repeats.	
Western	 blots	 correspond	 to	 the	 transfections	 shown.	 a-GAPDH	 blots	 are	 included	 as	
cytoplasmic	loading	controls.	The	western	blot	was	conducted	across	multiple	gels	due	to	the	
large	number	of	experimental	samples.		 	
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5.2.5 Mutation	alters	the	NCE’s	response	to	the	overexpression	of	transcription	factors	
The	activity	of	the	WT	and	mutant	ZIC2	NCEs	in	the	presence	of	overexpressed	ZIC2,	FOXA2	and	
FOXJ1	were	assayed	and	the	results	normalised	to	remove	any	effect	the	added	TFs	had	on	the	
construct’s	 promoter	 activity	 (Appendix	 Figure	 A3.8).	 In	 the	 ‘yellow’	 signalling	 environment,	
overexpression	of	the	TF	ZIC2	(a	candidate	to	interact	with	the	ZIC2	NCE)	augments	the	repressor	
activity	of	the	WT	NCE	(Figure	5.7	A	and	D,	Figure	5.8),	suggesting	that	ZIC2	can	interact	with	the	
NCE	(either	directly	or	indirectly)	when	in	the	presence	of	high	NODAL	signalling,	but	low	BMP	
and	WNT	signalling.	In	the	‘red’	signalling	environment,	however,	overexpression	of	ZIC2	elicits	
no	response	from	the	WT	NCE	(Figure	5.9	A,	Figure	5.10),	indicating	that	its	interaction	with	the	
NCE	is	signal	dependant.	Overexpression	of	FOXA2	induces	a	similar	response	from	the	WT	NCE	
in	both	signalling	environments	(Figure	5.7	B	and	D).	
Similarly,	 the	 introduction	 of	 each	 HPE-associated	 SNV	 alters	 the	 NCE’s	 response	 to	
overexpression	 of	 TFs.	 The	 ability	 of	 ZIC2	 to	 induce	 further	 NCE	 repression	 in	 the	 ‘yellow’	
signalling	environments	is	retained	with	the	introduction	of	the	M1	and	M6	variants,	but	lost	
with	the	introduction	of	M2-M5	variants	(Figure	5.7	A	and	E).	This	suggests	that	M2-M5	interfere	
with	ZIC2	directly	binding	to	the	NCE,	or	a	protein	complex	containing	(or	downstream	of)	ZIC2	
in	these	signalling	conditions.	The	WT	NCE	 is	unresponsive	to	FOXJ1	overexpression	 in	either	
signalling	environment	tested,	however	some	NCE	variants	(except	M2-M4	in	either	signalling	
environment)	 are	 capable	 of	 responding	 to	 FOXJ1	 (Figure	 5.7	 C	 and	 E,	 Figure	 5.8	 C	 and	 E),	
suggesting	the	introduction	of	the	mutations	creates	new	FOXJ1	binding	sites	or	binding	sites	
for	 FOXJ1	 co-factors.	 Moreover,	 the	 response	 from	 each	 variant	 NCE	 is	 dependent	 on	 the	
specific	TF	being	overexpressed.	M1,	for	example,	responds	to	ZIC2	overexpression	the	same	
manner	as	the	wildtype	NCE,	regardless	of	the	signalling	environment	it	is	assayed	in,	but	elicits	
a	response	different	to	the	wildtype	NCE	when	FOXA2	or	FOXJ1	are	overexpressed.	Together,	
these	results	indicate	that	the	effect	of	the	six	HPE-associated	SNVs	on	NCE	activity	is	not	only	
signal	dependant,	but	TF	dependant	as	well.		 	
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Figure	5.7:	The	addition	of	candidate	TFs	alters	the	response	of	the	wildtype	and	mutant	ZIC2	
NCE	 in	 a	 high	 NODAL,	 low	 BMP	 and	 WNT	 signalling	 environment.	 HEK293T	 cells	 were	
transfected	with	the	empty	reporter	construct	pGl-pZic3-DEST	(p-luc),	pGl-pZic3-WT	ZIC2	NCE	
(WT	NCE-luc),	and	 the	mutated	constructs	pGl-pZic3-M1	ZIC2	NCE	 to	pGl-pZic3-M6	ZIC2	NCE	
(M1-M6	NCE-luc),	as	well	as	ALK4-HA	to	stimulate	NODAL	signalling	and	V5-NOGGIN	to	inhibit	
BMP	signalling.	(a)	V5-ZIC2,	(b)	V5-FOXA2,	(c)	V5-FOXJ1	or	an	empty	control	vector	(V5-DEST)	
were	 also	 transfected.	 Reporter	 activity	 was	 measured	 as	 luminescence.	 Fold	 values	 were	
calculated	relative	to	p-luc	and	converted	to	the	relative	percent	(%)	change	in	activity	compared	
to	p-luc,	whereby	a	value	of	0-60	represent	an	increase	in	activity	compared	to	background	and	
-100-0	represents	repression	of	activity.	The	activity	of	the	(d)	WT	NCE	and	(e)	six	HPE-associated	
SNVs	is	summarised.	‘Y’	 indicates	that	the	mutated	NCE	responds	to	the	addition	of	a	TF	in	a	
similar	manner	to	the	wildtype	NCE,	whilst	a	‘N’	indicates	that	the	mutation	responds	differently.	
Error	 bars	 =	 S.E.M	of	 three	 external	 repeats;	 letters	 denote	 statistical	 significance	of	p<0.05	
calculated	 via	 a	 two-way	 ANOVA	 with	 Fischer’s	 unprotected	 post	 ad	 hoc	 test,	 where	 a	 is	
statistically	significant	to	b	and	so	on.		
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Figure	 5.8:	 Representative	 experiment	 and	 western	 blots	 for	 the	 addition	 of	 TFs	 to	 the	
wildtype	and	mutant	ZIC2	NCE	in	a	high	NODAL,	low	BMP	and	WNT	signalling	environment.	
HEK293T	cells	were	transfected	with	the	empty	reporter	construct	pGl-pZic3-DEST	(p-luc),	pGl-
pZic3-WT	ZIC2	NCE	(WT	NCE-luc),	and	the	mutated	constructs	pGl-pZic3-M1	ZIC2	NCE	to	pGl-
pZic3-M6	ZIC2	NCE	(M1-M6	NCE-luc),	in	addition	to	ALK4-HA	to	stimulate	NODAL	signalling	and	
V5-NOGGIN	 to	 inhibit	 BMP	 signalling,	 and	 (A)	 V5-ZIC2,	 (B)	 V5-FOXA2	or	 (C)	 V5-FOXJ1,	 or	 an	
empty	control	vector	(V5-DEST).	Reporter	activity	was	measured	as	luminescence.	In	each	case,	
a	 single	 representative	 experiment	 is	 shown,	 with	 error	 bars	 =	 S.D.,	 N=3	 internal	 repeats.	
Western	 blots	 correspond	 to	 the	 transfections	 shown.	 a-GAPDH	 (cytoplasmic)	 and	 a-TBP	
(nuclear)	 blots	 are	 included	 as	 loading	 controls.	 The	 western	 blots	 were	 conducted	 across	
multiple	gels	due	to	the	large	number	of	experimental	samples.		
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Figure	5.9:	The	addition	of	candidate	TFs	alters	the	response	of	the	wildtype	and	mutant	ZIC2	
NCE	in	a	high	NODAL,	medium	BMP	and	low	WNT	signalling	environment.	HEK293T	cells	were	
transfected	with	the	empty	reporter	construct	pGl-pZic3-DEST	(p-luc),	pGl-pZic3-WT	ZIC2	NCE	
(WT	NCE-luc),	and	 the	mutated	constructs	pGl-pZic3-M1	ZIC2	NCE	 to	pGl-pZic3-M6	ZIC2	NCE	
(M1-M6	NCE-luc),	as	well	as	ALK4-HA	to	stimulate	NODAL	signalling.	(a)	V5-ZIC2,	(b)	V5-FOXA2,	
(c)	V5-FOXJ1	or	an	empty	control	vector	(V5-DEST)	were	also	transfected.	Reporter	activity	was	
measured	as	luminescence.	Fold	values	were	calculated	relative	to	p-luc	and	converted	to	the	
relative	percent	(%)	change	in	activity	compared	to	p-luc,	whereby	a	value	of	0-60	represent	an	
increase	in	activity	compared	to	background	and	-100-0	represents	repression	of	activity.	The	
activity	of	the	(d)	WT	NCE	and	(e)	six	HPE-associated	SNVs	is	summarised.	‘Y’	indicates	that	the	
mutated	NCE	responds	to	the	addition	of	a	TF	in	a	similar	manner	to	the	wildtype	NCE,	whilst	a	
‘N’	indicates	that	the	mutation	responds	differently.	Error	bars	=	S.E.M	of	three	external	repeats;	
letters	denote	statistical	significance	of	p<0.05	calculated	via	a	two-way	ANOVA	with	Fischer’s	
unprotected	post	ad	hoc	test,	where	a	is	statistically	significant	to	b	and	so	on.		
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Figure	 5.10:	 Representative	 experiment	 and	 western	 blots	 for	 the	 addition	 of	 TFs	 to	 the	
wildtype	 and	 mutant	 ZIC2	 NCE	 in	 a	 high	 NODAL,	 medium	 BMP	 and	 low	 WNT	 signalling	
environment.	HEK293T	 cells	were	 transfected	with	 the	 empty	 reporter	 construct	 pGl-pZic3-
DEST	(p-luc),	pGl-pZic3-WT	ZIC2	NCE	(WT	NCE-luc),	and	the	mutated	constructs	pGl-pZic3-M1	
ZIC2	 NCE	 to	 pGl-pZic3-M6	 ZIC2	 NCE	 (M1-M6	 NCE-luc),	 in	 addition	 to	 ALK4-HA	 to	 stimulate	
NODAL	signalling	and	(A)	V5-ZIC2,	(B)	V5-FOXA2	or	(C)	V5-FOXJ1,	or	an	empty	control	vector	
(V5-DEST).	 Reporter	 activity	 was	 measured	 as	 luminescence.	 In	 each	 case,	 a	 single	
representative	experiment	is	shown,	with	error	bars	=	S.D.,	N=3	internal	repeats.	Western	blots	
correspond	to	the	transfections	shown.	a-GAPDH	(cytoplasmic)	and	a-TBP	(nuclear)	blots	are	
included	as	loading	controls.	The	western	blots	were	conducted	across	multiple	gels	due	to	the	
large	number	of	experimental	samples.		 	
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When	these	interactions	are	correlated	with	the	ZIC	and	FOX	binding	sites	predicted	to	occur	in	
the	ZIC2	NCE	(Chapter	4),	it	can	be	seen	that	both	the	M4	and	M5	SNVs	occur	within	a	binding	
site	 for	 the	FOX	 family	of	 transcription	 factors,	whilst	 the	 introduction	of	M6	 is	predicted	 to	
create	a	new	FOX	binding	site.	It	can	therefore	be	hypothesised	that	any	response	seen	in	the	
M1-M3	NCEs	from	the	overexpression	of	FOXA2	or	FOXJ1	is	most	likely	due	to	indirect	(i.e.	co-
factor)	 interactions	 (as	 they	 are	 not	 predicted	 occur	 within	 FOX	 binding	 sites)	 whilst	 the	
responses	elicited	from	M4-M6	NCEs	is	most	likely	due	to	direct	interactions.	As	no	mutations	
overlapped	with	a	ZIC	binding	site,	any	responses	elicited	from	overexpression	of	ZIC2	are	most	
likely	due	to	indirect	interactions.		
5.2.6 The	signalling	environments	assayed	correlate	with	in	vivo	signalling	environments	
of	the	mouse	embryo	
To	 assess	 whether	 the	 manipulation	 of	 signalling	 pathways	 in	 HEK293T	 cells	 mimics	 gene	
expression	 in	 the	node,	 the	 relative	change	 in	mRNA	expression	 levels	 in	endogenous	 target	
genes	was	measured.	Embryos	homozygous	for	the	Kumba	allele	of	Zic2	exhibit	decreased	Foxa2	
and	Foxj1	expression	in	the	node	(Barratt	et	al.,	2014;	Warr	et	al.,	2008),	suggesting	that	ZIC2	
functions	 upstream	 of	 both	 genes.	 On	 the	 other	 hand,	 overexpression	 of	 zic2	 in	 Xenopus	
embryos	also	results	 in	a	 loss	of	foxa2	expression	in	the	dorsal	blastopore	lip	(the	equivalent	
tissue	 to	 the	node)	 (Houtmeyers	et	al.,	 2016),	 suggesting	ZIC2	may	also	be	 required	 to	 limit	
expression	of	Foxa2	in	the	node.	It	is	possible	that	a	negative	feedback	loop	exists	in	which	high	
levels	of	FOXA2	and/or	ZIC2	represses	Zic2	transcription	to	prevent	Foxa2	overexpression.	
HEK293T	cells	were	transfected	with	V5-ZIC2,	V5-FOXA2	or	V5-DEST	and	exposed	to	both	the	
‘red’	 (high	 NODAL,	 medium	 BMP	 and	 low	WNT)	 and	 ‘yellow’	 signalling	 environments	 (high	
NODAL,	 low	 BMP	 and	WNT).	 In	 contrast	 to	 unstimulated	 HEK293T	 cells	 (Figure	 5.7	 A),	 the	
addition	of	ZIC2	into	the	‘red’	signalling	environment	results	in	a	significant	decrease	of	FOXA2	
expression	(Figure	5.7	B)	but	an	increase	in	FOXJ1	expression,	indicating	this	environment	does	
not	recapitulate	known	interactions	between	the	three	genes	assayed.	The	addition	of	ZIC2	in	a	
‘yellow’	signalling	environment	results	in	a	significant	increase	in	endogenous	FOXA2	levels,	and	
a	small	increase	in	FOXJ1	(Figure	5.7	C).	These	trends	correlate	with	ZIC2	positively	regulating	
FOXA2	and	FOXJ1	expression	in	the	murine	node	and	suggest	that	NCE	activity	in	the	‘yellow’	
signalling	 environment	 is	 an	 adequate	 model	 for	 this	 tissue.	 From	 these	 results,	 we	 can	
prediction	the	behaviour	of	the	ZIC2	NCE	in	this	tissue.	For	example,	the	addition	of	ZIC2	results	
in	 a	 decrease	 in	 endogenous	 ZIC2	 expression	 and	 further	 repression	 of	 the	 ZIC2	NCE	 in	 the	
‘yellow’	signalling	environment,	suggesting	that	ZIC2	uses	the	NCE	to	self-repress	in	the	murine	
node.		
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Figure	 5.11:	 HEK293T	 cells	 can	 be	 induced	 to	 mimic	 the	 signalling	 environment	 of	 the	
embryonic	 node.	 HEK293T	 cells	 were	 transfected	 with	 V5-ZIC2,	 V5-FOXA2	 or	 V5-FOXJ1	
transcription	 factors.	Results	were	normalised	 to	ABCE1	 or	USP39	 via	 the	DDCT	method,	 and	
percent	 change	 calculated	 relative	 to	 cells	 transfected	 with	 the	 empty	 vector	 V5-DEST	 to	
represent	endogenous	levels.	A	result	of	>0	indicates	an	increase	in	expression	from	endogenous	
levels,	whilst	<0	indicates	a	decrease	in	expression	from	endogenous	levels.	Error	bars	=	S.E.M	
of	three	external	repeats;	*	denote	statistical	significance	of	p<0.05	calculated	via	a	one-way	
ANOVA	with	Fischer’s	unprotected	post	ad	hoc	test.	(A-C)	FOXA2,	FOXJ1	and	ZIC2	endogenous	
gene	 expression	 changes	 when	 transcription	 factors	 are	 transfected	 into	 (A)	 unstimulated	
(basal)	HEK293T	cells,	(B)	cells	stimulated	with	ALK4-HA	to	create	a	high	NODAL,	medium	BMP	
and	low	WNT	signalling	environment,	or	(C)	cells	stimulated	with	ALK4-HA	and	V5-NOGGIN	to	
create	a	high	NODAL,	low	BMP	and	low	WNT	signalling	environment.	(A’-C’)	A	representative	
western	 blot,	 corresponding	 to	 the	 transfections	 and	 signalling	 environments	 shown.	a-TBP	
(nuclear)	and	a-GAPDH	(cytoplasmic)	are	included	as	loading	controls.		
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5.3 Discussion	
Multiple	mechanisms	 combine	 to	 precisely	 control	 target	 gene	 transcription	 during	 embryo	
development.	The	binding	of	specific	TF	complexes	to	ER	elements	to	either	enhance	or	repress	
gene	 transcription	 is	one	 such	mechanism.	The	composition	of	 these	TF	 complexes	 is	 tightly	
regulated	and	subject	to	the	signalling	pathways	that	are	active	in	the	cell	at	a	particular	time.	
In	this	chapter	I	have	shown	that,	regardless	of	signalling	environment,	the	default	role	of	the	
ZIC2	NCE	appears	to	be	as	repressive	element	and	not	an	enhancer	as	first	predicted	in	Chapter	
4.	The	introduction	of	a	single	nucleotide	mutation,	however,	is	sufficient	to	significantly	disrupt	
this	repressive	role.	Additionally,	I	have	shown	that	the	candidate	TFs	ZIC2,	FOXA2	and	FOXJ1	
interact	with	the	wildtype	and	mutant	ZIC2	NCEs	and	alter	reporter	activity	in	specific	signalling	
environments,	providing	direction	for	future	investigations	in	the	NCE	and	Zic2-associated	HPE.	
5.3.1 The	wildtype	ZIC2	NCE	is	a	repressor	in	HEK293T	cells	
The	default	role	of	the	ZIC2	NCE	appears	to	be	as	a	repressor	element,	as	heterologous	reporter	
assays	under	 the	 control	of	 the	wildtype	NCE	 consistently	 reported	a	 reduction	 in	 luciferase	
activity	when	compared	to	background	reporter	activity,	 regardless	of	 the	signalling	context.	
Moreover,	the	addition	of	TFs	that	are	candidates	to	 interact	with	the	NCE	(ZIC2,	FOXA2	and	
FOXJ1)	 did	 not	 alleviate	 this	 repressive	 role.	 This	 result	 was	 unexpected,	 as	 the	majority	 of	
identified	ER	elements	function	primarily	as	enhancers	both	in	cell	culture	and	in	vivo.	Though	
these	 elements	 can	 switch	 between	 enhancing	 and	 repressing	 roles	 in	 a	 context	 dependant	
manner,	 their	default	activity	 is	as	an	enhancer.	 Indeed,	as	 the	role	of	enhancer	elements	 in	
directing	gene	transcription	was	 identified	much	earlier	than	that	of	repressors,	the	research	
community’s	knowledge	on	enhancers	is	far	greater,	and	there	are	relative	few	examples	of	ER	
elements	with	a	primary	repressor	role.	The	3’UTR	of	HMGA2,	a	delayed	early	response	gene	
expressed	at	the	beginning	of	embryogenesis,	is	one	such	example.	Upon	transfecting	HeLa	cells	
with	 a	 construct	 containing	 the	 HMGA2	 3’UTR	 situated	 3’	 to	 a	 reporter	 gene,	 a	 12.7-fold	
decrease	 in	 luciferase	activity	was	detected.	While	 initial	deletion	of	 the	3’	end	of	 the	3’UTR	
resulted	in	further	repression,	continued	truncation	of	the	3’	end	resulted	in	a	20.5%	increase	
in	luciferase	activity	compared	to	the	wildtype	3’UTR.	This	increase,	however,	remained	lower	
than	the	background	levels	of	reporter	activity,	suggesting	the	default	role	of	the	HMGA2	3’UTR	
was	as	a	repressor	element	(Borrmann	et	al.,	2001).	Borrmann	concluded	that	the	increase	in	
reporter	activity	was	due	to	an	increase	in	transcript	stability,	as	truncating	the	3’UTR	removed	
multiple	AU-rich	motifs	contribute	to	mRNA	decay.	Removal	of	all	the	AU-rich	motifs,	however,	
still	 did	 not	 result	 in	 enhancer	 activity,	 suggesting	 that	 there	 remained	 a	 repressor	 element	
influencing	reporter	transcription	as	well	as	stability.	Whilst	the	HMGA2	3’UTR	luciferase	results	
are	similar	to	those	achieved	with	the	wildtype	ZIC2	NCE	in	this	chapter,	and	the	ZIC2	3’UTR	is	
also	predicted	to	contain	AU-rich	elements	that	 influence	transcript	stability	 (Chapter	6),	 the	
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positioning	of	the	ZIC2	NCE	upstream	of	the	Zic3	promoter	and	luciferase	gene	in	the	constructs	
used	here	ensure	that	luciferase	output	is	solely	due	to	the	ZIC2	NCE	acting	as	an	ER	element	
and	not	due	to	it	conferring	transcript	instability.	
There	remains	the	possibility,	however,	that	the	ZIC2	NCE	is	made	up	of	multiple	positive	and	
negative	regulatory	domains	like	those	seen	in	the	mouse	Albumin	ER	element	and	the	3’UTR	of	
HGMA1	(Borrmann	et	al.,	2001;	Herbst	et	al.,	1989).	A	series	of	truncated	ZIC2	NCE	constructs	
can	be	created	and	put	through	the	assays	outlined	in	this	chapter	to	determine	if	it	is	the	entire	
NCE	that	confers	repression	onto	a	target	reporter,	or	only	specific	domains.	Analysis	such	as	
this	would	also	allow	for	the	prediction	of	how	new	HPE	mutations	in	the	ZIC2	3’UTR	will	affect	
the	NCE,	as	those	that	occur	in	a	repressive	domain	are	more	likely	to	result	in	an	increase	in	
target	gene	expression,	whilst	those	that	occur	in	a	positive	domain	would	presumably	result	in	
repression	of	a	target.	Additionally,	one	of	the	hallmarks	of	an	active	ER	element	is	the	ability	to	
function	 independent	 of	 orientation.	 It	 remains	 to	 be	 determined	 whether	 the	 repressor	
function	 of	 the	 ZIC2	 NCE	 is	 maintained	 when	 the	 element	 is	 in	 the	 reverse	 orientation.	
Therefore,	 in	addition	to	a	series	of	truncated	NCE	constructs,	constructs	in	which	the	NCE	is	
reversed	should	also	be	investigated.		
In	vivo	foot	printing	of	the	murine	Alb1	enhancer	in	gut	endoderm	found	that	sequential	binding	
of	TFs	 is	required	for	function,	rather	than	enhanceosome	formation	in	one	go	(Gualdi	et	al.,	
1996).	Pioneering	TFs	such	as	FOXA2	were	shown	to	initiate	the	sequential	binding	to	enhancer	
elements,	priming	the	element	to	be	activated	before	other	TFs	were	recruited	to	the	element	
(Gualdi	et	al.,	1996;	Zaret	and	Carroll,	2011).	It	should	therefore	be	considered	that	addition	of	
FOXA2	may	 prime	 the	 ZIC2	 NCE	 for	 the	 formation	 of	 an	 enhanceosome,	 but	 cannot	 recruit	
sufficient	 endogenous	 proteins	 to	 create	 a	 functioning	 enhanceosome,	 either	 due	 to	 under	
expression	or	complete	lack	of	expression	in	HEK293T	cells.	This	does	seem	unlikely,	however,	
as	 this	 scenario	 would	 presumably	 lead	 to	 a	 small	 but	 detectable	 increase	 in	 activity	 upon	
addition	 of	 exogenous	 TFs.	 In	 contrast,	 addition	 of	 exogenous	 TFs	 consistently	 resulted	 in	
stronger	repression	of	reporter	activity	by	the	ZIC2	NCE.	Nevertheless,	transfection	of	multiple	
TFs	 into	 the	 above	 assays	 at	 the	 same	 time	 can	 be	 undertaken	 to	 determine	 whether	 a	
combination	of	proteins	elicits	a	stronger	response	from	the	ZIC2	NCE.		
Due	 to	 time	 constraints,	 only	 three	 of	 the	 possible	 nine	 candidate	 TFs	 were	 tested	 for	
interactions	with	the	NCE	and.	further	investigation	into	the	remaining	candidate	TFs	identified	
in	Chapter	4	is	warranted.	Both	ZIC3	and	ZIC5	are	thought	to	act	redundantly	with	ZIC2	in	the	
embryonic	tissues	where	they	are	co-expressed.	Whilst	this	precludes	the	late-streak	node	as	a	
possible	site	of	interaction	(as	Zic5	is	not	expressed	in	this	tissue,	and	Zic3	expression	in	the	node	
occurs	after	Zic2	expression	has	ceased	[Chapter	4;	Sutherland	et	al.	2013]),	either	ZIC	could	be	
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interacting	with	the	ZIC2	NCE	 in	the	PS	and	can	therefore	be	tested	 in	the	APS-like	signalling	
environment.	CDX2	has	been	shown	to	maintain	WNT	signalling	in	the	posterior	of	the	mouse	
embryo,	resulting	 in	the	generation	of	tissue	required	for	trunk	axial	extension	 (Young	et	al.,	
2009).	When	Cdx2	 is	mutated,	 posterior	 truncations	 result	 (Chawengsaksophak	et	 al.,	 2004,	
1997).	 In	 contrast,	 overexpression	 of	 the	 ZICs	 has	 been	 shown	 to	 inhibit	WNT	 signalling	 in	
HEK293T	cells	and	Xenopus	embryos	(Fujimi	et	al.,	2012;	Pourebrahim	et	al.,	2011).	A	repressive	
interaction	between	ZIC2	and	CDX2	is	suggested	by	the	inverse	expression	pattern	of	both	genes	
in	 the	PS,	as	Zic2	 expression	 recedes	anteriorly	down	 the	streak	at	 the	 same	 time	 that	Cdx2	
begins	to	be	expressed	in	the	tissue	that	Zic2	expression	has	ceased	in.		
5.3.2 The	six	individual	HPE-associated	SNVs	alter	NCE	activity	in	a	context-dependent	
manner	
Multiple	studies	have	demonstrated	that	SNVs	in	ER	elements	are	able	to	disrupt	the	binding	of	
TFs	to	the	element.	A	G>A	mutation	in	the	IRF6	enhancer	element	disrupts	the	binding	site	for	
AP-2a,	 resulting	 in	 an	 increased	 incidence	 of	 cleft	 lip	 in	 probands	 (Rahimov	 et	 al.,	 2008).	
Similarly,	four	distinct	SNVs	in	the	Lmbr1	intronic	enhancer	disrupt	SHH	expression	in	the	zone	
of	polarising	activity	of	the	limb	bud,	resulting	in	preaxial	polydactyly	in	both	man	and	mouse	
(Lettice	et	al.,	2003),	whilst	SNVs	 in	enhancers	 for	Tbx5	and	Sox9	have	been	shown	to	cause	
congenital	heart	defects	and	cleft	palates,	respectively	(Benko	et	al.,	2009;	Smemo	et	al.,	2012).	
The	reduction	in	ZIC2	NCE	repressor	activity	to	varying	degrees	upon	the	introduction	of	the	six	
HPE-associated	SNVs,	independent	of	the	signalling	environment	they	were	analysed	in,	agrees	
with	the	hypothesis	that	the	SNVs	are	causative.	If	NCE	function	in	stimulated	HEK293T	cells	is	
faithful	 to	NCE	 function	 in	 vivo,	 then	 alleviation	of	 repression	brought	 about	 by	 the	 SNVs	 is	
predicted	to	result	in	an	increase	in	Zic2	expression,	which	is	the	most	likely	target	of	the	NCE.	
This	increase	of	ZIC2	may	occur	in	cells	in	which	Zic2	is	normally	required	at	a	specific	level,	thus	
resulting	in	increased	interaction	with	downstream	targets,	or	exogenous	expression	in	cells	in	
which	Zic2	transcription	is	normally	repressed.	Though	most	Zic2-associated	HPE	cases	are	Zic2	
loss-of-function,	it	is	probable	that	this	gain	of	Zic2	function	will	also	lead	to	HPE.	One	published	
incidence	of	ZIC2	gain-of-function	in	human	HPE	is	known.	A	Q36P	mutation	in	the	ZIC2	CDS	was	
found	to	result	in	a	170%	increase	in	ZIC2	transactivation	activity	in	HEK293T	cells	when	coupled	
to	an	ApoE	promoter	(Brown	et	al.,	2005).	Though	this	mutation	has	not	been	definitively	shown	
to	cause	a	HPE	phenotype	on	its	own	via	mouse	models,	it	provides	precedent	for	ZIC2	gain-of-
function	as	a	mechanism	for	HPE	development.	Additional	evidence	comes	from	zic2	knockdown	
and	upregulation	via	morpholino	and	mRNA	injections,	respectively,	in	Xenopus	embryos.	These	
loss-	 and	 gain-of-function	 experiments	 both	 resulted	 in	 loss	 of	 foxa2	 expression	 in	 the	
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developing	embryo	and	gastrulation	defects	(Houtmeyers	et	al.,	2016).	It	is	therefore	feasible	
that	mutation	of	the	ZIC2	3’UTR	could	lead	to	a	gain	of	Zic2	transcript,	resulting	in	HPE.		
The	 finding	 that	 each	 individual	 SNV	 confers	 different	 NCE	 activity	 in	 a	 context-dependant	
manner	 supports	 the	 hypothesis	 that	 the	 NCE	 is	 made	 up	 of	 multiple	 domains	 that	 work	
together	 to	confer	net	 regulation,	 rather	 than	one	total	element.	Moreover,	 the	 finding	 that	
each	 SNVs	 elicits	 a	 different	 response	 to	 overexpression	 of	 TFs	 predicted	 to	 bind	 the	 NCE	
suggests	a	mechanism	is	at	play	whereby	the	SNV	alters	the	enhanceosome	or	repressosome	
that	 interacts	 with	 that	 specific	 region	 of	 the	 3’UTR.	 Additionally,	 it	 suggests	 that	 some	
mutations	would	 result	 in	 a	more	 severe	HPE	phenotype	 than	others.	 Indeed,	 those	human	
probands	in	which	the	SNVs	were	identified	exhibit	the	full	spectrum	of	HPE	defects	(Chapter	
1).	As	the	M4-M6	SNVs	are	hypothesised	to	disrupt	a	direct	interaction	with	FOXA2	or	FOXJ1	
(due	to	the	presence	of	predicted	FOX	binding	sites	and	altered	NCE	activity),	this	interaction	
should	be	confirmed	with	ChIP	or	EMSA	analysis.		
5.3.3 ZIC2	NCE	mouse	models	or	CRISPR	cell	lines	are	required	for	further	investigation	
Two	pertinent	avenues	of	investigation	that	were	not	addressed	in	this	chapter	are	(i)	whether	
the	ZIC2	NCE	directly	controls	expression	of	ZIC2,	or	a	nearby	gene	such	as	ZIC5,	at	gastrulation	
and	(ii)	whether	the	individual	HPE-associated	SNVs	are	sufficient	to	cause	a	HPE	phenotype.	
Indeed,	I	have	shown	that	the	mutations	can	disrupt	the	ability	of	the	NCE	to	function	in	the	
same	manner	as	the	wildtype	NCE,	but	this	does	not	necessarily	lead	to	a	HPE	phenotype.	One	
way	to	test	whether	the	ZIC2	NCE	specifically	controls	ZIC2	expression	is	to	investigate	whether	
the	 NCE	 directly	 interacts	 with	 the	 ZIC2	 promoter.	 This	 can	 be	 achieved	 via	 chromosome	
conformation	 capture	 (3C)	 coupled	 with	 sequencing	 (4C),	 which	 would	 map	 genome-wide	
interactions	with	the	ZIC2	promoter	 (Sahlén	et	al.,	2015).	Enrichment	of	 the	ZIC2	NCE	 in	this	
mapping	 would	 indicate	 that	 an	 interaction	 was	 occurring,	 and	 may	 also	 identify	 other	 ER	
elements	that	control	Zic2	expression.	This	method	would	still,	however,	only	indicate	that	the	
promoter	and	NCE	can	interact,	not	that	they	do	in	vivo.	The	best	way	to	investigate	the	role	of	
the	NCE	in	regulating	ZIC2	transcription	during	embryogenesis,	and	how	the	introduction	of	the	
six	SNVs	affects	this	regulation,	is	via	the	creation	of	transgenic	embryos	with	a	reporter	under	
the	control	of	the	wildtype	or	mutant	NCEs,	and	via	direction	mutation	of	the	NCE	via	CRISPR-
Cas9	mutagenesis.		
5.3.4 Conclusion	
ER	elements	have	evolved	as	a	method	for	gene	expression	modulation	in	response	to	signalling	
pathways	and	upstream	effectors.	This	 is	particularly	 important	 for	expression	of	Zic2	 in	 the	
node	of	the	gastrulating	embryo,	where	alterations	in	expression	are	known	to	lead	to	HPE.	In	a	
signalling	 environment	 that	 recapitulates	 aspects	 of	 node	 gene	 interactions	 (the	 ‘yellow’	
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signalling	environment),	the	repression	of	reporter	transcription	is	enhanced	by	overexpression	
of	the	TFs	ZIC2	and	FOXA2.	The	introduction	of	each	of	the	six	SNVs	disrupts	the	repressive	role	
of	 the	 NCE,	 suggesting	 that	 an	 increase	 in	 the	 NCEs	 target,	 presumed	 to	 be	 ZIC2,	 may	 be	
sufficient	to	cause	HPE.		
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Chapter	6: In	silico	and	in	vitro	analysis	of	ZIC2	transcript	stability	
	
Optimization	of	the	RT-qPCR	protocol,	cloning	and	decay	analysis	in	this	chapter	were	developed	
and	performed	in	conjunction	with	Kathryn	Dickson,	an	Honours	student	in	the	Arkell	lab.		
6.1 Introduction	
Gene	expression	 is	a	balance	of	transcription	production	and	degradation.	This	 is	particularly	
relevant	in	transient	biological	processes	such	as	embryo	development	where	a	gene	requires	
rapid	expression	in	a	short	period	of	time,	followed	by	a	large,	controlled	decrease	in	transcript	
levels.	 It	 is	 estimated	 that	 40-50%	of	 the	 changes	 in	 gene	expression	 in	 response	 to	 cellular	
signals	occurs	due	to	regulation	of	mRNA	stability	(Garneau	et	al.,	2007).	Transcript	degradation	
occurs	 via	 multiple	 cis-acting	 regulatory	 regions	 (such	 as	 AU-rich	 elements	 [ARE],	 GU-rich	
Elements	 [GRES],	 ARE	 Binding	 Proteins	 [AREBPs],	 miRNAs	 and	 alternative	 polyadenylation).	
These	elements	work	independently	or	cooperatively	to	confer	transcript	stability	or	promote	
destabilization,	and	determine	transcript	half-life	in	a	context-dependant	manner.		
6.1.1 Transcript	stability	machinery	
Eukaryotic	mRNAs	contain	two	main	stability	determinants	–	a	5’	7-methylguanosine	cap	(5’	cap)	
and	 a	 3’	 poly(A)	 tail	 (Figure	 6.1).	 Both	 are	 incorporated	 into	 the	 mRNA	 strand	 during	
transcription	(Garneau	et	al.,	2007)	and	both	protect	the	transcript	from	degradation.	Once	the	
capped	 and	 polyadenylated	 transcripts	 are	 transported	 to	 the	 cytoplasm	 and	 P-bodies,	 the	
poly(A)	tail	and	5’	cap	act	synergistically	to	initiate	translation.	The	5’	cap	binds	the	Translation	
Initiation	Complex	(TIC)	whilst	the	poly(A)	tail	is	bound	by	Poly(A)	Binding	Protein	(PABP).	Bound	
PABP	 also	 associates	with	 the	 TIC,	 forming	 a	 closed	 loop	 and	 increasing	 the	 integrity	 of	 the	
transcript	 by	 protecting	 it	 from	 exonucleases	 (Garneau	et	 al.,	 2007;	 Kuersten	 and	Goodwin,	
2003;	Weill	et	al.,	2012).	The	transcript	is	then	either	translated	immediately	via	association	with	
a	ribosome,	silenced	and	stored	in	P-bodies	for	translation	at	a	later	date,	or	decayed	(Garneau	
et	al.,	2007;	Parker	and	Sheth,	2007).	When	decay	is	 initiated,	most	eukaryotic	transcripts	go	
through	a	process	of	deadenylation	to	reduce	the	poly(A)	tail	~25-2000	bp	nascent	mRNA	down	
to	~80	bp	(Figure	6.1).	Deadenylation	can	be	carried	out	by	the	activity	of	deadenylases	PAN2-
3,	followed	by	the	CCR4-NOT	complex	(Garneau	et	al.,	2007),	or	via	the	deadenylase	Poly(A)-
specific	Ribonuclease	(PARN).	Both	deadenylation	pathways	are	mRNA	specific	and	it	is	currently	
unknown	why	one	is	favoured	over	the	other	for	individual	transcripts	(Garneau	et	al.,	2007;	Wu	
and	Brewer,	2012).	 	
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Figure	 6.1:	 The	 eukaryotic	mRNA	decay	pathway.	 (a)	 A	 5’	 cap	 is	 added	 to	 the	 5’	 end	of	 all	
eukaryotic	mRNA	during	the	elongation	step	of	transcription,	where	it	confers	protection	from	
early	 degradation	 onto	 a	 transcript.	 Following	 cleavage	 of	 a	 transcript	 at	 a	 poly(A)	 site,	 a	
homopolymeric	string	of	25-2000	adenine	nucleotides	termed	the	poly(A)	tail	is	added	to	the	3’	
end	by	Poly(A)	Polymerase	(PAP)	(Garneau	et	al.,	2007).	The	poly(A)	tail	protects	the	mRNA	from	
degradation,	 aids	 in	 the	 export	 of	 the	mature	mRNA	 to	 the	 cytoplasm,	 and	 is	 required	 for	
stabilizing	transcripts	to	facilitate	translation	initiation	(Garneau	et	al.,	2007;	Weill	et	al.,	2012).	
The	transcript	is	then	either	converted	into	protein,	stored	in	P-bodies	for	later	use	or	directed	
through	a	deadenylation	pathway	to	be	decayed.	 (b)	A	 transcript	 is	directed	 for	decay	when	
RBPs	and	miRNAs	bind	to	recognition	sites	in	the	3’UTR	of	a	transcript,	usually	located	in	an	ARE,	
and	form	an	exosome.	Deadenylases	such	as	PAN2-3/CCR4-NOT	or	Poly(A)-specific	Ribonuclease	
(PARN)	 bind	 to	 the	 poly(A)	 tail	 and	 trim	 the	 ~25-2000	 bp	 nascent	 mRNA	 down	 to	 ~80	 bp	
(Garneau	et	al.,	2007).	This	step	is	reversible.	(c)	The	transcript	is	then	either	decapped	(Brennan	
and	Steitz,	2001)	and	(d)	decayed	in	the	5-3	direction	via	exoribonucleases	that	bind	to	the	newly	
exposed	5’	end	such	as	XRN1	(Garneau	et	al.,	2007;	Wu	and	Brewer,	2012),	or	(e)	the	exposed	
3’	 end	 is	 degraded	 via	 an	 exosome	 consisting	 of	 six	 proteins	 with	 homology	 to	 a	 3’-5’	
phosphorolytic	exoribonuclease	and	several	accessory	proteins.	Once	the	body	of	the	transcript	
is	 decayed,	 the	 remaining	 5’	 cap	 is	 metabolized	 by	 the	 scavenger	 decapping	 enzyme	 DCP5	
(Garneau	et	al.,	2007;	Wu	and	Brewer,	2012).	ORF:	open	reading	frame,	AAAA:	poly(A)	tail.	 	
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Following	deadenylation,	transcripts	are	either	decayed	in	the	3’-5’	direction	via	the	scavenger	
decapping	enzyme	DCP5	(Figure	6.1),	or	the	5’	cap	is	removed	(Brennan	and	Steitz,	2001)	and	
the	 transcript	 is	 decayed	 in	 the	 5’-3’	 direction	 via	 the	 exoribonuclease	 XRN1.	 The	 choice	 of	
pathway	 is	 dependent	 on	 the	 individual	 transcript	 undergoing	 decay	 and	 the	 available	
machinery.	 Both	 the	 5’-3’	 and	 3’-5’	 pathways	 are	 involved	 in	 the	 decay	 of	 unstable	 ARE-
containing	mRNA	transcripts	in	mammals	(Garneau	et	al.,	2007;	Wu	and	Brewer,	2012).	A	less	
prominent	 decay	 pathway	 termed	 Endoribunucleolytic	 Decay	 (ED)	 also	 occurs	 in	 eukaryotic	
cells.	ED	is	initiated	when	an	actively	translating	transcript	is	cleaved	into	two	fragments	that	
are	susceptible	to	decay	by	XRN1	and	an	exosome	(Garneau	et	al.,	2007;	Wu	and	Brewer,	2012).	
Though	this	pathway	is	the	most	efficient	method	to	destroy	mRNA,	it	only	occurs	for	specific	
genes	and	the	transcripts	must	be	actively	translating	(Garneau	et	al.,	2007).		
6.1.2 In	silico	identification	and	analysis	of	transcript	stability	elements	
Regions	within	3’UTRs	have	been	shown	to	impact	the	stability	and	decay	of	mRNA	transcripts.	
These	elements	can	be	 located	 in	 the	5’UTR,	 introns	and	coding	regions	of	genes,	but	 in	 the	
3’UTR	 they	 are	 shielded	 from	 ribosomes	 and	 other	 translational	machinery	 (Garneau	 et	 al.,	
2007).	 To	 initiate	 the	 decay	 process,	 stability	 elements	 must	 first	 interact	 with	 the	 target	
transcript’s	3’UTR.	
AU-	and	GU-rich	elements	
AREs,	defined	by	the	pentamers	‘AUUUA’,	range	from	50-150	bp	in	length,	are	located	within	
regions	rich	in	adenine	(A)	and	uridine	(U)	nucleotides	(Chen	and	Shyu,	1995).	Their	predominant	
role	is	to	target	transcripts	for	degradation	via	binding	by	RNA	binding	proteins	(RBPs)	(Barreau	
et	al.,	2005;	Chen	and	Shyu,	1995;	Danckwardt	et	al.,	2008).	This	ability	was	first	demonstrated	
via	fusion	of	the	stable	rabbit	b-globin	gene	to	an	AU	rich	3’UTR	from	granulocyte	monocyte-
colony	stimulating	factor	(GM-CSF).	The	half-life	of	rabbit	b-globin	transcripts	was	reduced	from	
17	hours	to	less	than	30	minutes	in	NIH3T3	derived	cells	upon	the	introduction	of	the	51	bp	ARE	
region	(Shaw	and	Kamen,	1986).	While	AREs	typically	promote	transcript	degradation,	they	can	
also	provide	a	stabilising	influence	under	the	correct	circumstances	(Danckwardt	et	al.,	2008).		
Investigations	into	ARE	content	have	shown	that	flanking	sequences	effect	the	overall	influence	
of	the	ARE	on	mRNA	stability,	and	no	two	AREs	are	the	same.	A	nonamer	of	‘UUAUUUAUU’	or	
‘WWAUUUAWW’	is	the	minimum	sequence	required	for	ARE	function.	Without	the	flanking	bps,	
the	sequence	‘AUUUA’	does	not	affect	transcript	stability	(Chen	and	Shyu,	1995;	Garneau	et	al.,	
2007;	Zubiaga	et	al.,	1995).	Individual	AREs	can	function	independently,	however	multiple	ARE	
regions	 in	 the	 one	 transcript	 produce	 an	 additive	 effect.	 Two	 AREs	 in	 the	 cfos	 3’UTR	 were	
analysed	via	transient	transfection	of	NIH3T3	cells	with	constructs	containing	the	stable	rabbit	
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b-globin	gene	and	either	each	individual	ARE	or	both	combined.	Increased	transcript	instability	
was	 conferred	 when	 both	 AREs	 were	 present,	 indicating	 that	 each	 element	 enhanced	 the	
destabilising	ability	of	the	other.	Successive	mutagenesis	of	each	of	three	‘AUUUA’	motifs	in	the	
cfos	AREs	led	to	a	gradual	loss	of	this	destabilization	(Chen	et	al.,	1994).	The	distance	between	
pentamers	can	also	affect	transcript	stability.	The	3’UTR	of	the	PPP1R3	gene	(encoding	the	RG1	
protein	involved	in	the	balance	of	glycogen	synthesis	and	glycogenesis)	was	found	to	contain	a	
polymorphism	in	Pima	Indians	(Arizona)	that	removed	5	bp	between	two	ARE	pentamers.	This	
led	to	lower	transcript	stability	and	decreased	levels	of	RG1	protein,	which	coincides	with	a	high	
level	 of	 insulin	 resistance	 and	 type	 2	 diabetes	 amongst	 Pima	 Indians	 compared	 to	 control	
populations	(Hitti,	2012).	
Approximately	~7%	of	human	genes	contain	AREs,	with	the	majority	located	in	3’UTRs.	AREs	are	
over	 represented	 in	 transcripts	 involved	 in	 cell	 proliferation,	 transcriptional	 regulation	 and	
developmental	processes	(Bakheet	et	al.,	2006;	Garneau	et	al.,	2007;	Halees	et	al.,	2008).	There	
are	three	classes	of	AREs,	with	Class	I	and	III	elements	generally	found	in	transcripts	of	TFs	and	
cell	cycle	regulatory	protein	and	Class	II	AREs	predominately	found	in	the	mRNA	of	cytokines	
(Wu	and	Brewer,	2012).	Class	I	transcripts	contain	1-3	scattered	copies	of	the	‘AUUUA’	pentamer	
surrounded	 by	 predominately	 U	 rich	 regions,	 whilst	 Class	 II	 transcripts	 contain	 multiple	
overlapping	 copies	 of	 the	 pentamer	 in	 a	 U	 rich	 region.	 In	 contrast,	 Class	 III	 transcripts	 lack	
pentamers	and	instead	contain	only	A	and	U	rich	sequences	(Chen	and	Shyu,	1995;	Halees	et	al.,	
2008).		
Recently,	 genome-wide	 microarray	 analysis	 of	 mRNA	 decay	 rates	 in	 primary	 human	 T	 cells	
identified	a	new	subset	of	regulatory	elements,	termed	GREs.	Defined	by	the	conserved	11	bp	
sequence	of	‘UGUUUGUUUGU’,	GREs	are	found	in	the	3’UTR	of	11.98%	of	decaying	transcripts	
that	did	not	contain	AREs	or	other	known	RNA	regulatory	motifs	(Raghavan	et	al.,	2002;	Vlasova	
et	al.,	 2008).	 In	 comparison,	 9.90%	of	 short-lived	 transcript	 contain	 a	Class	 I	ARE	and	5.21%	
contain	 a	Class	 II	ARE	 (Vlasova	et	al.,	 2008).	Upon	 introduction	of	GREs	 from	c-jun,	 jun	B	 or	
TNFRSF1B	 into	a	 stable	b-globin	 reporter	 in	primary	human	T	 cells,	 transcript	destabilization	
occurred	and	decay	rates	increased	from	53	hours	to	~3	hours.	Similar	to	AREs,	the	majority	of	
transcripts	containing	GREs	encode	proteins	involved	in	important	regulatory	processes	such	as	
TFs,	proto-oncogenes	and	metabolism	regulators	(Vlasova	et	al.,	2008).	Though	relatively	little	
is	known	about	the	behaviour	of	GREs,	the	RNA	binding	protein	CUG-binding	protein	1	(CEF1)	is	
known	to	specifically	bind	GREs	and	mediate	GRE-dependant	mRNA	decay	(Vlasova-St.	Louis	and	
Bohjanen,	2011).		
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RNA	Binding	Proteins	
At	 least	 30	 RBPs	 are	 known	 to	 bind	 to	 AREs	 (termed	 AREBPs)	 and	 promote	 or	 prevent	
destabilising	RBPs	from	binding	the	transcript	(Weill	et	al.,	2012).	A	shorter	target	transcript	will	
have	fewer	AREBP	binding	sites	available	for	regulation	than	a	longer	transcript.	The	majority	of	
AREBPs	act	to	recruit	degradation	machinery	(such	as	deadenylases	and	exosome	proteins)	to	
the	ARE	to	facilitate	transcript	decay	(Garneau	et	al.,	2007).	The	best	classified	AREBPs	are	AU-
rich	 element	 RNA	binding	 protein	 1	 (AUF1),	 tristetraprolin	 (TTP),	 butyrate	 response	 factor	 1	
(BRF1),	KH-type	splicing	regulatory	protein	(KSRP)	and	Hu	proteins.	Of	these,	AUF1,	TTP,	BRF1	
and	KSRP	bind	to	AREs	and	promote	the	destabilisation	of	transcripts	(Shaw	and	Kamen,	1986)	
by	recruitment	of	the	deadenylases	CCR4-NOT	and	PARN	(Weill	et	al.,	2012).	AUF1	also	prevents	
PABP	from	binding	and	protecting	the	transcript,	thereby	allowing	the	transcript’s	poly(A)	tail	to	
be	 deadenylated.	 Moreover,	 AUF1,	 KSRP	 and	 TTP	 recruit	 exosomes	 to	 AREs	 after	 the	
deadenylation	process	to	promote	further	decay	(Chen	et	al.,	2001;	Loflin	et	al.,	1999).	AREBPs	
can	also	confer	stability	by	removing	mRNA	transcripts	from	decay	sites	or	by	competing	with	
destabilizing	 factors	 for	 binding	 substrates,	 preventing	 decay.	 It	 is	 also	 hypothesised	 that	
stabilizing	AREBPs	are	able	 to	 strengthen	 the	 interaction	between	PABP	and	 the	poly(A)	 tail,	
thereby	preventing	deadenylation	from	occurring	(Garneau	et	al.,	2007).	The	Hu	protein	family,	
made	up	of	HuR,	HuB,	HuC	and	HuD,	is	known	to	act	as	a	stabilising	factor	when	bound	to	AU	
rich	sequences	(Shaw	&	Kamen	1986;	Fan	&	Steitz	1998b).	HuR	appears	to	complex	with	mRNA	
transcripts	in	the	nucleus	and	protect	them	from	degradation	during	transport	to	the	cytoplasm,	
leading	to	an	increase	in	gene	expression	(Peng	et	al.	1998;	Fan	&	Steitz	1998).		
microRNAs	
miRNAs	are	~21-26	bp	long	RNA	molecules	known	to	trigger	endonucleolytic	cleavage,	promote	
repression	of	translation	and	accelerate	decapping	of	transcripts,	thereby	silencing	transcripts	
or	promoting	their	decay	(Valencia-Sanchez	et	al.,	2006).	It	is	estimated	that	up	to	30%	of	human	
genes	are	regulated	by	miRNAs	(Valencia-Sanchez	et	al.,	2006),	with	half	of	the	conserved	motifs	
in	3’UTRs	linked	to	miRNA	binding	(Lewis	et	al.,	2005).	Suh	et	al.	recently	found	that	miRNAs	are	
first	required	for	mRNA	regulation	at	6.5	dpc	and	are	supressed	globally	prior	to	this	stage,	with	
endogenous	siRNA	regulating	 these	stages	 instead	 (Suh	et	al.,	2010).	From	6.5	dpc	onwards,	
miRNAs	work	to	coordinate	cell	proliferation,	differentiation	and	apoptosis,	as	well	as	play	a	role	
brain	morphogenesis,	stress	resistance,	fat	metabolism	and	metabolic	regulation	(Brennecke	et	
al.,	2003;	Giraldez	et	al.,	2005;	Wightman	et	al.,	1993;	Xu	et	al.,	2003).		
To	promote	transcript	decay	via	miRNA,	the	AREBP	TTP	must	interact	with	the	Argonaut	(Argo)	
family	of	RNA-induced	silencing	complex	(RISC)	component	proteins,	whilst	the	miRNA	interacts	
with	 RISC	 itself.	 The	 TTP/RISC/miRNA	 complex	 that	 forms	 cooperates	 to	 recognise	 ARE	
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sequences	 in	 target	 transcripts	which	 are	 bound	by	 the	miRNA	 (Jing	et	 al.,	 2005).	 Following	
binding,	the	complex	sequesters	target	mRNA	into	P-bodies	in	the	cytoplasm,	increasing	their	
association	with	decapping	machinery	but	not	exosome	machinery,	and	results	in	5’-3’	direction	
decay	or	decay	by	an	as	yet	unidentified	pathway	(Valencia-Sanchez	et	al.,	2006).	Target	mRNAs	
can	also	be	stored	in	the	cytoplasmic	P-bodies	where	they	will	either	be	later	degraded	(Shyu	et	
al.	2008;	reviewed	in	Kulkarni	et	al.	2010)	or	returned	to	the	pool	of	mRNAs	yet	to	be	translated	
(Shyu	et	al.,	2008).	This	storage	is	thought	to	be	utilized	during	embryo	development	when	a	
high	 level	 of	 mRNA	 is	 being	made	 (Pillai	 et	 al.,	 2005)	 and	may	 play	 a	 part	 in	 the	 stringent	
temporal	expression	of	particular	signalling	pathways.		
3’UTRs	that	contain	more	than	one	ARE	pentamer	are	able	to	interact	with	numerous	different	
miRNAs	at	once,	or	with	multiple	copies	of	the	same	miRNA.	This,	coupled	with	differences	in	
the	strength	of	miRNA	target	binding,	results	in	miRNA	mediated	degradation	being	transcript	
specific	(Jing	et	al.,	2005).	Additionally,	as	miRNAs	are	able	to	bind	a	transcript	without	having	a	
perfectly	complimentary	sequence	to	the	target,	one	type	of	miRNA	is	able	to	bind	and	regulate	
multiple	transcripts	at	any	one	time	(Baek	et	al.,	2008;	Helwak	et	al.,	2013;	Selbach	et	al.,	2008).	
If	the	miRNA	is	a	complete	complementary	match	to	its	target	mRNA,	the	mRNA	is	cleaved	and	
its	protein	levels	are	reduced	or	absent.	If	it	is	an	imperfect	match,	the	mRNA	is	destabilized	and	
may	still	exhibit	a	reduction	by	an	as	yet	unidentified	mechanism	(Fabian	et	al.,	2010).	Because	
of	this	capacity	to	imperfectly	bind	a	transcript,	point	mutations	exert	less	influence	on	a	miRNAs	
ability	to	recognise	and	decay	a	transcript	than	other	decay	elements	such	as	RBPs.	Whilst	the	
introduction	of	polymorphisms	or	mutations	may	not	prevent	 the	miRNA	 from	regulating	 its	
target	mRNA,	it	will	change	the	strength	of	the	regulation.	This	has	been	demonstrated	in	miR-
189	and	SLITRK1	 in	humans	with	Tourette’s	syndrome,	whereby	a	 loss-of-function	frameshift	
mutation	 results	 in	 shorter	dendrites	due	 to	 inhibition	of	miRNA-mediated	mRNA	repression	
(Abelson	et	al.,	2005).		
Alternative	polyadenylation	
Cleavage	 of	 a	 transcript	 can	 occur	 at	 more	 than	 one	 PAS	 in	 a	 3’UTR.	 More	 than	 half	 of	
mammalian	 transcripts	 contain	 multiple	 sites	 to	 allow	 for	 the	 creation	 of	 different	 length	
transcripts	(Tian	et	al.,	2005).	For	cleavage	to	occur,	a	PAS	must	sit	~15-30	bp	upstream	of	the	
cleavage	 site	 and	 a	 U/GU	 rich	 sequence	 must	 be	 ~30	 bp	 downstream	 of	 the	 cleavage	 site	
(Beaudoing	et	al.,	2000;	Weill	et	al.,	2012).	Cleavage	and	polyadenylation	specific	factors	such	
as	 CFI,	 CFII	 and	 PAP	 bind	 to	 the	 PAS	 in	 mammals,	 whilst	 other	 factors,	 such	 as	 Cleavage	
Stimulating	Factor,	bind	to	the	downstream	GU	rich	region	(Beaudoing	et	al.,	2000).	Together,	
the	binding	of	these	factors	promotes	cleavage	of	the	transcript.	Following	cleavage,	a	poly(A)	
tail	is	added	to	the	3’	end	of	the	transcript	(Weill	et	al.,	2012).		
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Whilst	genes	can	contain	multiple	PAS	in	their	3’UTR,	the	most	distal	PAS	is	typically	the	default	
cleavage	site.	These	PASs	are	commonly	the	canonical	‘AAUAAA’	or	‘AUUAAA’,	which	together	
make	 up	 73.1%	 of	 all	 identified	 PAS’s	 in	 the	 genome.	 In	 contrast,	 the	 proximal	 PAS’s	 are	
predominantly	made	up	of	non-canonical	 sites,	of	which	nine	have	so	 far	been	 identified	via	
analysis	of	human	expressed	sequence	tags	(ESTs)	(Beaudoing	et	al.,	2000).	The	3’	default	sites	
allows	for	longer	transcripts	to	be	created	which	undergo	greater	regulation,	compared	to	those	
transcripts	that	use	proximal	PASs	and	contain	fewer	miRNA	and	RBP	binding	sites.	This	can	be	
seen	in	genes	required	for	embryonic	development:	those	required	in	early	development	and	in	
highly	 proliferative	 tissues	 are	more	 likely	 to	 utilize	multiple	 PAS	 to	 produce	 different	 sized	
transcripts,	whilst	those	required	for	later	development	tend	to	have	longer	transcripts	(Weill	
et	al.,	2012).	Alternative	polyadenylation	can	also	remove	mRNA	stability	sites	like	AREs,	which	
is	practical	for	regulating	gene	expression	by	rapid	transcript	turnover.	For	example,	the	3’UTR	
of	 FGF2,	 a	 gene	 required	 for	 embryo	 development	 and	wound	 healing	 (Martín	et	 al.,	 2006;	
Ribatti	et	al.,	1999),	makes	up	90%	of	 the	mRNA	transcript	and	contains	eight	PASs.	When	a	
destabilizing	ARE	that	sits	between	the	first	and	second	poly(A)	site	is	removed	by	alternative	
polyadenylation,	transcript	half-life	changes	from	110	minutes	to	26-14	minutes,	as	determined	
by	 transfection	 of	 in	 vitro	 transcribed,	 capped	 and	 polyadenylated	 mRNAs	 and	 analysis	 of	
transcripts	with	a	chloramphenicol	acetyltransferase	reporter	in	Cos-7	cells	(Touriol	et	al.,	1999).		
Mutations	 anywhere	 in	 the	 PAS	 region	 may	 disrupt	 poly(A)	 processing	 as	 successful	
polyadenylation	requires	a	functional	PAS,	GU	rich	region	and	cleavage	site	(Beaudoing	et	al.,	
2000).	The	majority	of	mutations	found	within	a	transcripts	cleavage	site	or	in	the	GU	rich	region	
are	gain-of-function.	 In	contrast,	mutations	 that	occur	 in	or	near	 the	PAS	are	usually	 loss-of-
function	 (Danckwardt	 et	 al.,	 2008).	 For	 example,	 two	 thalassemias	 in	 humans	 have	 been	
attributed	to	mutations	in	the	‘AAUAAA’	PAS	of	both	the	a-globin	and	b-globin	genes,	resulting	
in	 inactive	 or	 severely	 inhibited	 gene	 expression	 and	 defective	 haemoglobin	 production	
(Harteveld	et	al.,	1994;	Higgs	et	al.,	1983;	Jankovic	et	al.,	1990;	Orkin	et	al.,	1985).		
6.1.3 Enhancer	elements	transcribe	RNA	
Enhancer	 RNAs	 (eRNAs)	 are	 short-lived	 nuclear	 RNAs,	 50-2000	 bp	 long	 on	 average,	 and	
transcribed	 from	 regions	 of	 enhancer	 elements	 devoid	 of	 H3K4me3	 (Darrow	 and	 Chadwick,	
2013;	Kim	et	al.,	2010).	eRNAs	are	commonly	bidirectionally	transcribed	from	an	enhancer	in	
low	levels	and	contain	a	5’	cap	(Djebali	et	al.,	2012;	Kim	et	al.,	2010;	Lam	et	al.,	2013),	but	in	
contrast	 to	other	RNAs,	are	not	generally	 spliced	or	polyadenylated	 (Koch	et	al.,	2011).	Only	
eRNA	transcripts	that	are	unidirectionally	transcribed	have	been	found	to	be	polyadenylated,	
and	these	transcripts	are	usually	>3	kb	(Darrow	and	Chadwick,	2013;	Kim	et	al.,	2010;	Koch	et	
al.,	2011).	Though	the	transcription	rates	of	eRNAs	positively	correlate	to	that	of	nearby	protein	
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coding	genes,	eRNAs	exhibit	shorter	half-lives	than	mRNAs	and	lncRNAs	(Kim	et	al.,	2010;	Lam	
et	al.,	2013).	Additionally,	eRNA	transcripts	are	enriched	at	active	enhancers	 interacting	with	
target	promoters	(Lin	et	al.,	2012;	Sanyal	et	al.,	2012)	and	are	suggested	to	be	a	better	predictor	
of	 enhancer	 activity	 and	 identifier	 of	 target	 genes	 than	 conventional	 bioinformatics	 such	 as	
sequence	 conservation,	 chromatin	 modifications	 and	 TF	 binding	 (Andersson,	 2014).	 The	
function	of	eRNAs	is	still	under	investigation,	however	targeted	degradation	of	eRNAs	via	RNAi	
or	RNase-H	results	in	reduced	expression	of	nearby	protein	coding	genes	in	mouse	macrophages	
(Lam	 et	 al.,	 2013),	 suggesting	 eRNAs	 contain	 some	 functional	 role	 in	 gene	 regulation.	
Additionally,	studies	in	multiple	human	and	mouse	cell	lines	have	proposed	a	role	for	eRNA	in	
stabilizing	 enhancer-promoter	 interactions	 and	 chromatin	 looping	 (Li	 et	 al.	 2013),	 as	well	 as	
recruitment	of	RNA	Pol	II	to	target	promoters	(Lam	et	al.,	2014).		
6.1.4 Chapter	6	aims	
• To	annotate	stability	elements	within	the	ZIC2	3’UTR.	
• To	assess	the	effect	of	the	3’UTR	and	NCE	on	transcript	half-life.		
• To	assess	the	effect	of	the	six	HPE-associated	SNVs	on	transcript	half-life.		 	
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6.2 Results	
6.2.1 The	ZIC2	3’UTR	contains	AU-rich	elements	
Bioinformatic	analyses	can	predict	stability	elements	in	3’UTR	sequences.	When	the	human	and	
mouse	Zic2	3’UTR	sequences	were	analysed	via	prediction	algorithms	at	the	AREsite	database	
(Gruber	et	al.,	2011),	a	conserved	64	bp	region	(overlapping	SNVs	M3	and	M4)	that	is	predicted	
to	 be	 a	 Class	 I	 ARE	 was	 identified	 in	 both	 species	 (Figure	 6.2).	 The	 motif	 has	 ‘AUUUA’	
pentameters	 at	 both	 the	 5’	 and	 3’,	 but	 only	 the	 3’	 pentamer	 contains	 the	 known	minimum	
flanking	 AU	 sequence	 required	 for	 ARE	 function	 (WWAUUUAWW).	 In	 support	 of	 this,	 the	
predicted	ZIC2	ARE	sequence	was	significantly	enriched	in	A	and	U	nucleotides	when	compared	
to	genomic	3’UTRs	(p<0.001,	two-tailed	Chi-square,	Table	6.1)	and	compared	to	the	remaining	
nucleotides	in	the	ZIC2	3’UTR.	It	is	important	to	note,	however,	that	the	putative	ARE	may	be	
longer	than	64	bp	as	distal	parameters	of	ARE	regions	are	not	well	defined	in	the	literature.		
The	presence	of	a	GRE	in	the	3’UTR	has	been	found	to	confer	stability	on	a	transcript	similar	to	
AREs.	 Thus,	 the	ZIC2	 3’UTR	 sequence	was	 analysed	 for	 the	presence	of	 a	GRE	based	on	 the	
conserved	‘UGUUUGUUUGU’	motif,	allowing	for	one	mismatch.	The	11	bp	motif	was	not	found	
in	 either	 the	 human	 nor	 mouse	 ZIC2	 3’UTR,	 suggesting	 that	 a	 GRE	 is	 not	 involved	 in	 ZIC2	
transcript	degradation.		
6.2.2 The	ZIC2	3’UTR	contains	binding	sites	for	RNA	binding	proteins	and	miRNAs	
The	RBPmap	database	(Paz	et	al.,	2014)	and	the	RBPDB	database	(Berglund	et	al.,	2008)	were	
used	to	identify	predicted	RBP	binding	sites	in	the	ZIC2	3’UTR	(Appendix	Figure	A4.1).	Predictions	
were	performed	at	90%	stringency	and	based	on	peer-reviewed	and	published	data.	Table	6.2	
summarises	the	40	RBPs	predicted	to	bind	the	human	ZIC2	3’UTR	at	316	binding	sites,	and	their	
binding	frequency.	Unlike	the	predicted	TF	binding	sites	in	Chapter	4,	the	RBP	binding	sites	are	
not	 enriched	 in	 the	 ZIC2	 conserved	 region	 (NCE)	 (Chi-squared	 goodness	 of	 fit	 test,	 p>0.05;	
Appendix	Figure	A4.1,	Table	6.3).	Furthermore,	the	predicted	RBP	sites	do	not	cluster	within	the	
ARE.	3’UTR	AREs	are	typically	enriched	in	AREBP	binding	sites	that	regulate	transcript	decay	or	
stabilization.	Whilst	there	are	11	predicted	binding	sites	for	HuR	within	the	ZIC2	3’UTR,	none	
occur	in	the	predicted	ARE	region.	HuR	is	known	promote	transcript	stability	when	bound	to	an	
ARE,	and	the	absence	of	HuR	binding	sites	suggests	the	ZIC2	ARE	most	likely	promotes	transcript	
decay.	It	cannot	be	excluded	that	HuR	can	bind	this	region	with	an	as	yet	unidentified	binding	
site,	however.		
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Figure	 6.2:	 The	 ZIC2	 3’UTR	 contains	 multiple	 predicted	 transcript	 stability	 elements.	 An	
alignment	of	the	mouse	and	human	ZIC2	3’UTRs.	A	64	bp	region	was	identified	as	a	putative	ARE	
based	on	the	presence	of	two	‘AUUUA’	pentamers	and	a	region	high	in	A/U	nucleotides	in	both	
the	 (a)	mouse	 and	 (b)	 human	ZIC2	 3’UTR.	 This	ARE	 region	overlaps	with	 the	 identified	HPE-
associated	 SNVs	 M3	 and	 M4.	 Upon	 analysis	 for	 poly(A)	 sites,	 the	 murine	 Zic2	 3’UTR	 was	
predicted	to	contain	four	poly(A)	sites	(designated	mP0,	mP1,	mP2	and	mP3,	with	P0	unlikely	to	
be	 functional),	 whilst	 the	 human	 ZIC2	 3’UTR	 was	 predicted	 to	 contain	 three	 poly(A)	 sites	
(designated	hP1,	hP2	and	hP3).	Sites	P2	and	P3	were	conserved	between	the	mouse	and	human	
3’UTR,	but	P1	was	not.	(c)	Long	RNAs	are	predicted	to	be	transcribed	from	within	the	ZIC2	3’UTR.	
CSHL	Long	RNA-seq	(>200	nt;	dark	blue)	and	CSHL	Small	RNA-seq	(<200	nt;	yellow)	(Cheng	et	al.,	
2015;	 Langmead	et	al.,	 2009;	Parkhomchuk	et	al.,	 2009)	UCSC	Genome	Browser	 tracks	were	
used	to	annotate	RNA	molecules	predicted	to	be	transcribed	from	within	the	ZIC2	3’UTR.	It	is	
possible	that	these	RNA	molecules	represent	eRNA.	RNA-seq	contigs	with	their	5’	in	the	CDS	of	
Zic2	were	excluded	from	analysis.	Black,	HPE-associated	SNVs;	pink,	poly(A)	sites;	dark	green	
triangles,	 forward	 oligonucleotides	 used	 in	 the	 poly(A)	 RT-qPCR	 assay;	 light	 green,	 reverse	
oligonucleotides	used	in	the	poly(A)	RT-qPCR	assay;	light	green	rectangle,	ARE.	
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Table	6.1:	The	ZIC2	3’UTR	ARE	is	enriched	in	AU	nucleotides.	A	two-tailed	Chi-square	was	used	
to	compare	the	AU	and	GC	content	in	the	ZIC2	3’UTR	putative	ARE	(Observed)	with	the	AU	and	
GC	content	in	3’UTRs	across	the	human	genome	(Expected)	(L.	Zhang	et	al.,	2004).	A	significance	
threshold	of	p<0.05	was	used,	with	*	indicating	statistical	significance.		
	
	 Nucleotides	 Observed	 Expected	
ZIC2	3’UTR	vs	Genome	 AU	 62.9%	 57.6%	
GC	 37.1%	 42.4%	
	 Chi-square	 1.026	with	1	degree	of	freedom	
	 p	 =0.3110	
ZIC2	ARE	vs	ZIC2	3’UTR	 AU	 79.7%	 62.9%	
GC	 20.3%	 37.1%	
	 Chi-square	 12.398	with	1	degree	of	freedom	
	 p	 <0.001*	
ZIC2	ARE	vs	Genome	 AU	 79.7%	 57.6%	
GC	 20.3%	 42.4%	
	 Chi-square	 19.869	with	1	degree	of	freedom	
	 p	 <0.0001*	
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Table	6.2:	The	frequency	of	each	RBP	predicted	to	bind	the	ZIC2	3’UTR.	Table	correlates	with	
Appendix	Figure	A4.1,	which	shows	the	positions	of	the	binding	sites.	Frequency	refers	to	the	
number	of	binding	sites	predicted	to	occur	for	each	RBP.	A	*	denotes	RBPs	with	binding	sites	
predicted	to	occur	in	the	putative	ARE.	
RBP	 Frequency	 RBP	 Frequency	
A1CF	 4*	 PABPC	 7	
A2BP	 1	 PCBP	 10	
BRUNOL	 1	 PTBP	 20*	
CNOT	 1*	 PUM	 12*	
CPEB	 8	 QKI	 1*	
CUGBP	 6	 RALY	 11	
EIF4B	 3*	 RBM	 14*	
ELAVL	 14	 RBMX	 8*	
ESRP	 1	 SART	 5	
FUS	 3	 SFPQ	 4	
G3BP	 2	 SRSF	 29*	
HNRNP	 21	 TARDBP	 12	
HNRPLL	 2	 TRA	 24	
HUR	 11	 TUT	 1*	
IGF2BP	 2	 U2AF	 7	
KHDRBS	 14*	 YBX	 3	
KHSRP	 2	 YTHDC	 1	
MATR	 2	 ZC3H	 8	
MBNL	 31*	 ZCRB	 3*	
NOVA	 5	 ZNF	 1	
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Enrichment	of	 predicted	RBP	binding	 sites	 occurs	 at	 five	 out	 of	 the	 six	HPE-associated	 SNVs	
nucleotides	 (p<0.01;	 Table	 6.3),	 including	M3	which	 resides	 within	 the	 ARE.	 In	 contrast,	 no	
putative	binding	sites	overlap	with	M4,	which	also	resides	within	the	ARE.	This	suggests	that	
select	regions	within	the	64	bp	ARE	exhibit	RBP	binding	site	clusters,	but	not	the	entire	element.	
Upon	in	silico	introduction	of	the	six	 identified	SNVs,	the	binding	sites	of	some	RBPs,	such	as	
A1CF,	were	 lost,	whilst	new	binding	sites	were	also	created	(Appendix	Figure	A4.1	and	Table	
6.4),	including	a	site	overlapping	with	M4.	The	SNVs	therefore	may	change	the	content	of	the	
exosome	bound	to	this	region	during	the	decay	process	and	alter	transcript	stability.		
Like	RBPs,	regulation	of	ZIC2	transcript	decay	may	occur	via	the	binding	of	miRNAs	to	the	ZIC2	
3’UTR.	The	human	ZIC2	3’UTR	was	screened	for	miRNA	binding	sites	using	the	database	miRanda	
(Betel	et	 al.,	 2008;	 John	et	 al.,	 2004),	miRNASNP	 (Gong	et	 al.,	 2015)	 and	DIANA-microT-CDS	
(Paraskevopoulou	 et	 al.,	 2013;	 Reczko	 et	 al.,	 2012).	 Predictions	 were	 performed	 at	 90%	
stringency	based	on	peer-reviewed	and	published	ChIP	data.	Appendix	Figure	A4.2	and	Table	
6.5	detail	the	248	miRNAs	that	are	predicted	to	bind	the	ZIC2	3’UTR	at	420	sites.	Similar	to	RBPs,	
miRNA	binding	sites	were	not	enriched	in	the	NCE	or	ARE	regions	(p>0.05;	Table	6.6),	but	were	
enriched	 at	 the	 six	 HPE-associated	 SNVs	 (p<0.01).	 Along	 with	 the	 lack	 of	 RBP	 binding	 site	
enrichment	 at	 the	 ARE,	 this	 suggests	 the	 entire	 3’UTR	 is	 required	 to	 direct	mRNA	 decay	 by	
binding	of	RBPs	and	miRNAs,	rather	than	the	ARE	alone.		
To	determine	what	effect,	if	any,	the	six	HPE-associated	SNVs	had	on	miRNA	binding	to	the	ZIC2	
3’UTR,	miRNASNP	and	mrSNP	databases	were	utilised	(Deveci	et	al.,	2014;	Gong	et	al.,	2015).	As	
miRNA	are	able	to	bind	to	their	targets	without	a	complete	complimentary	site,	introducing	the	
six	 SNVs	 into	 the	 3’UTR	 did	 not	 create	 new	 or	 remove	 any	 existing	 miRNA	 binding	 site	
predictions.	Their	introduction,	however,	did	result	in	a	change	in	the	predicted	strength	of	the	
miRNAs	binding	to	the	ZIC2	3’UTR,	as	those	sites	with	a	higher	 level	of	complementation	are	
more	 strongly	 bound	 by	miRNA	 than	 those	 with	 lower	 complementation	 (Brennecke	 et	 al.,	
2005).	The	introduction	of	M1	and	M6	are	predicted	to	result	in	an	increase	in	binding	strength	
for	four	miRNAs,	whilst	the	introduction	of	M2	and	M4	are	predicted	to	result	in	a	decrease	in	
binding	strength	 for	 three	miRNAs	(Table	6.7).	These	results	suggest	 that	 the	 introduction	of	
SNVs	into	the	ZIC2	3’UTR	may	change	the	regulation	of	ZIC2	transcripts	by	altering	the	ability	of	
miRNAs	to	interact	with	the	3’UTR	and	direct	decay.	
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Table	6.3:	Predicted	RBP	binding	sites	are	enriched	at	the	HPE-associated	SNVs	in	the	wildtype	
ZIC2	3’UTR.	A	two-tailed	Chi-squared	goodness	of	fit	test	was	performed	to	determine	whether	
the	 predicted	RBP	 binding	 sites	were	 randomly	 distributed	within	 the	 3’UTR.	 Significance	 of	
p<0.05	(*)	or	p<0.01	(**)	indicates	predicted	binding	site	enrichment	in	the	region	being	tested.	
(a)	Binding	site	enrichment	in	the	non-coding	conserved	element	(NCE;	540	bp)	compared	to	
the	non-conserved	region	(559	bp)	of	the	ZIC2	3’UTR.	(b)	Binding	site	enrichment	in	the	AU-rich	
element	 (ARE;	 64	 bp)	 compared	 to	 the	 remaining	 ZIC2	 3’UTR	 (1035	 bp).	 (c)	 Binding	 site	
enrichment	at	the	individual	HPE-associated	SNVs	(1	bp)	compared	to	the	non-mutated	3’UTR	
(1089	bp).	Observed	and	expected	values	are	indicated.	Degrees	of	freedom	=	1	for	all	analyses.		
A	 Observed	(n=316)	 Expected	 !2	 p	
Non-conserved	
region	 153	 160.74	 0.759	 0.3838	
NCE	 163	 155.26	
	 	 	 	 	
B	 Observed	(n=316)	 Expected	 !2	 p	
Non-ARE	 298	 297.60	
0.009	 0.9234	
ARE	 18	 18.40	
	 	 	 	 	
C	 Observed	(n=316)	 Expected	 !2	 P	
M1	 3	 0.29	 25.348	 0.0001**	
M2	 3	 0.29	 25.348	 0.0001**	
M3	 3	 0.29	 25.348	 0.0001**	
M4	 0	 0.29	 0.290	 0.5900	
M5	 4	 0.29	 47.506	 0.0001**	
M6	 4	 0.29	 47.506	 0.0001**	
Non-mutated	
3’UTR	
n	–	mutant	
observed		 315.75	 	 	
	 	
		 203	
Table	6.4:	RBP	binding	sites	are	lost	or	gained	following	introduction	of	the	six	HPE-associated	
identified	SNVs.	Table	correlates	with	Appendix	Figure	4.1.	
	
Mutation	 Lost	RBP	 Gained	RBP	
M1	 CPEB	
HNRNP	
MBNL	
RBMX	
M2	 PCBP	 HNRNP	
SRSF	
M3	 PUM	
A1CF	
-	
M4	 -	 A1CF	
M5	 KHDRBS	
PUM	
PABPC	
QKI	
M6	 A1CF	 -	
	
	
	
	
	
	
	
	
	
	
Table	6.5:	The	 frequency	of	each	miRNA	predicted	to	bind	the	ZIC2	3’UTR.	Table	correlates	
with	Appendix	Figure	A4.2,	which	shows	the	positions	of	the	binding	sites.	Frequency	refers	to	
the	number	of	binding	sites	predicted	to	occur	for	each	miRNA.	A	*	denotes	miRNA	predicted	
to	bind	within	the	putative	ARE.	
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miRNA	 Freq.	 miRNA	 Freq.	 miRNA	 Freq.	
hsa-let-7	 2	 hsa-miR-182	 1	 hsa-miR-520d-5p	 3*	
hsa-let-7a-2-3p	 2	 hsa-miR-185-5p	 1	 hsa-miR-522-3p	 2*	
hsa-let-7c-3p	 1	 hsa-miR-191-3p	 1	 hsa-miR-524-5p	 3*	
hsa-let-7g-3p	 2	 hsa-miR-204-3p	 1	 hsa-miR-539	 1	
hsa-miR-7-1-3p	 1	 hsa-miR-205	 1	 hsa-miR-539-3p	 1	
hsa-miR-7-2-3p	 1	 hsa-miR-212	 1	 hsa-miR-543	 5*	
hsa-miR-10b-3p	 1	 hsa-miR-224-3p	 2*	 hsa-miR-548	 4*	
hsa-miR-18a-5p	 1	 hsa-miR-297	 1	 hsa-miR-548aa	 3	
hsa-miR-18b	 1	 hsa-miR-302a-5p	 2	 hsa-miR-548aj-3p	 5	
hsa-miR-23a-3p	 3	 hsa-miR-320a	 3	 hsa-miR-548aj-5p	 1	
hsa-miR-23b-3p	 3	 hsa-miR-320b	 3	 hsa-miR-548ap-3p	 3	
hsa-miR-23c	 3	 hsa-miR-320c	 3	 hsa-miR-548ar-3p	 4	
hsa-miR-30a	 1	 hsa-miR-320d	 3	 hsa-miR-548as-3p	 3	
hsa-miR-30c	 1	 hsa-miR-323a	 1	 hsa-miR-548aw	 1	
hsa-miR-30d	 1	 hsa-miR-323a-3p	 3	 hsa-miR-548c-3p	 5	
hsa-miR-30e	 1	 hsa-miR-335-3p	 4	 hsa-miR-548e-5p	 3	
hsa-miR-32	 2*	 hsa-miR-337	 1	 hsa-miR-548f-5p	 1	
hsa-miR-33a	 1	 hsa-miR-340-5p	 1*	 hsa-miR-548g-5p	 1	
hsa-miR-33b	 1	 hsa-miR-371b-5p	 1	 hsa-miR-548t-3p	 3	
hsa-miR-92a-2-5p	 1	 hsa-miR-373-5p	 1	 hsa-miR-548u	 1	
hsa-miR-96-5p	 1	 hsa-miR-374b-3p	 1	 hsa-miR-548x-3p	 5	
hsa-miR-105-5p	 3*	 hsa-miR-374c	 2*	 hsa-miR-548x-5p	 1	
hsa-miR-125	 1	 hsa-miR-377-3p	 3	 hsa-miR-564	 2	
hsa-miR-125b-2-3p	 3	 hsa-miR-421	 1	 hsa-miR-582	 1	
hsa-miR-126-5p	 1	 hsa-miR-451b	 1*	 hsa-miR-583	 2	
hsa-miR-129-5p	 2	 hsa-miR-485-3p	 1	 hsa-miR-586	 2	
hsa-miR-1292-5p	 1	 hsa-miR-491	 3	 hsa-miR-590-3p	 2	
hsa-miR-1305	 2	 hsa-miR-491-5p	 1	 hsa-miR-607	 2	
hsa-miR-132	 1	 hsa-miR-493-5p	 2*	 hsa-miR-608	 1	
hsa-miR-1321	 1	 hsa-miR-494	 2	 hsa-miR-609	 3	
hsa-miR-133a-5p	 1	 hsa-miR-494-3p	 3	 hsa-miR-616-5p	 1	
hsa-miR-136-3p	 1	 hsa-miR-497	 1	 hsa-miR-620	 1	
hsa-miR-138	 1	 hsa-miR-497-3p	 3	 hsa-miR-624-3p	 1	
hsa-miR-140-3p	 1	 hsa-miR-499	 2	 hsa-miR-639	 1	
hsa-miR-145	 1	 hsa-miR-499a-3p	 2	 hsa-miR-655	 3*	
hsa-miR-149-3p	 1	 hsa-miR-499b-3p	 2	 hsa-miR-659-3p	 1	
hsa-miR-153-5p	 4	 hsa-miR-500a-5p	 1	 hsa-miR-663a	 1	
hsa-miR-181	 1	 hsa-miR-503-3p	 1	 hsa-miR-675-3p	 2	
hsa-miR-181a	 2*	 hsa-miR-513	 2	 hsa-miR-765	 2	
hsa-miR-181b	 2*	 hsa-miR-513b	 3	 hsa-miR-766-5p	 1	
hsa-miR-181c	 2*	 hsa-miR-513b-5p	 3	 hsa-miR-873-5p	 1	
hsa-miR-181d	 2*	 hsa-miR-5196-5p	 1	 hsa-miR-876	 1	
	
	 	
		 205	
	
miRNA	 Freq.	 miRNA	 Freq.	 miRNA	 Freq.	
hsa-miR-876-3p	 1	 hsa-miR-3928	 1	 hsa-miR-4749-5p	 2	
hsa-miR-1237-3p	 1	 hsa-miR-4253	 1	 hsa-miR-4756-5p	 1	
hsa-miR-1238	 2	 hsa-miR-4262	 3	 hsa-miR-4761-5p	 1	
hsa-miR-1238-3p	 1*	 hsa-miR-4270	 2	 hsa-miR-4766-5p	 2	
hsa-miR-1246	 2*	 hsa-miR-4282	 1	 hsa-miR-4775	 2*	
hsa-miR-1252	 1	 hsa-miR-4306	 1	 hsa-miR-4784	 1	
hsa-miR-1255b-2-3p	 1	 hsa-miR-4311	 2	 hsa-miR-4788	 1	
hsa-miR-1261	 1*	 hsa-miR-4419a	 1	 hsa-miR-4789-5p	 1	
hsa-miR-1270	 1	 hsa-miR-4422	 3	 hsa-miR-5008-5p	 1	
hsa-miR-1271-5p	 1	 hsa-miR-4423-5p	 1	 hsa-miR-5582-3p	 3	
hsa-miR-1277-5p	 2*	 hsa-miR-4429	 3	 hsa-miR-5583-3p	 1*	
hsa-miR-1284	 1	 hsa-miR-4432	 1	 hsa-miR-5680	 3	
hsa-miR-1289	 1	 hsa-miR-4441	 2	 hsa-miR-5688	 1	
hsa-miR-1292-5p	 1	 hsa-miR-4446-3p	 1	 hsa-miR-6071	 1	
hsa-miR-1305	 2	 hsa-miR-4457	 3	 hsa-miR-6074	 1	
hsa-miR-1321	 1	 hsa-miR-4463	 1	 hsa-miR-6125	 2	
hsa-miR-1323	 2	 hsa-miR-4464	 1	 hsa-miR-6127	 1	
hsa-miR-1908	 1	 hsa-miR-4476	 1	 hsa-miR-6129	 1	
hsa-miR-3115	 1	 hsa-miR-4485	 1	 hsa-miR-6130	 1	
hsa-miR-3137	 1*	 hsa-miR-4490	 1	 hsa-miR-6133	 1	
hsa-miR-3148	 1	 hsa-miR-4495	 2	 hsa-miR-6504-3p	 3*	
hsa-miR-3150b-3p	 1	 hsa-miR-4633	 2	 hsa-miR-6510-5p	 1	
hsa-miR-3152-5p	 1	 hsa-miR-4633-5p	 1	 hsa-miR-6515-3p	 1	
hsa-miR-3153	 1	 hsa-miR-4644	 1	 hsa-miR-6715a-3p	 2	
hsa-miR-3154	 5	 hsa-miR-4646-5p	 1	 hsa-miR-6715b-3p	 1	
hsa-miR-3162-5p	 1	 hsa-miR-4651	 1	 hsa-miR-6748-5p	 2	
hsa-miR-3163	 1	 hsa-miR-4668-3p	 2	 hsa-miR-6754-5p	 2	
hsa-miR-3173-3p	 1	 hsa-miR-4670-3p	 1	 hsa-miR-6756-5p	 3	
hsa-miR-3177-3p	 1	 hsa-miR-4672	 1	 hsa-miR-6759-5p	 2	
hsa-miR-3179	 1	 hsa-miR-4694-3p	 5*	 hsa-miR-6766-5p	 2	
hsa-miR-3180	 1	 hsa-miR-4699-3p	 2*	 hsa-miR-6776-3p	 2	
hsa-miR-3196	 1	 hsa-miR-4706	 2	 hsa-miR-6780a-3p	 1*	
hsa-miR-3200-5p	 1	 hsa-miR-4719	 3	 hsa-miR-6793-5p	 2	
hsa-miR-3202	 4	 hsa-miR-4721	 1	 hsa-miR-6796-5p	 1	
hsa-miR-3622b-5p	 1	 hsa-miR-4728-5p	 1	 hsa-miR-6835-3p	 2	
hsa-miR-3650	 1	 hsa-miR-4731-5p	 1	 hsa-miR-6839-3p	 1	
hsa-miR-3658	 1	 hsa-miR-4734	 1	 hsa-miR-6875-3p	 2*	
hsa-miR-3671	 1	 hsa-miR-4735-3p	 1	 hsa-miR-7159-5p	 2	
hsa-miR-3679-3p	 1	 hsa-miR-4739	 1	 hsa-miR-7515	 4	
hsa-miR-3692-3p	 1	 hsa-miR-4742-3p	 2*	 hsa-miR-7849-3p	 1	
hsa-miR-3692-5p	 2	 hsa-miR-4747-5p	 1	 hsa-miR-7853-5p	 3*	
hsa-miR-3914	 4	 hsa-miR-4748	 1	 	 	
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Table	 6.6:	 Predicted	miRNA	 binding	 sites	 are	 enriched	 at	 the	 HPE-associated	 SNVs	 in	 the	
wildtype	ZIC2	3’UTR.	A	two-tailed	Chi-squared	goodness	of	fit	test	was	performed	to	determine	
whether	 the	 predicted	 miRNA	 binding	 sites	 were	 randomly	 distributed	 within	 the	 3’UTR.	
Significance	of	p<0.05	(*)	or	p<0.01	(**)	indicates	predicted	binding	site	enrichment	in	the	region	
being	tested.	(a)	Binding	site	enrichment	in	the	non-coding	conserved	element	(NCE;	540	bp)	
compared	to	the	non-conserved	region	(559	bp)	of	the	ZIC2	3’UTR.	(b)	Binding	site	enrichment	
in	the	AU-rich	element	(ARE;	64	bp)	compared	to	the	remaining	ZIC2	3’UTR	(1035	bp).	(c)	Binding	
site	 enrichment	 at	 the	 individual	HPE-associated	 SNVs	 (1	 bp)	 compared	 to	 the	non-mutated	
3’UTR	(1089	bp).	Observed	and	expected	values	are	indicated.	Degrees	of	freedom	=	1	for	all	
analyses.		
A	 Observed	(n=420)	 Expected	 !2	 p	
NCE	 218	 206.37	
1.289	 0.2563	Non-conserved	
region	 202	 213.63	
	 	 	 	 	
B	 Observed	(n=420)	 Expected	 !2	 p	
ARE	 32	 24.45	
2.476	 0.1156	
Non-ARE	 388	 395.55	
	 	 	 	 	
C	 Observed	(n=420)	 Expected	 !2	 p	
M1	 10	 0.38	 243.76	 0.0001**	
M2	 12	 0.38	 355.65	 0.0001**	
M3	 6	 0.38	 83.19	 0.0001**	
M4	 5	 0.38	 56.22	 0.0001**	
M5	 9	 0.38	 195.71	 0.0001**	
M6	 6	 0.38	 83.19	 0.0001**	
Non-mutated	
3’UTR	
n	–	mutant	
observed		 419.62	 	 	
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Table	6.7:	Predicted	changes	in	thermodynamic	binding	upon	introduction	of	the	six	identified	
SNVs.	Changed	were	predicted	via	mrSNP	and	miRNASNP	databases	(Deveci	et	al.,	2014;	Gong	
et	al.,	2015).	A	*	indicates	a	change	in	thermodynamic	strength	that	is	unlikely	to	have	a	large	
impact.	
	
Mutation	 miRNA	 Energy	when	WT	 Energy	 When	
Mutated	
Direction	of	Change	
M1	 hsa-miR-3163	 -16	kcal/mol	 -39.4	kcal/mol	 Increased		
M1	 hsa-miR-4694	 0	kcal/mol	 -40.1	kcal/mol	 Increased	
M2	 hsa-miR-3148	 -41.3	kcal/mol	 -17.3	kcal/mol	 Decreased	
M2	 hsa-miR-4476	 -15.29	kcal/mol	 -12.42	kcal/mol	 Decreased	
M4	 hsa-miR-3137	 -15.77	kcal/mol	 -15.04	kcal/mol	 Decreased	*	
M6	 hsa-miR-582	 -13.9	kcal/mol	 -40.8	kcal/mol	 Increased	
M6	 hsa-miR-493-5p	 -12.66	kcal/mol	 -12.80	kcal/mol	 Increased	*	
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6.2.3 The	ZIC2	3’UTR	contains	multiple	PASs	
The	location	of	PASs	in	the	human	and	mouse	ZIC2	3’UTR	were	predicted	using	the	Poly(A)	Signal	
Miner	(Liu	et	al.,	2003)	and	AREsite	database	(Gruber	et	al.,	2011)	which	identify	putative	PASs	
via	the	‘AAUAAA’	and	‘AUUAAA’	motifs.	A	probability	score	greater	than	0.6	indicates	a	site	that	
is	predicted	to	be	functional.	In	the	mouse	3’UTR,	four	putative	PASs	were	annotated,	of	which	
three	(mP1-mP3)	are	predicted	to	be	real	(Table	6.8).	The	second	site	(mP1)	was	not	conserved	
between	 the	 mouse	 and	 human	 genomes,	 whilst	 the	 third	 and	 fourth	 sites	 (P2	 and	 P3,	
respectively)	were	highly	conserved	between	both	genomes.	In	comparison	to	the	mouse	3’UTR,	
three	putative	poly(A)	sites	were	identified	in	the	human	3’UTR	and	designated	hP1,	P2	and	P3	
(Figure	6.2).	Whilst	hP1	and	P2	are	likely	to	be	real	(p>0.6),	P3	exhibited	a	low	probability	score	
and	may	 be	 a	 sequence	 artefact.	 Nevertheless,	 the	 high	 level	 of	 conservation	 between	 the	
mouse	and	human	P3	suggests	this	PAS	is	worth	investigating	further.	Three	additional	PAS	were	
predicted	 upstream	 of	 hP1	 (designated	 hPA0.1,	 hPA0.2	 and	 hPA0.3),	 however	 these	 were	
clustered	together	in	an	AU	rich	string	of	nucleotides	and	are	unlikely	to	be	functional	(p>0.6).	
In	summary,	both	human	and	mouse	ZIC2	3’UTRs	are	predicted	to	contain	three	PASs,	of	which	
only	the	two	most	distal	PASs	are	conserved.	The	3’UTR	of	both	species	was	screened	for	an	
additional	nine	non-canonical	PASs	(identified	in	(Beaudoing	et	al.,	2000)),	however	these	were	
not	predicted	to	occur	in	either	human	or	mouse	ZIC2	3’UTR	transcripts.		
hP1,	mP1,	P2	and	P3	do	not	overlap	directly	with	a	predicted	SNV.	P2	occurs	 in	 the	nine	bp	
between	M3	and	M4	in	both	species	and	is	also	in	the	middle	of	the	predicted	ARE	region	(Figure	
6.2).	This,	coupled	with	the	large	number	of	predicted	RBP	and	miRNA	binding	sites,	suggests	
that	the	region	surrounding	M3	and	M4	in	the	ZIC2	3’UTR	is	an	active	site	of	transcript	regulation	
and	that	the	SNVs	may	affect	transcript	stability.	Similarly,	both	hPA1	and	mPA1	occur	within	28	
bp	of	a	SNV	 (M1	and	M2,	 respectively),	 suggesting	 these	mutations	may	be	able	 to	exert	an	
influence	on	alternative	polyadenylation.	The	overall	predicted	effect	of	the	six	HPE-associated	
SNVs	on	ZIC2	mRNA	stability	is	summarised	in	Table	6.9.	
To	determine	if	one	PAS	in	the	ZIC2	3’UTR	was	preferentially	used	in	mouse	and	human	tissue,	
published	 ZIC2	 EST	 transcripts	 on	 UniGene	 (Pubmed)	 with	 known	 tissue	 of	 origin	 were	
assembled	 and	 their	 transcript	 length	 compared	 in	 multiple	 tissues.	 The	 sequence	 of	 each	
transcript	 was	 aligned	 to	 both	 the	 human	 and	 mouse	 ZIC2	 3’UTR,	 allowing	 for	 up	 to	 five	
mismatches	in	the	sequence.	Upon	alignment	to	the	ZIC2	3’UTR,	the	PAS	closest	to	the	end	of		
		 	
		 209	
Table	6.8:	The	mouse	and	human	ZIC2	3’UTRs	are	predicted	to	contain	multiple	poly(A)	sites.	
Sites	 were	 predicted	 using	 the	 Poly(A)	 Signal	Miner	 (Liu	 et	 al.,	 2003)	 and	 AREsite	 database	
(Gruber	et	al.,	2011).	A	probability	score	>0.6	indicates	a	site	that	is	predicted	to	be	real.	Human	
sites	are	denoted	by	h,	murine	sites	by	m.	Poly(A)	sites	correlate	with	Figure	6.2.	
	
PAS	 Start	
bp	
PAS	
Type	
Probability	
Score	
Conserved	
between	 mouse	
and	human?	
hP0.1	 239	 AATAAA	 0.499	 No	
hP0.2	 246	 AATAAA	 0.505	 No	
hP0.3	 254	 AATAAA	 0.520	 No	
hP1	 810	 AATAAA	 0.969	 No	
hP2	 891	 ATTAAA	 0.705	 Yes	
hP3	 1062	 AATAAA	 0.092	 Yes	
mP0	 85	 ATTAAA	 0.238	 No	
mP1	 562	 ATTAAA	 0.883	 No	
mP2	 895	 ATTAAA	 0.673	 Yes	
mP3	 1065	 AATAAA	 0.68	 Yes	
	
	
	
	
	
	
	
Table	 6.9:	 The	 six	HPE-associated	 SNVs	 are	 predicted	 to	 influence	ZIC2	 transcript	 stability.	
SNVs	 that	 are	 predicted	 to	 alter	 the	 destabilising	 or	 stabilising	 influence	 conferred	 by	 each	
element	onto	the	ZIC2	mRNA	are	denoted	with	an	X.	
Stability	element	 M1	 M2	 M3	 M4	 M5	 M6	
ARE	region	 	 	 X	 X	 	 	
RBPs	 X	 X	 X	 X	 X	 X	
miRNA	 X	 X	 	 X	 	 X	
Poly(A)	sites	 X	 X	 X	 X	 	 	
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the	transcript	was	determined	and	correlated	to	the	tissue	of	transcript	origin.	A	total	of	thirteen	
adult	samples	(but	no	embryonic	samples)	were	available	for	the	human	ZIC2	transcript	(Table	
6.10).	All	five	brain	tissue	samples	and	all	three	bone	tissue	samples	utilised	the	most	distal	PAS	
(P3),	whilst	only	one	of	five	lung	samples	terminated	at	this	site	(Table	6.10).	The	remaining	four	
lung	 transcripts	 appear	 to	 terminate	midway	 through	 the	 3’UTR	where	 no	 PAS	 is	 predicted,	
suggesting	that	there	may	be	a	yet	unidentified	PAS	in	this	region	or	an	experimental	artefact.	
No	other	tissue	types	were	able	to	be	aligned	to	the	ZIC2	3’UTR,	and	only	one	mouse	record	was	
available,	preventing	analysis	of	mouse	PASs.	
6.2.4 The	3’UTR	Influence	ZIC2	Transcript	Decay	Rates	
To	analyse	whether	the	3’UTR	is	involved	in	post-transcriptional	regulation	of	ZIC2	transcripts,	
an	assay	was	designed	to	evaluate	transcript	levels	following	transcriptional	blockade	in	cultured	
mammalian	cells	and	relative	quantification	of	ZIC2	transcript.	It	was	expected	that	the	presence	
of	 the	 3’UTR,	 which	 contains	 the	 putative	 ARE	 region,	 will	 alter	 steady-state	 levels	 of	 ZIC2	
transcript	and	significantly	 increase	the	rate	of	decay.	Optimization	of	 the	RT-qPCR	protocol,	
selection	 of	 appropriate	 reference	 genes	 and	 oligonucleotide	 efficiency	 testing	 were	 all	
performed	 in	 conjunction	 with	 Kathryn	 Dickson	 (Appendix	 Section	 4.1-4.3).	 Total	 RNA	 was	
extracted	 from	HEK293T	cells	 transfected	with	pV5-ZIC2	or	pV5-ZIC2-3’UTR	 (Appendix	Figure	
A4.3)	and	checked	for	integrity	and	lack	of	gDNA	contamination	prior	to	RT-qPCR	analysis.	Cells	
transfected	with	pV5-ZIC2	were	exhibited	a	significantly	higher	fold	change	in	ZIC2	expression	
above	 background	 levels	 than	 cells	 transfected	 with	 pV5-ZIC2-3’UTR	 (Figure	 6.3	 A	 and	 B),	
indicating	that	the	presence	of	the	3’UTR	decreased	steady-state	ZIC2	transcript	levels.	
To	determine	if	this	difference	was	due	to	transcript	degradation,	transcription	was	halted	via	
the	 addition	 of	 the	 transcriptional	 inhibitor	 DRB	 (5,6-dichloro-1-beta-D-
ribofuranosylbenzimidazole)	and	mRNA	decay	rates	assessed.	HEK293T	cells	 transfected	with	
pV5-ZIC2	and	pV5-ZIC2-3’UTR,	along	with	untransfected	cells,	were	treated	with	200	μM	DRB	or	
the	vehicle	control	(0.2%	DMSO)	24	hr	post	transfection	and	RT-qPCR	used	to	quantify	the	fold	
change	in	ZIC2	expression	at	multiple	time	points	(0	hours	[not	treated	with	DRB],	2	and	4	hours).	
The	level	of	ZIC2	transcript	in	DRB	treated	cells	was	calculated	as	a	percentage	of	the	level	in	
vehicle	 only	 treated	 cells	 from	 the	 equivalent	 time	 point,	 and	 plotted	 over	 time.	 The	 fold	
changes	of	ZIC2	expression	quantified	in	cells	treated	with	fresh	DRB	were	lower	than	those	in	
the	 equivalent	 vehicle	 control	 treated	 cells,	 indicating	 DRB	 was	 having	 an	 inhibitory	
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Table	6.10	Human	EST	clones	and	tissue	expression.	
GenBank	ID	 cDNA	Clone	 End	
Position	
Poly(A)	
site	
Tissue	 Nearby	
AI458310.1	 IMAGE:2150307	 414	 -	 Lung	 41	bp	upstream	(5’)	of	M1	
AA885663.1	 IMAGE:1500176	 482	 -	 Lung	 26	bp	downstream	(3’)	of	
M1	
95	bp	upstream	(5’)	of	M2	
AA900219.1	 IMAGE:1604674	 588	 -	 Lung	 10	bp	downstream	(3’)	of	
M2	
BE219194.1	 IMAGE:3176777	 624	 -	 Lung	 46	bp	downstream	(3’)	of	
M2	
BF594212.1	 IMAGE:3564059	 1075	 PA3	 Brain	 3’	transcript	end	at	1082	
BF438724.1	 IMAGE:3275267	 1081	 PA3	 Brain	 3’	transcript	end	at	1082	
BU619638.1	 UI-H-FH1-bfq-o-
01-0-UI	
1082	 PA3	 Bone	 3’	transcript	end	at	1082	
CA427434.1	 UI-H-FH1-bfi-b-
11-0-UI	
1082	 PA3	 Bone	 3’	transcript	end	at	1082	
AA491603.1	 IMAGE:910539	 1082	 PA3	 Bone	 3’	transcript	end	at	1082	
R42515.1	 IMAGE:29730	 1082	 PA3	 Brain	 3’	transcript	end	at	1082	
AI359104.1	 IMAGE:2012588	 1082	 PA3	 Brain	 3’	transcript	end	at	1082	
R61372.1	 IMAGE:	37980	 1082	 PA3	 Brain	 3’	transcript	end	at	1082	
BG149342.1	 IMAGE:3366742	 1082	 PA3	 Lung	 3’	transcript	end	at	1082	
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Figure	6.3:	The	3’UTR	decrease	ZIC2	mRNA	half-life.	(a-b)	ZIC2	expression	was	normalized	to	
(a)	ABCE1	or	(b)	PPP1R8.	The	fold	change	was	calculated	via	2-DDCT.	(c-d)	The	percentage	of	ZIC2	
mRNA	remaining	over	time	after	treatment	with	DRB,	calculated	relative	to	ZIC2	expression	in	
DMSO	treated	cells.	DRB	(200	μM)	or	DMSO	only	was	used	to	treat	HEK293T	cells,	24	hours	post	
transfection	with	pV5-ZIC2	(blue	line)	or	pV5-ZIC2-3’UTR	(orange	line).	RNA	was	extracted	from	
cells	 at	 0,	 2	 and	 4	 hours	 following	 DRB	 treatment	 and	 the	 fold	 change	 in	 ZIC2	 expression	
quantified	by	RT-qPCR	at	each	time	point	as	2−∆∆	CT.	The	fold	change	in	ZIC2	expression	in	DRB	
treated	cells	was	calculated	as	a	percentage	of	that	quantified	from	DMSO	only	treated	cells	
transfected	with	the	same	base	construct,	at	the	equivalent	time	point.	The	trend	line	shows	
the	 exponential	 relationship	 of	 the	 proportion	 of	 ZIC2	 mRNA	 remaining	 over	 time.	 (c)	 The	
percentage	of	ZIC2	mRNA	remaining	normalised	using	ABCE1.	(d)	The	percentage	of	ZIC2	mRNA	
remaining	normalised	using	PPP1R8.	(e)	The	half-life	of	ZIC2	mRNA	in	the	presence	and	absence	
of	the	3’UTR.	N=3.	*:	p<0.001,	Student’s	T-Test;	n=3;	error	bars:	S.E.M.	
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effect	on	 transcription	as	expected	 (not	 shown).	The	percentage	of	ZIC2	mRNA	 remaining	 in	
inhibited	cells	transfected	with	either	construct	appeared	to	decrease	in	an	exponential	fashion	
over	time	(Figure	6.3	C	and	D),	therefore	the	half-life	of	ZIC2	mRNA	in	cells	transfected	with	the	
constructs	was	approximated	from	the	nonlinear	regression	of	the	data	points.	ZIC2	mRNA	in	
cells	 transfected	 with	 pV5-ZIC2-3’UTR	 was	 found	 to	 have	 a	 shorter	 half-life	 than	 in	 cells	
transfected	with	 pV5-ZIC2	 (Figure	 6.3	 E),	 indicating	 that	 the	 inclusion	 of	 the	 3’UTR	 leads	 to	
increased	ZIC2	mRNA	degradation	within	a	 cell.	As	 constructs	 containing	 the	mutated	3’UTR	
were	unable	to	be	created,	analysis	of	how	the	six	SNVs	influenced	transcript	decay	rates	could	
not	be	performed.	
6.2.5 The	Zic2	3’UTR	employs	the	most	distal	poly(A)	site	at	gastrulation	
To	 determine	 which	 of	 the	 three	 mouse	 PASs	 were	 most	 likely	 to	 be	 used	 during	 embryo	
development,	 two	 approaches	 were	 taken:	 Rapid	 Amplification	 of	 cDNA	 Ends	 (RACE)	 and	
relative	quantification	of	the	Zic2	transcript	at	multiple	locations	within	the	3’UTR	via	RT-qPCR.	
For	RACE,	the	Zic2	3’UTR	was	PCR	amplified	from	wildtype	C3H/HeH	murine	embryo	mRNA	(at	
7.5	dpc,	8.5	dpc	and	9.5	dpc)	that	had	been	converted	to	cDNA	using	a	standard	RACE	dT-adaptor	
oligonucleotide,	and	Sanger	sequenced.	Though	the	sequences	obtained	did	initially	align	to	the	
Zic2	3’UTR,	accurate	full-length	sequences	were	unable	to	be	obtained	due	polymerase	slippage	
at	the	3’	end	and	no	determination	could	be	made	regarding	the	poly(A)	that	was	being	utilised.		
As	an	alternative	method,	four	pairs	of	oligonucleotides	were	designed	to	amplify	each	region	
of	the	3’UTR	5’	to	the	predicted	poly(A)	site	via	RT-qPCR	(Appendix	Table	A1.2,	Figure	6.4).	It	
was	hypothesised	that	if	the	most	distal	poly(A)	site	was	being	used	(mP3),	then	all	four	pairs	of	
oligonucleotides	 would	 result	 in	 amplification	 of	 the	 same	 relative	 amount	 of	 Zic2	 mRNA.	
Conversely,	if	the	first	poly(A)	site	was	the	predominant	poly(A)	site	active	at	gastrulation	(P1),	
it	was	expected	that	the	levels	of	Zic2	mRNA	at	P0	and	P1	would	be	high	in	contrast	to	low	Zic2	
levels	at	P2	and	P3	sites.	RT-qPCR	was	performed	on	total	mRNA	extracted	from	embryos	at	6.5,	
7.5,	8.5	and	9.5	dpc,	and	the	results	normalised	to	H2afz	or	Ubc	via	the	2-DDCT	method.	H2afz	and	
Ubc	were	chosen	as	reference	genes	as	they	are	stably	expressed	across	multiple	time	points	at	
gastrulation	 (Barratt	et.	al.	unpublished	manuscript,	Appendix	Section	A4.4).	 Fold	changes	 in	
mRNA	levels	were	calculated	relative	to	the	lowest	expression	value.	Upon	analysis,	a	trend	can	
be	seen	across	the	four	age	groups	analysed	where	the	 level	of	Zic2	mRNA	proximal	to	P3	 is	
equal	to	or	increased	(as	can	be	seen	at	8.5	dpc)	compared	to	Zic2	mRNA	levels	at	P0	and	P1,	
suggesting	that	the	most	distal	poly(A)	is	the	site	being	utilised	across	all	four	ages	of	embryo	
development	 (Figure	 6.4).	 A	 significant	 peak	 in	 mRNA	 expression	 at	 P2		
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Figure	6.4:	The	distal	Zic2	3’UTR	poly(A)	site	P3	is	the	most	likely	site	used	during	gastrulation.	
Total	mRNA	was	extracted	from	murine	embryos	at	the	stages	show	and	ZIC2	3’UTR	mRNA	levels	
upstream	of	each	predicted	PAS	measured	via	RT-qPCR.	Results	were	normalised	to	H2afz	or	
Ubc	via	the	2-DDCT	method,	and	fold	change	calculated	relative	to	the	lowest	expression	value.	
Error	 bars	 =	 S.E.M	of	 three	 external	 repeats;	 letters	 denote	 statistical	 significance	of	p<0.05	
calculated	 via	 a	 one-way	 ANOVA	 with	 Fischer’s	 unprotected	 post	 ad	 hoc	 test.	 The	 letter	 a	
denotes	 statistical	 significance	 to	 b	 and	 so	 on	within	 each	 age	 group	 (e.g.	 6.5	 dpc)	 but	 not	
between	age	groups	(ie.	the	letter	a	at	6.5	dpc	does	not	correlate	to	a	at	7.5	dpc,	etc).	Colours	
of	forward	and	reverse	oligonucleotides	(triangles)	on	the	3’UTR	correlate	with	hP0,	hP1,	hP2	
and	hP3	in	(a)	and	(b).		
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was	detected	 from	7.5	 -	9.5	dpc.	Whilst	a	peak	such	as	 this	may	 indicate	non-specific	mRNA	
amplification	at	off-target	 sites	or	primer	dimers	 (investigated	 in	Appendix	 Section	A4.5	and	
Table	A4.1),	 it	may	 also	 indicate	 that	 additional	 non-coding	mRNA	 is	 being	produced	 at	 this	
region	of	the	Zic2	3’UTR,	such	as	eRNA.		
6.2.6 Long	non-coding	RNA	transcripts	correlate	with	the	Zic2	3’UTR	
To	investigate	whether	the	peak	seen	at	P2	correlates	with	predicted	transcription	of	eRNA	or	
other	non-coding	RNAs,	the	UCSC	Genome	Browser	was	utilised.	As	no	tracks	which	annotate	
Long	RNA-seq	contigs	in	the	mouse	Zic2	3’UTR	were	able	to	be	identified,	the	CSHL	Long	RNA-
seq	(>200	nt)	and	CSHL	Small	RNA-seq	(<200	nt)	tracks	were	used	with	the	human	ZIC2	3’UTR	
(assembly	GRCh37/hg19)	(Cheng	et	al.,	2015;	Langmead	et	al.,	2009;	Parkhomchuk	et	al.,	2009).	
Both	 tracks	 contain	 data	 from	 a	 range	 of	 cell	 types,	 including	 but	 not	 limited	 to	 H1-hESCs,	
GM12878	and	HeLa	cell	lines.	RNA-seq	contigs	with	their	5’	in	the	CDS	of	ZIC2	were	excluded	
from	analysis,	as	eRNAs	by	definition	must	occur	within	an	ER	element.	Upon	analysis,	eight	
differently	sized	long	RNA	and	six	differently	sized	small	RNA	molecules	were	predicted	to	be	
transcribed	from	within	the	ZIC2	3’UTR	(Figure	6.2	C).	When	the	human	sequence	was	aligned	
to	the	mouse	3’UTR,	the	majority	of	the	long	RNA	molecules	overlap	with	the	P2	oligonucleotide	
amplicon	position	in	both	the	human	and	mouse	Zic2	3’UTR,	suggesting	that	the	significant	peak	
detected	at	P2	in	the	RT-qPCR	experiment	may	indeed	be	from	eRNA	or	a	similar	non-coding	
RNA	(this	assumes	the	production	of	eRNA	is	conserved	between	man	and	mouse).	Interestingly,	
one	predicted	long	RNA	molecule	overlaps	with	the	P3	oligonucleotides	in	both	the	human	and	
mouse	Zic2	3’UTR,	which	may	account	for	the	small	but	significant	 increase	 in	Zic2	 transcript	
detected	at	P3	in	8.5	dpc	embryos.		
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6.3 Discussion	
During	 embryo	 development,	mRNA	 transcripts	 and	 proteins	 are	 required	 in	 a	 spatially	 and	
temporally	 restricted	 manner,	 with	 errors	 in	 this	 expression	 often	 leading	 to	 catastrophic	
defects.	To	prevent	such	errors,	an	intricate	system	of	mRNA	decay	mechanisms	has	evolved.	In	
this	chapter,	I	have	shown	that	the	ZIC2	3’UTR	promotes	ZIC2	transcript	decay,	most	likely	via	a	
combination	of	AREBPs	and	miRNAs	 interacting	with	an	ARE	within	the	3’UTR.	Additionally,	 I	
have	shown	that	 the	distal	PAS	of	 the	3’UTR	 is	used	during	murine	gastrulation,	and	that	an	
increase	in	transcript	levels	within	the	3’UTR	correlates	to	a	predicted	long	non-coding	RNA	that	
is	likely	to	be	eRNA.		
6.3.1 The	Zic2	3’UTR	promotes	transcript	decay	
The	 presence	 of	 the	 ZIC2	 3’UTR	 correlates	 with	 a	 decrease	 in	 ZIC2	mRNA	 half-life	 (0.64	 hr	
compared	to	1.73	hr	when	normalised	to	ABCE1).	This	agrees	with	multiple	studies	which	found	
a	negative	correlation	with	increased	3’UTR	length	and	mRNA	stability	(Michalova	et	al.,	2013;	
Sharova	et	al.,	2009).	The	removal	of	the	3’UTR	from	the	ZIC2	transcript	likely	prevents	trans-
elements	involved	in	3’UTR	mediated	destabilisation	such	as	miRNAs	and	RBPs	from	targeting	
the	 element	 and	 destabilising	 the	 transcript.	 The	 half-life	 of	 ZIC2	 transcripts	 when	 in	 the	
presence	of	the	3’UTR	differs	from	the	rate	of	1.97	hours	previously	determined	via	a	microarray	
based	study	using	mouse	embryonic	stem	cells	(Sharova	et	al.,	2009).	As	it	is	known	that	tissue	
specific	factors	are	involved	in	mediating	mRNA	decay	(Barreau	et	al.,	2005),	the	half-life	of	ZIC2	
in	various	cell	types	cannot	be	expected	to	be	similar.	Furthermore,	as	Sharova	et	al	examined	
endogenous	expression	they	did	not	assess	whether	the	presence	of	the	3’UTR	influenced	the	
stability	 of	 the	 ZIC2	 transcript.	 The	 results	 presented	 in	 this	 chapter	 do	 agree	 with	 one	
conclusion	from	Sharova	et	al,	however,	which	is	that	ZIC2	exhibits	a	relatively	short	half-life	(<2	
hr)	compared	to	the	median	half-life	for	mRNA	turnover	(~10	hrs)	in	cultured	cells	(Sharova	et	
al.,	2009;	Yang	et	al.,	2003).	A	short	half-life	is	expected	for	TFs	and	developmental	genes,	as	it	
allows	rapid	up-	and	down-regulation	in	response	to	environmental	triggers	(Yang	et	al.,	2003).		
Whilst	not	addressed	in	this	study,	it	is	presumed	that	the	reduction	in	ZIC2	transcript	half-life	
seen	in	the	presence	of	the	3’UTR	can	be	attributed	in	part	to	the	presence	of	the	ARE.	As	such,	
an	investigation	into	whether	the	putative	ARE	outlined	above	is	functional	and	the	minimum	
sequence	required	to	promote	mRNA	decay	should	be	conducted.	By	deleting	the	surrounding	
regions	 of	 the	 UTR	 that	 are	 not	 predicted	 to	 be	 part	 of	 the	 ARE	 from	 the	 pV5-ZIC2-3’UTR	
constructs,	or	deleting	the	ARE	region	from	the	3’UTR,	the	effect	the	putative	ARE	region	has	on	
ZIC2	transcript	decay	can	be	determined.	If	this	ARE	is	indeed	the	main	driver	of	ZIC2	transcript	
decay	then	it	is	likely	that	deletion	of	this	fragment	will	produce	a	significant	increase	in	ZIC2	
mRNA	half-life.	In	comparison,	if	the	surrounding	regions	are	not	essential	for	transcript	decay	
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rates	then	the	removal	of	these	regions	should	produce	a	decay	similar	to	what	is	seen	with	the	
entire	3’UTR	still	present.	An	alternative	form	of	this	same	experiment	is	to	clone	the	predicted	
ARE	region	of	the	Zic2	3’UTR	into	the	rabbit	b-globin	gene,	which	has	a	strictly	defined	half-life	
and	 is	commonly	used	 to	analyse	ARE	domains	 (Chen	et	al.,	1994;	Li	et	al.,	2013;	Ysla	et	al.,	
2008).	If	the	half-life	of	the	b-globin	transcript	is	dramatically	altered	by	the	introduction	of	this	
ARE	region,	then	this	will	confirm	that	it	is	indeed	a	true	ARE	and	the	driving	force	behind	ZIC2	
transcript	decay.		
Not	 all	 of	 the	 PASs	 predicted	 in	 the	 3’UTR	 appear	 to	 be	 active	 during	 the	 early	 stages	 of	
embryogenesis.	The	distal	3’	PAS	is	considered	the	default	site	for	most	transcripts	due	to	the	
availability	of	regulatory	sites	within	the	full	length	3’UTR	(Beaudoing	et	al.,	2000;	Weill	et	al.,	
2012).	 A	 preference	 for	 the	 distal	 PAS	 at	 gastrulation	 agrees	 with	 the	 idea	 that	 Zic2	 is	 a	
transiently	expressed	TF	that	must	undergo	carefully	controlled	rapid	expression	followed	by	
rapid	decay	to	pattern	the	embryo.	Whether	P3	remains	the	default	PAS	at	other	embryonic	or	
adult	 stages	 remains	 to	 be	 elucidated,	 however.	 Single-Molecule	 sequencing	 chemistry	with	
Real-Time	detection	(SMRT;	PacBio)	and	Full-length	Isoform	Sequencing	(Iso-Seq;	PacBio)	can	
be	employed	to	determine	the	precise	PAS	and	cleavage	sites	that	are	utilised	in	both	human	
cell	 lines	 and	murine	 embryos.	 These	 techniques	 allow	 the	 sequencing	 of	 long	 stretches	 of	
alternatively	transcribed	RNAs	without	the	requirement	of	PCR	amplification	and	are	suitable	
for	genes	with	a	high	GC	content	and	large	amounts	of	repetitive	sequences	such	as	the	ZICs.	
Briefly,	poly(A)+	RNA	molecules	are	extracted	from	the	desired	tissues	and	converted	to	cDNAs	
via	 priming	 with	 Anchored	 Oligo(dT)20	 oligonucleotides.	 A	 SMRTbell	 sequencing	 library	 is	
generated,	 with	 templates	 complexed	 to	 polymerases	 and	 bound	 to	 magnetic	 beads.	 DNA	
sequencing	is	then	carried	out	with	a	PacBio	RS	II	sequencer,	producing	transcriptome	data	that	
can	 then	 be	 analysed.	 This	 technique	 is	 optimised	 to	 pick	 up	 any	 polyadenylated	 lncRNA	
molecules	 (Tombácz	 et	 al.,	 2016)	 produced	 from	 the	 ZIC2	 3’UTR	 and	 can	 presumably	 be	
employed	on	total	RNA	extracts	for	detection	of	bidirectional	un-polyadenylated	lncRNAs	such	
as	 eRNA.	 Additionally,	 the	 sensitivity	 of	 the	 techniques	 will	 allow	 for	 the	 analysis	 of	 finely	
dissected	 embryonic	 tissues	with	 relatively	 few	 cells,	 such	 as	 the	 node.	 Identification	 of	 the	
predominant	transcript	in	the	node	will	aid	in	narrowing	down	regions	of	the	Zic2	3’UTR	where	
mutations	 will	 most	 likely	 effect	 node	 development	 and	 function.	 Finally,	 if	 CRISPR	 can	 be	
utilised	to	introduce	the	six	HPE-associated	SNVs	into	human	cell	lines	or	mouse	embryos,	the	
influence	of	each	mutation	on	PAS	and	transcript	quantity	can	be	measured.	Once	the	poly(A)	
cleavage	sites	in	use	in	the	ZIC2	3’UTR	have	been	elucidated,	the	effect	of	transcript	isoforms	on	
mRNA	decay	rate	can	be	determined	by	PCR	amplifying	the	3’UTR	truncated	at	each	PAS,	cloning	
it	 into	 a	plasmid	 containing	Zic2	 cDNA,	 and	analysing	 transcript	 stability	 via	 the	decay	 assay	
		 219	
established	in	this	chapter.	It	is	expected	that	the	shorter	the	transcript,	the	longer	the	half-life	
as	there	is	a	reduction	in	the	number	of	available	miRNA	and	RBP	binding	sites.	
Due	to	cloning	difficulties	the	influence	of	the	six	HPE-associated	SNVs	on	the	ZIC2	decay	rate	
could	 not	 be	 established.	 This	 goal	 therefore	 remains	 a	 paramount	 objective	 before	 further	
decay	analysis	 is	attempted.	 Interestingly,	previous	analysis	on	c-fos	AREs	found	that	specific	
nucleotide	changes	had	a	dramatic	effect	on	transcript	stability.	Mutations	in	which	an	A	or	U	
are	changed	to	a	G	or	C	dramatically	increase	the	stabilization	of	a	transcript	(Chen	et	al.,	1994),	
presumably	due	to	a	reduction	in	the	AU	richness	and	RBP/miRNA	binding	sites	that	define	ARE	
domains.	As	such,	it	is	expected	that	M3	(U>C)	and	M4	(A>G)	would	exert	the	largest	effect	on	
stability	as	they	are	located	within	the	predicted	ARE	region,	potentially	increasing	the	half-life	
of	ZIC2	transcripts	and	resulting	in	an	increase	in	ZIC2	protein.	All	six	SNVs,	however,	have	the	
potential	to	alter	transcript	decay,	whether	it	be	by	altering	the	RBPs	and	miRNAs	predicted	to	
bind	the	3’UTR,	or	by	altering	the	PAS	used.	Whilst	none	of	the	mutations	occur	directly	within	
a	predicted	PAS,	it	is	likely	that	those	mutations	that	occur	within	the	15-30	bp	stretch	between	
a	PAS	and	cleavage	site	(such	as	M4)	could	presumably	alter	polyadenylation	either	by	increasing	
transcript	length	or	increasing	transcript	stability.	For	example,	Orkin	et	al.	previously	identified	
a	 T>C	 substitution	 in	 a	 conserved	 PAS	 in	 the	 b-globin	 3’UTR	 that	 sufficiently	 disrupts	
polyadenylation,	 resulting	 in	 a	 900	 bp	 increase	 in	 transcript	 length	 (Orkin	 et	 al.,	 1985).	
Alternatively,	it	is	possible	that	the	mutations	near	the	distal	PAS	will	result	in	a	shift	to	a	5’	PAS.	
Whilst	the	mutant	transcript	produced	would	still	undergo	decay,	its	half-life	would	most	likely	
increase	due	to	the	loss	of	miRNA	and	RBP	binding	sites.	As	such,	the	transcript	would	exist	in	
the	 cells	 for	 longer	 than	 necessary,	 resulting	 in	 an	 increase	 in	 protein	 above	 the	 threshold	
required.	To	circumvent	the	cloning	difficulties	encountered	in	this	chapter,	the	mutant	V5-ZIC2-
3’UTR	 constructs	 required	 for	 the	decay	assay	would	need	 to	be	bought	 from	a	 commercial	
company,	or	CRISPR-Cas9	used	to	mutate	HEK293T	cells	directly.		
6.3.2 Multiple	RBPs	and	miRNAs	are	predicted	to	interact	with	the	ZIC2	3’UTR	
Bioinformatic	analysis	identified	40	RBPs	and	248	miRNAs	predicted	to	bind	the	ZIC2	3’UTR.	It	
should	be	noted,	however,	that	these	are	mere	predictions	and	not	indicative	of	in	vitro	or	in	
vivo	binding.	As	one	functional	TFBS	is	estimated	to	occur	per	1000	predicted	sites	(Wasserman	
and	 Sandelin,	 2004),	 it	 is	 presumed	 that	 the	 rate	 of	 true	 RBP	 binding	 sites	 is	 similar.	
Nevertheless,	 to	 determine	 the	 exact	 mechanisms	 behind	 targeted	 decay	 of	 ZIC2	 during	
embryogenesis,	the	candidate	RBPs	and	miRNAs	that	are	predicted	to	bind	the	Zic2	3’UTR	and	
influence	its	transcript	decay	need	to	be	narrowed	down.	HEK293	cells	lack	TTP	family	members,	
therefore	the	candidate	pool	of	RBPs	bound	to	the	ZIC2	3’UTR	is	already	reduced	in	this	cell	line	
(Al-Souhibani	et	al.,	2010;	Blackshear,	2002).	Pulldown	of	biotinylated	RNA	oligonucleotides	that	
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correspond	 to	 the	 ZIC2	 ARE	 followed	 by	 western	 blot	 analysis	 with	 antibodies	 for	 HEK293	
specific	RBPs	such	as	AUF1	can	be	used	to	determine	whether	multiple	isoforms	of	each	RBP	are	
bound	to	the	ZIC2	ARE,	and	whether	preferential	binding	between	isoforms	is	occurring	(based	
on	the	predicted	molecular	weights	of	the	bands	observed	on	band	intensities,	respectively),	as	
seen	in	experiments	of	the	TSP-1	3’UTR	(McGray	et	al.,	2011).	Similarly,	biotinylated	miRNAs	can	
be	used	to	pulldown	proteins	they	bind	to,	with	a	ZIC2	antibody	used	in	western	blot	analysis	to	
determine	if	the	miRNA	is	binding	the	3’UTR.	Two	caveats	exist	with	this	method,	however:	(i)	it	
requires	a	ZIC2	antibody,	of	which	a	satisfactory	commercial	antibody	is	currently	lacking,	and	
(ii)	 the	narrowing	down	of	 candidate	miRNAs	 from	248	 to	a	number	 that	 can	be	 reasonably	
analysed.	Once	candidate	RBPs	and	miRNAs	have	been	sufficiently	narrowed	down,	their	effect	
on	ZIC2	transcript	half-life	can	be	determined	via	introduction	into	the	decay	assay.		
6.3.3 Are	ZIC3	and	ZIC5	transcripts	subject	to	decay?		
There	is	strong	evidence	for	overlapping	function	between	the	ZIC	family,	particularly	between	
ZIC2,	ZIC3	and	ZIC5	during	gastrulation.	Additionally,	the	Muenke	laboratory	(NHGRI,	NIH)	have	
identified	a	putative	NCE	region	within	the	ZIC3	3’UTR	that	contains	Heterotaxy-associated	SNVs	
(Roessler	 and	Muenke,	 personal	 communication).	 Comparatively,	 no	mutations	 in	ZIC5	 have	
been	 linked	to	human	hydrocephaly	despite	homozygous	Zic5	 cDNA	mutations	 in	 the	mouse	
resulting	 in	hydrocephaly	 (Arkell	 lab,	unpublished	data).	 It	 is	 therefore	unlikely	 that	 the	non-
coding	regions	of	ZIC5	have	been	analysed	in	human	hydrocephaly	patients.	Consequently,	it	is	
possible	that	mutations	in	a	regulatory	region	of	the	ZIC5	3’UTR	are	contributing	to	human	cases	
of	this	disease	and	remain	unidentified.	If	the	3’UTRs	of	ZIC3	and	ZIC5	are	found	to	significantly	
contribute	to	transcript	decay	via	the	mechanisms	identified	above,	it	would	provide	direction	
for	future	mutagenesis	screens	in	human	patients.		
6.3.4 Conclusion	
Post-transcriptional	 regulation	 of	 mRNA	 is	 used	 by	 cells	 to	 strictly	 control	 the	 spatial	 and	
temporal	expression	of	genes.	Via	transcript	decay	mechanisms,	gene	expression	can	be	rapidly	
turned	off	when	the	protein	is	no	longer	required.	Defects	in	this	process,	however,	can	lead	to	
exogenous	 gene	 expression	 or	 levels	 of	 protein	 above	 the	 required	 threshold,	 resulting	 in	
disease.	From	the	analysis	shown	in	this	chapter,	it	appears	that	ZIC2	expression	and	transcript	
half-life	 is	 regulated	by	multiple	mRNA	stability	elements	 residing	within	 the	3’UTR	 including	
AREs,	 alternative	 poly(A)	 sites	 and	 eRNAs.	 The	 use	 of	 the	 most	 3’	 PAS	 during	 gastrulation	
produces	a	 transcript	 that	 contains	all	 of	 the	predicted	 stability	elements,	 correlating	with	a	
need	for	rapid	degradation	of	the	Zic2	transcript	during	this	time	to	restrict	gene	expression	to	
specific	tissues	of	the	embryo.		
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Chapter	7: In	vivo	analysis	of	the	Zic2	NCE		
	
The	work	in	this	chapter	on	PiggyBac	transgenics	was	performed	with	the	Muenke	laboratory	
at	 the	National	Human	Genome	Research	 Institute	 (NHGRI)	 and	 the	Transgenic	Core	 Facility	
(NIH,	Maryland,	USA),	whilst	the	CRISPR	mutagenesis	work	was	performed	in	with	the	Burgio	
laboratory	at	the	John	Curtin	School	of	Medical	Research	(JCSMR)	Transgenesis	Facility	(ANU,	
Canberra,	Australia).	These	facilities	aided	in	the	production	of	transgenic	and	CRISPR	mutants.		
7.1 Introduction	
To	establish	 if	 the	ZIC2	NCE	has	enhancer	activity,	Roessler	et	al.	 (2012a)	previously	 created	
transient	transgenic	zebrafish	by	cloning	the	putative	NCE	region	into	a	ZED	vector	containing	
both	GFP	(reporter	of	ZIC2	NCE	activity)	and	RFP	(internal	control).	The	wildtype	ZIC2	NCE	was	
inserted	into	the	vector	in	both	the	forward	(5’	–	3’)	and	the	reverse	orientation	(3’	–	5’)	and	
transgenic	zebrafish	embryos	analysed.	NCEs	in	the	forward	orientation	that	contained	the	six	
individual	HPE-associated	 SNVs	were	also	 inserted.	Despite	 a	high	 level	 of	 transgenesis,	GFP	
expression	specific	 for	 the	ZIC2	NCE	could	not	be	 reliably	detected	 in	 the	 resulting	embryos.	
Further	attempts	to	detect	low	level	GFP	signal	via	WMISH	resulted	in	artificial	signal	from	the	
vector	backbone	(Roessler	et	al.,	2012a)	or	inconsistent	expression	between	founder	lines	(SK.	
Hong,	E.	Roessler	and	M.	Muenke,	personal	communication,	Appendix	Figure	A5.1).	The	results	
suggested	that	 (i)	 the	ZED	constructs	are	not	the	best	method	of	transgenesis	to	use	 in	such	
experiments,	(ii)	zebrafish	are	not	the	best	animal	to	model	ZIC2	NCE	activity,	or	(iii)	the	ZIC2	
NCE	does	not	regulate	ZIC2	expression	during	embryogenesis.	In	parallel,	experiments	to	test	
the	construct	in	mice	were	planned.	Traditional	transgenic	and	mutagenesis	approaches	in	mice	
exhibit	 relatively	 low	 success	 rates,	 and	 can	 take	 9-12	 months	 before	 viable	 offspring	 are	
available	for	analysis.	Over	the	past	decade,	however,	new	genome	editing	technologies	have	
emerged	 as	 useful	 tools	 for	 high-throughput	 and	 specific	 editing	 of	 the	 mouse	 genome.	 I	
attempted	to	use	two	different	mouse	mutagenesis	strategies	 to	evaluate	ZIC2	NCE	 function	
and	the	pathogenesis	of	the	six	SNVs	in	vivo:	PiggyBac	transgenics	(gain-of-function)	and	CRISPR-
mutagenesis	(loss-of-function).	
7.1.1 The	PiggyBac	transposase	
A	transposon	is	a	sequence	of	DNA	or	RNA	with	the	ability	to	change	its	position	in	the	genome.	
A	 transposon	 consists	 of	 two	 elements	 –	 a	 DNA	 transgene	 consisting	 of	 the	 desired	 cargo	
sequence	flanked	on	either	side	by	two	inverted	terminal	repeats	(ITRs),	and	a	transposase	that	
catalyses	 the	 insertion	of	 the	DNA	component	 into	 the	target	genome	via	a	genetic	 ‘cut	and	
paste’	 method	 (Figure	 7.1).	 This	 system	 can	 be	 modified	 for	 transgenesis	 through	 the	 co-
		 222	
injection	 of	 the	 synthesized	 transposase	 mRNA	 with	 the	 circular	 transgene	 DNA	 (the	 cargo	
component	and	 ITRs)	 into	 the	pronuclei	of	zygotes	of	 the	preferred	model	organism	(Mátés,	
2011).	 Genome	 integration	 is	 essentially	 random,	 although	 PiggyBac	 does	 require	 a	 TTAA	
nucleotide	sequence	 in	order	 to	correctly	 insert	 its	DNA	cargo	 into	 the	genome	(Bjork	et	al.,	
2010;	Fraser	et	al.,	1996).		
Transposons	are	commonly	used	for	transgenesis	and	insertional	mutagenesis	in	a	wide	range	
of	 model	 organisms	 (e.g.	 Drosophila,	 Caenorhabditis	 elegans	 and	 plants).	 Due	 to	 a	 lack	 of	
naturally	active	transposons	in	mammals,	however	it	is	only	recently	that	they	have	begun	to	be	
utilized	 in	 transgenic	 mice	 and	 rats	 (Dupuy	 et	 al.,	 2002;	 Mátés,	 2011).	 Two	 transposases	
previously	used	to	generate	transgenic	mice	are	SleepingBeauty	and	PiggyBac.	SleepingBeauty	
was	 reconstructed	over	 two	decades	ago	 from	defective	 transposon	 sequences	 found	 in	 the	
salmonid	genome	(Ivics	et	al.,	1997).	Although	it	is	the	most	common	transposon	system	used	
in	mammalian	experiments,	SleepingBeauty	offers	a	germ-line	transgenic	efficiency	of	only	15%	
(Dupuy	et	al.,	2002).	Since	its	discovery,	a	hyperactive	form	has	been	developed	which	increased	
transgenic	efficiency	100-fold.	Though	the	hyperactive	form	works	successfully	in	cultured	cells,	
the	efficiency	often	fails	to	translate	into	stable	gene	transfer	of	primary	cells	 in	vivo	 (Mátés,	
2011;	Mátés	et	 al.,	 2009).	 In	 contrast,	 the	PiggyBac	 transposase,	 isolated	 from	 the	 cabbage	
looper	moth	(Trichoplusia	ni)	is	unique	due	to	its	high	efficiency	rate,	large	cargo	capacity,	and	
ability	to	form	functional	protein	fusions	and	restore	a	donor	site	to	its	original	condition	upon	
excision,	 leaving	no	 trace	of	 transposon	 insertion	 (Cadiñanos	 and	Bradley,	 2007;	Ding	et	 al.,	
2005;	Wang	et	al.,	2008;	Wu	et	al.,	2006).	The	PiggyBac	transposase	has	a	reported	transgenic	
efficiency	of	up	to	65%	depending	on	the	DNA	component	being	inserted	(Ding	et	al.,	2005),	and	
has	successfully	demonstrated	long	term	integration	into	the	murine	genome	(Doherty	et	al.,	
2012).		
Transposons	 have	 greatly	 reduced	 the	 production	 time	 required	 to	 generate	 mutated	
mammalian	 germlines	 (Horie	 et	 al.,	 2003),	 and	 have	 allowed	 for	 the	 production	 of	 forward	
genetic	screens	in	vivo	to	identify	genes	involved	in	diseases	such	as	solid	tumours	(Collier	et	al.,	
2005).	 Transgene	 genomic	 integration	 is	 often	 subject	 to	 position	 effects,	 however,	 where	
endogenous	 regulatory	 elements	 act	 on	 the	 promoter	 of	 an	 inserted	 transgene	 to	 produce		
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Figure	7.1:	PiggyBac	uses	a	“cut	and	paste”	mechanism.	The	PiggyBac	transposase	recognises	
and	binds	to	transposon	specific	ITRs	on	the	transgene	vector.	It	then	excises	the	cargo,	in	this	
case	ZIC2	NCE-lacZ	flanked	by	cHS4	sites,	from	the	vector	and	integrates	the	cargo	into	the	host	
genome	 at	 TTAA	 chromosomal	 sites.	 ITR:	 inverted	 terminal	 repeats;	 cHS4:	 Chicken	 insulator	
sites;	b-globin:	b-globin	minimal	promoter;	SV40	PA:	SV40	PolyA	fragment.		 	
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false	reporter	expression.	To	mitigate	this	effect	in	the	transposon	transgenic	system,	insertion	
of	insulator	sequences	that	flank	the	cargo	component	of	the	transgene	vector	can	be	utilised	
(Dupuy	et	 al.,	 2002).	One	 such	 insulator,	 the	 chicken	 hypersensitive	 site-4	 (cHS4)	 chromatin	
insulator,	is	thought	to	be	a	good	candidate	to	mitigate	these	effects	(Aker	et	al.,	2007;	Bjork	et	
al.,	2010),	with	previous	incorporation	of	the	insulator	into	PiggyBac	vectors	resulting	in	a	1.5	
fold	increase	in	transgene	expression	in	human	cell	lines	(Sharma	et	al.,	2012).		
7.1.1.1 Gain-of-function	transgenic	approach	–	the	ZIC2	NCE	and	PiggyBac	transposons	
Due	 to	 the	 increased	 efficiency	 of	 the	 PiggyBac	 transposon,	 I	 aimed	 to	 (i)	 establish	 a	 high	
efficiency	system	for	the	creation	of	mouse	transgenics	and	(ii)	utilise	this	method	to	determine	
whether	the	Zic2	NCE	regulates	Zic2	expression	during	gastrulation,	and	if	the	six	HPE-associated	
SNVs	disrupt	this	regulation.	Transposon	cargo	constructs	containing	a	transgene	made	up	of	
the	Zic2	NCE	followed	by	a	b-globin	minimal	promoter	and	lacZ	reporter	were	created	(Figure	
7.1).	Four	cHS4	insulator	fragments	were	included	in	the	construct	to	minimize	position	effects	
based	on	data	from	Bryan	Bjork	(Bjork	et	al.	2010;	B.	Bjork,	personal	communication)	who	found	
that	 the	 inclusion	 of	 two	 cHS4	 fragments	 aided	 in	 the	 production	 of	 PiggyBac	 transgenic	
embryos.		
7.1.2 CRISPR-Cas9	mutagenesis	
Via	CRISPR-Cas9	mutagenesis,	DNA	can	be	manipulated	to	create	gene	knockouts	or	used	to	
introduce	foreign	DNA	(such	as	reporters),	deletions	and	point	mutations	into	a	specific	region	
of	the	genome.	The	CRISPR-Cas9	system	uses	RNA-guided	nucleases	to	cleave	specific	genetic	
elements	 and	 allows	 for	 the	 mutation,	 insertion	 and	 removal	 of	 components	 of	 the	 target	
organisms	 genome.	 Originally	 isolated	 from	 the	 bacterial	 genome,	 the	 CRISPR	 Associated	
protein	9	(Cas9)	is	guided	by	trans-activating	CRISPR	RNA	(tracrRNA)	that	provides	a	stem-loop	
structure	that	the	Cas9	protein	binds	to,	and	CRISPR	RNA	(crRNA)	containing	the	target	sequence	
and	tracrRNA	recognition	sequence.	When	the	tracrRNA	and	crRNA	hybridize,	they	form	a	guide	
RNA	that	allows	the	Cas9	protein	to	target	and	degrade	foreign	nucleic	acids	(Gasiunas	et	al.,	
2012;	Jinek	et	al.,	2012).	This	system	has	been	modified	by	fusing	tracrRNA	and	crRNAs	to	form	
a	single-guide	RNA	(sgRNA)	that	can	be	designed	to	induce	targeted	single	or	double	stranded	
breaks	(DSBs)	in	the	genome	via	Cas9	(Jinek	et	al.,	2012).	Upon	breaking,	the	cells	endogenous	
non-homologous	 end	 joining	 (NHEJ)	 repair	 pathway	 ligates	 the	 DNA	 strands	 back	 together.	
While	this	may	result	in	precise	end	joining	or	targeted	deletions,	it	can	also	lead	to	the	insertion	
of	point	mutations,	disrupting	the	target’s	reading	frame.	As	such,	it	is	an	effective	method	to	
use	for	the	creation	of	gene	knockouts	(Singh	et	al.,	2014).	The	DSBs	can	also	be	repaired	via	
manipulation	 of	 the	 cells	 endogenous	 homology-directed	 repair	 (HDR)	 mechanisms.	 By	
introducing	 an	 alternative	 repair	 template	 with	 locus-specific	 homology	 alongside	 the	 Cas9	
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protein,	exact	point	mutations	and	indels	can	be	introduced	in	the	hosts	genome.	To	target	Cas9	
to	a	specific	DNA	sequence,	however,	the	target	sequence	must	be	 immediately	5’	to	a	3	bp	
protospacer	adjacent	motif	 (PAM)	sequence	 (defined	as	NGG)	and	be	complementary	 to	 the	
sgRNA	sequence	(Yang	et	al.,	2014).	
Whilst	 extremely	 versatile,	 CRISPR-aided	 mutagenesis	 can	 also	 be	 unpredictable,	 with	
superfluous	sequence	changes	routinely	found	at	the	site	of	repair	due	to	the	error	prone	NHEJ	
repair	system.	Furthermore,	founder	animals	are	frequently	mosaic	for	the	introduced	mutation	
(Jacobi	 et	 al.,	 2017;	 Mianné	 et	 al.,	 2017).	 Off-target	 effects,	 which	 occur	 when	 the	 guide	
sequences	have	 sufficient	homology	 to	 sites	 in	 the	genome	 that	are	not	 the	 target,	 are	also	
common,	with	overexpression	of	Cas9	and	guide	RNA	correlating	with	a	high	incidence	of	these	
events	(Fu	et	al.,	2013).	Despite	these	downsides,	CRISPR-mutagenesis	boasts	an	efficiency	rate	
of	up	to	100%	for	both	HDR	and	NHEJ	in	mice,	dependant	on	the	mode	of	delivery	and	method	
of	editing	employed	(reviewed	in	Singh	et	al.	2014).		
7.1.2.1 Loss-of-function	transgenic	approach	–	Deletion	of	the	Zic2	NCE	via	CRISPR-Cas9	
Due	 to	 the	 versatility	 and	 control	 provided	 by	 CRISPR-mutagenesis,	 I	 aimed	 to	 utilise	 this	
technique	to	delete	the	Zic2	NCE	from	the	mouse	genome	and	determine	what	role,	if	any,	it	
plays	in	HPE	development.	To	do	this,	both	direct	deletion	and	tiling	CRISPR	deletion	approaches	
were	employed,	whereby	a	set	of	target	guides	spanning	the	length	of	the	murine	Zic2	3’UTR	
were	designed	and	introduced	into	zygotes	together,	along	with	Cas9	protein,	via	microinjection	
or	electroporation.	The	resulting	DSBs	would	result	in	a	series	of	different	deletions	within	the	
3’UTR,	include	the	entire	NCE,	which	would	allow	us	to	map	the	subsequent	phenotypes	and	
gene	expressions	patterns	to	a	particular	region	within	the	3’UTR	(Figure	7.2).	The	tiling	CRISPR	
approach	 has	 successfully	 been	 used	 to	 target	 NCEs	 in	 the	 past,	 although	 to	 a	much	 larger	
degree,	such	as	the	creation	of	1176	distinct	deletions	of	the	CXCL1	3’UTR	in	BEAS-2B	cells	(Zhao	
et	al.,	2017).		
7.1.3 Chapter	7	aims	
As	 previous	 attempts	 to	 model	 the	 activity	 of	 the	 ZIC2	 3’UTR	 in	 zebrafish	 have	 failed,	 the	
challenge	 is	 to	 now	 produce	 mouse	 models	 that	 accurately	 report	 the	 target	 gene	 being	
regulated	by	the	ZIC2	3’UTR	and	any	effects	that	occur	when	the	3’UTR,	and	specifically	the	NCE,	
is	altered.		
The	aims	of	this	chapter	were:	
• To	 generate	 a	 highly	 efficient	 system	 for	 the	 creation	 of	mouse	 transgenics	 via	 the	
PiggyBac	transposase.		
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• To	use	 lacZ	 transposon	transgenics	to	determine	 if	 the	ZIC2	NCE	drives	expression	of	
Zic2	during	gastrulation	and	whether	the	six	mutated	forms	of	the	ZIC2	NCE	alter	lacZ	
reporter	expression	from	the	wildtype	NCE.	
• To	optimize	the	deletion	of	non-coding	regions	in	mice	via	CRISPR-Cas9.	
• To	 determine	 what	 effect	 deletion	 of	 the	 endogenous	 Zic2	 NCE	 has	 on	 embryo	
development	and	gene	expression	at	gastrulation.		 	
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Figure	7.2:	CRISPR	Zic2	NCE	deletion	via	non-homologous	end	joining	(NHEJ).	Cas9	protein	is	
targeted	by	guide	DNA	to	induce	double	stranded	breaks	(DSB);	in	this	example	on	either	side	
of	the	Zic2	NCE.	Upon	breaking,	the	Zic2	NCE	 is	released	and	the	remaining	DNA	strands	are	
ligated	together	via	NHEJ.	This	can	result	in	a	number	of	different	mouse	genotypes,	such	as	but	
not	limited	to	(a)	mutants	homozygous	for	the	NCE	deletion,	(b)	mutants	heterozygous	for	the	
NCE	deletion,	or	 (c)	mutants	heterozygous	 for	 the	NCE	deletion	with	additional	 insertions	or	
point	mutations.			
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7.2 Results	
7.2.1 Generation	of	PiggyBac	transgene	constructs	
PiggyBac	 transposon	vectors	 (pBB232,	pBB256,	pBB259	and	pBB262)	were	a	gift	 from	Bryan	
Bjork	(Harvard	Medical	School,	Boston,	MA;	Bjork	et	al.	2010).	The	properties	of	each	construct	
are	outlined	in	Table	7.1	(Appendix	Figure	A5.2).	As	pBB262	contained	four	copies	of	the	cHS4	
insulator	sequence	and	thus	the	best	protection	from	position	effects	during	transgenesis,	this	
vector	was	chosen	for	the	initial	ZIC2	3’UTR	transgenesis	experiments.	Gatewayâ	Entry	vectors	
(pCR8-GW-TOPO-NCE)	containing	608	bp	of	either	the	wildtype	or	mutated	forms	of	the	human	
ZIC2	3’UTR	(Appendix	Figure	A5.3)	were	provided	by	the	Muenke	laboratory	(NHGRI,	NIH).	The	
608	bp	3’UTR	fragment	includes	the	entire	540	bp	ZIC2	NCE	region	and	will	be	referred	to	as	the	
NCE	in	all	constructs.		
The	608	bp	wildtype	ZIC2	NCE,	and	each	of	the	six	mutated	versions	of	the	ZIC2	NCE,	were	PCR	
amplified	from	the	pCR8-GW-TOPO-NCE	constructs	with	oligonucleotides	containing	homology	
to	the	pBB262	MCS	at	the	5’	ends	and	In-Fusion	cloned	into	pBB262	that	had	been	linearized	
with	 Xbal	 in	 the	 MCS	 (Figure	 7.3,	 Chapter	 2,	 Appendix	 Table	 A1.2,	 Appendix	 Figure	 A5.3).	
Following	isolation	and	large-scale	prepping,	pBB262-ZIC2	NCE	constructs	were	digested	with	
NotI	 and	 XhoI.	 In	 parallel,	 p1229,	 a	 Bluescript	 II	 KS	 vector	 containing	 a	 4354	 bp	 lacZ	
reporter/SV40	PolyA	cassette	was	digested	with	NotI	and	XhoI	to	release	the	lacZ/SV40	PolyA.	
This	was	subsequently	cloned	 into	the	digested	pBB262-NCE	constructs,	resulting	 in	wildtype	
and	mutant	pBB262-NCE-lacZ	plasmids.	A	negative	control	was	created	by	transferring	the	lacZ	
cDNA	from	p1229	to	the	MCS	of	pBB262,	following	digestion	of	both	constructs	with	XbaI	and	
XhoI,	 to	generate	pBB262-lacZ.	A	positive	control	was	created	via	digestion	of	pmNeT-lacZ,	a	
transgenic	construct	containing	the	mouse	notochord	enhancer	for	Foxa2.	This	construct	had	
previously	 been	 used	 to	 create	 a	 conventional	 transgenic	 line	 (mNet)	 that	 exhibited	 lacZ	
reporter	expression	in	the	mouse	node	and	notochord	at	8.0-9.0	dpc	(Ruth	Arkell,	unpublished;	
Figure	7.4).	The	original	mNet	mouse	line	at	the	ANU	(Canberra,	Australia)	was	used	to	confirm	
the	X-Gal	staining	protocol	was	optimised	for	lacZ	detection	in	gastrulating	and	post-gastrulation	
embryos	(Figure	7.4),	and	to	provide	a	comparison	for	future	pBB262-mNet-lacZ	embryos.		
Prior	to	their	use	in	mouse	pronuclear	injections,	all	PiggyBac	constructs	were	tested	for	their	
ability	to	express	the	lacZ	reporter	via	transfection	into	HEK293T	cells.	As	can	be	seen	in	Figure	
7.5,	 lacZ	expression	was	detected	24	hours	post	transfection	for	all	constructs	containing	the	
reporter	gene,	confirming	construct	integrity.		 	
		 229	
Table	7.1:	Properties	of	the	four	PiggyBac	transposon	vectors.	Vectors	were	gifted	from	Bryan	
Bjork	(Harvard	Medical	School,	Boston,	MA;	Bjork	et	al.	2010).	Plasmid	maps	can	be	found	in	
Appendix	Figure	A5.2.	MCS:	multiple	cloning	site;	cHS4:	chicken	insulator	fragment;	ITR:	inverted	
terminal	repeats.		
	
Plasmid	 Purpose	 ITR	 cHS4	 insulator	
sequences	
pBB232	
(pT3Ts-
Pbase)	
Contains	 the	 Pbase	 (PiggyBac)	 transposase	 open	
reading	 frame.	 PiggyBac	 is	 transcribed	 to	 mRNA	
and	 injected	alongside	pBB	constructs	 containing	
the	desired	transgene	cargo.	
No	 None	
pBB256	 Delivery	of	desired	transgene	cargo.	 Yes	 None	
pBB259	 Delivery	of	desired	transgene	cargo.	 Yes	 Two	 in	 total,	 one	
copy	 on	 either	 side	
of	the	MCS.	
pBB262	 Delivery	of	desired	transgene	cargo.	 Yes	 Four	 in	 total,	 two	
copies	 on	 either	
side	of	the	MCS.	
	
	
	
	
	
	
Figure	 7.3:	 Generation	 of	 ZIC2	 NCE-lacZ	 PiggyBac	 constructs.	 (a)	 The	MCS	 (orange)	 of	 the	
PiggyBac	vector	pBB262	was	digested	with	XbaI	to	linearize	the	vector.	pBB262	contains	four	
cHS4	insulator	fragments	(purple)	and	two	ITRs	(green).	(b)	The	ZIC2	NCE	fragment	(yellow)	was	
PCR	amplified	from	pCR8-GW-TOPO-NCE	constructs.	The	primers	used	to	amplify	the	ZIC2	NCE	
contained	an	artificial	NotI	site	and	regions	homologous	to	the	pBB262	MCS.	(c)	The	ZIC-NCE	
amplicon	 and	 linearized	pBB262	 vector	were	 joined	 via	 an	 In-Fusion	 (Clontech)	 reaction,	 (d)	
resulting	in	pBB262-NCE.	pBB262-NCE	was	digested	with	NotI	and	XhoI	to	linearize	the	vector.	
(e)	Simultaneously,	p1229	was	digested	with	NotI	and	XhoI,	 resulting	 in	release	of	a	b-globin	
minimal	 promoter-lacZ/SV40	 PolyA	 cassette.	 (f)	 The	 b-globin-lacZ/SV40	 PolyA	 cassette	 was	
subsequently	 ligated	 into	 pBB262-NCE	 to	 create	 pBB262-NCE-lacZ	 constructs.	 cHS4:	 chicken	
insulator	fragments;	ITR:	inverted	terminal	repeats;	MCS:	multiple	cloning	site.		
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Figure	7.4:	lacZ	expression	is	detected	in	the	node	and	notochord	of	mNet	embryos.	7	somite	
stage	embryos	of	the	genotypes	shown	following	X-Gal	staining.	(a,	c)	Lateral	view;	anterior	is	
to	the	left.	(b,	d)	Ventral	view;	anterior	is	to	the	top.	lacZ	expression	is	detected	in	the	node	and	
notochord	of	mNetlacZ/+	embryos.	s:	somites.		
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Figure	7.5:	PiggyBac	transposon	constructs	express	lacZ.	HEK293T	cells	were	transfected	with	
the	plasmids	indicated	and	stained	with	X-Gal	to	identify	lacZ	reporter	expression.	(a)	Each	ZIC2	
NCE	PiggyBac	construct,	 (b)	 the	mNet	PiggyBac	construct,	and	the	 (c)	pTracer-CMV/Bsd/lacZ	
produced	lacZ	expression	in	HEK293T	cells.	Expression	was	not	detected	in	the	negative	control.		
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7.2.2 Zic2	reference	gene	expression	
If	 the	NCE	 controls	 the	expression	of	Zic2	 in	 vivo,	 lacZ	 reporter	 expression	 in	 the	 transgenic	
embryos	is	expected	to	recapitulate	some	or	all	domains	of	Zic2	expression.	Zic2	expression	at	
6.5-7.75	dpc	has	been	documented	(Chapter	4,	[Elms	et	al.	2004]),	but	Zic2	expression	at	older	
ages	has	not.	C3H/HeH	wildtype	embryos	were	dissected	at	8.5	and	9.5	and	WMISH	for	Zic2	
performed.	As	12.5	dpc	was	the	equivalent	age	in	murine	development	to	when	GFP	expression	
was	detected	in	transgenic	zebrafish	embryos	by	Roessler	et.	al.	(2012),	Zic2	expression	was	also	
examined	at	this	stage.	As	shown	in	Figure	7.6,	Zic2	is	expressed	in	the	neural	tube	and	headfolds	
at	8.5	dpc,	and	the	neural	tube,	fore	and	mid-brain,	and	developing	forelimbs	at	9.5	dpc.	At	12.5	
dpc,	Zic2	appears	to	be	expressed	in	the	diencephalon,	midbrain	and	hindbrain,	along	with	the	
midline	 and	 somites/developing	 vertebrae.	 Expression	 can	 also	 be	 detected	 in	 the	 apical	
ectodermal	ridge	(AER)	and	zone	of	polarizing	activity	(ZPA)	of	the	developing	fore-	and	hindlegs.	
Sectioning	of	the	embryos	is	required	to	confirm	the	exact	distribution	of	transcripts,	however.		
7.2.3 PiggyBac	is	a	highly	efficient	method	for	the	creation	of	transgenic	embryos		
Prior	to	dissection	of	PiggyBac	transgenic	embryos,	a	positive	control	was	required	to	batch	test	
each	round	of	X-Gal	stain	at	the	National	Institute	of	Health	(Maryland,	USA)	where	the	PiggyBac	
experiments	were	being	conducted.	As	the	original	mNet	line	was	at	the	ANU,	a	Sox10lacZ	strain	
(Britsch	et	al.,	2001)	already	present	at	the	NIH	Transgenic	Core	Facility	was	chosen.	Sox10lacz/+	
females	were	timed	mated	with	wildtype	(Sox10+/+)	males.	Embryos	were	dissected	at	14.5	dpc	
and,	along	with	ear	notches	from	Sox10lacz/+	females,	stained	in	X-Gal	overnight.	Blue	staining	in	
both	the	embryos	and	ear	notches	indicated	that	the	batch	of	X-Gal	was	sufficient	for	use	on	
PiggyBac	transgenic	embryos	(Appendix	Figure	A5.4).		
To	create	transient	transgenic	ZIC2	NCE-lacZ	embryos,	PiggyBac	transposon	mRNA	and	pBB262	
transgene	 constructs	 (pBB262-mNet-lacZ,	 pBB262-lacZ	 and	pBB262-NCE-lacZ)	 linearized	with	
XmnI	were	co-injected	into	the	pronucleus	by	Gene	Elliot	at	the	NIH	Transgenic	Core	Facility.	A	
total	of	19	transgenesis	rounds	were	conducted,	with	the	concentrations	of	transposase	mRNA	
and	 reporter	 DNA	 for	 each	 injection	 outlined	 in	 Table	 7.2.	 Tn(pb-pBB262-mNet-lacZ)Ark	 transgenic	
embryos	were	dissected	at	8.5	dpc	as	this	is	the	known	time	of	mNet	enhancer	activity,	whilst	
Tn(pb-pBB262-NCE-lacZ)Ark	and	Tn(pb-pBB262-lacZ)Ark	embryos	were	dissected	at	7.5	dpc,	9.5	dpc	or	12.5	dpc.	
All	 recovered	 embryos	were	 genotyped	 for	 the	 presence	 of	 lacZ.	 In	 total,	 23	 embryos	were	
recovered	following	pBB262-mNet-lacZ	pronuclear	injection	and	261	embryos	were	recovered	
following	 pBB262-NCE-lacZ	 injection.	 As	 shown	 in	 Table	 7.2,	 the	 concentration	 of	 DNA	 and	
mRNA	injected	appeared	to	influence	the	rate	of	transgenesis	for	pBB262-NCE-lacZ	(rounds	1-2	
versus	 rounds	 5-14)	 but	 not	 pBB262-mNet-lacZ	 (rounds	 3-4	 versus	
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Figure	7.6:	Zic2	expression	 in	post-gastrulation	murine	embryos.	 (a,	c-e)	Lateral	 (anterior	to	
the	left)	and	(b)	ventral	(anterior	to	the	top)	view	of	wildtype	embryos	after	WMISH	to	Zic2.	(a-
b)	Zic2	appears	to	be	expressed	in	the	headfold	neurectoderm	at	8.5	dpc,	(c)	in	the	neural	tube	
of	the	fore-	and	mid-brain,	and	developing	forelimb	at	9.5	dpc,	(d-e)	and	in	the	diencephalon,	
midbrain	 and	hindbrain,	midline,	 developing	 vertebrae	of	 the	 spine,	 apical	 ectodermal	 ridge	
(arrowheads)	and	zone	of	polarizing	activity	(*)	of	the	developing	fore-	and	hind-legs.	S:	somites.		
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Table	 7.2:	 PiggyBac	 transgenic	 injections.	 The	 expected	 number	 of	 lacZ/+	 embryos	 was	
calculated	as	68%	of	the	total	number	of	viable	embryos,	as	this	was	the	value	reported	in	the	
literature	 (Bjork	 et	 al.,	 2010).	 Number	 of	 lacZ/+	 embryos:	 the	 number	 of	 embryos	 which	
genotyped	positive	for	the	lacZ	transgene,	indicating	transgenesis	was	successful.	Transgenesis	
rate	was	calculated	as	the	percent	of	embryos	that	genotypes	positive	for	the	 lacZ	transgene	
out	of	the	total	number	of	viable	embryos.	Resorption	rate	was	calculated	as	the	percentage	of	
empty	decidua	out	of	total	decidua.	ND:	not	determined.	PsP:	pseudopregnant.	
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	 	 pBB262-NCE-lacZ	
1	 10	 4	 34	 23	 14	 9.5	 0	 0	 7-7.5	 0.0	 39.1	
2	 7	 4	 34	 28	 18	 12.2	 2	 0	 7-7.5	 11.1	 35.7	
5	 13	 2	 23	 52	 31	 21.1	 25	 0	 6-7.5	 80.6	 40.4	
6	 9	 2	 23	 30	 10	 6.8	 8	 0	 7-7.5	 80.0	 66.7	
7	 7	 2	 23	 35	 27	 18.4	 9	 0	 7-7.5	 33.3	 22.9	
9	 11	 2	 23	 40	 19	 12.9	 10	 0	 7-7.5	 52.6	 52.5	
10	 17	 2	 23	 59	 23	 15.6	 17	 0	 8.5-9.5	 73.9	 61.0	
11	 8	 2	 23	 22	 9	 6.1	 4	 1	 12.5	 44.4	 59.1	
13	 3	 2	 23	 16	 12	 8.1	 4	 0	 12.5	 33.3	 25.0	
14	 5	 2	 23	 11	 6	 4.0	 2	 1	 8.5	 33.3	 45.5	
15	 5	 2	 23	 9	 2	 1.4	 0	 0	 9.5	 0.0	 77.8	
16	 5	 2	 23	 27	 18	 12.2	 ND	 0	 7.5	 ND	 33.3	
17	 13	 2	 23	 49	 18	 12.2	 ND	 0	 9.5	 ND	 63.3	
18	 10	 2	 23	 40	 18	 12.2	 ND	 0	 8.5	 ND	 55.0	
19	 10	 2	 23	 64	 36	 24.5	 ND	 3	 12.5	 ND	 43.8	
Total:	 133	 	 	 505	 261	 177.4	 81	 5	 Avg:	 40.2	 48.1	
	 	 pBB262-mNet-lacZ	(positive	control)	
3	 6	 4	 34	 12	 8	 5.4	 7	 0	 8-8.5	 87.5	 33.3	
4	 6	 4	 34	 21	 11	 7.5	 10	 0	 8-8.5	 90.9	 47.6	
8	 6	 2	 23	 11	 4	 2.7	 4	 0	 8-8.5	 100.0	 63.6	
Total:	 18	 	 	 44	 23	 15.6	 21	 0	 Avg:	 92.8	 48.2	
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round	 8),	 suggesting	 the	 transgenesis	 rate	 was	 construct	 dependant.	 Overall,	 the	 average	
transgenesis	rates	for	both	constructs	(92.8%	for	pBB262-mNet-lacZ	and	40.2%	for	pBB262-NCE-
lacZ;	Table	7.2)	suggests	the	PiggyBac	transposase	is	highly	effective	at	introducing	transgenes	
into	 the	murine	 genome,	 compared	 to	 standard	 transgenesis	where	 ~2-5%	of	microinjected	
pronuclei	are	recovered	as	transgenic	founders	(Nakanishi	et	al.,	2002;	Wall,	2001).	
7.2.4 lacZ	expression	could	not	be	detected	in	transgenic	embryos	
It	was	expected	that	the	number	of	lacZ	expressing	embryos	would	correlate	with	the	number	
of	embryos	that	genotyped	positive	for	the	lacZ	reporter.	Despite	detecting	a	medium-high	level	
of	transgenesis	in	both	Tn(pb-pBB262-mNet-lacZ)Ark	embryos	and	Tn(pb-pBB262-NCE-lacZ)Ark	embryos,	only	6%	
of	 embryos	 that	 genotyped	 positive	 for	 the	 pBB262-NCE-lacZ	 transgene	 exhibited	 lacZ	
expression	when	stained	with	X-Gal	 (Figure	7.7,	Appendix	Figure	A5.5).	This	small	expression	
rate	is	consistent	with	the	NCE	acting	as	a	transcriptional	repressor	(Chapter	5).	Moreover,	the	
lacZ	expression	patterns	detected	in	the	positive	embryos	were	variable,	suggesting	that	it	is	not	
a	true	readout	of	NCE	activity.	However,	0%	of	positive	control	embryos	that	genotyped	positive	
for	pBB262-mNet-lacZ	exhibited	lacZ	expression,	suggesting	that	the	cHS4	insulators	within	the	
transgene	were	overriding	the	promoter	and	supressing	 lacZ	expression.	This	 lack	of	positive	
control	expression	prevented	meaningful	interpretation	of	the	experimental	transgene.	As	such,	
the	six	HPE-associated	SNV	constructs	(M1-M6)	were	not	tested	and	no	pBB262-lacZ	(negative	
control)	injections	were	performed.	
7.2.5 Optimization	of	Zic2	3’UTR	CRISPR-Cas9	mutagenesis	
Design	 of	 the	 CRISPR	 guide	 strands,	 as	 well	 as	 pronuclei	 injection	 and	 implantation,	 and	
genotyping	of	pups,	was	carried	out	in	conjunction	with	the	Transgenesis	Facility	(JCSMR,	ANU,	
Canberra).	Eight	guides	targeting	the	Zic2	3’UTR	were	initially	designed	and	selected	using	the	
algorithms	available	 via	 the	 Zhang	CRISPR	design	 site	 (Zhang	 Lab	 and	MIT,	 2015)	 (Table	7.3,	
Figure	7.8).	Of	the	eight	selected	guides	(Table	7.3),	two	that	were	situated	either	side	of	the	
Zic2	NCE	(designated	G2	and	G3)	were	initially	chosen	for	the	mutagenesis	experiments.	G2	and	
G3	DNA	 sequences	were	 cloned	 into	 the	 guide	 plasmid	 constructs	 and	 the	 isolated	 plasmid	
incorporated	 into	 pronuclei	 of	 fertilized	 zygotes	 (either	 by	 injection	 or	 electroporation)	
(Appendix	 Figure	 A5.6).	 These	 experiments	 formed	 part	 of	 the	 Transgenesis	 Facility’s	
optimisation	of	CRISPR-Cas9	protocols,	resulting	in	inter-experimental	variation	in	the	method	
of	 zygote	 incorporation,	 the	 form	 in	 which	 reagents	 were	 used,	 and	 the	 concentration	 of	
reagents	(Table	7.4	and	Table	7.5).	The	stage	at	which	the	transferred	embryos	developed	to	
before	 analysis	 also	 varied.	 A	 total	 of	 25	 CRISPR-Cas9	 rounds	 sessions,	 in	 which	 ~20	 2-cell	
embryos	were	 implanted	per	dam,	yielded	only	 three	embryos	with	altered	sequence	at	 the	
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Figure	 7.7:	PiggyBac	 transgenic	 embryos.	 Lateral	 view	 of	 embryos	 of	 the	 genotypes	 shown	
following	X-Gal	staining.	(a)	A	Tn+/+	and	(b)	Tn(pb-pBB262-mNet-lacZ)Ark/+	embryo	(positive	control)	for	
the	stages	shown.	Anterior	is	to	the	left.	No	lacZ	expression	was	detected	in	any	Tn(pb-pBB262-mNet-
lacZ)Ark/+	embryo.	Ventral	view	of	an	(c)	early-streak	embryo	and	a	(d)	mid-streak	Tn(pb-pBB262-NCE-
lacZ)Ark/+	embryo	of	the	genotypes	shown	following	X-gal	staining.	Anterior	is	to	the	left.	No	lacZ	
expression	 was	 detected.	 Lateral	 view	 of	 (e)	 Tn+/+	 and	 (f-g)	 Tn(pb-pBB262-NCE-lacZ)Ark/+	 8-8.5	 dpc	
embryos	 following	X-Gal	 staining.	Anterior	 is	 to	 the	 left.	 (h)	Ventral	 view.	One	Tn(pb-pBB262-NCE-
lacZ)Ark/+	embryo	(g-h)	exhibited	lacZ	expression	in	the	node	and	midbrain	(black	arrows).	Lateral	
view	 of	 (i)	 Tn+/+	 and	 (j-k)	 Tn(pb-pBB262-NCE-lacZ)Ark/+	 embryos	 at	 12.5	 dpc	 following	 X-gal	 staining.	
Anterior	is	to	the	left.	(j)	X-gal	stain	trapping	was	detected	in	some	Tn(pb-pBB262-NCE-lacZ)Ark/+	embryos	
(black	 arrow),	 but	 this	 was	 not	 true	 lacZ	 expression.	 Four	 Tn(pb-pBB262-NCE-lacZ)Ark/+	 embryos	 (k,	
Appendix	 Figure	 A5.5)	 exhibited	 lacZ	 expression,	 however	 the	 expression	 pattern	 was	
inconsistent	between	embryos.	S:	somites.		 	
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Table	 7.3:	 Selected	 Zic2	 3’UTR	 CRISPR-mutagenesis	 guides.	 Guides	 were	 assessed	 via	 the	
following	criteria:	a	score	of	1-20	is	considered	a	low-quality	guide,	20-49	a	mid-quality	guide,	
and	≥50	a	high-quality	guide	(Zhang	Lab	and	MIT,	2015).	‘Off	target’	denotes	the	total	number	
of	matching	sites	for	the	guide	within	the	genome,	with	brackets	indicating	the	number	of	off	
target	sites	occurring	within	coding	regions	only.	‘Mismatches’	represent	the	number	of	non-
paired	 bases	 a	 the	 predicted	 off	 target	 sites.	 Preferred	 guides	 have	 a	 score	 of	 ≥50,	 ≥2	
mismatches	and	a	minimal	number	of	off-target	sites.	PAM:	Protospacer	Adjacent	Motif.		
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Figure	 7.8:	 Location	 of	 CRISPR-mutagenesis	 guides	 within	 the	 Zic2	 3’UTR.	 Guide	 strands	
(orange)	were	designed	to	target	multiple	locations	within	the	Zic2	3’UTR.	Black:	six	human	HPE-
associated	SNVs,	green:	putative	ARE	region,	pink:	predicted	poly(A)	sites.	
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Table	7.4:	Rounds	of	Zic2	3’UTR	CRISPR	mutagenesis	performed	via	microinjection.	Viability	
from	2	cell	(%):	the	percentage	of	viable	embryos	when	dissected	out	of	the	total	number	of	
implanted	2	cells.	Resorption	rate	(%):	the	percentage	of	non-viable	embryos	when	compared	
to	 total	 number	 of	 decidua.	 The	 preparation	 of	 the	 Cas9	 protein,	 guide	 strands,	 zygote	
harvesting	 and	microinjection	were	 all	 performed	 by	 the	 JCSMR	 Transgenesis	 Facility	 (ANU,	
Canberra).	ND:	not	determined;	plDNA:	plasmid	DNA;	WT:	wildtype.	
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Table	7.5:	Rounds	of	Zic2	3’UTR	CRISPR	mutagenesis	performed	via	electroporation.	Viability	
from	2	cell	(%):	the	percentage	of	viable	embryos	when	dissected	out	of	the	total	number	of	
implanted	2-cells.	Resorption	rate	(%):	the	percentage	of	non-viable	embryos	when	compared	
to	 total	 number	 of	 decidua.	 The	 preparation	 of	 the	 Cas9	 protein,	 guide	 strands,	 zygote	
harvesting	and	electroporation	were	all	performed	by	 the	 JCSMR	Transgenesis	Facility	 (ANU,	
Canberra).	 V/ms/pulse:	 volts,	 milliseconds,	 number	 of	 pulses;	 ND:	 not	 determined;	 plDNA:	
plasmid	DNA;	WT:	wildtype.		
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NCE.	 To	 exclude	 the	 possibility	 that	 modification	 of	 the	 NCE	 leads	 to	 in	 utero	 lethality,	
genotyping	of	microinjected	2-cell	embryos	and	sequencing	of	the	genotyping	amplicons	was	
performed.	 The	 Zic2	 3’UTR	 was	 wildtype	 in	 all	 embryos	 examined	 (n=10,	 data	 not	 shown),	
excluding	lethality	as	the	cause	of	the	low	mutagenesis	frequency	and	instead	indicating	a	low	
frequency	of	DNA	breaks	induced	by	G2	and	G3.		
To	increase	the	likelihood	of	the	selected	guides	generating	in	vivo	cuts,	the	remaining	guides	
were	synthesised	as	RNA,	enabling	their	cutting	ability	to	be	tested	in	vitro	via	a	cleavage	assay.	
As	shown	in	Figure	7.9	and	Table	7.7,	G6,	G7,	G8	and	G10	appeared	to	induce	Cas9	to	the	PCR	
target.	When	G6,	G7	and	G8	were	co-injected	 into	pronuclei	with	Cas9	protein,	only	a	 small	
number	 of	 pups	 were	 recovered	 (Figure	 7.10).	 All	 three	 pups,	 however,	 carried	 a	 variant	
sequence	at	 the	Zic2	3’UTR.	Additional	guides	specifically	 targeting	 the	NCE	have	since	been	
designed	and	are	being	used	in	the	current	rounds	of	Zic2	3’UTR	CRISPR-Cas9	mutagenesis.		
7.2.6 Analysis	of	Zic2	3’UTR	CRISPR-Cas9	embryos	and	mice	
In	the	25	rounds	of	CRISPR-Cas9	mutagenesis	performed	with	G2	and	G3,	three	embryos	were	
identified	 as	 possible	mutants	 via	 genotyping.	 Those	 embryos	 at	 the	mid-streak	 stage	were	
analysed	via	WMISH	to	Zic2	and	compared	to	wildtype	littermates,	whilst	those	at	early	somite	
stages	 were	 analysed	 with	 WMISH	 to	 SHH.	 Each	 modified	 embryo	 showed	 expression	
differences	 relative	 to	 control	 littermates	 (Figure	 7.11).	 Further	 attempts	 to	 document	 the	
precise	Zic2	3’UTR	modification	in	each	embryo	via	Sanger	sequencing	were	not	successful.		
From	the	two	CRISPR-mutagenesis	rounds	using	G6,	G7,	and	G8,	three	pups	were	found	to	have	
putative	mutations	within	the	Zic2	3’UTR	via	Sanger	sequencing	of	the	genotyping	amplicon.	The	
first,	designated	F0#8,	exhibited	a	1	bp	deletion	and	a	2	bp	deletion	in	the	Zic2	3’UTR,	upstream	
of	the	NCE	(Figure	7.10).	The	second,	F0#9,	exhibited	a	267	bp	deletion	and	an	overlapping	2	bp	
insertion	in	the	Zic2	3’UTR,	upstream	of	the	NCE,	whilst	the	third,	F0#10,	exhibited	a	deletion	of	
unknown	size	in	the	same	region.	No	visible	phenotype	characteristic	of	other	Zic2	heterozygous	
mutant	strains	(curly	tail	or	belly	spot)	was	seen	in	any	of	the	mice.		
Due	to	the	presence	of	large	deletions,	F0#9	and	F0#10	were	retained	for	further	analysis.	Their	
progeny	will	be	genotyped	and	Sanger	sequenced	to	confirm	the	presence	and	exact	location	of	
the	 Zic2	 3’UTR	 deletions,	 and	 phenotyped	 for	 Zic2-associated	 defects	 such	 as	 HPE,	 LR	
randomization	and	spina	bifida.	As	the	deletions	occur	upstream	of	the	NCE	region,	it	is	expected	
that	homozygote	pups	from	these	lines	will	not	exhibit	HPE.	If	this	is	correct,	these	lines	can	act	
as	 a	 negative	 control	 for	 any	 Zic2	 NCE	 deletions	 that	 arise	 from	 the	 ongoing	 CRISPR-Cas9	
mutagenesis	experiments.		 	
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Figure	 7.9:	 Four	Zic2	3’UTR	 guides	 sufficiently	 induced	Cas9	 cutting	 in	 an	 in	 vitro	 cleavage	
assay.	A	cleavage	assay	was	performed	by	Nay	Chi	(JCSMR	Transgenesis	Facility)	on	G5-G10.	A	
730	bp	Zic2	3’UTR	PCR	amplicon	was	incubated	Cas9	protein	and	individual	guides	made	up	of	
crRNA	annealed	to	tracrRNA.	 (a)	Successful	cleavage	of	the	amplicon	was	determined	by	the	
production	of	two	distinct	products	at	the	expected	size.	(b)	When	analysed	on	a	1.5%	agarose	
gel,	 G6,	 G7,	 G8	 and	 G10	 were	 found	 to	 successful	 cleave	 the	 Zic2	 3’UTR	 amplicon	 (*).	 L:	
HyperLadder	50	bp	(Bioline).	
A	
Guide	 UTR	amplicon	 Band	1	expected	size	 Band	2	expected	size	
G5	 730	bp	 99	bp	 631	bp	
G6	 730	bp	 109	bp	 621	bp	
G7	 730	bp	 175	bp	 555	bp	
G8	 730	bp	 373	bp	 357	bp	
G9	 730	bp	 423	bp	 307	bp	
G10	 730	bp	 659	bp	 71	bp	
	
B	
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Figure	7.10:	Sequence	analysis	of	founder	animals	with	putative	deletions	in	the	Zic2	3’UTR.	
(a)	Sanger	sequencing	traces	for	three	founder	(F0).	A	double	indicates	a	deletion.	(b)	Location	
of	putative	mutations	in	the	Zic2	3’UTR	for	the	corresponding	founder	mice.		
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Figure	7.11:	Analysis	of	unconfirmed	Zic2	NCE	mutant	embryos.	pZic2+/DNCE	represents	putative	
Zic2	NCE	mutants.	Anterior	is	to	the	left.	(a-d)	WMISH	to	Shh.	(a-b)	Ventral	view	of	3s	embryos	
of	 the	 genotypes	 shown.	 The	 pZic2+/DNCE	 embryo	 exhibited	 a	 discontinued	 notochord	 and	
expanded	node	staining	(black	arrowheads).	(c-d)	Lateral	view	of	7s	embryos	of	the	genotypes	
shown.	 The	 pZic2+/DNCE	 embryo	 exhibited	 a	 discontinued	 notochord	 (black	 arrowhead)	 and	
reduced	Shh	expression	(*).	(e-f’)	Lateral	view	of	mid-streak	stage	embryos	of	the	genotypes	
shown	with	WMISH	to	Zic2.	The	pZic2+/DNCE	embryo	appeared	to	have	either	expanded	Zic2	in	
the	 node	 and	 surrounding	 endoderm,	 or	 a	 reduced	 endoderm	 layer	 (black	 arrowhead).	 (g-i)	
Examples	 of	 Sanger	 sequencing	 traces	 for	 embryos	 of	 the	 genotypes	 shown.	
Mutations/inconclusive	reads	are	annotated	by	a	red	arrowhead.	S:	somites,	MS:	mid-streak.		
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7.3 Discussion	
The	aim	of	this	chapter	was	to	investigate	the	role	of	the	Zic2	NCE,	using	both	gain-of-function	
(PiggyBac	transposon	transgenics)	and	loss-of-function	(CRISPR-Cas9	mutagenesis)	approaches,	
to	determine	if	the	NCE	regulated	Zic2	expression	during	gastrulation	and	if	it	played	a	role	in	
HPE	pathogenesis.	Whilst	PiggyBac	was	shown	to	be	a	highly	effective	method	for	creation	of	
transgenic	 embryos,	 this	 did	 not	 translate	 to	 reproducible	 NCE	 driven	 lacZ	 expression	 at	
gastrulation.	Similarly,	whilst	CRISPR-Cas9	was	used	to	successfully	delete	a	portion	of	the	Zic2	
3’UTR,	this	region	was	not	within	the	NCE.		
7.3.1 Technical	difficulties	prevented	the	assessment	of	ZIC2	UTR	function	via	either	gain-	
or	loss-of-function	methods	
The	PiggyBac	transgenesis	system	led	to	a	high	frequency	of	transgenesis,	but	a	low	frequency	
of	reporter	expression.	For	Tn(pb-pBB262-NCE-lacZ)Ark	embryos,	this	may	be	due	to	the	Zic2	NCE	acting	
as	a	repressor	at	the	stages	analysed,	as	suggested	by	heterologous	reporter	assays	in	HEK293T	
cells	(Chapter	5).	The	mNet-lacZ	positive	control	also	failed	to	produce	reporter	expression.	One	
factor	 that	 may	 have	 prevented	 expression	 of	 the	 lacZ	 reporter	 in	 all	 constructs	 is	 over-
insulation	from	the	cHS4	fragments	within	the	transgene.	The	cHS4	insulator	fragments	in	the	
pBB262	plasmids	were	included	to	minimize	position	effects	upon	the	inserted	transgenes	from	
adjacent	regulatory	elements	and	to	prevent	post-integration	silencing,	but	 it	 is	possible	that	
their	enhancer-blocking	properties	blocked	the	activity	of	 the	b-globin	promoter	and/or	NCE	
and	mNet	element	activity,	resulting	in	no	or	inconsistent	lacZ	expression.	Whilst	interference	
between	cHS4	insulators	and	promoter-enhancer	activity	has	previously	been	reported	(Groth	
et	al.,	2013),	these	effects	were	on	activation	of	endogenous	promoters	 in	the	host	genome.	
Though	the	b-globin	minimal	promoter	used	in	all	PiggyBac	experiments	reported	in	this	thesis	
was	the	same	promoter	used	in	the	initial	creation	of	the	mNet	line	(Ruth	Arkell,	unpublished)	
indicating	it	can	be	utilised	during	mouse	gastrulation,	and	the	initial	optimisation	experiments	
by	Aker	et.	al.	(2007)	for	the	cHS4	insulators	used	in	this	Chapter	were	conducted	with	a	b-globin	
minimal	promoter,	it	remains	possible	that	the	insulator-promoter	combination	used	in	these	
experiments	does	not	drive	robust	expression	at	the	specific	stages	analysed.	To	investigate	this	
possibility,	a	series	of	transgenics	made	plasmids	with	varying	numbers	of,	or	no,	cHS4	insulator	
fragments	(Table	7.1)	should	be	tested.	Alternatively,	different	promoters	known	to	be	active	at	
gastrulation	could	be	incorporated	into	the	pBB262-NCE-lacZ	construct.		
Another	possibility	is	that	the	transgenesis	protocol	is	genotoxic.	This	could	occur	due	to	chance	
integration	 at,	 and	 interruption	 of,	 an	 essential	 gene	within	 the	murine	 genome,	 or	 due	 to	
unstable	 transgene	 integration	 and	 continued	 genome	 mobility	 that	 can	 lead	 to	 genome	
rearrangements	such	as	those	previously	been	reported	with	PiggyBac	 transgenics	(Huang	et	
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al.,	2010;	Yusa	et	al.,	2011).	One	method	to	control	for	this	possibility	is	to	use	a	single	plasmid	
construct	 that	 combines	 both	 the	 transposase	 and	 transpositioning	 transgene.	 By	 sharing	 a	
single	poly(A)	 sequence,	 the	 transposase	 self-inactivates	after	 the	 initial	 transposition	event,	
preventing	further	events	from	occurring	(Chakraborty	et	al.,	2014).	Genotoxicity	is	expected	to	
result	 in	 a	 decrease	 transgenic	 efficiency	 only,	 however,	 and	 is	 unlikely	 to	 account	 for	 the	
complete	lack	of	lacZ	expression	in	the	positive	control.		
In	 addition	 to	 issues	 with	 the	 PiggyBac	 constructs,	 it	 is	 possible	 that	 variation	 in	 genetic	
background	could	account	for	the	mNet-lacZ	transgene	successfully	expressing	lacZ	in	previous	
experiments	but	not	in	the	transgenics	reported	here,	as	multiple	studies	report	wide	ranges	of	
phenotypic	variation	dependant	on	the	mouse	strain	used	(Doetschman,	2009;	Schachter	and	
Krauss,	2008).	The	expected	variation	is	minimal,	however,	since	the	original	mNet	line	and	the	
PiggyBac	transgenics	reported	in	this	Chapter	were	produced	on	the	same	inbred	strain	(FVB),	
but	 different	 sub-strains.	 It	 is	 mostly	 likely	 a	 combination	 of	 the	 events	 discussed	 above,	
however,	 that	 resulted	 in	 a	 failure	 of	 the	 PiggyBac	 transgenics.	 As	 such,	 optimization	 and	
redesign	will	need	to	take	place	before	further	transgenics	are	attempted.	Whilst	conventional	
transgenics	with	DNA	cargo	1-2	kb	in	size	are	still	subject	to	position	effect	variegation	(PEV)	in	
conjunction	with	a	lower	transgenesis	rate,	alternative	methods	such	as	bacterial	(BAC)	or	yeast	
(YAC)	 artificial	 chromosomes	 may	 be	 a	 suitable	 alternative	 to	 transposons.	 BAC	 and	 YAC	
transgenics	 both	 exhibit	 position-independent	 expression	 due	 to	 the	 presence	 of	 a	 larger	
fragment	that	contain	the	 local	surrounding	genomic	sequence	 (Giraldo	and	Montoliu,	2001;	
Matthaei,	2007),	and	BAC	transgenics	are	reported	to	exhibit	reproducible	expression	in	85%	of	
transgenic	lines	(Gong	et	al.,	2003).		
The	difficulties	encountered	with	the	CRISPR-Cas9	loss-of-function	approach	are	most	likely	site	
specific	 since	 (i)	 the	 introduction	 of	 deletions	 via	 incorporation	 of	 multiple	 guides	 typically	
achieves	high	mutagenesis	efficiencies	 (Meyer	et	al.,	 2015;	 Sanjana	et	al.,	 2016;	 Zhou	et	al.,	
2014)	and	(ii)	the	JCSMR	Transgenesis	Facility	report	that	50%	of	NHEJ-dependant	projects	are	
successful	after	 the	 first	microinjection	session	 (Burgio	 laboratory,	personal	communication).	
The	presence	of	only	a	few	NGG	PAM	sites	within	the	NCE	itself	present	difficulties,	especially	if	
the	 guides	 sequences	 flanking	 these	 sites	 cannot	 sufficiently	 target	 Cas9	 to	 this	 region.	 An	
alternative	 CRISPR	 endonuclease	 is	 therefore	 required.	 Cpf1	 has	 recently	 been	 shown	 to	
efficiently	cleave	target	DNA	in	a	manner	similar	to	Cas9,	but	it	targets	T-rich	motifs	and	does	
not	require	tracrRNA	in	contrast	to	Cas9	which	requires	a	G-rich	PAM	site	and	the	presence	of	a	
tracrRNA	bound	to	crRNA	to	guide	the	protein	to	a	target	sequence	(Zetsche	et	al.,	2015).	As	the	
Zic2	NCE	was	found	to	be	enriched	for	A	and	T	nucleotides	(Chapter	6),	the	use	of	Cpf1	in	future	
CRISPR	 mutagenesis	 experiments	 would	 provide	 multiple	 new	 PAM	 recognition	 sequences	
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within	the	conserved	domain	and	may	prove	more	successful	than	Cas9.	Cpf1	would	also	aid	in	
the	introduction	of	the	HPE-associated	SNVs	into	the	NCE,	which	would	be	difficult	to	achieve	
with	Cas9	unless	unusually	long	homology	oligonucleotides	are	used.	
7.3.2 The	ZIC2	NCE	likely	controls	ZIC2	gene	expression	
Based	on	 the	 results	 shown	 in	 this	Chapter	 and	Chapters	4,	 5	 and	6	of	 this	 thesis,	 it	 can	be	
concluded	 that	 the	wildtype	 ZIC2	 NCE	 possess	 two	main	 roles:	 transcription	 repression	 and	
promotion	of	mRNA	decay.	In	its	role	as	an	ER	element,	the	NCE	acts	to	repress	transcription	of	
a	 reporter	 gene	 in	 a	 node-like	 signalling	 environment,	 with	 the	 six	 HPE-associated	 SNVs	
disrupting	this	ability.	Moreover,	the	addition	of	TFs	such	as	FOXA2,	FOXJ1	and	ZIC2	modulate	
this	repressive	function	in	a	context-specific	manner.	Deletion	of	this	region	from	the	murine	
genome	appears	to	result	in	an	increase	in	Zic2	expression,	however	more	data	is	required	to	
confirm	this	result.	In	its	role	regulating	transcript	decay,	an	ARE	within	the	NCE,	along	with	the	
use	of	the	most	distal	poly(A)	site	during	gastrulation,	determines	ZIC2	half-life	via	predicted	
interactions	with	RBPs	and	miRNAs.	The	production	of	a	lncRNA	from	within	the	NCE,	predicted	
to	 be	 eRNA,	 suggests	 a	 third,	 as	 yet	 unknown	 role	 for	 the	ZIC2	 3’UTR.	 From	 these	 results,	 I	
conclude	that	the	Zic2	NCE	likely	controls	Zic2	expression	during	gastrulation.		
The	 introduction	 of	 M5	 into	 the	 NCE	 is	 the	 most	 likely	 to	 disrupt	 ER	 function	 by	 altering	
interactions	with	TFs	in	the	node,	whilst	M3	and	M4	are	predicted	to	disrupt	the	stability	of	the	
Zic2	transcript	due	to	their	location	within	the	putative	ARE	and	nearby	the	poly(A)	site.	These	
three	SNVs	are	therefore	the	best	candidates	for	CRISPR-mediated	HDR	mutagenesis	in	the	Zic2	
NCE	and	can	be	used	 to	determine	 if,	 and	how,	a	 single	nucleotide	change	can	 lead	 to	HPE.	
Additionally,	it	would	be	prudent	to	delete	minimal	sections	of	the	NCE	to	determine	the	exact	
function	of	each	region.	It	 is	expected	that	certain	regions	of	the	NCE	would	produce	a	more	
prominent	 phenotype	 based	 off	 the	 importance	 of	 the	 TFs	 binding	 to	 that	 region,	 or	 the	
presence	of	RNA	regulatory	elements	such	as	the	ARE	or	poly(A)	sites.	By	determining	the	most	
active	regions	of	the	NCE	involved	in	Zic2	regulation,	or	embryo	development	as	a	whole,	it	will	
allow	human	geneticists	to	categorise	those	SNVs	that	are	most	likely	to	lead	to	HPE	based	on	
their	location	in	the	3’UTR.		
The	bigene	nature	of	ZIC2	and	ZIC5	suggests	that	the	NCE	may	also	play	a	role	in	regulating	ZIC5	
during	gastrulation.	This	hypothesis	is	supported	by	the	identification	of	a	human	proband	with	
ZIC2-associated	HPE	who	also	exhibits	hydrocephaly	(Weiss	et	al.,	2017),	a	known	phenotype	of	
Zic5	null	alleles	in	mice	(Inoue	et	al.	2004;	Arkell	lab,	unpublished	data).	Future	analyses	of	the	
NCE	 CRISPR	 mutants	 should	 include	 examination	 of	 Zic5	 expression	 and	 determination	 of	
whether	the	mutant	embryos	exhibit	hydrocephalus.		
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7.3.3 A	‘Goldilocks	zone’	of	ZIC2	expression	may	be	required	to	prevent	HPE		
Analysis	of	ZIC2	coding	domain	mutations	has	led	to	a	clear	expectation	that	HPE	pathogenesis	
arises	from	ZIC2	loss-of-function.	It	was	therefore	hypothesised	that	the	NCE	in	the	ZIC2	3’UTR	
would	promote	ZIC2	transcription,	and	that	introduction	of	the	six	HPE-associated	SNVs	would	
result	in	loss	of	enhancer	function	and	reduced	levels	of	ZIC2	transcript.	The	analysis	presented	
in	 this	 thesis,	 however,	 suggests	 the	 inverse	 is	 occurring.	 The	default	 role	of	 the	ZIC2	 3’UTR	
appears	to	be	as	a	repressor	of	reporter	expression	in	a	node-like	signalling	environment,	and	
the	introduction	of	the	six	HPE-associated	SNVs	results	in	loss	of	this	repressive	ability.	As	such,	
it	is	expected	that	if	ZIC2	is	a	target	of	the	NCE,	the	mutations	would	result	in	an	increase	in	ZIC2	
expression.	 Similarly,	 the	 proximity	 of	 the	 HPE-associated	 SNVs	 to	 the	 PASs	within	 the	 ZIC2	
3’UTR	predicts	increased	transcript	half-life	and	elevated	levels	of	ZIC2	protein	when	they	are	
introduced.		
The	dual	roles	of	the	ZIC2	3’UTR	characterized	in	this	thesis	suggest	that	the	3’UTR	acts	to	reduce	
ZIC2	levels	during	normal	development	and	that	mutation	of	the	3’UTR	results	in	an	increase	in	
ZIC2.	Gain	of	ZIC2	function	has	only	been	implicated	in	one	human	case	of	ZIC2-associated	HPE	
thus	far,	with	the	CDS	mutation	Q36P	resulting	in	a	170%	increase	in	ZIC2	transactivation	activity	
on	the	ApoE	promoter	when	tested	in	vitro	(Brown	et	al.,	2005).	Recent	experiments	in	Xenopus	
embryos	provide	further	support	for	this	mechanism	by	demonstrating	that	both	knocking	out	
zic2	(via	morpholino	injections)	and	upregulating	zic2	(via	mRNA	injections)	resulted	in	the	same	
phenotype:	 the	 loss	 of	 foxa2	 organizer	 expression	 and	 defects	 in	 embryo	 development	
(Houtmeyers	 et	 al.,	 2016).	 It	 is	 therefore	 feasible	 that	mutation	 of	 the	 ZIC2	 3’UTR	 leads	 to	
elevated	ZIC2	transcript	and	HPE.	Potentially,	a	‘Goldilocks	zone’	of	ZIC2	expression	is	required	
for	 normal	 embryo	 development	 (Figure	 7.12).	 If	 ZIC2	 expression	 is	 too	 little,	 or	 too	much,	
defects	such	as	HPE	will	occur.		
It	 is	 possible	 that	 hypermorphic	 mutations	 occur	 more	 frequently	 than	 thought,	 but	 are	
obscured	by	embryonic	 lethality.	This	correlates	with	known	features	of	Zic2-associated	HPE,	
such	as	the	positive	correlation	between	ZIC2	mutation	and	HPE	severity	or	lethality	(Table	1.2)	
(Solomon	 et	 al.,	 2010b).	Without	 sufficient	 evidence	 from	mutant	 embryos,	 it	 is	 difficult	 to	
confirm	the	existence	of	this	‘Goldilocks	zone’	directly.	Therefore,	to	confirm	if	any	of	the	NCE	
SNVs	result	in	an	increase	in	ZIC2	expression	as	predicted	in	this	thesis,	the	full	range	of	CRISPR	
mutants	attempted	in	this	chapter	(tiled	NCE	deletions),	and	mutants	for	the	six	individual	SNVs,	
need	to	be	made	and	analysed.	Examination	of	Zic2	expression	via	WMISH	and	RT-qPCR	will	
determine	whether	 Zic2	 is	 upregulated	 by	 the	mutations,	 and	 phenotyping	 of	 embryos	 will	
determine	if	this	 is	sufficient	to	cause	HPE.	 If	the	‘Goldilocks	zone’	hypothesis	proposed	here	
proves	correct,	it	will	cement	a	new	aetiology	for	ZIC2-associated	HPE.	 	
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Figure	7.12:	The	‘Goldilocks	zone’	hypothesis	of	ZIC2-associated	HPE.	(a)	The	majority	of	ZIC2-
associated	HPE	cases	can	be	attributed	to	loss	of	ZIC2	transcript	or	function	(LOF).	(b)	Based	on	
the	data	presented	in	this	thesis,	and	evidence	from	Xenopus	embryos	and	one	HPE	proband,	
we	 hypothesis	 that	 gain	 of	 ZIC2	 transcript	 or	 function	 (GOF)	 can	 also	 lead	 to	 embryonic	
malformations	such	as	HPE.	This	would	result	in	a	‘Goldilocks	zone’,	where	ZIC2	is	expression	is	
not	too	little	or	too	much,	but	the	right	level	to	promote	normal	embryonic	development.		
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Appendix	A1 	
	
Table	A1.1:	Constructs	used	throughout	this	thesis.	
Construct	name	 Description	 Reference	
Gateway	Cloning		
pENTR1A,	2B	and	3C	 Entry	vectors	used	for	Gateway	Cloning	(Invitrogen).	Contain	multiple	cloning	site	(MCS)	
surrounding	the	negative	selection	gene	ccdB,	all	of	which	is	bordered	by	two	attL	sites	for	LR	
recombination	based	cloning.	Each	plasmid	(1A,	2B	and	3C)	has	a	different	frame.		
Thermo	Fisher	Scientific	
pcDNA3.1/nV5-DEST	 pcDNA3.1/nV5-DEST	(Invitrogen)	Destination	vector	used	for	Gateway	Cloning.	Contains	the	
cytomegalovirus	(CMV)	promoter	upstream	of	a	V5	epitope	tag	followed	by	two	attR	sites	
surrounding	a	ccdB	gene	for	Gateway	LR	recombination	based	cloning.	In	mammalian	cells,	
expresses	a	V5	tag	fused	to	N-	terminus	of	sequence	inserted	between	attR	sites.	
Thermo	Fisher	Scientific	
pENTR3C-Foxa2	 See	section	2.1	 	
pENTR1A-Foxj1	 See	section	2.1	 	
pENTR2B-NOGGIN	 See	section	2.1	 	
pENTR3C-ZIC2	 See	section	2.1	 	
pCR8-GW-TOPO-NCE	
(Wildtype	and	
mutant)	
pCR8-GW-TOPO	Gateway	entry	vector	containing	608	bp	of	the	wildtype	and	mutant	human	
ZIC2	3’UTR,	including	the	NCE	region.		
Muenke	laboratory	
(NHGRI,	NIH;	Maryland,	
USA)	
pGL4.20-DEST-luc	 See	section	2.1	 	
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pGL-b-globin-DEST-
luc	
See	section	2.1	 	
pGL-Hsp68-DEST-luc	 See	section	2.1	 	
pGL-pZIC3-DEST-luc	 See	section	2.1	 	
Expression	constructs	
pALK4-HA	 Constitutively	active	form	of	Rat	Alk4	with	HA	epitope	tag	in	pcDNA3.0	 (Bernard	et	al.,	2006)	
pV5-Foxa2	 See	section	2.1	 	
pV5-Foxj1	 See	section	2.1	 	
pV5-NOGGIN	 See	section	2.1	 	
pV5-ZIC2	 See	section	2.1	 	
pV5-ZIC2-3’UTR	 See	section	2.1	 	
Luciferase	reporter	constructs	(non-Gateway	Destination)	
pGL4.20	 pGL4.20(luc2/Puro)	reporter	vector.	Contains	a	MCS	upstream	of	luciferase	reporter	gene	luc2	
(codon	optimised	for	expression	in	mammalian	cell	lines).	The	backbone	has	been	engineered	
to	reduce	undesired	non-specific	transcription	factor	binding.	
Promega	
pGL4.20-b-globin-NCE	
(wildtype)	
See	section	2.1	 	
pGL4.20-Hsp68-NCE	
(wildtype)	
See	section	2.1	 	
pGL4.20-pZIC3-NCE	
(wildtype	and	
mutant)	
See	section	2.1	 	
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pGL-(CAGA)12-luc	 Twelve	tandem	optimised	CAGA	boxes	(a	SMAD3	and	SMAD4	binding	site),	upstream	of	a	TK	
minimal	promoter	followed	by	the	luciferase	reporter	gene.	Used	to	measure	levels	of	Nodal	
and	Activin	signalling	activation.	
(Dennler	et	al.,	1998;	
Kumar	et	al.,	2001)	
pGL-b-globin-
TOPFLASH-luc	
Three	tandem	optimised	TCF	binding	sites	upstream	of	a	b-globin	minimal	promoter	(isolated	
from	pKS:b-globin:lacZ)	followed	by	the	luciferase	reporter	gene.	Used	to	measure	levels	of	
WNT/β-catenin	signalling	activation.	
Helen	Bellchambers	
(Arkell	laboratory)	
pGL-BRE-luc	 Three	distinct	BMP	response	elements	(BREs),	upstream	of	a	TK	minimal	promoter	followed	by	
the	luciferase	reporter	gene.	Used	to	measure	levels	of	BMP	signalling	activation.	
(Korchynskyi	and	Ten	
Dijke,	2002;	Morikawa	et	
al.,	2011)	
pGl-pZIC3-luc	 A	340	bp	untested	ZIC3	promoter	upstream	of	a	luciferase	reporter	(pGL3.0)	 Muenke	laboratory	
(NHGRI,	NIH;	Maryland,	
USA)	
Riboprobes	
pCDNA-CDX2	 The	complete	CDS	of	Cdx2	(Accn.	No:	NM007673)	in	pCDNA	3.1	 Stefan	Broer,	ANU	
pGEM-T-Easy-Dand5	 See	section	2.1	 	
pGEM-T-Easy-Dkk1	 The	complete	Dkk1	CDS	(Accn.	No.	JN966751)	in	pGEM-T-Easy	 (Ip	et	al.,	2014)	
pBS-Foxa2	 1.5	kb	complete	murine	Foxa2	CDS	(clone	c21)	in	pBS-KS	II	 (Sasaki	and	Hogan,	1993)	
pYX-ASC-Foxj1	 Complete	murine	Foxj1	CDS	(Accn.	No:	BC082543)	in	pYX-ASC	 (Cruz	et	al.,	2010)	
pBS-Lefty1/2	 500	bp	mature	protein	coding	region	for	both	murine	Lefty1	and	Lefty2	in	pBS-KS	II	 (Meno	et	al.,	1996)	
pBS-Lhx1	 2.4	kb	fragment	of	the	murine	Lhx1	(Lim1)	CDS	in	pBS-KS	II	 (Shawlot	and	Behringer,	
1995)	
pBS-Nodal	 2	kb	complete	murine	Nodal	CDS	in	pBS-KS	II	 (Conlon	et	al.,	1994)	
pGEM-T-Easy-Noto	 See	section	2.1	 	
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pT7T3D-Nppa	 1	kb	fragment	of	Nppa	CDS,	IMAGE	402095	(Accn.	No:	W77688)	in	pT7T3D	 Dominic	Norris,	MRC	
Harwell,	UK	
pBS-Pitx2	 Complete	1754	bp	Pitx2	gene	(IMAGE	371701)	in	pBS-KS	II	 (Ryan	et	al.,	1998)	
pBS-Pkd1l1	 805	bp	fragment	of	the	Pkd1l1	CDS	in	pBS-KS	II	 (Field	et	al.,	2011)	
pGEM-T-Easy-Rfx3	 See	section	2.1	 	
pBS-Shh	 2.6	kb	complete	Shh	CDS	in	pBS-KS	II	 (Echelard	et	al.,	1993)	
pBS-Sox2	 530	bp	fragment	of	the	Sox2	CDS	in	pBS-KS	II	 (Wood	and	Episkopou,	
1999)	
pBS-Sox3	 900	bp	fragment	of	the	Sox2	CDS	in	pBS-KS	II	 (Wood	and	Episkopou,	
1999)	
pT7T3D-Sox17	 1111	bp	of	the	Sox17	CDS,	IMAGE	1529001	(Accn	No:	AW985818)	in	pT7T3D	 Dominic	Norris,	MRC	
Harwell,	UK	
pGEM-T-Easy-Zic2	 738	bp	of	Zic2	Exon	1	to	beginning	of	zinc	finger	domain	(Accn.	No.	NM009574.1)	in	pGEM-T-
Easy	
(Elms	et	al.,	2003)	
pGEM-T-Easy-Zic3	 Bases	646-1266	of	Zic3	(Accn.	No.	NM009575)	in	pGEM-T-Easy.	Exon	1	up	to	zinc	finger	
domain	
(Elms	et	al.,	2004)	
pGEM-T-Easy-Zic5	 788	bp	fragment	spaning	the	5’	UTR	and	exon1	of	Zic5	in	pGEM-T-Easy	 Arkell	laboratory	
Other	
pGEM-3’UTR-WT	 See	section	2.1	 	
pBB232	 Contains	the	Pbase	(PiggyBac)	transposase	open	reading	frame.		 Bryan	Bjork	(Harvard	
Medical	School,	Boston,	
MA;	Bjork	et	al.	2010)	
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pBB256,	pBB259	and	
pBB262	
Constructs	for	the	delivery	of	desired	transgene	cargo.	Each	construct	contains	two	inverted	
terminal	repeats.	The	MCS	is	flanked	by	the	repeats,	along	with	two	(pBB259)	or	four	(pBB262)	
copies	of	the	cHS4	chicken	insulator	fragment.	For	more	information,	see	Chapter	7.	
Bryan	Bjork	(Harvard	
Medical	School,	Boston,	
MA;	Bjork	et	al.	2010)	
p1229	 The	4	kb	lacZ	gene	and	SV40	PolyA	tail	in	pBS-KS	II	with	a	b-globin	minimal	promoter	in	pBS-KS	
II	
Nick	Warr	(Arkell	
laboratory)	
pBB262-ZIC2	NCE	
(wildtype	and	
mutant)	
See	section	2.1	 	
pBB262-NCE-lacZ	
(wildtype	and	
mutant)	
See	section	2.1	 	
pBB262-lacZ	 See	section	2.1	 	
pmNETg	 The	1617	bp	mNet	fragment	cloned	upstream	of	lacZ	in	p1229	 Ruth	Arkell	(Arkell	
laboratory)	
pBB262-mNet	 See	section	2.1	 	
pBB262-mNet-lacZ	 See	section	2.1	 	
pKS:b-globin:lacZ	 The	52	bp	b-globin	minimal	promoter	upstream	of	a	lacZ	reporter	in	pBS-KS	II	 (Yee	and	Rigby,	1993)	
pBS-Hsp68	 The	293	bp	heat	shock	protein	68	(Hsp68)	promoter	in	pBS-KS	II	 (Adachi	et	al.,	1999)	
pGEM-T-Easy-Hsp68	 See	section	2.1	 	
pTracer-CMV-Bsd-
lacZ	
Two	Tracer™	mammalian	expression	vector	with	CMV	promoter	that	express	GFP	fused	to	the	
selectable	marker	Blasticidin.	Contains	a	lacZ	reporter.		
Tscharke	laboratory	
(ANU),	Thermo	Fisher	
Scientific	
pTOPO-Blunt-II	 The	pTOPO-Blunt-II	vector	is	designed	to	clone	blunt-ended	PCR	products	generated	by	
thermostable	proofreading	polymerases.	Used	to	efficiently	clone	in	CRISPR	guide	strands.		
Thermo	Fisher	Scientific	
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pTOPO-Blunt-II-G2	 ZIC2	NCE	guide	2	(G2)	cloned	into	the	pTOPO-Blunt-II	vector.	 JCSMR	Transgenesis	
Facility	
pTOPO-Blunt-II-G2	 ZIC2	NCE	guide	3	(G3)	cloned	into	the	pTOPO-Blunt-II	vector.	 JCSMR	Transgenesis	
Facility	
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Table	A1.2:	Oligonucleotides	used	throughout	this	thesis.	
Oligonucleotide	
Name	
Sequence	(5’	–	3’)	 For	
Cloning	and	sequencing	
RA104	 TAC	GAC	TCA	CTA	TAG	GG	 Sequencing	plasmids	(T7)	
RA105	 ATT	AAC	CCT	CAC	TAA	AG	 Sequencing	plasmids	(T3)	
RA561	 GTT	TTC	CCA	GTC	ACG	AC	 Sequencing	plasmids	(M13)	
RA562	 ACA	GGA	AAC	AGC	TAT	GAC	 Sequencing	plasmids	(M13)	
RA1411	 AAC	TAA	GCA	GAA	GGC	CA	 Sequencing	plasmids	(pENTR)	
RA1412	 GTG	CAA	TGT	AAC	ATC	AG	 Sequencing	plasmids	(pENTR)	
RA1443		 TAG	CTG	TAC	ATC	TAG	ATG	TGT	ACA	TAG	CGG	ACT	
CCT	CCT	TTC	
Cloning	the	ZIC2	NCE	into	pBB262-ZIC2	NCE	via	In-Fusion	Cloning.	
Contains	a	XbaI	restriction	site.	
RA1445	 TTG	TCA	ATC	CTC	AGC	TG	 Sequencing	the	ZIC2	3’UTR	
RA1446	 CCT	AAA	GTG	ATG	GGC	TT	 Sequencing	the	ZIC2	3’UTR	
RA1464	 TAG	GGG	GCC	CTC	TAG	AGC	GGC	CGC	TGG	GTC	GAA	
TTC	GCC	CTT	GTC	AAT	
Cloning	the	ZIC2	NCE	into	pBB262-ZIC2	NCE	via	In-Fusion	Cloning.	
Contains	XbaI	and	NotI	restriction	sites.	
RA1506	 TCAGATCTCGAACTAGTGGATCCCC	 Cloning	the	b-globin	minimal	promoter	into	pGL-b-globin-DEST-luc.	
Contains	a	BglII	restriction	site.	
RA1507	 CTAAGCTTTCGGCTAGAAGCAAATG	 Cloning	the	b-globin	minimal	promoter	into	pGL-b-globin-DEST-luc.	
Contains	a	HindIII	restriction	site.	
RA1545	 ATGGTACCCAGCCTGTGGATGTTCA	 Cloning	Foxj1	into	pENTR1A-Foxj1.	Contains	a	KnpI	restriction	site.	
RA1546	 ATGCGGCCGCCCTGACTTGAGCACTGT	 Cloning	Foxj1	into	pENTR1A-Foxj1.	Contains	a	NotI	restriction	site.	
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RA1570	 GGAAACCCTAGTCAGAA	 Cloning	Dand5	into	pGEM-T-Easy-Dand5.	
RA1571	 CATGAATGAACCTTGGC	 Cloning	Dand5	into	pGEM-T-Easy-Dand5.	
RA1590	 ATTGAGCTCCTTGCACA	 Cloning	Noto	into	pGEM-T-Easy-Noto.	
RA1591	 TGGTGAGTGACATTCAG	 Cloning	Noto	into	pGEM-T-Easy-Noto.	
RA1592	 AGCGAAGTCGAAAGTGA	 Cloning	Rfx3	into	pGEM-T-Easy-Rfx3.	
RA1593	 TCCTTCTTGACACCTGA	 Cloning	Rfx3	into	pGEM-T-Easy-Rfx3.	
RA1596	 GACTCGAGTGAATGGTACGTGTGAC	 Cloning	the	ZIC2	3’UTR	into	pGEM-3’UTR-WT.	Contains	an	XhoI	
restriction	site.	
RA1597	 GACTCGAGTTTGCAGTTTCAACACATTT	 Cloning	the	ZIC2	3’UTR	into	pGEM-3’UTR-WT.	Contains	an	XhoI	
restriction	site.	
RA1626	 TCAAGCTTGGATTTGTGGGGTTTCG	 Cloning	the	Hsp68	promoter	into	pGEM-T-Easy-Hsp68.	Contains	an	
HindIII	restriction	site.	
RA1640	 AGATCTGATTACGCCAAGCTTGC	 Cloning	the	Hsp68	promoter	into	pGEM-T-Easy-Hsp68.	Contains	an	
BglII	restriction	site.	
RA1776	 ATGGTACCTCAGAGGCATGGAGCGCT	 Cloning	NOGGIN	into	pENTR2B-NOGGIN.	Contains	an	KpnI	restriction	
site.	
RA1777	 TAGCGGCCGCAGTCGGTGGGGATCGATC	 Cloning	NOGGIN	into	pENTR2B-NOGGIN.	Contains	an	NotI	restriction	
site.	
RA1824	 CAGTCGACTACTTCCAGCATGCTGGGA	 Cloning	Foxa2	into	pENTR3C-Foxa2.	Contains	a	SalI	restriction	site.	
RA1825	 GACTCGAGCATGTCCCCAGTGACCAGA	 Cloning	Foxa2	into	pENTR3C-Foxa2.	Contains	a	XhoI	restriction	site.	
RT-qPCR	
RA96	 ACA	GGT	TGG	AGC	TGC	TTT	GT	 RT-qPCR	of	mouse	Zic2	
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RA99	 TCT	CTG	TAT	GTC	TGA	AAC	TG	 RT-qPCR	of	mouse	Zic2	3’UTR	PolyA	site	mP1,	Amplification	of	the	
Zic2	3’UTR	for	3’RACE	
RA252	 TCG	TTG	CGG	AAG	CAC	ATG	AA	 RT-qPCR	of	mouse	Zic2	
RA1177	 GTC	AAC	CAC	ATC	CGC	GTG	CA	 RT-qPCR	of	human	ZIC2	
RA1247	 GGT	CGC	AGC	CCT	CAA	ACT	CAC	 RT-qPCR	of	human	ZIC2	
RA1604	 CTT	CAG	CGG	AGG	ACT	CTA	CG	 RT-qPCR	of	human	PPP1R8	
RA1605	 GGG	GCA	AGG	TTT	GGG	TAT	GG	 RT-qPCR	of	human	PPP1R8	
RA1606	 GGAATGCAAAAAGAGTTGTCCTG	 RT-qPCR	of	human	ABCE1	
RA1607	 CGAGGGATAGGCAACCTGTG	 RT-qPCR	of	human	ABCE1	
RA1719	 GCG	CAG	CCA	TCC	TGG	AGT	A	 RT-qPCR	of	mouse	H2afz	
RA1720	 CCG	ATC	AGC	GAT	TTG	TGG	A	 RT-qPCR	of	mouse	H2afz	
RA1766	 CGA	CTG	GAG	CAG	CTA	CTA	TGC	 RT-qPCR	of	human	FOXA2	
RA1767	 TAC	GTG	TTC	ATG	CCG	TTC	AT	 RT-qPCR	of	human	FOXA2	
RA1768	 CAA	CTT	CTG	CTA	CTT	CCG	CC	 RT-qPCR	of	human	FOXJ1	
RA1769	 CGA	GGC	ACT	TTG	ATG	AAG	C	 RT-qPCR	of	human	FOXJ1	
RA1780	 CCA	ACT	TCA	ATG	AAT	GGT	AC	 RT-qPCR	of	mouse	Zic2	3’UTR	poly(A)	site	mP0	
RA1781	 AGA	CGA	TCC	TAA	GGT	GC	 RT-qPCR	of	mouse	Zic2	3’UTR	poly(A)	site	mP0	
RA1782	 CAT	GTG	GGA	AGG	AAA	GTG	 RT-qPCR	of	mouse	Zic2	3’UTR	poly(A)	site	mP1	
RA1714	 AGT	CTC	CCT	TCT	GTT	TC	 RT-qPCR	of	mouse	and	human	ZIC2	3’UTR	poly(A)	site	mP2	
RA1715	 CAC	ATG	TAA	ACC	CAG	CT	 RT-qPCR	of	mouse	and	human	ZIC2	3’UTR	poly(A)	site	mP2	
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RA1716	 CTT	GCT	ACA	GAG	GAA	AC	 RT-qPCR	of	mouse	Zic2	3’UTR	poly(A)	site	mP3	
RA1717	 CAA	ACC	ACT	TAA	ACC	TTC	 RT-qPCR	of	mouse	Zic2	3’UTR	poly(A)	site	mP3	
RA1730	 CGT	CGA	GCC	CAG	TGT	TAC	CAC	CAA	GAA	GG	 RT-qPCR	of	mouse	Ubc	
RA1731	 CCC	CCA	TCA	CAC	CCA	AGA	ACA	AGC	ACA	AG	 RT-qPCR	of	mouse	Ubc	
Genotyping	
RA247	 GGG	AGA	AACT	CTT	TCC	AGT	GTG	AG	 Kumba	HRMA	and	ADA	genotyping	
RA248	 GCT	TCT	TCC	TGT	CGC	TGC	TG	 Kumba	HRMA	and	ADA	genotyping	
RA748	 CAC	ACA	CAC	ATT	TCT	CTG	TCC	 mNet	HRMA	genotyping	(control)	
RA749	 TAG	CTC	AGT	GCT	TGC	AAG	GTT	A	 mNet	HRMA	genotyping	(control)	
RA1058	 ATC	GGC	CTC	AGG	AAG	ATT	 mNet	HRMA	genotyping,	PiggyBac	pBB262-NCE-lacZ	genotyping,	
PiggyBac	pBB262-mNet-lacZ	genotyping	and	PiggyBac	pBB262-lacZ	
genotyping	
RA1059	 CAC	ATC	AGA	CTA	ATC	ACC	TCG	 mNet	HRMA	genotyping,	PiggyBac	pBB262-mNet-lacZ	genotyping	
RA1547	 GTG	GGC	ATA	AAC	TGT	TTC	AG	 PiggyBac	pBB262-NCE-lacZ	genotyping	
RA1548	 GCT	AGC	TGT	ACA	TCT	AGA	AC	 PiggyBac	pBB262-lacZ	genotyping	
RA1778	 GGC	ATG	AAA	AGC	AAA	ATC	TCT	CT	 Genotyping	of	CRISPR	mutant	embryos	
RA1779	 CCT	CCA	AAG	AAT	GCA	AGG	TGG	 Genotyping	of	CRISPR	mutant	embryos	
Other	
RA98	 TTT	CTC	CCA	TTC	CCT	GTT	CC	 Amplification	of	the	Zic2	3’UTR	for	3’	RACE	
RA748	 CAC	ACA	CAC	ATT	TCT	CTG	TCC	 Genomic	DNA	detection	in	mouse	RNA	samples	
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RA749	 TAG	CTC	AGT	GCT	TGC	AAG	GTT	A	 Genomic	DNA	detection	in	mouse	RNA	samples	
RA1595	 TGA	GAT	CTT	TAA	AGG	GGC	GGT	TGA	 Genomic	DNA	detection	in	human	RNA	samples	
RA1622	 GCG	TAG	TAA	ACT	TGC	AG	 Genomic	DNA	detection	in	human	RNA	samples	
RA1703	 GGC	CAC	GCG	TCG	ACT	AGT	ACT	TTT	TTT	TTT	TTT	TTT	TV	
dT-adapter	oligonucleotide	for	3’	RACE	
RA1704	 GGC	CAC	GCG	TCG	ACT	AGT	AC	 3'	RACE	PCR	oligonucleotide	for	recognition	of	RA1703	
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Figure	A2.1:	Sequence	of	the	ZIC3	3’UTR	and	putative	NCE	region.	A	putative	ZIC3	NCE	(blue)	
was	identified	within	the	ZIC3	3’UTR	by	E.	Roessler	and	M.	Muenke	(personal	communication,	
unpublished,	NIH)	 in	 the	same	bioinformatics	screen	that	 identified	the	ZIC2	NCE	 in	 the	ZIC2	
3’UTR.		
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Figure	A2.2:	Predicted	transcription	factor	binding	sites	in	the	ZIC2	3’UTR.	Pink,	mutations	that	
disappear	when	the	corresponding	SNVs	are	introduced;	yellow,	binding	sites	created	when	the	
corresponding	SNVs	are	introduced;	and	green,	binding	sites	that	remain	unchanged	in	both	the	
wildtype	and	mutated	3’UTR.	Binding	sites	were	predicted	by	ENCODE,	JASPAR	and	TRANSFAC	
(Mathelier	et	al.,	2014;	Matys	et	al.,	2006;	Rosenbloom	et	al.,	2013).	HPE-associated	SNVs	are	
annotated	in	black.		
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Figure	A3.1:	The	human	ZIC2	putative	promoter.	A	promoter	region	is	predicted	to	occur	within	
1	kb	upstream	of	the	human	ZIC2	5’UTR.	The	region	is	predicted	to	contain	multiple	CpG	islands	
(salmon	pink),	TATA	boxes	(purple)	and	transcription	start	sites	(yellow),	all	hallmarks	of	active	
promoters	 (Akan	 and	 Deloukas,	 2008;	 Antequera	 and	 Bird,	 1999).	 Blue:	 promoter	 regions	
predicted	 by	 Proscan,	 TSSG,	 TSSW	 and	 the	 UCSC	 Genome	 Browser	 (Prestridge,	 1995;	
Rosenbloom	 et	 al.,	 2015;	 Solovyev,	 2008;	 Solovyev	 and	 Salamov,	 1997;	 Solovyev	 and	
Shahmuradov,	2003).		 	
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Figure	A3.2:	Attempts	 to	clone	 the	putative	ZIC2	promoter.	Previous	attempts	by	myself	 to	
amplify	the	putative	ZIC2	promoter	for	cloning	were	unsuccessful.	As	such,	(a)	the	putative	ZIC2	
promoter	sequence	with	BglII	and	HindIII	restriction	sites	flanking	either	end	(b)	was	synthesised	
into	pUC57	 by	 Genscript.	 The	 resulting	 plasmid	 and	 pGL-DEST	were	 digested	with	BglII	 and	
HindIII	to	release	the	ZIC2	promoter	and	ccdb	resistance	fragments.	Ligation	of	the	digested	ZIC2	
promoter	 fragment	 into	 the	 digested	 pGL-DEST	 backbone	was	 attempted	 to	 create	 (c)	 pGl-
pZIC2-DEST,	however	no	successful	constructs	were	able	to	be	isolated.		 	
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Figure	A3.3:	Plasmid	maps.	(a)	pCRW-8-TOPO-NCE,	(b)	pGL-DEST	with	no	promoter,	(c)	pGL-b-
globin-DEST:	pGL-DEST	with	a	b-globin	promoter	 cloned	between	attR2	and	 luc	 via	BglII	 and	
HindIII	sites,	(d)	pGL-Hsp68-DEST:	pGL-DEST	with	a	Hsp68	promoter	cloned	between	attR2	and	
luc	 via	 BglII	 and	 HindIII	 sites,	 (e)	 pGL-pZIC3-DEST:	 pGL-DEST	 with	 a	 ZIC3	 promoter	 cloned	
between	attR2	and	luc	via	BglII	and	HindIII	sites.		 	
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Figure	A3.4:	Plasmid	maps.	(a)	pGl-WT	ZIC2	NCE	with	no	promoter,	(b)	pGl-b-globin-WT	ZIC2	
NCE	with	 a	b-globin	 promoter,	 (c)	pGl-Hsp68-WT	ZIC2	 NCE	with	 a	Hsp68	 promoter,	 (d)	pGl-
pZIC3-WT	ZIC2	NCE	with	a	ZIC3	promoter.	The	six	HPE-associated	SNVs	were	introduced	into	the	
ZIC2	NCE	in	the	pGl-pZIC3-WT	ZIC2	NCE	constructs	to	create	pGl-pZIC3-M6	ZIC2	NCE	(M1-M6).	
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Figure	A3.5:	The	addition	of	LiCl	and	V5-NOGGIN	alters	the	signalling	environment	of	HEK293T	
cells.	(a)	The	addition	of	LiCl	stimulates	WNT	signalling	in	HEK293T	cells	and	also	decreases	BMP	
and	NODAL	signalling	to	create	a	medium	NODAL,	high	BMP	and	high	WNT	environment.	(b)	
The	addition	of	V5-NOGGIN	inhibits	BMP	signalling	 in	HEK293T	cells	and	also	decreases	WNT	
signalling.	It	has	no	effect	on	NODAL	signalling,	to	create	a	low	NODAL,	mediium	BMP	and	low	
WNT	environment.	HEK293T	cells	were	 transfected	with	 the	NODAL	 reporter	 (CAGA)12,	BMP	
reporter	BRE	or	WNT	reporter	TOPFLASH,	as	well	as	V5-NOGGIN	to	inhibit	BMP	signalling,	or	an	
empty	 control	 vector	 (V5-DEST).	 Cells	 were	 cultured	 in	 DMEM	 with	 LiCl	 to	 promote	 WNT	
signalling,	or	DMEM	on	its	own	as	a	control.	Reporter	activity	was	measured	as	luminescence.	
Error	bars	=	S.E.M	of	 three	external	 repeats;	**:	p<0.01,	Student’s	T-Test.	 (c)	Representative	
BMP	signalling	experiment	and	western	blots.	A	single	representative	experiment	is	shown,	with	
error	bars	=	S.D.,	N=3	internal	repeats.	Western	blots	correspond	to	the	transfections	shown.	a-
GAPDH	blots	are	included	as	loading	controls	 	
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Figure	A3.6:	BMP	signalling	is	already	high	in	HEK293T	cells.	Constitutively	active	forms	of	the	
BMP	receptors	ALK3-HA	and	ALK6-HA	were	gifted	from	the	Miyanzono	laboratory,	University	of	
Tokyo.	HEK293T	cells	were	transfected	with	the	BMP	reporter	BRE	as	well	as	(a)	ALK3-HA	or	(b)	
ALK6-HA	to	stimulate	BMP	signalling,	or	an	empty	control	vector	(V5-DEST).	Reporter	activity	
was	measured	as	luminescence	and	fold	values	calculated	relative	to	unstimulated	cells.	Whilst	
ALK3-HA	did	generate	a	significant	fold	increase	in	BMP	signalling,	the	increase	seen	was	minor	
compared	to	that	seen	in	Nodal	signalling	when	stimulated	with	ALK4-HA,	and	WNT	signalling	
when	stimulated	with	LiCl.	 It	can	therefore	be	concluded	that	BMP	signalling	 is	already	at	 its	
peak	in	HEK293T	cells.	Error	bars	=	S.E.M	of	three	external	repeats;	*:	p<0.05,	Student’s	T-Test.		
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Figure	 A3.7:	 The	 activity	 of	 the	 ZIC3	 promoter	 (pZIC3)	 changes	 in	 different	 signalling	
environments.	HEK293T	cells	were	transfected	with	the	empty	reporter	construct	pGl-pZIC3-
DEST	(p-luc)	and:	incubated	in	(a)	LiCl	to	stimulate	WNT	signalling,	(b)	transfected	with	ALK4-HA	
to	stimulate	NODAL	signalling	or	an	empty	control	vector	(V5-DEST),	(c)	V5-NOGGIN	to	inhibit	
BMP	signalling	or	V5-DEST,	or	(d)	both	ALK4-HA	and	V5-NOGGIN	to	stimulate	a	high	NODAL/low	
BMP	environment	or	V5-DEST.	Reporter	activity	was	measured	as	luminescence	and	fold	values	
calculated	relative	to	p-luc	without	signalling	manipulation.	Error	bars	=	S.E.M	of	three	external	
repeats;	*:	p<0.05,	**:	p>0.01,	Student’s	T-test.	
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Figure	A3.8:	The	addition	of	ZIC2,	FOXA2	and	FOXJ1	alter	ZIC3	promoter	activity	 (pZIC3)	 in	
different	 signalling	 environments.	HEK293T	 cells	 were	 transfected	with	 the	 empty	 reporter	
construct	 pGl-pZIC3-DEST	 (p-luc)	 and	 (a-c)	 transfected	 with	 ALK4-HA	 to	 stimulate	 NODAL	
signalling	 or	 (d-f)	 both	 ALK4-HA	 and	 V5-NOGGIN	 to	 stimulate	 a	 high	 NODAL/low	 BMP	
environment.	Cells	were	also	transfected	with	either	(a,	d)	V5-ZIC2,	(b,	e)	V5-FOXA2,	(c,	f)	V5-
FOXJ1	or	an	empty	control	vector	(V5-DEST).	Reporter	activity	was	measured	as	luminescence	
and	fold	values	calculated	relative	to	p-luc	without	signalling	manipulation.	Error	bars	=	S.E.M	
of	three	external	repeats;	*:	p<0.05,	**:	p>0.01,	Student’s	T-test.	
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Figure	A4.1:	Location	of	RBP	binding	sites	predicted	to	occur	in	the	ZIC2	3’UTR.	Gold,	mutations	
that	disappear	when	the	corresponding	SNVs	are	introduced;	green,	binding	sites	created	when	
the	corresponding	SNVs	are	introduced;	and	blue,	binding	sites	that	remain	unchanged	in	both	
the	wildtype	and	mutated	3’UTR.	Binding	sites	were	predicted	by	RBPmap	database	(Paz	et	al.	
2014)	and	the	RBPDB	database	(Berglund	et	al.	2008).	HPE-associated	SNVs	are	annotated	 in	
black.		
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Figure	A4.2:	Location	of	miRNA	binding	sites	predicted	to	occur	in	the	ZIC2	3’UTR.	Binding	sites	
(yellow)	were	predicted	by	miRanda	(John	et	al.	2004;	Betel	et	al.	2008),	miRNASNP	(Gong	et	al.	
2015)	and	DIANA-microT-CDS	(Reczko	et	al.	2012;	Paraskevopoulou	et	al.	2013).	HPE-associated	
SNVs	are	annotated	in	black.		
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The	following	optimisation	(A4.1-4.3)	was	performed	by	Kathryn	Dickson	(Arkell	laboratory	
member)	and	has	been	replicated	from	her	Honours	Thesis	with	permission.	
	
A4.1	HEK293T	Reference	Gene	Selection	
To	 accurately	measure	 the	mRNA	decay	 levels	 of	ZIC2	 transcripts	 in	 vitro,	 it	 is	 important	 to	
optimise	 the	 RT-qPCR	 assay	 before	 quantification	 can	 begin.	 This	 requires	 the	 selection	 of	
reference	genes	that	are	expressed	in	a	similar	manner	to	ZIC2.	Reference	genes	should	have	
minimal	variation	in	expression	in	the	cell	or	tissue	type	examined	and	be	expressed	at	a	similar	
level	 to	ZIC2	 to	 ensure	 there	 is	 adequate	overlap	between	 their	 amplification	 levels.	 Similar	
dynamic	 ranges	 between	 ZIC2	 and	 reference	 genes	 will	 result	 in	 accurate	 quantification	 of	
starting	transcript	copy	numbers	from	the	same	amount	of	RNA.		
To	select	appropriate	reference	genes,	the	RefGenes	tool	on	the	Genevestigator	database	was	
utilised	(Hruz	et	al.,	2011).	Based	on	the	pool	of	public	microarray	data	available	in	RefGenes,	
four	reference	genes	were	selected	as	candidates	to	be	used	 in	the	ZIC2	mRNA	assay.	These	
genes	were	all	stably	expressed	 in	HEK	cells	within	a	similar	range	to	ZIC2,	and	all	genes	had	
previously	 been	 used	 in	 other	 RT-qPCR	 assays:	 PPP1R8,	 ABCE1,	 MAD2L2	 and	 USP39.	 The	
PrimerBank	 database	 (Spandidos	 et	 al.,	 2009)	 was	 used	 to	 select	 oligonucleotides	 for	 each	
reference	gene	that	have	been	successfully	used	by	other	researchers	in	RT-qPCR	assays.		
A4.2	Reference	Gene	Efficiency	Test	
The	performance	of	RT-qPCR	assays	can	be	assessed	via	amplification	efficiency	and	the	limit	of	
the	 dynamic	 range.	 The	 amplification	 efficiency	 of	 a	 qPCR	 assay	 can	 be	 affected	 by	 many	
variables	including	primer	design,	amplicon	size	and	the	presence	of	PCR	inhibitors	within	the	
reaction	mix.		
Before	mRNA	decay	rates	of	ZIC2	can	be	analysed,	the	RT-qPCR	protocol	and	reference	genes	
must	be	optimised.	The	efficiency	of	the	primers	chosen	to	detect	mRNA	levels	can	be	analysed	
via	the	use	of	a	standard	curve	generated	by	serial	dilutions	of	the	template.	A	well-optimised	
assay	will	 produce	 an	 efficiency	 of	 90-105%,	where	 100%	 represents	 a	 doubling	 of	 the	 PCR	
product	every	cycle	(Bustin	et	al.,	2009).	A	linear	standard	curve	with	a	regression	line	(R2)	of	
0.98	or	higher	also	indicates	an	optimised	reaction.	To	create	standard	curves	for	the	ZIC2	and	
reference	 gene	 assays,	 a	 log10	 dilution	 series	 of	 total	 RNA	 template	 (extracted	 from	
untransfected	HEK	293T	cells)	were	used,	ranging	from	100	ng	to	0.01	ng	per	reaction.	For	each	
concentration,	 the	 mean	 CT	 value	 was	 plotted	 against	 the	 log	 of	 the	 dilution	 factor.	 The	
efficiencies	of	 the	assays	were	 then	calculated	based	on	 the	 slope	of	 the	 linear	 least	 square	
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regression	line.	The	standard	curve	was	plotted	using	Microsoft	Excel	and	the	linear	regression	
and	coefficient	of	determination	(R2)	of	the	standard	curve	were	calculated	using	the	Microsoft	
Excel	LINEST	function.	The	efficiency	of	the	assay	was	calculated	from	the	slope	of	the	regression	
line	of	the	standard	curve	using	the	formula	E	=	10-1/slope.		
The	efficiencies	for	ZIC2,	ABCE1,	PPP1R8	and	USP39	were	all	found	to	be	within	the	acceptable	
range	 (Table	 2.4).	 Additionally,	 the	 high	 regressions	 (R2)	 obtained	 from	 the	 standard	 curves	
suggest	that	each	primer	set	has	a	dynamic	range	over	at	least	five	orders	of	magnitude.	Thus,	
these	sets	of	primers	are	optimised	to	measure	mRNA	levels	and	were	therefore	employed	in	
the	relative	quantification	of	ZIC2	expression.		
A4.3	DRB	cell	viability	assay		
Trypan	Blue	staining	was	used	to	assess	the	viability	of	HEK	293T	cells	treated	with	60	μM	to	300	
μM	of	the	transcriptional	inhibitor	DRB	suspended	in	DMSO.	DRB	inhibits	the	kinases	responsible	
for	phosphorylating	the	carboxy-terminal	domain	of	the	largest	RNA	Pol	II	subunit	preventing	
elongation	of	transcripts	(Bensaude,	2011).	Nonviable	cells	have	disrupted	membranes	allowing	
the	uptake	of	Trypan	Blue,	turning	the	cytoplasm	blue,	while	the	intact	membranes	of	viable	
cells	 prevents	 this,	 retaining	 a	 clear	 cytoplasm	 (Strober,	 2001).	 The	 proportion	 of	 viable	 to	
nonviable	cells	 can	be	determined	visually	based	on	 the	colour	of	 the	cells.	Cell	 suspensions	
were	 obtained	 by	 detaching	 adherent	 cells	 with	 Trypsin-EDTA	 (0.5	 g/L;	 Life	 Technologies),	
neutralized	in	an	equal	volume	of	supplemented	DMEM	as	described	in	section	2.4.1.	An	equal	
volume	 of	 Trypan	 Blue	 stain	 (0.4%	 Trypan	 Blue	 [Matheson,	 Coleman	 and	 Bell]	 in	 1	 X	 PBS	
[Amresco])	was	added	to	the	cell	suspension	and	gently	mixed.	A	10	μL	aliquot	of	the	cell/Trypan	
Blue	mix	was	loaded	onto	a	clean	haemocytometer	and	visualised	under	a	light	microscope	at	
100	 X	magnification.	 The	 number	 of	 viable	 and	 nonviable	 cells	 in	 4	 x	 1	mm2	 squares	 of	 the	
haemocytometer	grid	were	counted	and	used	to	calculate	the	proportion	of	nonviable	cells	in	
the	suspension.		
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Figure	A4.3:	Plasmid	maps.	(a)	pENTR3C-hZIC2,	(b)	pV5-ZIC2,	(c)	pGEM-3’UTR-WT,	(d)	pV5-ZIC2-
3’UTR.	
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A4.4	Validation	of	Reference	Genes	for	RT-qPCR	Studies	of	Murine	Gastrulation	
	
The	following	section	 is	taken	from	a	manuscript	being	prepared	for	submission.	Figures	and	
tables	are	located	at	the	end	of	the	section.		
	
Kristen	S.	Barratt,	Koula	Diamand,	Ruth	M.	Arkell*	
	
Introduction	
Early-mid	embryogenesis	is	a	period	of	dynamic	expression,	characterized	by	rapid	changes	in	
cell	 division,	 morphology	 and	 number.	 Pre-fertilisation	 (3.5	 dpc;	 days	 post	 coitum),	 the	
blastocyst	is	made	of	32	cells	dividing	roughly	every	12	hours.	By	the	onset	of	gastrulation	(6.5	
dpc),	the	embryo	consists	of	~900	cells.	Those	within	the	proliferative	zone	of	the	embryo	proper	
divide	approximately	every	2-3	hours	whilst	those	outside	of	this	zone	divide	every	~6.5	hours	
(Snow	 1977).	 Transcriptome	 mining	 of	 murine	 embryos	 revealed	 genes	 involved	 in	 cellular	
metabolism	and	RNA	transcription	are	upregulated	at	this	stage,	reflecting	a	requirement	for	
the	acceleration	of	 cell	 proliferation	 (Kojima	et	 al.	 2014).	 This	 rapid	 turnover	of	 cells	 can	be	
attributed	to	the	need	for	a	constant	source	of	progenitor	cells	for	germ	layer	formation	(Power	
and	 Tam	 1993),	 the	 specialisation	 of	 tissues	 within	 the	 embryo,	 and	 multiple	 signalling	
pathways,	such	as	TGFb	superfamily,	WNT	and	FGF,	working	to	establish	the	major	embryonic	
axes	and	direct	cell	movements	 in	a	spatially	and	temporally	restricted	manner	(Pfister	et	al.	
2007).	 By	 7.5	 dpc	 the	 embryo	 has	 expanded	 to	 ~15000	 cells,	 with	 the	 proliferative	 zone	
estimated	to	produce	half	of	the	existing	cells	at	this	stage	(Snow	1977).	Pluripotency	genes	are	
downregulated	whilst	WNT	pathway	and	neurulation	genes	are	upregulated	(Kojima	et	al.	2014).	
As	the	specialisation	of	organs	and	tissues	progresses,	organisms	become	vastly	heterogeneous	
and	 gene	 expression	 becomes	 compartmentalised	 and	 specific.	 As	 such,	 changes	 in	 gene	
expression	often	occur	rapidly	and	transiently	during	this	time.	For	example,	whilst	microarray	
analysis	of	murine	embryos	detected	2-4	fold	fluctuations	in	gene	expression	between	6.25	and	
9.0	dpc,	the	largest	fluctuations	were	found	to	occur	at	the	onset	of	patterning	(8.0-8.5	dpc),	
and	were	not	replicated	in	the	times	preceding	or	following	this	stage	(Mitiku	and	Baker	2007).	
By	 8.5	 dpc,	 the	 embryo	 has	 doubled	 in	 size	 compared	 to	 7.5	 dpc.	 Here,	 neurulation	 genes	
maintain	 their	 high	 level	 of	 expression,	 accompanied	 by	 enrichment	 of	 vasculogenesis	 and	
organogenesis	genes,	an	increase	in	transcript	diversity,	and	the	downregulation	of	cell	cycling	
and	 division	 genes.	 This	 stall	 in	 cell	 proliferation	 is	 attributed	 to	 cells	 committing	 to	 lineage	
specification	(Mitiku	and	Baker	2007;	Kojima	et	al.	2014),	allowing	organogenesis	to	proceed	at	
9.5	dpc.		
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It	 is	 these	vast	 fluctuations	 in	 cell	number	and	gene	expression	 that	 create	difficulties	when	
attempting	to	quantify	gene	expression	at	gastrulation.	While	whole-mount	in	situ	hybridization	
provides	spatial	gene	expression	data,	it	does	not	possess	the	ability	to	quantify	this	expression.	
Comparatively,	transcriptome	analysis	provides	temporal	gene	expression	analysis,	but	provides	
large	amounts	of	data	for	analysis	and	cannot	be	performed	without	high	cost	and	effort.	RT-
qPCR,	 however,	 affords	 the	 user	 the	 ability	 to	 quantify	 the	 small	 and	 rapid	 transcriptional	
changes	 that	 occur	 during	 gastrulation	 and	 between	 samples,	 and	 is	 frequently	 used	 as	 a	
phenotyping	tool	at	these	stages	to	detect	gene	expression	changes	in	mutant	embryos.		
	
In	RT-qPCR,	the	expression	level	of	a	target	gene	is	measured	against	the	expression	of	a	stably	
expressed	 ‘reference	 gene’	 to	minimise	 error.	 Stability	 in	 this	 context	 refers	 to	 the	 balance	
between	 the	 decay	 rate	 of	 already	 transcribed	 mRNA	 and	 the	 rate	 of	 gene	 transcription,	
resulting	in	a	steady	state	level	of	available	mRNA.	The	assumptions	made	when	choosing	stable	
reference	 genes	 are	 that	 target	 and	 reference	 genes	 are	 expressed	 at	 a	 similar	 level,	 that	
expression	of	 the	 reference	gene	will	be	consistent	between	samples	 tested,	and	 that	 it	will	
undergo	 the	 same	 errors	 as	 the	 target	 during	 cDNA	 preparation	 and	 subsequent	 analysis	
(Vandesompele	et	al.	2002;	Bustin	et	al.	2009;	Guenin	et	al.	2009;	Chapman	and	Waldenström	
2015).	 In	 reality,	 the	 expression	 of	 any	 reference	 gene	 can	 vary	 considerably	 between	
experimental	conditions	 (Guenin	et	al.	2009).	Previous	publications	have	found	that	the	best	
candidate	reference	gene	was	context	dependent	and	changed	between	the	different	tissues	
being	examined.	Additionally,	as	 reference	genes	are	considered	 ‘housekeeping	genes’,	 their	
expression	is	generally	strong,	which	can	result	in	large	discrepancies	in	transcript	abundance	
relative	to	the	target	being	analysed	(Hruz	et	al.	2011).	These	issues	are	compounded	when	you	
consider	 that	 it	 is	 total	mRNA	being	evaluated,	and	enzymatic	 reactions	 (such	as	 the	 rate	of	
reverse	transcription	or	PCR)	can	introduce	variations	that	effect	the	strength	of	the	detected	
signals.	By	not	addressing	these	factors,	significant	biases	can	be	introduced	into	an	experiment,	
resulting	 in	 incorrect	 data	 interpretation.	 As	 there	 is	 no	 ‘one	 size	 fits	 all’	 reference	 gene	 in	
experimental	data,	multiple	studies,	including	the	MIQE	guidelines	for	the	minimum	information	
for	publication	of	RT-qPCR	data,	recommend	using	two-to-three	concurrent	reference	genes	to	
validate	each	data	set	(Vandesompele	et	al.	2002;	Bustin	et	al.	2009;	Kozera	and	Rapacz	2013).	
A	 recent	study,	however,	 identified	 that	 these	guidelines	are	not	 routinely	 followed,	with	an	
average	 of	 1.23	 reference	 genes	 used	 in	 normalisation	 in	 published	 papers	 (Chapman	 and	
Waldenström	2015).	To	enable	the	informed	selection	of	reference	genes,	algorithms	such	as	
geNorm	(Vandesompele	et	al.	2002;	Mestdagh	et	al.	2009),	Bestkeeper	(Pfaffl	et	al.	2004)	and	
Normfinder	 (Andersen	 et	 al.	 2004)	 were	 created	 to	 determine	 the	 most	 stably	 expressed	
referenced	genes	that	can	then	be	used	in	quantification	of	targets.		
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Previous	 studies	by	Willems	et	al	 (2006)	and	Veazey	et	al	 (2011)	have	attempted	 to	address	
these	issues	by	recommending	stable	reference	genes	suitable	for	comparisons	of	embryonic	
and	extra-embryonic	stem	cells	(Veazey	and	Golding	2011),	or	reference	genes	that	are	stable	
from	 pre-implantation	 (3.5	 dpc),	 through	 gastrulation	 (7.5	 dpc)	 and	 patterning	 (9.5	 dpc)	 to	
organogenesis	(11.5	dpc)	(Willems	et	al.	2006).	As	the	recommendations	by	Willems	et	al	(2006)	
are	stable	over	such	a	wide	range	of	embryonic	stages,	they	may	not	be	suitable	for	specific,	
restricted	periods	of	time	such	as	gastrulation	and	patterning	(6.5-9.5	dpc).	We	therefore	set	
out	to	provide	such	recommendations.			
	
In	this	study	we	compare	the	expression	profiles	of	five	common	reference	genes	(Actb,	Gapdh,	
H2afz,	 Tbp	 and	 Ubc)	 to	 determine	 those	 that	 are	 most	 stably	 expressed	 during	 murine	
gastrulation	and	thus	are	most	suited	for	use	as	normalisation	controls	in	RT-qPCR.	To	evaluate	
the	stability	of	candidate	genes,	total	RNA	was	isolated	from	embryos	at	6.5,	7.5,	8.5	and	9.5	
dpc.	Upon	quantification,	RT-qPCR	was	used	to	measure	the	transcript	levels	of	all	five	candidate	
reference	genes.	Via	the	use	of	NormFinder,	geNorm	and	BestKeeper	algorithms,	H2afz	and	Ubc	
were	 deemed	 the	most	 stably	 expressed	 of	 the	 five	 candidates	 during	murine	 gastrulation.	
Contingent	on	this,	the	expression	of	Zic1	and	Zic2	at	gastrulation	were	normalised	against	H2afz	
and	Ubc,	with	the	resulting	expression	consistent	with	previously	published	expression	patterns.	
Our	results	suggest	that	the	careful	selection	of	stable	reference	genes	for	data	normalisation	
will	produce	a	more	accurate	quantification	of	target	transcript	levels	during	gastrulation.		
	
Methods	
Embryo	collection	and	RNA	extraction	
Wildtype	C3H/HeH	mice	were	maintained	in	a	light	cycle	of	12	h	light:	12	h	dark,	the	midpoint	
of	the	dark	cycle	being	12	A.M.	For	the	production	of	staged	embryos,	12	P.M.	on	the	day	of	the	
appearance	of	the	vaginal	plug	is	designated	0.5	dpc.	Embryos	were	collected	at	6.5,	7.5,	8.5	and	
9.5	dpc,	staged	according	to	Downs	and	Davies	(Downs	and	Davies	1993),	and	pooled	based	on	
their	age.	The	total	RNA	was	extracted	immediately	with	the	NucleoSpin®	RNA	kit	(Macherey-
Nagel)	 according	 to	 the	manufacturer’s	 instructions	 and	 quantified	 via	 nanodrop.	 Additional	
DNaseI	 treatment	 (#04716728001,	 10U,	 Roche)	 was	 performed	 to	 ensure	 no	 genomic	 DNA	
contamination	was	present.	 This	was	 confirmed	 via	 standard	PCR	with	oligonucleotides	 that	
spanned	intron	1	of	Shh	(RA#748:	CAC	ACA	CAC	ATT	TCT	CTG	TCC	and	RA#749:	TAG	CTC	AGT	
GCT	TGC	AAG	GTT	A),	whereby	no	amplification	indicated	the	samples	were	free	from	genomic	
DNA.	RNA	integrity	was	confirmed	via	agarose	gel	electrophoresis.	RNA	samples	were	stored	for	
up	to	two	weeks	maximum	at	-80°C	before	RT-qPCR	analysis.		
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Primer	design	and	RT-qPCR	analysis	
Primer	sequences	for	Actb	and	Ubc	were	obtained	from	Mamo	et	al	(2007),	whilst	sequences	
for	Gapdh,	H2afz	and	Tbp	were	obtained	from	Primer	Bank	(Wang	and	Seed	2003).	Primers	were	
selected	over	intron-exon	boundaries	whenever	possible	to	limit	genomic	DNA	amplification.		
	
One-step	RT-qPCR	was	performed	on	50	ng	of	RNA	per	sample,	using	the	SensiFAST	SYBR	Hi-
ROX	One-Step	Kit	(Bioline)	at	the	recommended	conditions.	cDNA	conversion	and	melt	curve	
analysis	were	performed	using	a	StepOnePlus™	Real-Time	PCR	System	(Applied	Biosystems®)	
and	StepOne	 software	 (version	2.2.2;	Applied	Biosystems®).	PCR	efficiencies	were	calculated	
using	the	slope	of	a	calibration	curve	as	described	in	Bustin	et	al	(2009).	For	quantification,	the	
assay	 for	each	gene	consisted	of	 three	 internal	 replicates	per	gene	per	embryo	age.	At	 least	
three	 independent	 experiments	 were	 performed	 for	 each	 RT-qPCR.	 Mean	 values	 were	
calculated	and	the	CT	value	used	for	analysis	with	Bestkeeper,	converted	into	a	logarithmic	scale	
via	the	calculation	2Cq	for	analysis	with	Normfinder	or	a	linear	scale	for	analysis	with	geNorm.	
The	relative	fold	expression	of	Zic1	and	Zic2	were	calculated	as	per	the	Livak	method	(Livak	and	
Schmittgen	2001).	
	
Results	
A	survey	of	the	literature	identified	five	commonly	used	candidate	reference	genes	in	mouse	
embryonic	studies	-	Actb,	Gapdh,	H2afz,	Tbp	and	Ubc	(Table	A4.1).	To	determine	which	of	these	
candidates	was	most	stable	during	mouse	gastrulation,	 total	RNA	was	extracted	and	purified	
from	pooled	wildtype	embryos	at	6.5,	7.5,	8.5	and	9.5	dpc	(n=3	independent	pools	per	age,	with	
n=4+	embryos	per	pool).	The	RNA	was	quantified	and	used	to	determine	both	the	efficiency	of	
the	primers	in	the	RT-qPCR	reaction,	as	well	as	the	stability	of	the	candidate	reference	genes.	
The	final	CT	values	were	analysed	for	stability	using	Normfinder,	geNorm	and	Bestkeeper.	
	
Primer	efficiency	
All	of	the	reference	gene	primer	pairs	were	tested	for	their	amplification	efficiency.	A	primer	
pair	was	considered	efficient	if	they	produced	an	R2	value	≥0.98	and,	ideally,	a	slope	value	of	-
3.32	 resulting	 in	an	efficiency	of	100%	(where	100%	represents	doubling	of	 the	PCR	product	
every	cycle).	Due	to	normal	experimental	variability,	efficiency	values	between	90-110%	were	
also	acceptable	for	the	conditions	of	this	RT-qPCR	assay.	The	efficiencies	of	the	RT-qPCR	assays	
for	Actb,	Gapdh,	Hprt,	H2afz,	Tbp,	Ubc,	Zic1	and	Zic2	were	all	found	to	be	within	the	accepted	
range	(n=3,	Table	A4.2)	and	thus	could	be	used	to	analyse	the	stability	of	the	candidate	reference	
genes.		
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Analysis	of	Reference	Gene	Stability	
Normfinder	
Mean	CT	values	for	each	reference	gene	at	each	embryonic	stage	were	used	to	calculate	an	RQ	
value,	which	could	be	analysed	with	Normfinder	(Andersen	et	al.	2004).	By	taking	into	account	
inter-	 and	 intra-	 group	 variation,	 a	 stability	 value	 is	 calculated.	 The	 most	 stably	 expressed	
candidate	gene	during	gastrulation	was	 calculated	 to	be	Gapdh	 (stability	 value	0.212)	 (Table	
A4.3).	Ubc	(0.247)	and	H2afz	(0.251)	were	comparatively	unstable	on	their	own	and	therefore	
would	not	be	good	choices	for	normalisation	of	a	target	individually.	Normfinder	does,	however,	
predict	 that	 a	 combination	 of	 both	Ubc	 and	H2afz	 (with	 a	 joint	 stability	 value	 of	 0.151)	will	
provide	 the	most	 consistent	 results	 when	 normalising	 a	 target,	 rather	 than	 using	Gapdh	 in	
conjunction	with	Ubc.		
	
geNorm	
Mean	CT	values	for	each	reference	gene	at	each	embryonic	stage	were	used	to	calculate	an	M	
value	and	CV	value	 via	 geNorm.	The	M	value	 represents	 the	average	pairwise	 variation	of	 a	
specific	gene	in	comparison	to	all	other	genes,	with	a	low	M	value	(<1)	signifying	the	most	stable	
gene	in	a	heterogeneous	sample	(Hellemans	et	al.	2007;	Guenin	et	al.	2009).	Similarly,	the	CV	
value	indicates	the	intra-assay	coefficient	of	variation,	with	a	low	number	(<0.5)	representing	
stability	(Hellemans	et	al.	2007).	Comparable	to	the	results	produced	by	Normfinder,	geNorm	
predicted	H2afz	to	be	the	most	stably	expressed	reference	gene	tested,	followed	by	Ubc	(Table	
A4.3).		
Bestkeeper	
Mean	 CT	 values	 for	 each	 reference	 gene	 at	 each	 embryonic	 stage	 were	 analysed	 with	
Bestkeeper	(Pfaffl	et	al.	2004)	and	an	R	value	generated.	The	R	value	represents	the	Pearson	
coefficient	of	correlation,	with	a	value	of	or	close	to	1	representing	a	stable	gene.	Similar	to	the	
results	obtained	by	geNorm,	Bestkeeper	determined	H2afz	to	be	the	most	stable	reference	gene	
(Table	 3).	 Gapdh	 was	 also	 determined	 to	 be	 relatively	 stable,	 followed	 by	 Ubc	 and	 Tbp.	
Comparatively,	Actb	was	considered	the	most	unstable	reference	gene	for	all	three	algorithms	
tested.	
	
As	H2afz	and	Ubc	were	predicted	to	be	the	most	stable	combination	of	genes	by	Normfinder	
with	a	joint	stability	value	of	0.151,	and	both	genes	were	ranked	1	and	2	respectively	in	GeNorm,	
and	 1	 and	 3	 respectively	 in	 Bestkeeper,	 they	were	 chosen	 as	 the	most	 stable	 of	 the	 tested	
reference	genes	to	normalise	further	gene	expression	studies	to.	It	should	be	noted	that	Gapdh	
performed	 comparatively	well	 to	Ubc,	 and	 thus	 could	 act	 as	 a	 sufficient	 substitute	 in	 future	
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analysis.	Actb	and	Tbp,	however,	were	consistently	ranked	the	least	stable	of	the	genes	tested	
and	 are	 thus	 not	 recommended	 for	 use	 in	 further	 gene	 expression	 studies	 which	 span	
gastrulation.	Taken	together,	the	data	from	all	three	algorithms	predict	Ubc	and	H2afz	as	stable	
reference	 genes	 and	 are	 therefore	 recommended	 for	 RT-qPCR	 normalisation	 during	 mouse	
gastrulation.	
	
Zic	expression	during	gastrulation	
The	 expression	 of	 the	 transcription	 factors	 Zic1	 and	 Zic2	were	 analysed	 using	 the	 reference	
genes	deemed	to	be	most	stable	during	this	period	of	time	–	Ubc	and	H2afz.	Zic2	is	known	to	be	
highly	active	during	axis	formation	and	node	development	at	6-7.5	dpc	(Elms	et	al.	2004;	Warr	
et	al.	2008),	as	well	as	neural	crest	induction	at	8-8.5	dpc	(Elms	et	al.	2003),	with	Zic2	loss-of-
function	resulting	in	congenital	malformations	such	as	Holoprosencephaly	(Brown	et	al.	2005)	
and	cardiac	defects	reminiscent	of	Heterotaxy	(Barratt	et	al.	2014).	In	comparison,	the	Zic	family	
member	Zic1	exhibits	no	detectable	expression	prior	to	8.5	dpc	(Elms	et	al.	2004).	As	neurulation	
progresses,	Zic1	is	first	reliably	detected	in	the	trunk	neural	tube	in	a	similar	pattern	to	Zic2,	with	
both	genes	later	expressed	in	the	dorsal	spinal	cord,	dorsal	cranial	neural	tube	and	the	somites	
(Nagai	 et	 al.	 1997;	 Elms	 et	 al.	 2004).	 As	 such,	 the	 comparative	 expression	 of	 Zic1	 and	 Zic2	
throughout	gastrulation	and	organogenesis	provide	an	opportunity	to	test	the	effectiveness	of	
H2afz	and	Ubc	as	stable	reference	genes.		
	
When	normalised	to	either	Ubc	or	H2afz	using	the	2-DDCT	method	(Figure	A4.4),	the	relative	fold	
expression	 of	 Zic1	 was	 relatively	 undetectable	 from	 6.5-8.5	 dpc	 and	 peaked	 at	 9.5	 dpc,	
consistent	 with	 the	 known	 expression	 pattern	 of	 Zic1	 mRNA	 during	 embryogenesis.	
Comparatively,	 the	 relative	 fold	 expression	 of	 Zic2	 was	 found	 to	 peak	 at	 6.5	 dpc	 when	
normalised	to	either	reference	gene,	demonstrating	a	gradual	decrease	in	expression	by	9.5	dpc.	
This	reduction	in	expression	levels	is	presumably	due	to	changes	in	the	ratio	of	Zic2	expressing	
tissue	compared	non-Zic2	expressing	tissues	at	these	later	stages.	Whilst	Zic2	expression	at	6.5	
dpc	 encompasses	 the	majority	 of	 the	 embryo	 (being	 expressed	 in	 the	 extra	 embryonic	 and	
embryonic	 ectoderm	 of	 the	 egg	 cylinder	 [Elms	 et	 al.	 2004]),	 by	 9.5	 dpc	 expression	 is	 tissue	
specific	and	restricted	to	only	the	dorsal	portion	of	the	embryo.		
	
Discussion	
The	selection	of	a	reference	gene	that	is	stable	throughout	the	tissues	and	time	periods	being	
examined	 is	 critical	 for	 correct	 RT-qPCR	 analysis.	 Additionally,	 the	 use	 of	multiple	 reference	
genes	to	analyse	the	same	data	is	essential	to	prevent	misinterpretation	of	result.	The	dynamic	
changes	that	occur	in	embryonic	tissues	during	development	pose	a	particular	challenge	when	
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attempting	 to	 analyse	 gene	 expression	 at	 specific	 stages.	 In	 this	 study,	 we	 evaluated	 and	
compared	the	stability	of	 five	candidate	 reference	genes	during	gastrulation	 (6.5	dpc)	 to	 the	
start	of	organogenesis	(9.5	dpc)	via	the	use	of	RT-qPCR	in	combination	with	the	statistical	tools	
geNorm,	Normfinder	and	Bestkeeper.	Past	studies	have	found	that	there	is	no	large	difference	
between	the	output	rankings	between	each	algorithm	(Willems	et	al.	2006;	De	Spiegelaere	et	
al.	2015).	A	similar	result	was	found	in	this	study,	with	Ubc	and	H2afz	consistently	performing	
better	when	analysed	for	stability	with	each	tool.	Gapdh	was	also	considered	stable	by	two	of	
the	three	analysis	tools	utilised,	and	therefore	remains	a	viable	candidate	when	analysing	gene	
expression	at	gastrulation.			
	
Previous	analysis	of	stable	 reference	genes	spanning	3.5-9.5	dpc	by	Willems	et.	al.	 identified	
Actb	and	Tbp	as	the	most	stably	expressed	reference	genes	(Willems	et	al.	2006).	This	result	
contrasts	with	our	analysis	presented	here,	where	Actb	and	Tbp	consistently	ranked	the	least	
stable	 in	 each	 of	 the	 three	 algorithms	 used.	 This	 difference	 in	 recommendation	 from	 both	
studies	 can	 presumably	 be	 attributed	 to	 the	 wider	 range	 of	 embryonic	 stages	 covered	 by	
Willems	et	al,	suggesting	that	whilst	Actb	and	Tbp	are	stable	when	comparing	large	changes	in	
embryonic	development	 stage,	 they	are	not	 stably	expressed	during	 the	 restricted	period	of	
gastrulation.	The	contrasting	results	presented	here,	and	those	contrasting	results	achieved	by	
other	studies	(Meller	et	al.	2005;	Zhang	et	al.	2005;	Hruz	et	al.	2011),	reflect	the	importance	of	
ensuring	 the	reference	genes	used	 in	a	study	are	suitable	 to	 the	tissue	stage	and	type	being	
examined.	
	
Following	the	selection	of	Ubc	and	H2afz	as	stable	reference	genes,	their	validity	was	tested	via	
the	relative	quantification	of	Zic1	and	Zic2	expression	at	gastrulation	and	early	organogenesis.	
The	results	achieved	in	this	paper	correlate	with	the	known	expression	profiles	of	both	genes	
during	this	time	period,	and	past	published	RT-PCR	results	(Elms	et	al.	2004;	Houtmeyers	et	al.	
2013)	whereby	Zic2	expression	remains	high	throughout	gastrulation	whilst	Zic1	expression	is	
relatively	undetectable	until	cranial	neural	crest	development	at	8.5	dpc.	
	
As	 technologies	 progress	 and	 large-scale	 data	 analysis	 becomes	 the	 norm,	 stable	 reference	
genes	are	routinely	being	selected	from	within	microarray	experiments.	These	reference	genes	
routinely	perform	better	than	those	selected	from	external	RT-qPCR	studies,	owing	to	the	fact	
that	the	microarray	reference	genes	are	already	exposed	to	the	same	conditions	as	the	genes	
being	targeted	for	quantification.	Errors	still	exist	in	these	methods,	however,	with	probe	choice	
remaining	an	issue	due	to	incomplete	hybridization	and	non-specific	binding	(Hruz	et	al.	2011).	
Though	some	databases	have	complied	this	microarray	data	for	aid	in	reference	gene	selection,	
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they	 still	 do	 not	 currently	 have	 the	 specificity	 to	 identify	 stable	 genes	 spanning	 murine	
gastrulation	time	points,	despite	having	over	50,000	experimentally	validated	microarray	entries	
(Hruz	et	al.	2011).	Similarly,	whilst	new	tools	such	as	iTranscriptome	can	be	used	to	establish	
whether	a	candidate	reference	gene	is	expressed	in	high	levels	in	a	7.0	dpc	mouse	embryo	(for	
example,	H2afz	is	expressed	ten-fold	higher	than	Ubc	at	this	stage)	via	a	digital	WMISH	(Peng	et	
al.	2016),	it	cannot	yet	provide	information	about	the	expression	of	candidates	across	a	range	
of	 time	 points.	 Until	 such	 time	 as	 these	 technologies	 progress,	 the	 evaluation	 of	 candidate	
reference	genes	via	stability	assays	are	essential	before	target	RT-qPCR	quantification	can	occur.		
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Table	A4.1:	Description	of	the	six	candidate	reference	genes	analysed.	
	
Symbol	 Name	 Reference	Sequence	
Actb	 Beta-actin	 NM_007393	
Gapdh	 Glyceraldehyde-3-phosphate	dehydrogenase	 GU214026	
H2afz	 H2A	histone	family,	member	Z	 NM_016750	
Tbp	 TATA	box	binding	protein	 U63933	
Ubc	 Ubiquitin	 NM_019639	
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Table	A4.2:	Primer	sequences	and	their	mean	RT-qPCR	efficiencies	(n=3).	An	efficiency	of	100%	represents	doubling	of	the	PCR	product	every	cycle.	A	primer	
pair	was	considered	efficient	if	R2	value	≥0.98	and	an	efficiency	value	between	90-110%.
Gene	 	 Primer	sequence	(5’	–	3’)	 Primer	location	 Product	size	(bp)	 Slope	 R2	 Efficiency	
Actb	 F	 ATG	AGC	TGC	CTG	ACG	GCC	AGG	TCA	TC	 Exon	3	 192	 -3.34	 0.99	 99.17%	
R	 TGG	TAC	CAC	CAG	ACA	GCA	CTG	TGT	TG	 Exon	4	
Gapdh	 F	 TGA	CGT	GCC	GCC	TGG	AGA	AA	 Exon	4	 98	 -3.28	 0.99	 101.81%	
R	 AGT	GTA	GCC	CAA	GAT	GCC	CTT	CAG	 Exon	5	
H2afz	 F	 GCG	CAG	CCA	TCC	TGG	AGT	A	 Exon	3	 202	 -3.30	 0.99	 101.00%	
R	 CCG	ATC	AGC	GAT	TTG	TGG	A	 Exon	5	
Tbp	 F	 GAA	GAA	CAA	TCC	AGA	CTA	GCA	GCA	 Exon	5	 128	 -3.36	 0.99	 98.29%	
R	 CTT	ATG	GGG	AAC	TTC	ACA	TCA	CAG	 Exon	5	
Ubc	 F	 CGT	CGA	GCC	CAG	TGT	TAC	CAC	CAA	GAA	GG	 Exon	1	 112	 -3.33	 0.99	 99.47%	
R	 CCC	CCA	TCA	CAC	CCA	AGA	ACA	AGC	ACA	AG	 Exon	1	
Zic2	 F	 TCG	TTG	CGG	AAG	CAC	ATG	AA	 Exon	2	 178	 -3.27	 0.98	 102.34%	
R	 ACA	GGT	TGG	AGC	TGC	TTT	GT	 Exon	3	
Zic1	 F	 GCA	AGA	TGT	GCG	ATA	AGT	CC	 Exon	2	 159	 -3.28	 0.99	 101.84%	
R	 GGT	TGT	CTG	TTG	TGG	GAG	AC	 Exon	3	
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Table	A4.3:	Stability	ranking	of	the	five	candidate	reference	genes	using	Normfinder,	geNorm	
and	 Bestkeeper.	 For	 Normfinder,	 a	 low	 stability	 value	 indicates	 a	 stably	 expressed	 gene	
(Andersen	et	al.,	2004),	whilst	for	Bestkeeper,	a	ranking	close	or	equal	to	1	indicates	the	most	
stable	 gene	 (Pfaffl	 et	 al.,	 2004).	 For	 geNorm,	 M	 value	 of	 <1	 and	 a	 CV	 value	 of	 <0.5	 is	
recommended	for	heterogeneous	samples	(Hellemans	et	al.,	2007).	
	
Stability	
Ranking	
Normfinder	 geNorm	 Bestkeeper	
Gene	 Stability	
Value	
Gene	 M	value	 CV	
value		
Gene	 R	Value	
1	 Gapdh	 0.212	 H2afz	 0.540	 0.095	 H2afz	 0.999	
2	 Ubc*	 0.247	 Ubc	 0.674	 0.247	 Gapdh	 0.986	
3	 H2afz*	 0.251	 Gapdh	 0.770	 0.311	 Ubc	 0.775	
4	 Tbp	 0.254	 Tbp	 0.812	 0.351	 Tbp	 0.773	
5	 Actb	 0.403	 Actb	 0.832	 0.374	 Actb	 0.520	
*	Whilst	Gapdh	is	calculated	to	be	the	most	individual	stable	gene	by	Normfinder,	Ubc	and	H2afz	
are	recommended	as	the	best	combination	of	two	genes	with	a	joint	stability	value	of	0.151.	
	
	
	
	
	
	
	
Figure	A4.4:	Relative	Zic1	and	Zic2	expression	during	murine	gastrulation,	normalised	to	Ubc	
and	H2afz.	Expression	was	calculated	using	the	2-DDCT	method.			 	
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A4.5	Identification	of	PAS	oligonucleotide	non-specific	targets		
Whilst	the	addition	of	betaine	into	the	RT-qPCR	amplification	reactions	reduces	the	likelihood	
of	 primer	 dimers	 forming,	 it	 does	 not	 discount	 non-specific	 off-target	 amplification.	 Primer-
BLAST	was	utilised	to	check	for	off-target	oligonucleotide	binding	for	P2	oligonucleotides	(Ye	et	
al.,	 2012).	 The	 ten	 most	 likely	 off-target	 amplicons	 are	 listed	 in	 Table	 A4.4.	 Of	 the	 ten	
possibilities,	the	first	is	the	Zic2	3’UTR,	confirming	that	the	oligonucleotide	pair	is	targeting	this	
mRNA.	The	remaining	nine	all	require	>2	nucleotide	mismatches	between	each	oligonucleotide	
and	the	target	DNA	for	amplification	to	take	place.	Four	of	the	non-specific	targets	are	unlikely	
to	be	efficiently	amplified	due	to	an	amplicon	length	of	>500	nt.	Additionally,	amplification	of	
each	non-specific	target	is	unlikely	as	at	least	one	nucleotide	mismatch	occurs	within	the	five	
most	3’	nucleotides	 for	each	 target.	 It	 is	well	 documented	 that	mismatches	 in	 the	3’	 end	of	
oligonucleotides	affect	target	amplification	significantly	more	than	mismatches	 in	the	5’	end.	
Whilst	two	nucleotide	mismatches	have	been	shown	to	prevent	amplification	at	the	3’	end,	a	
single	nucleotide	mismatch	will	 result	 in	reduced	amplification	efficiency	 (Stadhouders	et	al.,	
2010;	Ye	et	al.,	2012).	As	such,	it	is	possible	that	the	increase	that	is	seen	at	P2	could	be	due	to	
off-target	 amplification.	 It	 should	 be	 noted,	 however,	 that	 each	 Zic2	 3’UTR	 poly(A)	
oligonucleotide	pair	 is	predicted	 to	produce	multiple	off-target	amplicons	when	 run	 through	
Primer-BLAST.				
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Table	A4.4:	P2	oligonucleotide	off-target	amplicons.	Off-target	amplicons	were	predicted	from	
Primer-BLAST	(Ye	et	al.	2012).	3’	end	mismatch:	a	mismatch	occurs	between	the	oligonucleotide	
and	at	 least	one	of	 five	most	3’nucleotides	 in	 the	 template.	*:	 amplicon	 size	 is	 too	 large	 for	
efficient	amplification	under	the	RT-qPCR	conditions	used.		
Gene	 Amplicon	
length	(bp)	
Forward	 primer	
mismatches	
Forward	 primer	
mismatches	
3’	 end	
mismatch	
Zic2	 101	 0	 0	 0/0	
Pcca,	 transcript	
variant	X1	
2438*	 3	 2	 1/1	
Clstn3		 2222*	 4	 2	 1/0	
Tnrc6a,	transcript	
variant	X15	
104	 3	 3	 1/1	
Adgre5,	
transcript	 variant	
X3	
169	 3	 4	 1/0	
113	 4	 5	 0/1	
Cacna1c	 832*	 3	 4	 1/0	
Slc35d1	 212	 4	 3	 1/0	
Htr4	 364	 3	 4	 1/1	
Slc8a3	 3724*	 4	 3	 1/1	
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Appendix	A5 	
	
Figure	A5.1:	ZIC2	NCE-GFP	 transgenic	 zebrafish	 exhibited	 inconsistent	 reporter	 expression.	
Analysis	of	wildtype	(WT)	and	mutant	(MUT1-6)	zebrafish	expressing	GFP	under	the	control	of	
the	ZIC2	NCE.	Expression	of	GFP	in	founder	lines	(MM)	created	with	the	same	3’UTR	constructs	
was	inconsistent;	therefore,	no	definitive	expression	pattern	could	be	discerned.	Photos	were	
provided	by	S.K.	Hong,	E.	Roessler	and	M.	Muenke	at	the	NHGRI,	NIH	(Maryland,	USA).		
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Figure	A5.2:	 Plasmid	maps.	 (a)	pBB232,	 (b)	pBB256,	 (c)	pBB259,	 (d)	pBB262.	 cHS4:	 Chicken	
insulator	 fragments;	 MCS:	 multiple	 coning	 site;	 ITR:	 inverted	 terminal	 repeats;	 ORF:	 open	
reading	frame.		
	 	
	314	
	
Figure	A5.3:	Plasmid	maps.	(a)	pCRW-8-TOPO-NCE,	(b)	pBB262	with	XbaI	and	XhoI	restriction	
sites	annotated,	(c)	pBB262-NCE	with	NotI	and	XhoI	restriction	sites	annotated,	(d)	p1229	with	
NotI	 and	 XhoI	 restriction	 sites	 annotated,	 (e)	 pBB262-NCE-lacZ,	 (f)	 pBB262-lacZ	 (negative	
control).	(g)	pBSK-mNet-lacZ,	(h)	pBB262-mNet-lacZ	(positive	control).	cHS4:	Chicken	insulator	
fragments;	MCS:	multiple	coning	site;	ITR:	inverted	terminal	repeats;	ORF:	open	reading	frame.		
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Figure	 A5.4:	 lacZ	 expression	 is	 detected	 Sox10	 embryos.	 (a)	 Sox10+/+	 and	 (b)	 Sox10(lacZ/+)	
embryos	 at	 14.5	 dpc;	 anterior	 is	 to	 the	 left.	 Sox10	 embryos	 were	 used	 to	 batch	 test	 X-Gal	
solution.		
	
	
	
	
Figure	A5.5:	lacZ	expression	in	Tn(pb-pBB262-NCE-lacZ)Ark/+	pBB262-NCE	embryos.	(a-c)	Tn(pb-pBB262-NCE-
lacZ)Ark/+	 with	 varying	 lacZ	 expression	 patterns.	 Expression	 patterns	 were	 inconsistent	 and	
unreplicable	amongst	lacZ	positive	embryos.	Photographs	taken	by	Gene	Elliot,	NIH	transgenic	
Core	Facility	(Maryland,	USA).		
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Figure	A5.6:	CRISPR	guide	plasmid	maps.	(a)	pCR-Blunt	II-TOPO-G2	(b)	pCR-Blunt	II-TOPO-G3.		
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